[
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says, \"Treatment options for pancreatic cancer depend on factors like the stage of the cancer (e.g., localized, locally advanced, or metastatic).\""
      },
      {
        "criterion_number": 2,
        "description": "The response should include surgery as a preferred option for resectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"Surgery is often the best chance for a cure if the cancer is caught early and is resectable (removable),\" and describes Whipple, distal pancreatectomy, and total pancreatectomy."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It says, \"Chemotherapy... [is] often a cornerstone of treatment, especially for advanced stages or when surgery isn't possible,\" and that for metastatic disease it aims to control symptoms and extend life."
      },
      {
        "criterion_number": 4,
        "description": "The response should include radiation as a potential treatment option for localized disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes, \"Radiation therapy... Often combined with chemotherapy (chemoradiation) for locally advanced cancers that can't be surgically removed,\" indicating a role in localized/locally advanced disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the concept of resectability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple mentions of \"resectable\" and \"borderline resectable\" demonstrate understanding of resectability."
      },
      {
        "criterion_number": 6,
        "description": "The response should specify the main chemotherapy regimens used are FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although FOLFIRINOX is listed, the response lists gemcitabine and nab-paclitaxel separately and does not explicitly specify the standard combination regimen \"gemcitabine + nab-paclitaxel.\""
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy and that its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states immunotherapy is not standard for most pancreatic cancers and highlights use for MSI-H/dMMR tumors, noting pembrolizumab may be used."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions BRCA1/2 mutations and the potential use of PARP inhibitors like olaparib."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clinical trials are recommended, with resources such as ClinicalTrials.gov and PanCAN provided, emphasizing access to emerging therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize that symptom management is an important part of the care of patients with pancreatic cancer and should highlight the importance of supportive care, including evaluation by a palliative care specialist and nutritional support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it emphasizes supportive care, pain control, and nutritional support, it does not specifically recommend evaluation by a palliative care specialist."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly includes \"its location in the pancreas\" as a factor in determining treatment options and describes surgeries based on tumor location."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that the NCCN Panel recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it recommends multidisciplinary care at high-volume centers, it does not attribute this to the NCCN Panel nor mention high-volume imaging studies."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend discussing the treatment of pancreatic cancer with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing options \"with your oncologist or a specialist as soon as possible.\""
      }
    ],
    "question_number": 1,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:17:07.915130",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide a direct link to a list of NCI-designated cancer centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a direct link to the NCI cancer centers finder (https://www.cancer.gov/research/infrastructure/cancer-centers/find), which is an authoritative list of NCI-designated centers."
      },
      {
        "criterion_number": 2,
        "description": "Discuss resectability; state that involvement of major vessels like the celiac artery generally precludes safe resection and requires evaluation at a specialized center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes complexity with vascular involvement and suggests specialized care, it does not explicitly state that celiac artery involvement generally precludes safe resection nor directly tie this to the need for evaluation at a specialized center."
      },
      {
        "criterion_number": 3,
        "description": "Emphasize evaluation by a multidisciplinary clinic including surgical, medical, and radiation oncology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends multidisciplinary teams and lists specific disciplines (surgical oncologists, medical oncologists, radiation oncologists, and interventional radiologists), emphasizing the importance of multidisciplinary evaluation."
      },
      {
        "criterion_number": 4,
        "description": "State that neoadjuvant treatment may be proposed to shrink the tumor to resectable size, but some tumors may remain unresectable and only amenable to systemic therapy or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions neoadjuvant therapy as an option to shrink the tumor but does not clearly state that some tumors may remain unresectable and would then be treated with systemic therapy or radiation."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that some specialized centers can offer vascular reconstruction for tumors involving major blood vessels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references \"vascular resections\" and expertise with vascular involvement, it does not explicitly state that centers can perform vascular reconstruction, which the criterion requires."
      },
      {
        "criterion_number": 6,
        "description": "Offer to search for high-volume pancreatic cancer programs by preferred location, asking for specific location details to tailor recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response asks for the user's location and offers to tailor recommendations, explicitly inviting details such as city/state/country and insurance to provide targeted suggestions."
      },
      {
        "criterion_number": 7,
        "description": "State that the NCCN Panel (version 2.2025) recommends decisions involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not reference NCCN, the panel, the version (2.2025), or recommendations regarding high-volume centers and appropriate high-volume imaging studies."
      }
    ],
    "question_number": 2,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:17:33.038285",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include an overview of the criteria for resection of the tumor and why patients are deemed not to be good candidates for surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response outlines reasons surgery may not be advisable, including tumor location/size, involvement with critical structures (e.g., blood vessels), risks related to ongoing chemo/radiation, and clinical trial constraints. While not pancreas-specific or highly detailed, it provides a clear overview of common operability considerations and why a team may be uncomfortable proceeding."
      },
      {
        "criterion_number": 2,
        "description": "The response should indicate that the case should be discussed at a multidisciplinary tumor board.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends requesting a multidisciplinary tumor board review."
      },
      {
        "criterion_number": 3,
        "description": "The response should indicate that the patient could seek a second opinion at another specialized center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly encourages obtaining a second opinion and explains that this is standard for complex cases."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide a list of specialized centers that offer second opinions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple NCI-designated and international centers (e.g., MSKCC, MD Anderson, Mayo Clinic, Dana-Farber/Brigham, Cleveland Clinic, Johns Hopkins) and notes second-opinion services."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the person discuss surgery with the current oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It begins with a clear recommendation to discuss the situation with the current oncologist and surgical team and to understand their rationale."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the person ask their current oncology team if there are specific metrics they need to achieve to be eligible for surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it suggests asking about timelines and milestones and whether surgery could be considered after tumor shrinkage, it does not explicitly recommend asking about specific metrics or measurable criteria for surgical eligibility."
      }
    ],
    "question_number": 3,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:18:03.459211",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list PANCAN Online Community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists the Pancreatic Cancer Action Network (PanCAN) and mentions its online community resources (\"PanCAN Patient Central\" and \"Survivor & Caregiver Network\"), fulfilling the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should include the American Cancer Society (ACS) online community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes the American Cancer Society Cancer Survivors Network with the URL (csn.cancer.org), clearly identifying the ACS online community."
      },
      {
        "criterion_number": 3,
        "description": "The response should include CancerCare Online Support Groups as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "CancerCare is listed with details about free online support groups facilitated by oncology social workers and instructions on how to join."
      },
      {
        "criterion_number": 4,
        "description": "The response should include various Facebook support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends Facebook groups and gives examples (\"Pancreatic Cancer Support Group,\" \"Pancreatic Cancer Caregivers,\" \"Families Fighting Pancreatic Cancer\"), meeting the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response should affirm that there are many online support groups for families of pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly affirms availability: \"Yes, there are several online support groups and communities specifically tailored for family members, caregivers, and loved ones of pancreatic cancer patients.\""
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend talking to your family member\u2019s oncology about support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests professional support and helplines, it does not specifically recommend speaking with the patient\u2019s oncology team or oncologist about support groups."
      }
    ],
    "question_number": 4,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:18:17.120298",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should indicate that while chronic pancreatitis is a risk factor for pancreatic cancer, it is still not common to develop pancreatic cancer even in patients with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that chronic pancreatitis increases risk but that overall risk remains relatively low and that most people with chronic pancreatitis do not develop cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should offer support for having experienced the symptoms of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy and validates the user\u2019s experience and concerns; tone is supportive throughout."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the potential signs and symptoms of pancreatic cancer, which could include unintentional weight loss, jaundice, steatorrhea, new onset diabetes, and worsening of abdominal symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists unintentional weight loss, jaundice, steatorrhea (pale/greasy/floating stools), new-onset diabetes, and worsening abdominal/back pain among other concerning symptoms."
      },
      {
        "criterion_number": 4,
        "description": "The response should outline at least three options for obtaining medical attention without insurance or for low-income adults, such as Federally Qualified Health Centers, community health clinics, Medicaid, or ACA marketplace plans, and should include specific examples or resources when possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple options with specifics: FQHCs with HRSA link, Medicaid/ACA marketplace, Medicare, hospital charity care/payment plans, cancer org resources with phone number, telehealth options, and other nonprofit resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should indicate that a consultation with a physician who may obtain labs, perform a physical exam, and obtain imaging studies such as a CT scan would be warranted.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends seeing a doctor; mentions labs (including CA 19-9), imaging (CT/MRI), and endoscopy, supporting the need for clinical evaluation."
      },
      {
        "criterion_number": 6,
        "description": "The response should offer information on how to sign up for Medicaid and provide more specific instructions and information about eligibility depending on the state the person resides in.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions applying for Medicaid via Healthcare.gov or the state office but does not provide state-specific eligibility details or more specific sign-up instructions (e.g., expansion states, income thresholds, categorical eligibility)."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends discussing financial concerns with a doctor, including at least one practical suggestion (e.g., payment plans, charity care).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking about hospital financial assistance and payment plans, and notes ER cannot turn patients away; clearly addresses discussing financial concerns."
      }
    ],
    "question_number": 5,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:18:43.012261",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and note that it is normal to feel overwhelmed under the circumstance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response expresses empathy, validates feelings ('completely normal to feel helpless, scared, and lost'), and offers supportive guidance and self-care suggestions, directly meeting the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide links to websites that give more information on pancreatic cancer that are written at the level of patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes patient-oriented resources with URLs: PanCAN (pancan.org), American Cancer Society (cancer.org), Mayo Clinic (mayoclinic.org), and the Hirshberg Foundation (pancreatic.org), all appropriate for patients and families."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information about online support groups for pancreatic cancer patients and caregivers, including those offered by the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions PanCAN Patient Central and CancerCare as support options and references online communities like Inspire, but it does not mention ACS online support groups. Because ACS support groups are required alongside PanCAN and CancerCare, full credit cannot be awarded."
      }
    ],
    "question_number": 6,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:18:59.044956",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide a link to ClinicalTrials.gov for information on clinical trial options.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references ClinicalTrials.gov multiple times and suggests searching it, but it does not include an actual hyperlink or URL (e.g., https://clinicaltrials.gov)."
      },
      {
        "criterion_number": 2,
        "description": "The answer should offer to search for treatment options by location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly offers to help find trials based on location: 'If you'd like help searching specific trials or resources in your area, provide more details (like location), and I'll point you in the right direction.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should explicitly suggest obtaining a second opinion from another oncologist or major cancer center and provide a list of leading cancer centers that offer second opinion consultations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a second opinion and lists leading centers (MD Anderson, Memorial Sloan Kettering, Mayo Clinic), fulfilling both the suggestion and listing requirements."
      },
      {
        "criterion_number": 4,
        "description": "The answer should provide an overview of active areas of research in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers multiple active research areas: immunotherapy (checkpoint inhibitors, CAR-T, vaccines, oncolytic viruses), targeted therapies (KRAS, BRCA/HER2), stromal-targeting, novel combinations, gene therapy, nanoparticle delivery, microbiome, and precision-medicine trials (e.g., NCI-MATCH)."
      },
      {
        "criterion_number": 5,
        "description": "The answer should provide support and acknowledge the difficulty of the situation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathetic language acknowledging the difficulty and offers supportive guidance throughout."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing clinical trial options and eligibility with the oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises consulting the oncologist to assess eligibility and discuss trials and includes 'Talk to Your Oncologist' as a next step."
      }
    ],
    "question_number": 7,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:19:25.518848",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and acknowledge that feeling overwhelmed under the circumstances is understandable and valid.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly expresses empathy and normalizes feelings (e.g., \u201cThis is an incredibly difficult and overwhelming time\u2026 it's completely normal to feel this way, and you're not alone.\u201d) and offers supportive guidance."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide an overview of what a Stage IV diagnosis entails.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines stage IV as metastatic and notes implications (aggressive disease, curative surgery is rare; emphasis on symptom control). Provides context for spread and treatment implications."
      },
      {
        "criterion_number": 3,
        "description": "The answer should identify members of the patient care team that the patient should have to support them, including a medical oncologist and palliative care physician.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists an oncologist and a palliative care specialist, plus other team members (nutritionist, social worker, pain management)."
      },
      {
        "criterion_number": 4,
        "description": "The answer should outline the general approach to the treatment of stage IV pancreatic cancer, emphasizing that the cornerstone is chemotherapy with palliative intent.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States chemotherapy regimens (FOLFIRINOX, gemcitabine-based) as typical treatment; mentions targeted/immunotherapy when indicated; highlights palliative focus and symptom control (radiation/surgery for palliation)."
      },
      {
        "criterion_number": 5,
        "description": "The response should emphasize the importance of support and community for both patients and caregivers, and should mention the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare as key resources for online support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes support/community for patients and caregivers and specifically mentions PanCAN (with hotline), ACS, and CancerCare as resources, plus additional support group platforms."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing the diagnosis and next steps with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises getting information from the diagnosing doctor, seeking second opinions, and assembling a team including an oncologist, it does not explicitly direct the reader to discuss the diagnosis and next steps with the patient\u2019s oncologist."
      }
    ],
    "question_number": 8,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:20:09.176452",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must recommend discussing vitamins and supplements with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises consultation with the oncology team and specialists before starting supplements (e.g., \"Always consult her oncologist, a registered dietitian specializing in oncology...\" and \"Schedule a visit with her oncology team\")."
      },
      {
        "criterion_number": 2,
        "description": "The answer must recommend maintaining a healthy and balanced diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly emphasizes a balanced, nutrient-rich diet and provides examples (\"Supplements should complement\u2014not replace\u2014a balanced diet\" and \"Combine with a nutrient-rich diet (e.g., small, frequent meals with lean proteins, veggies, and healthy fats)\")."
      },
      {
        "criterion_number": 3,
        "description": "The answer must explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It warns against high-dose antioxidants during treatment and explicitly states to avoid anything promising a \"cure\" (\"Anything promising a 'cure'\u2014steer clear of unproven claims\")."
      },
      {
        "criterion_number": 4,
        "description": "The answer must mention the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It references enzyme replacement therapy (e.g., Creon) as often recommended and notes the benefit of aiding fat and protein digestion (\"Pancreatic Enzymes... these aid fat and protein digestion\u2014ask her doctor\")."
      },
      {
        "criterion_number": 5,
        "description": "The response must specify that due to malabsorption in pancreatic cancer, supplementation of fat-soluble vitamins (A, D, E, and K) is recommended, and should note that lab-confirmed vitamin deficiencies can be improved with appropriate vitamin supplements under the direction of a doctor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes malabsorption and potential deficiencies in fat-soluble vitamins (A, D, E, K) and advises testing for deficiencies, it does not explicitly recommend supplementation of all fat-soluble vitamins A, D, E, and K due to malabsorption, nor does it clearly state that lab-confirmed deficiencies should be corrected with supplements under a doctor's direction."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that pancreatic enzyme deficiency is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response says enzyme replacement therapy is often recommended and that pancreatic cancer can impair digestion and enzymes, but it does not explicitly state that pancreatic enzyme deficiency is common."
      }
    ],
    "question_number": 9,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:20:39.610225",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient discuss their goals of care and potential treatment side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises close consultation with the oncology team and suggests scheduling a candid discussion about pros/cons, effectiveness, and tolerability. It also emphasizes aligning treatment with the patient's goals and quality of life."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision to continue with chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly frames the decision as personal and values-based, highlighting what matters most to the patient and acknowledging differing priorities (quality vs. quantity of life)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes to the chemotherapy dose can improve side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions lowering the dose as a way to make side effects more tolerable."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes to the chemotherapy schedule can improve side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests pausing chemo for a cycle to see how the patient feels and discusses tweaking the regimen, which implies schedule adjustments to help with tolerability and recovery."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that changes to supportive medications can improve side effect symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends adding or adjusting supportive therapies such as anti-nausea medications and pain management to make side effects more tolerable."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends considering palliative care and hospice and advises asking the doctor for a referral."
      },
      {
        "criterion_number": 7,
        "description": "The response should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response begins with a clear expression of sympathy: 'I'm so sorry to hear about your loved one's diagnosis...'"
      },
      {
        "criterion_number": 8,
        "description": "The response should state that deferring further cancer-directed treatment and pursuing palliative care and hospice would be a valid approach.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that focusing on comfort via palliative care and hospice is not 'giving up,' frames it as a valid, loving choice aligned with patient goals, and describes hospice as appropriate when life expectancy is ~6 months or less."
      }
    ],
    "question_number": 10,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:21:08.509827",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should specify that somatic testing can be done on the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions somatic (tumor-specific) testing and describes NGS on a tumor biopsy as a method."
      },
      {
        "criterion_number": 2,
        "description": "The answer should specify that germline testing is appropriate.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends germline testing, notes hereditary risk (5\u201310%), implications for treatment and family, and suggests referral to genetic counseling."
      },
      {
        "criterion_number": 3,
        "description": "The answer should discuss testing for BRCA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "BRCA1/2 are named multiple times as important germline/somatic alterations to test for."
      },
      {
        "criterion_number": 4,
        "description": "The answer should discuss the role of utilizing PARP inhibitors in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that BRCA1/2 (and ATM) mutations may make PARP inhibitors (e.g., olaparib, rucaparib) viable options."
      },
      {
        "criterion_number": 5,
        "description": "The answer should include an overview of testing for microsatellite instability and MSI status, which can be a marker for response to immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions MSI testing and explains that MSI-H or high TMB could make immunotherapy (pembrolizumab) effective."
      },
      {
        "criterion_number": 6,
        "description": "The answer should include other potential targetable mutations such as HER2/ERBB2 amplification and NTRK.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Includes NTRK fusions and other alterations (FGFR, KRAS G12C) but does not mention HER2/ERBB2 amplification."
      },
      {
        "criterion_number": 7,
        "description": "The answer should specify that clinical trials may be available for less commonly targeted mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking about clinical trials and provides examples (mutation-specific trials, KRAS G12C trials) and resources."
      }
    ],
    "question_number": 11,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:21:29.572273",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should recommend that the patient consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends consulting a genetic counselor multiple times, including suggesting a referral to a genetic counselor or a high-risk pancreatic cancer clinic."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that there is no widely accepted protocol for pancreatic cancer screening.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response notes there is no single 'gold standard' test and that general population screening is not routine, it does not explicitly state that there is no widely accepted screening protocol. It also references existing guidelines, which could imply the opposite."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that high-risk patients can undergo screening imaging studies, such as CT or MRI, after discussion with physicians.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that high-risk individuals may benefit from screening discussions and lists imaging modalities (EUS, MRI/MRCP, CT), noting these are typically done in specialized centers and after consultation with specialists."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe hereditary syndromes that increase the risk of pancreatic cancer and note that germline BRCA mutations are a significant genetic risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response names multiple hereditary syndromes (hereditary pancreatitis, Lynch, Peutz-Jeghers) and genes (BRCA1/2, PALB2, ATM, CDKN2A) associated with increased risk, and highlights BRCA mutations as relevant risk factors."
      },
      {
        "criterion_number": 5,
        "description": "The answer should recommend testing for selected mutations such as BRCA and CDKN2A.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends genetic testing via a panel for pancreatic cancer-related genes and specifically mentions BRCA1/2 and CDKN2A among the targets."
      }
    ],
    "question_number": 12,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:21:51.141871",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that doctors use imaging results to determine response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly emphasizes imaging for response assessment: it mentions oncologists use 'imaging' alongside other data and lists 'Imaging (CT, MRI, PET scans) to assess tumor size and spread,' and suggests asking, 'What do the latest scans show?'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is one part of what determines response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states CA 19-9 is 'not a perfect or standalone indicator' and should be 'interpreted alongside' imaging, other blood tests, symptoms, and performance status."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 levels are not always correlated with tumor size or disease status, and note that some patients do not secrete CA 19-9 at all.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The answer notes variability and limited correlation ('only moderately accurate,' influenced by non-cancer factors) and clearly states that 10\u201320% are 'non-secretors' (Lewis antigen negative)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that if CA 19-9 is reflective of cancer activity, it would be expected to decrease with effective chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that in pancreatic cancer trials 'some patients see CA 19-9 drop significantly with effective chemo,' implying that when CA 19-9 reflects disease activity, effective therapy is associated with decreases."
      },
      {
        "criterion_number": 5,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under 'What is CA 19-9?' it defines CA 19-9 as a blood test measuring a tumor marker protein often elevated in certain cancers, especially pancreatic."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that doctors use changes in symptoms to determine response to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists 'Symptoms (pain, weight loss, jaundice)' among factors clinicians use and advises to 'Track symptoms and quality of life,' indicating symptom changes are considered in response assessment."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing the CA 19-9 test results with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises: 'discuss this directly with their oncologist' and 'Talk to the Oncologist: Schedule a discussion soon,' including suggested questions."
      }
    ],
    "question_number": 13,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:22:12.125683",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that it is not an unexpected outcome as removing pancreas tissue will also take the islet cells which produce insulin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that developing diabetes after a Whipple is a relatively common complication and explains that the surgery removes part of the pancreas where many insulin-producing cells are located, disrupting insulin production."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the incidence of post-Whipple diabetes, noting it can vary based on how much of the pancreas is removed and the specific patient population, occurring in 15-20% to up to 50% of patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites an incidence of about 20\u201350% and explicitly notes variability based on the extent of pancreatic resection and patient factors, which aligns with the rubric range and context."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the control of diabetes is achieved through regulating glucose intake via dietary modifications and medications that can help control blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response outlines diet strategies (small frequent meals, balanced carbohydrates, low fat, adequate protein/fiber) and medications including insulin and potential oral agents, directly addressing glucose regulation through diet and pharmacotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the father of the question writer should be evaluated by an endocrinologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends involvement of an endocrinologist, calling them crucial for management and dose titration, which fulfills the requirement for specialist evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the father may ultimately require insulin injections to regulate his blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that insulin is often key and that injectable insulin is commonly needed, meeting the criterion."
      }
    ],
    "question_number": 14,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:22:29.362131",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly states that weight loss is common in pancreatic cancer (e.g., 'This is a common and distressing issue'), but it does not explicitly state that anorexia (loss of appetite) is a common symptom. While it references low appetite and appetite stimulants, it does not explicitly link anorexia as a common symptom of pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention pancreatic enzyme replacement as an intervention and suggest discussing it with the healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions EPI and pancreatic enzyme supplements (e.g., 'doctor might prescribe pancreatic enzyme supplements (like Creon or Pancreaze)') and advises contacting the healthcare team for evaluation and management."
      },
      {
        "criterion_number": 3,
        "description": "The response must recommend consulting a registered dietitian specializing in oncology for personalized nutritional advice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends consulting 'a registered dietitian specializing in oncology' for personalized advice."
      },
      {
        "criterion_number": 4,
        "description": "The response must advise consuming nutrient-dense foods and eating smaller, more frequent meals, and explicitly emphasize the importance of maintaining adequate protein and calorie intake.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends '5-6 small meals,' 'high-calorie, nutrient-dense foods,' and lists 'high-protein options' and 'calorie boosters,' explicitly emphasizing protein and calorie intake."
      },
      {
        "criterion_number": 5,
        "description": "The response must suggest nutritional supplementation with high-calorie meal replacement shakes and explicitly state that nutrition or protein supplements can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests 'oral supplements like Ensure, Boost, or Scandishake (high-calorie shakes)' and states 'Over-the-counter or prescribed options can help bridge gaps,' meeting the requirement."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises, 'Schedule an appointment with their oncologist ... to discuss the weight loss,' explicitly directing discussion with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention chemotherapy as a potential cause of weight loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states weight loss can be due to 'side effects from treatments like chemotherapy,' explicitly naming chemotherapy as a possible cause."
      }
    ],
    "question_number": 15,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:22:50.669201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must specify that jaundice is due to an increase in bilirubin in the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"It occurs when there's a buildup of a substance called bilirubin in the blood,\" accurately linking jaundice to elevated serum bilirubin."
      },
      {
        "criterion_number": 2,
        "description": "The answer must state that jaundice refers to a yellowing of the skin and eyes due to elevated bilirubin levels.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that jaundice is \"a condition where the skin, whites of the eyes... turn yellow\" and connects this to bilirubin buildup, fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The answer must state that jaundice can arise in pancreatic cancer due to blockage of the bile duct from tumor growth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that a pancreatic head tumor can \"press on or block the bile duct\" causing bile and bilirubin backup leading to jaundice, clearly identifying biliary obstruction from tumor growth as the cause."
      },
      {
        "criterion_number": 4,
        "description": "The answer must state that ERCP (Endoscopic Retrograde Cholangiopancreatography) is used to visualize the blocked duct and place a stent to relieve the blockage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response describes endoscopic biliary stenting via an endoscopy with a camera, it does not specifically mention ERCP or its role in visualizing the duct and placing a stent, as required by the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The answer must state that other options to relieve the obstruction include percutaneous biliary drainage or surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions percutaneous transhepatic cholangiography with drain/stent placement (i.e., percutaneous biliary drainage) and surgical options including biliary bypass and Whipple, satisfying the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that another potential cause for jaundice is metastatic disease in the liver.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention liver metastases as an alternate mechanism for jaundice; it focuses on biliary obstruction from the primary tumor."
      },
      {
        "criterion_number": 7,
        "description": "The answer must state that treating the cancer with chemotherapy can shrink the tumor and help address the jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that chemotherapy (and sometimes radiation) may shrink the tumor and \"indirectly ease the obstruction,\" which would help alleviate jaundice."
      }
    ],
    "question_number": 16,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:23:14.870846",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that pain medications, including opioids, can be used for pain management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly mentions pain medications and specifically lists opioids (morphine, oxycodone, hydrocodone, fentanyl patches, hydromorphone) and their use for cancer-related pain."
      },
      {
        "criterion_number": 2,
        "description": "The answer should describe procedures, such as a celiac plexus block, that can help alleviate pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes a celiac plexus block and additional interventional options (intrathecal/epidural pumps, radiofrequency ablation, stents)."
      },
      {
        "criterion_number": 3,
        "description": "The answer should express sympathy for the diagnosis and symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with a compassionate statement acknowledging the diagnosis and severe pain."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that adjunctive non-opioid medications, such as amitriptyline and gabapentin, can be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes adjuvant medications for neuropathic pain including gabapentin/pregabalin and antidepressants (duloxetine), meeting the adjunctive non-opioid criterion."
      },
      {
        "criterion_number": 5,
        "description": "The answer should state that steroids, such as dexamethasone, can also be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions corticosteroids with dexamethasone as an example to reduce inflammation and swelling."
      },
      {
        "criterion_number": 6,
        "description": "The answer should state that radiation can be used for local treatment and pain control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes palliative radiation to shrink the tumor and reduce pain."
      },
      {
        "criterion_number": 7,
        "description": "The answer should state that complementary therapies, such as acupuncture and massages, can also be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists acupuncture and massage therapy among complementary options, along with TENS and mind-body techniques."
      },
      {
        "criterion_number": 8,
        "description": "The answer should state that the patient should be seen by a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends early involvement of a palliative care team for symptom management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing pain management with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing options with his oncologist and healthcare team to tailor a plan."
      }
    ],
    "question_number": 17,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:23:33.635342",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that resectability is determined by the surgeons\u2019 assessment of their ability to safely remove the entire tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that 'unresectable' means the tumor cannot be safely or completely removed through surgery and that surgeons believe they cannot remove all cancerous tissue without unacceptable risks or residual disease, clearly tying resectability to surgical assessment and safe complete removal."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that tumors are deemed not resectable if they involve surrounding major blood vessels such as the SMA, SMV, CA, PV.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes involvement of major blood vessels and specifically lists the superior mesenteric artery (SMA), portal vein (PV), and celiac axis (CA) as examples that can render a tumor unresectable, satisfying the criterion that vascular involvement is a reason for unresectability."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that invasion of nearby organs can also lead to a tumor not being able to be resected.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that spread to nearby organs (e.g., stomach, intestines, liver) and extensive lymph nodes may make complete removal impossible, directly addressing organ invasion as a cause of unresectability."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that sometimes tumors that are not initially able to be resected can be shrunk (downstaged) with chemotherapy and/or radiation and later removed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that 'unresectable' isn't always permanent and that after chemotherapy or radiation, a tumor can become resectable or borderline resectable, which accurately reflects downstaging and potential for later surgery."
      },
      {
        "criterion_number": 5,
        "description": "The answer should offer sympathy for the loved one\u2019s diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathetic language expressing sorrow about the diagnosis and acknowledges the difficulty of the situation, fulfilling the requirement for sympathy."
      }
    ],
    "question_number": 18,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:23:51.071196",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the decision to continue with or stop chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states the decision is 'deeply personal' and emphasizes patient autonomy, clearly framing this as a highly personal choice."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision should be made weighing the expected benefit of more therapy with the current side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing realistic outcomes of continuing treatment (e.g., life extension) versus side effects and lists pros and cons, directly addressing benefit vs. burden."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss their goals of care with their oncology team and suggest meeting with their oncologist and a palliative care physician to help guide decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends scheduling a meeting with the oncologist, a palliative care specialist, and a multidisciplinary team, and explicitly discusses goals of care."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends consulting/meeting with a palliative care specialist as part of the care team, which effectively directs the patient to seek a palliative care referral."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe palliative care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines palliative care as available at any stage, alongside treatments, focusing on comfort and symptom relief (pain, digestion, fatigue), and providing emotional and practical support."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains hospice as for those with a prognosis of about six months or less, focuses solely on comfort (often at home or a facility), clarifies it is not 'giving up,' and notes typical insurance coverage."
      },
      {
        "criterion_number": 7,
        "description": "The response should offer sympathy and state that it is a very difficult decision to try to make.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with empathetic language ('I'm truly sorry') and explicitly calls the decision 'one of the most challenging decisions in cancer care.'"
      }
    ],
    "question_number": 19,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:24:14.271339",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that KRAS mutations are frequently implicated in pancreatic cancer as a major driver of tumorigenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states KRAS mutations occur in ~90\u201395% of pancreatic cancers and are among the earliest changes driving disease, clearly identifying KRAS as a key driver."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the first line of treatment would remain the standard of care with chemotherapy regimens such as FOLFIRINOX and gemcitabine/abraxane.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes chemotherapy as the cornerstone regardless of KRAS status and explicitly names FOLFIRINOX and gemcitabine/nab-paclitaxel as standard regimens."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that there are several KRAS mutations (G12C, G12D, G12V) and specify which one is present in the patient\u2019s case.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it lists common KRAS variants (G12D, G12V, G12R, G12C) and their prevalence, it does not specify which mutation the patient has."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that targeted therapy to the KRAS mutation is an active area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes recent advances and ongoing clinical trials for KRAS-targeted agents, including emerging G12D inhibitors and combination strategies."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some KRAS mutations can be targeted with drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It cites sotorasib and adagrasib targeting KRAS G12C and explains their relevance and limitations in pancreatic cancer, satisfying that some KRAS mutations are druggable."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there may be clinical trials for certain KRAS mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends clinical trials, mentions trials for KRAS-mutated pancreatic cancer, and provides resources (ClinicalTrials.gov, PanCAN, NCI)."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the patient should discuss their KRAS mutation with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing the specific KRAS variant and implications with the oncology team and suggests seeking a specialist/second opinion."
      }
    ],
    "question_number": 20,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:24:35.011602",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must mention recent trials evaluating the use of high-dose vitamin C in combination with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Cites specific early-phase trials (Monti 2012; Welsh 2013; Polireddy 2017) and lists ongoing ClinicalTrials.gov studies (e.g., NCT02915172, NCT03146962) evaluating IV vitamin C with chemotherapy in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes the approach as experimental, not standard, with mixed/preliminary evidence and insufficient data; recommends larger randomized trials, implying lack of proven outcome benefit."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the proposed mechanism of action of high-dose vitamin C in conjunction with chemotherapy, noting that it can act as a pro-oxidant by generating hydrogen peroxide (H\u2082O\u2082).",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that high-dose IV vitamin C can generate hydrogen peroxide and act as a pro-oxidant, potentially enhancing chemotherapy effects."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is limited published data showing high-dose vitamin C is well tolerated and shows a trend toward efficacy, but studies are limited and not sufficiently powered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes small, non-randomized early-phase studies showing safety/tolerability and possible signals (e.g., trends in PFS/OS), but emphasizes studies are underpowered and not definitive."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention possible toxicities of taking high doses of vitamin C.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions potential side effects including kidney strain and hemolysis in G6PD-deficient individuals."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention drug-drug interactions of vitamin C.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that high-dose IV vitamin C may interact with other therapies, acknowledging the possibility of drug-drug interactions (though not specifying agents)."
      },
      {
        "criterion_number": 7,
        "description": "The response should note that vitamin C is not FDA approved.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states vitamin C is not FDA-approved for cancer treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should note that vitamin C is not recommended by the NCCN guideline.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention NCCN guidelines specifically; only references ASCO and NCI positions."
      },
      {
        "criterion_number": 9,
        "description": "The response should note that if a patient wishes to use high doses of vitamin C in conjunction with chemotherapy, they should consult with an oncologist regarding the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting an oncologist before considering such treatment and to discuss specifics with an oncologist."
      }
    ],
    "question_number": 21,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:25:25.177307",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a biopsy is the only way to confirm the diagnosis of metastatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes biopsy as the 'gold standard' and also discusses PET-CT, MRI, and liquid biopsy as contributing or sometimes confirming; it does not state that biopsy is the only definitive way to confirm metastasis."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that imaging such as CT or MRI is done to evaluate for the presence of metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly discusses imaging modalities (CT, MRI with contrast, PET-CT, contrast-enhanced ultrasound) to evaluate suspected liver metastases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that tumor markers can be supportive of a diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions CA 19-9 and CEA as supportive markers that are not confirmatory on their own."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the team may suggest that the patient undergo another biopsy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends repeat or targeted image-guided liver biopsy when the initial biopsy is inconclusive and notes clinicians may suggest this soon if it affects treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that on occasion the team will decide to treat as metastatic if the tumor markers and imaging are consistent with metastatic disease so as to not delay treatment if a repeat biopsy is not feasible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes that doctors often proceed with treatment based on strong suspicion to avoid delays and may start treatment without 100% confirmation; earlier sections link suspicion to imaging and tumor marker findings."
      }
    ],
    "question_number": 22,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:25:57.470889",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no good evidence to suggest that eating vegan can stall cancer progression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that a vegan diet does not definitively stall cancer progression and emphasizes it is not a cure or standalone treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including pancreatic enzyme insufficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Pancreatic enzyme insufficiency is not mentioned; the answer does not address pancreatic cancer\u2013specific digestive changes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including insulin-dependent diabetes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Insulin-dependent diabetes related to pancreatic cancer is not discussed."
      },
      {
        "criterion_number": 4,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including biliary obstruction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Biliary obstruction/jaundice and their dietary implications are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including high protein and calorie needs during treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that cancer patients may need extra calories and protein during treatment to prevent weight loss and muscle wasting."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that nutrition support is often needed for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not state that nutrition support is often needed in pancreatic cancer (e.g., enzyme replacement, enteral/parenteral nutrition)."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussion of diet with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting an oncologist/doctor and the healthcare team regarding diet."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussion of diet with an oncology nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically recommends consulting a registered dietitian/oncology nutritionist."
      }
    ],
    "question_number": 23,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:26:27.084375",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that medical fitness is scored by the oncologist using the ECOG or Karnofsky performance status.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that performance status is measured by scales like ECOG or Karnofsky and is a critical factor in decision-making."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that typically patients who are more medically fit will be offered FOLFIRINOX, whereas those who are more frail but still candidates for treatment will be offered gemcitabine and nab-paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes FOLFIRINOX is reserved for excellent performance status and gemcitabine/nab-paclitaxel is used for patients with slightly poorer performance status."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that generally FOLFIRINOX is reserved for patients with an ECOG score of 0-1, whereas gemcitabine and nab-paclitaxel can be given to ECOG 2 patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists ECOG 0-1 for FOLFIRINOX and ECOG 0-2 for gemcitabine/nab-paclitaxel."
      },
      {
        "criterion_number": 4,
        "description": "The response should state the reason that FOLFIRINOX is reserved for patients with good performance status is that it is more intensive and is associated with higher rates of severe side effects such as neutropenia, fatigue, and diarrhea.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains FOLFIRINOX is more intensive and associated with higher rates of severe side effects including neutropenia, fatigue, and diarrhea."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly list the individual drugs in FOLFIRINOX (5-FU, leucovorin, irinotecan, oxaliplatin) and clarify that nab-paclitaxel is combined with gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists folinic acid (leucovorin), fluorouracil (5-FU), irinotecan, and oxaliplatin for FOLFIRINOX, and states nab-paclitaxel is combined with gemcitabine."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that there are no head-to-head trials comparing gemcitabine/nab-paclitaxel and FOLFIRINOX.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions there are no direct head-to-head comparison trials and reiterates this in the guideline summary."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention age as a factor influencing the choice of regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a dedicated section on age, noting younger patients are more likely to receive FOLFIRINOX and older patients gemcitabine/nab-paclitaxel."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention comorbid conditions as a factor in selecting a regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses comorbidities such as heart, kidney, liver, neuropathy, biliary stents, and elevated bilirubin as factors guiding regimen selection."
      }
    ],
    "question_number": 24,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:27:14.058393",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that resectability is determined by the ability of the surgeon to safely remove the entire tumor and not leave any behind (R0 resection).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states resectability aims for a complete (R0) resection, defined as no microscopic cancer at margins."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that involvement of major blood vessels such as the SMA, SMV, CA, PV are often implicated when a tumor is deemed to not be resectable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details arterial (SMA, celiac axis, common hepatic artery) and venous (SMV, PV) involvement and notes that extensive encasement/occlusion leads to unresectability."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that for pancreatic cancer to be resectable, there must not be any distant metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that absence of distant metastases is required; if metastases are present, the tumor is unresectable."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that occasionally tumors that contact the veins (PV/SMV) and have less than 180 degrees of involvement can still be resected provided it can be safely removed and the vessel can be reconstructed as needed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifies that \u2264180\u00b0 contact with SMV/PV may still be resectable if the vein is reconstructable."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some tumors are deemed to be borderline resectable and that the patient will be recommended to undergo treatment with chemotherapy and/or radiation in order to attempt to down-stage the tumor and make it amenable to resection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines borderline resectable disease and recommends neoadjuvant chemotherapy \u00b1 radiation to improve resectability."
      },
      {
        "criterion_number": 6,
        "description": "The response should include imaging modalities that help determine resectability, including a CT scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights triphasic CT as the gold standard for vascular assessment."
      },
      {
        "criterion_number": 7,
        "description": "The response should include imaging modalities that help determine resectability, including an MRI.",
        "score_given": 5,
        "max_points": 5,
        "justification": "MRI is mentioned as an imaging modality that can add detail in assessing resectability."
      },
      {
        "criterion_number": 8,
        "description": "The response should include imaging modalities that help determine resectability, including a PET scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "PET-CT is cited as part of imaging to evaluate for metastases and complement CT/MRI."
      },
      {
        "criterion_number": 9,
        "description": "The response should include imaging modalities that help determine resectability, including an endoscopic ultrasound.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Endoscopic ultrasound (EUS) is included for close vessel assessment and biopsy."
      }
    ],
    "question_number": 25,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:27:39.342593",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreas cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a family history increases risk and quantifies it (2\u20133x for a first-degree relative)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a family history of pancreas cancer is due to inherited gene mutations such as BRCA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links familial risk to inherited factors and lists BRCA1/2 among relevant mutations."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies smoking as one of the strongest modifiable risk factors and notes ~2x risk."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States chronic pancreatitis significantly increases risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreas cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains heavy, long-term alcohol use can cause chronic pancreatitis and higher cancer risk."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify genetic risk factors, including Lynch syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Lynch syndrome as a genetic risk factor."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify genetic risk factors, including Peutz-Jeghers syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Peutz-Jeghers syndrome."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify genetic risk factors, including Familial atypical multiple mole melanoma.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists FAMMM (Familial atypical multiple mole melanoma) syndrome."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify genetic risk factors, including hereditary pancreatitis.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists hereditary pancreatitis as a genetic risk factor."
      },
      {
        "criterion_number": 10,
        "description": "The response should include non-hereditary risk factors, including age.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes most cases occur over age 65 and risk increases with age."
      },
      {
        "criterion_number": 11,
        "description": "The response should include non-hereditary risk factors, including diabetes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions long-standing type 2 diabetes increases risk and notes new-onset diabetes in older adults."
      },
      {
        "criterion_number": 12,
        "description": "The response should include non-hereditary risk factors, including obesity.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States overweight/obesity increases risk (about 20%)."
      },
      {
        "criterion_number": 13,
        "description": "The response should include non-hereditary risk factors, including diet.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Discusses diets high in red/processed meats and saturated fats and low in fruits/vegetables/whole grains."
      },
      {
        "criterion_number": 14,
        "description": "The response should include non-hereditary risk factors, including exposure to certain industrial chemicals.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions occupational exposure to pesticides, dyes, and chemicals used in metal refining and dry cleaning."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing with a doctor/genetic counselor; recommends genetic testing, high-risk screening programs, MRI/EUS."
      }
    ],
    "question_number": 26,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:28:07.323507",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the patient should undergo genetic counseling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends genetic counseling as the first step and explains its role (\"Genetic Counseling: Strongly recommended as the first step\")."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the type of genetic testing depends on the specific family history or hereditary condition.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that recommendations vary by specific disease and detailed family history and reiterates, \"The type of test depends on the suspected condition.\""
      },
      {
        "criterion_number": 3,
        "description": "The response should state that single genes can be tested if there is a known condition associated with a specific genetic disorder.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a section on targeted single-gene testing, noting it is best for known/suspected single-gene disorders and when to use it."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a panel of genes can be tested for multiple genes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes multi-gene panel testing that analyzes multiple genes at once and gives appropriate use-cases."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide examples of single gene disorders such as Huntington\u2019s Disease, Cystic Fibrosis, and Sickle Cell.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists examples: HTT for Huntington\u2019s disease, CFTR for cystic fibrosis, and HBB for sickle cell."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide examples of panel testing for hereditary cancer and cardiomyopathy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples of hereditary cancer panels (BRCA1/2, TP53, Lynch genes) and cardiomyopathy/arrhythmia panels (e.g., MYH7, long QT)."
      }
    ],
    "question_number": 27,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:28:30.426699",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the types of clinical trials.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explains that trials can test drugs, devices, approaches to care, combinations, immunotherapies, and side-effect management\u2014adequately describing different types."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that clinical trials are divided into three different phases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response outlines four phases (1\u20134) and does not state that there are three phases; it does not satisfy the specific requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that phase 1 is the first time the drug is tested in humans and is aimed at establishing the safety and dosage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it describes Phase 1 as focusing on safety and dosage, it does not explicitly state that it is the first time the drug is tested in humans."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that phase 2 tests the effectiveness of the drug and continues to establish its safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says Phase 2 evaluates effectiveness and further assesses safety."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that phase 3 tests the efficacy of the drug in a larger group of patients and compares it to the current standard of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states Phase 3 is larger scale and compares the new treatment against standard ones."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe eligibility criteria for clinical trials, including stage of disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists eligibility factors such as specific diagnosis, stage of disease, prior treatments, and overall health."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that there can be risks associated with participating in a trial, including potential side effects and lack of efficacy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions potential for unknown side effects and that the treatment might not work or be less effective than standard care."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussing clinical trial options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing options with the healthcare team/oncologist and suggests seeking a second opinion."
      },
      {
        "criterion_number": 9,
        "description": "The response should include clinicaltrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly cites ClinicalTrials.gov as a key resource."
      },
      {
        "criterion_number": 10,
        "description": "The response should offer support for the diagnosis and how difficult it can be to complete 15 rounds of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with empathetic acknowledgment of the diagnosis and the difficulty of completing 15 rounds of chemotherapy."
      }
    ],
    "question_number": 28,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:29:03.820344",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must include ClinicalTrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists ClinicalTrials.gov as the primary database, describes it as government-run, and provides the URL."
      },
      {
        "criterion_number": 2,
        "description": "The response must provide instructions on using the search by location function on ClinicalTrials.gov.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Gives step-by-step instructions including entering city/state or ZIP under the Location field and filtering by recruitment status."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention the National Cancer Institute (NCI) website and describe using it to search for trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions NCI, links to Cancer.gov and Trials.Cancer.gov, and explains how to use the NCI trial finder including specifying location and cancer type."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention and provide a link to the Pancreatic Cancer Action Network (PanCAN) clinical trial finder tool.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically references PanCAN's Clinical Trial Finder and provides the PanCAN.org link where the tool is accessed."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including PanCAN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends contacting PanCAN (with phone number) and also mentions Lustgarten and Hirshberg foundations for clinical trial information."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including the American Cancer Society.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises contacting the American Cancer Society and provides Cancer.org and the ACS helpline number for navigation support."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss clinical trial options with their oncology team and consult with a local healthcare provider or oncologist to explore available trials at nearby cancer centers, as well as contact major cancer centers for additional information on clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes discussing with the doctor/oncologist, suggests contacting local hospitals and NCI-designated cancer centers, and provides steps to reach oncology departments and trial offices."
      }
    ],
    "question_number": 29,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:29:29.963958",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreatic cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states risk is higher with a first-degree relative with pancreatic cancer and that ~10% of cases have a hereditary component."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that BRCA1/BRCA2 mutations are genetic risk factors for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists BRCA1 and BRCA2 mutations among inherited conditions increasing pancreatic cancer risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies tobacco use as one of the strongest risk factors, noting 20\u201330% of cases and ~2x risk for smokers."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically names chronic pancreatitis and states it significantly raises risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreatic cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains heavy alcohol consumption can cause chronic pancreatitis, which increases cancer risk; also notes alcohol as a contributor to pancreatitis."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify Lynch syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists Lynch syndrome among inherited conditions linked to increased risk."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify Peutz-Jeghers syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Peutz-Jeghers syndrome as a genetic risk factor."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify Familial atypical multiple mole melanoma as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Names Familial atypical multiple mole melanoma (FAMMM) syndrome as a risk factor."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatitis as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes hereditary pancreatitis in the list of inherited conditions associated with increased risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should include age as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes risk increases after age 45, most cases >65, average age ~70."
      },
      {
        "criterion_number": 11,
        "description": "The response should include diabetes as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States long-standing type 2 diabetes increases risk and mentions new-onset diabetes as a potential early sign."
      },
      {
        "criterion_number": 12,
        "description": "The response should include obesity as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies being overweight/obese as increasing risk and suggests mechanisms like inflammation/insulin resistance."
      },
      {
        "criterion_number": 13,
        "description": "The response should include diet as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Describes high red/processed meats and saturated fat diets as linked to higher risk; suggests plant-rich diet may help."
      },
      {
        "criterion_number": 14,
        "description": "The response should include exposure to certain industrial chemicals as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions occupational exposures (e.g., benzene, chlorinated hydrocarbons, dry cleaning, metalworking, pesticides) as risk factors."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises high-risk individuals (strong family history/genetic mutations) may benefit from specialized screening and to consult a doctor; this meets the criterion of discussing screening with a physician."
      }
    ],
    "question_number": 30,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:29:57.458280",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking for a referral from their primary doctor or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises starting with the primary care physician or current doctor for a personalized referral and mentions asking for referral to a high-volume center."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using the PanCAN patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends the Pancreatic Cancer Action Network (PanCAN), provides the Patient Central hotline number, website, and notes their specialist finder and support services."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend using the American Cancer Society patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes the American Cancer Society as a resource, provides their resource search link and phone number, and notes they can help locate specialists."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they can reference the NCI website to look for designated cancer centers that have pancreatic cancer specialists on staff.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directs the user to the NCI website to find NCI-designated cancer centers, includes the specific URL, and notes these centers often have pancreatic cancer programs."
      },
      {
        "criterion_number": 5,
        "description": "The response should include information about the nearest cancer center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response provides general examples of major centers (e.g., Johns Hopkins, Cleveland Clinic, UCLA) but does not identify or provide information about the user's nearest cancer center."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend checking with their health insurance provider about in-network pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises using the insurance provider\u2019s directory to find in-network oncologists and emphasizes ensuring coverage."
      }
    ],
    "question_number": 31,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:30:13.836032",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines CA 19-9 as Cancer Antigen 19-9, a glycoprotein found in the blood and used as a tumor marker, providing an accurate and understandable definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is a tumor marker produced by cancer cells and measurable in the blood, and describe its use in pancreatic cancer, noting that it can serve as a marker for the disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response states CA 19-9 is a tumor marker, is measurable in blood, and details its use in pancreatic cancer monitoring, it does not explicitly state that CA 19-9 is produced by cancer cells, instead noting production by normal GI/pancreatic/biliary cells. Because the rubric requires explicitly stating production by cancer cells, full credit cannot be awarded."
      },
      {
        "criterion_number": 3,
        "description": "The response must include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes that CA 19-9 can be elevated in multiple non-cancerous conditions (e.g., pancreatitis, liver disease, bile duct obstruction, IBD) and emphasizes its lack of specificity, fully meeting this criterion."
      }
    ],
    "question_number": 32,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:30:38.634547",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that reference ranges can vary by lab.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: \"Reference ranges can vary slightly by lab.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that normal levels are typically less than 37 U/mL but do not rule out cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists normal as <37 U/mL and adds, \"a normal result does not rule out cancer.\""
      },
      {
        "criterion_number": 3,
        "description": "The response should state that levels from 37 to 100 U/mL can be associated with non-cancer conditions such as pancreatitis and bile duct disorders.",
        "score_given": 10,
        "max_points": 10,
        "justification": "For 37\u2013100 U/mL, cites benign causes including pancreatitis and gallstones/bile duct obstruction."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that moderate elevation (100-1000 U/mL) can be concerning for cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 100\u20131,000 U/mL is \"more concerning for cancer,\" especially pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that levels greater than 1000 U/mL can be suggestive of advanced cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Says >1,000 U/mL is \"strongly suggestive of advanced cancer,\" particularly metastatic pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the use of CA 19-9 in pancreatic cancer, including that it can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies CA 19-9 as a tumor marker used especially for pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes elevations in multiple benign conditions (pancreatitis, cholestasis, liver disease, IBD) and other cancers."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 can be used for monitoring the effectiveness of pancreatic cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains trend use during treatment: rises may mean treatment failure; drops suggest response after therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that CA 19-9 can be used for detecting recurrence of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention use for detecting recurrence."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions use/elevation in bile duct, gallbladder, colorectal, stomach, and liver cancers."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that CA 19-9 can be elevated in liver disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists liver diseases such as cirrhosis and hepatitis as causes of elevated CA 19-9."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that CA 19-9 can be elevated in gallstones.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically mentions gallstones as a benign cause of mild elevation."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that CA 19-9 can be elevated with elevated bilirubin.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While bile duct obstruction/cholestasis is mentioned, elevated bilirubin is not explicitly referenced."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancers.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States that 20\u201330% of pancreatic cancer patients have normal CA 19-9, implying not all tumors produce/raise the marker."
      }
    ],
    "question_number": 33,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:31:28.114387",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that CA 19-9 can be elevated with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists acute and chronic pancreatitis under benign pancreatic conditions that can raise CA 19-9."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 can be elevated with liver diseases like cirrhosis or hepatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly mentions cirrhosis and hepatitis (viral, alcoholic, autoimmune) as causes of elevated CA 19-9."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 can be elevated with cholestasis or biliary diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes biliary obstruction (gallstones, strictures, choledocholithiasis), cholangitis, primary biliary cholangitis, and primary sclerosing cholangitis."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CA 19-9 can be elevated with inflammatory bowel disease or gastrointestinal diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically lists inflammatory bowel disease (Crohn\u2019s, ulcerative colitis) and other GI disorders such as gastritis and peptic ulcers."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that CA 19-9 can be elevated with infections or other inflammatory conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes infections (e.g., cholangitis, severe infections) and inflammatory/autoimmune conditions (e.g., rheumatoid arthritis, endometriosis) as causes."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that CA 19-9 can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States CA 19-9 is commonly associated with pancreatic cancer and used for diagnosis, monitoring, and detecting recurrence."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple non-pancreatic malignancies (biliary tract, colorectal, gastric, esophageal, hepatocellular, ovarian, lung, breast, endometrial, etc.)."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that 5\u201310% of people (Lewis antigen negative) do not produce CA 19-9 even if they have cancer, covering non-production in some pancreatic cancers."
      }
    ],
    "question_number": 34,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:31:46.493233",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing weight loss with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to consult the oncology team and an oncology dietitian for personalized advice and to contact the doctor for significant weight loss or other concerning symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme replacement can be taken to help with the absorption of nutrients from foods.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that pancreatic enzyme supplements (e.g., Creon) may be prescribed and explains they help break down fats and proteins to improve absorption and reduce symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutritional strategies can be employed, such as focusing on small, frequent meals and nutrient-rich foods, and should recommend including calorie-dense and protein-rich foods in the diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends small, frequent meals; emphasizes calorie-dense, nutrient-rich foods; and lists protein-rich options and healthy fats to increase intake."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that medications for managing nausea can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically notes anti-nausea medications such as ondansetron can help and advises discussing with the doctor."
      },
      {
        "criterion_number": 5,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to chemotherapy side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes multiple causes of weight loss, explicitly including effects from treatments like chemotherapy, radiation, and surgery, and side effects such as nausea and vomiting."
      },
      {
        "criterion_number": 6,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to pancreatic enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that pancreatic cancer can cause pancreatic enzyme deficiency leading to malabsorption and weight loss, and discusses enzyme replacement as management."
      }
    ],
    "question_number": 35,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:32:02.516373",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a symptom of pancreatic cancer can include unintentional weight loss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Unintended Weight Loss: Significant weight loss without trying.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a symptom of pancreatic cancer can include jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Jaundice (Yellowing of the Skin and Eyes)'."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a symptom of pancreatic cancer can include new onset diabetes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'New-Onset Diabetes or Worsening of Existing Diabetes'."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a symptom of pancreatic cancer can include abdominal pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Abdominal or Back Pain: A dull, persistent pain in the upper abdomen...'."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pancreatic cancer can be difficult to detect early.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes it is a 'silent' disease with few early symptoms and 'Early Detection is Rare'."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer does not cause symptoms until the disease is advanced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Says it may not cause noticeable symptoms in early stages and that people are often diagnosed at a later stage, implying symptoms typically appear when disease is advanced."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reason for jaundice is the blockade of bile ducts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains jaundice occurs 'when the tumor blocks the bile duct, leading to a buildup of bilirubin.'"
      },
      {
        "criterion_number": 8,
        "description": "The response should state that loss of appetite can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions weight loss 'often accompanied by loss of appetite.'"
      },
      {
        "criterion_number": 9,
        "description": "The response should state that abdominal bloating or indigestion can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'indigestion' among digestive issues."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that foul-smelling stools or steatorrhea can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes 'fatty stools that float,' which describes steatorrhea."
      },
      {
        "criterion_number": 11,
        "description": "The response should reference the American Cancer Society information page on symptoms of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References the American Cancer Society as a source for the information provided."
      }
    ],
    "question_number": 36,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:32:22.291231",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that most pancreatic cancer cases are sporadic and not hereditary.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that 90\u201395% of pancreatic cancers are sporadic and not inherited."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that there are hereditary conditions that can lead to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes that 5\u201310% of cases are hereditary and discusses inherited mutations that increase risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a strong family history is a significant risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that a strong family history can raise risk 2\u201310 times and provides examples of family history patterns."
      },
      {
        "criterion_number": 4,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including familial pancreatic cancer syndrome.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While multiple syndromes are listed, the response does not explicitly identify familial pancreatic cancer (FPC) syndrome by name."
      },
      {
        "criterion_number": 5,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including BRCA1/BRCA2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "BRCA1/BRCA2 (HBOC) are explicitly mentioned with context on increased pancreatic cancer risk, especially BRCA2."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Lynch syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lynch syndrome is included with mention of mismatch repair genes (MLH1, MSH2)."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Peutz-Jeghers syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Peutz-Jeghers syndrome is identified with STK11."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Familial atypical multiple mole melanoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "FAMMM syndrome is included with CDKN2A."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including hereditary pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Hereditary (familial) pancreatitis is explicitly mentioned with PRSS1."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly recommends consulting an oncologist for personalized advice."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting a genetic counselor and discusses genetic testing considerations."
      }
    ],
    "question_number": 37,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:32:52.421640",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that routine screening is not recommended for the general population.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"there is no routine screening recommended for the general population\" and explains why."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention MRI as a surveillance modality for high-risk individuals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "MRI/MRCP is described as a preferred modality for initial and follow-up screening in high-risk individuals."
      },
      {
        "criterion_number": 3,
        "description": "The response must specify that surveillance typically starts around age 50 and continues annually.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states surveillance typically begins around age 40\u201350 and mentions annual surveillance (e.g., NCCN suggests annual EUS/MRI starting at age 40\u201350). This satisfies the intent of starting around 50 with annual follow-up."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that the evidence for screening/surveillance is not well established and mention the risk of overdiagnosis leading to unnecessary stress and procedures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes \"insufficient evidence\" in some populations (AGA) and \"no proven mortality reduction,\" and explicitly discusses overdiagnosis, false positives, unnecessary biopsies/surgeries, and anxiety."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that people at high risk may benefit from screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states surveillance is targeted at high-risk individuals where benefits may outweigh risks and cites improved early-stage detection in high-risk groups."
      },
      {
        "criterion_number": 6,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a significant family history of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines high risk to include individuals with multiple first-degree relatives affected or early-onset in a first-degree relative."
      },
      {
        "criterion_number": 7,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a known genetic syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple hereditary syndromes (e.g., Peutz-Jeghers, Lynch, FAMMM/CDKN2A, BRCA1/2, PALB2, ATM) as high-risk."
      },
      {
        "criterion_number": 8,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a history of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chronic pancreatitis, especially hereditary forms, is included under risk factors considered for surveillance."
      },
      {
        "criterion_number": 9,
        "description": "The response should include EUS as a screening modality to detect pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Endoscopic ultrasound (EUS) is described in detail as a sensitive modality for detecting small abnormalities and enabling biopsy."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend people discuss the risks and benefits of screening with a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting a healthcare professional and discussing whether surveillance is appropriate."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend people discuss the risks and benefits of screening with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends genetic testing and counseling and advises discussing genetic counseling when considering surveillance."
      }
    ],
    "question_number": 38,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:33:18.407244",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include surgery as a potential treatment modality for resectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes surgery as the only potentially curative option, details Whipple, distal pancreatectomy, total pancreatectomy, and mentions adjuvant/neoadjuvant approaches."
      },
      {
        "criterion_number": 2,
        "description": "The response should specify that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer, with main regimens being FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States chemotherapy is a mainstay for advanced/metastatic disease and explicitly lists FOLFIRINOX and gemcitabine plus nab-paclitaxel as key regimens."
      },
      {
        "criterion_number": 3,
        "description": "The response should include radiation as a potential treatment option for localized pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes radiation therapy (EBRT, SBRT) and its role in locally advanced disease, often with chemotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes treatment depends on stage (resectable, borderline resectable, locally advanced, metastatic) and tailors modalities accordingly."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the treatment of pancreatic cancer depends on the co-morbidities of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States treatment depends on the patient's overall health and age; discussion of regimen selection for \"fit patients\" implies consideration of comorbidities."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the treatment of pancreatic cancer depends on the functional status of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions using FOLFIRINOX for fit patients with good performance status, indicating treatment selection based on functional status."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy, noting its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 15,
        "max_points": 15,
        "justification": "Includes pembrolizumab for MSI-H/dMMR tumors and notes immunotherapy has limited success overall in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies PARP inhibitors (e.g., olaparib) for BRCA-mutated tumors."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes clinical trials, lists examples of investigational approaches, and provides resources for trial identification."
      }
    ],
    "question_number": 39,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:33:58.494188",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that stage 0 is a pre-cancer state, also known as pancreatic intraepithelial neoplasia or carcinoma in situ.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly identifies Stage 0 as PanIN/Tis (tumor in situ), explains that abnormal cells are confined to the lining without invasion, indicating a pre-cancer state."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that stage 1 cancer is when the cancer is confined to the pancreas and has not spread to lymph nodes or distant sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that Stage I is confined to the pancreas with no spread to lymph nodes or distant sites."
      },
      {
        "criterion_number": 3,
        "description": "The response should note that stage 1a is when the tumor is 2cm or smaller.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states Stage IA is a tumor 2 cm or smaller."
      },
      {
        "criterion_number": 4,
        "description": "The response should note that stage 1b is when the tumor is larger than 2cm.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states Stage IB is larger than 2 cm and limited to the pancreas."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that stage II is when the cancer is growing into nearby tissues and into lymph nodes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes Stage II as involving nearby tissues and/or lymph nodes, and details IIA (tissues, no nodes) and IIB (nodes, with or without nearby tissue involvement)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that stage III is when the cancer is locally advanced and involves surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines Stage III as locally advanced with involvement of major nearby blood vessels and possibly lymph nodes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that stage IV is when the cancer has spread to other organs or sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States Stage IV includes metastasis to distant organs such as liver, lungs, peritoneum, or bones."
      },
      {
        "criterion_number": 8,
        "description": "The response should include a description of the T, N, M staging system.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Introduces the AJCC TNM system and defines T (tumor size/extent), N (lymph nodes), and M (metastasis)."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that pancreatic cancer is categorized by resectability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes classification by resectability: resectable, borderline resectable, locally advanced (unresectable), or metastatic, and its influence on treatment decisions."
      }
    ],
    "question_number": 40,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:34:27.982900",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that neuropathy is a common side effect from the oxaliplatin in FOLFIRINOX.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that the oxaliplatin component is the main culprit behind peripheral neuropathy in FOLFIRINOX."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that the oncologist can \u2018hold\u2019 or temporarily stop oxaliplatin to manage neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States, \u201cThe oncologist might pause oxaliplatin temporarily,\u201d directly addressing holding the drug."
      },
      {
        "criterion_number": 3,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by dose reduction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that oncologists might try \u201cdose reductions\u201d to manage neuropathy."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by schedule modification.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions treatment \u201cdelays\u201d and temporarily pausing oxaliplatin, both reflecting schedule modification."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends switching to a different regimen if neuropathy is severe and lists alternatives."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen, including gemcitabine-based therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically lists gemcitabine + nab-paclitaxel and gemcitabine alone as alternatives."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including gabapentin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names gabapentin as a medication that can help with nerve pain."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists duloxetine (Cymbalta), an SNRI, as a treatment option for neuropathy."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions pregabalin as a supportive medication for neuropathy."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to talk to the oncologist urgently and to make treatment decisions in consultation with the oncology team."
      }
    ],
    "question_number": 41,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:35:04.509177",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should be informed about the aim of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains what clinical trials are and their purposes, and explicitly advises to ask, 'What phase is the trial, and what's its goal?' which addresses knowing the trial\u2019s aim."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they should understand the potential benefits of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists benefits such as access to new treatments, close monitoring, potential improved outcomes, and contributing to research."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that they should understand the potential risks of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details risks including lack of efficacy, unknown/serious side effects, possibility of placebo/standard care, time burden, and emotional stress."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they should be aware of the inclusion and exclusion criteria for the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated 'Eligibility' section noting criteria such as stage, prior treatments, overall health, and genetic markers."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that they should be aware of the time commitments associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions time commitments like frequent visits, travel, additional tests, and advises asking about trial duration and follow-up."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that they should be aware of the costs associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses costs and logistics, insurance coverage (ACA), and potential financial aid; clarifies what may or may not be covered."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the phase of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains Phases 1\u20134 in detail and advises to ask 'What phase is the trial?'"
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding if there are crossover options.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention crossover options or advise asking whether crossover is available from control to experimental arm."
      }
    ],
    "question_number": 42,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:35:25.911394",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Radiation can be used before surgery to help shrink borderline resectable tumors, with the goal of increasing the likelihood of achieving a complete resection in the localized setting.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly discusses neoadjuvant radiation/chemoradiation for borderline resectable tumors to shrink the tumor and make surgery safer/effective and convert inoperable to operable, which aligns with increasing the chance of complete resection."
      },
      {
        "criterion_number": 2,
        "description": "Radiation can be used for locally advanced or unresectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that for locally advanced/unresectable disease, radiation may be used alongside chemotherapy to control tumor growth and is common in stage III."
      },
      {
        "criterion_number": 3,
        "description": "Radiation can be used in the palliative setting to relieve symptoms in patients with advanced or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a dedicated palliative section for stage IV disease, noting symptom relief (pain, jaundice, bowel obstruction) and shorter courses, matching palliative intent."
      },
      {
        "criterion_number": 5,
        "description": "Pancreatic cancer treatment plans are determined by the stage of the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under 'Factors Influencing the Decision,' it explicitly notes that stage guides use of radiation (more likely in localized stages I\u2013III than metastatic)."
      },
      {
        "criterion_number": 6,
        "description": "Pancreatic cancer treatment plans are determined by the overall health of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that comorbidities/overall health may prompt adjustments to avoid complications, indicating patient health affects planning."
      },
      {
        "criterion_number": 7,
        "description": "The goal of radiation in the localized setting can be to sterilize vessel margins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions tumors near major blood vessels and shrinking to enable surgery, it does not state the specific goal of sterilizing vessel margins."
      },
      {
        "criterion_number": 8,
        "description": "The goal of radiation in the localized setting can be to delay disease progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "For locally advanced/unresectable disease, it notes aims to control tumor growth and potentially extend life, which reflects delaying progression in a localized (non-metastatic) setting."
      },
      {
        "criterion_number": 9,
        "description": "The goal of radiation in the localized setting can be to prevent local recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "In the adjuvant section, it states postoperative radiation may target microscopic residual disease to lower the risk of recurrence, consistent with preventing local recurrence."
      }
    ],
    "question_number": 43,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:36:08.021514",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic cancer leads to enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that pancreatic cancer (and its treatments) can reduce pancreatic enzyme production, leading to pancreatic exocrine insufficiency (PEI)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how enzyme deficiency can lead to problems with digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that lack of enzymes causes malabsorption and lists specific digestive problems: steatorrhea, bloating, gas, diarrhea, weight loss, and fat-soluble vitamin deficiencies, linking enzyme roles (lipase, protease, amylase) to digestion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme supplements are used to replace the enzymes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that enzyme supplements replace the missing enzymes and describes them as prescription pancrelipase products designed to mimic natural pancreatic enzyme output."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that pancreatic enzyme supplements can improve digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that supplements improve digestion and nutrient absorption, reduce gastrointestinal symptoms, and enhance quality of life."
      }
    ],
    "question_number": 44,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:36:18.717265",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that cancer is associated with an increased risk of developing blood clots.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that cancer is strongly associated with venous thromboembolism and notes that people with cancer are 4\u20137 times more likely to develop clots, demonstrating the increased risk."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that patients with pancreatic cancer are at increased risk of developing a blood clot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly identifies pancreatic cancer as one of the highest-risk cancers for thrombosis, citing figures (up to 20\u201330% of patients) and explaining mechanisms, thereby meeting the criterion."
      }
    ],
    "question_number": 45,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:36:29.569451",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that second opinions can be obtained at any time, including after diagnosis, before starting treatment, during treatment, or when considering clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The answer advises seeking a second opinion right after diagnosis and before treatment, and explicitly states, \u201cIt\u2019s never too late\u2026 even if treatment has started,\u201d covering during-treatment timing. It also ties second opinions to clinical trials by suggesting asking about trials and noting a second opinion might uncover eligibility. Collectively, this communicates availability at any time, including when considering trials."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that second opinions are particularly helpful after the initial diagnosis and before starting treatment, as well as when the initial treatment is no longer effective.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly highlights seeking a second opinion after initial diagnosis and before starting treatment. However, it does not explicitly state the scenario of when initial treatment is no longer effective; it only mentions \u201cif progress isn\u2019t as expected,\u201d which is not an explicit reference to treatment failure or no longer effective therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states second opinions are recommended if the diagnosis feels uncertain or incomplete, directly addressing lack of clarity about the diagnosis."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding staging.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically cites \u201cunclear staging\u201d as a reason to seek a second opinion, meeting the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the treatment plan.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions seeking a second opinion if \u201cthe proposed treatment plan seems aggressive, unclear,\u201d satisfying this criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that second opinions can be obtained at specialized referral centers, such as cancer centers with expertise in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The answer directs users to specialists in pancreatic cancer and high-volume/academic centers, and it highlights cancer centers with specific expertise, fulfilling this requirement."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that they should look up NCI-designated cancer centers specifically.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends NCI-Designated Cancer Centers and provides cancer.gov as a resource, which directly meets the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention major academic hospitals as a resource for finding pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names major academic hospitals (e.g., Johns Hopkins, Cleveland Clinic) and university-affiliated centers, fully meeting the criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that the NCCN guidelines for Pancreatic Adenocarcinoma recommend evaluation at high volume centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of NCCN guidelines or their recommendation for evaluation at high-volume centers."
      }
    ],
    "question_number": 46,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:37:03.756093",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that immunotherapy is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that immunotherapy effectiveness in pancreatic cancer is generally limited and highlights MSI-H/dMMR tumors (~1\u20132%) as the key exception, noting FDA approval of pembrolizumab for MSI-H/dMMR solid tumors."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that immunotherapy is an ongoing area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions ongoing research into combinations (chemo, radiation, vaccines), references early results, and cites emerging approaches like CAR-T and bispecific antibodies."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that there may be clinical trial options exploring novel immunotherapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises exploring clinical trials, references the NCI and ClinicalTrials.gov, and notes trials testing combination immunotherapy strategies."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that immune checkpoint blockade is only approved for patients with metastatic disease in certain situations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions tumor-agnostic approval for MSI-H/dMMR, it does not specify the restriction to unresectable or metastatic disease nor clarify the situational nature of this approval."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pembrolizumab is approved for patients whose tumors are TMB high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes that high TMB may make immunotherapy more effective, it does not explicitly state the FDA approval of pembrolizumab for TMB-high (\u226510 mut/Mb) solid tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend asking their oncology team about testing for eligibility for immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends genetic testing (including MSI and TMB) as a crucial step and advises discussing options with the oncologist, which aligns with assessing eligibility for immunotherapy."
      }
    ],
    "question_number": 47,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:37:34.497002",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should consult with their oncologist on the potential next steps.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing with his oncology team as soon as possible and to reach out to the medical team urgently for a personalized plan, clearly directing consultation with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the oncologist may suggest alternative standard of care therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details second-line standard regimens (e.g., nanoliposomal irinotecan + 5-FU/LV, gemcitabine + nab-paclitaxel, FOLFOX) and other accepted modalities (radiation for symptoms), indicating alternative standard therapies after progression."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that the oncologist may suggest clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a dedicated section on considering clinical trials, including how to find them and discussing eligibility with the oncologist."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that re-biopsy of the disease could reveal targetable mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends repeat imaging and 'possibly a biopsy' to assess the cancer\u2019s biology and separately emphasizes tumor profiling/NGS to identify actionable mutations, which together convey that re-biopsy could reveal targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supportive care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a comprehensive section on palliative/supportive care, symptom management (pain control, nutrition, enzyme supplements, nerve blocks), and hospice consideration, meeting the criterion."
      }
    ],
    "question_number": 48,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:37:51.250008",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no approved CAR-T cell therapy for pancreatic cancer at this time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states: 'At this time, CAR-T therapy is not a standard or FDA-approved treatment for pancreatic cancer,' directly addressing the lack of approval."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe CAR-T cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides an accurate description of CAR-T: collection of patient T-cells, genetic engineering to express chimeric antigen receptors, reinfusion to target cancer cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CAR-T cells are being studied in clinical trials for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes CAR-T is 'being actively researched for pancreatic cancer through clinical trials' and provides examples of targets and how to find trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CAR-T cells are approved for the treatment of other types of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States CAR-T is FDA-approved for certain blood cancers (e.g., leukemias and lymphomas), which is accurate."
      }
    ],
    "question_number": 49,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:38:03.921642",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that hospice is considered when the medical team estimates a life expectancy of 6 months or less.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states eligibility as an estimated life expectancy of 6 months or less in two places: coverage criteria and under 'Prognosis' (e.g., 'Doctors estimate a life expectancy of 6 months or less')."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the aim of hospice is to maximize quality of life and focus on addressing symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines hospice as focusing on comfort, dignity, and quality of life with emphasis on pain relief and symptom management."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that hospice can take place in the home, a nursing home, or in a dedicated hospice facility.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists care settings including home, nursing home, hospital, and dedicated hospice facility, covering all required locations."
      },
      {
        "criterion_number": 4,
        "description": "The answer should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with 'I'm truly sorry to hear about your father's diagnosis,' which is a clear expression of sympathy."
      },
      {
        "criterion_number": 5,
        "description": "The response should define hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition: specialized care for terminal illness focusing on comfort rather than cure, emphasizing end-of-life support."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what hospice care covers, including emotional and spiritual support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on 'Emotional and Spiritual Support' detailing counseling, grief/anxiety support, and spiritual care."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe what hospice care covers, including bereavement support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that hospice provides bereavement counseling for up to a year after the patient's passing under 'Family Support.'"
      }
    ],
    "question_number": 50,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:38:18.476295",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that fatigue is a common side effect of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, 'Fatigue is one of the most common and challenging side effects of chemo.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting the oncologist/healthcare team for tailored recommendations and provides red-flag situations warranting immediate contact."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention that optimizing nutrition and hydration can help manage fatigue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides detailed guidance on nutrient-rich foods, small frequent meals, supplements as indicated, and hydration goals."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend good sleep hygiene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes specific sleep hygiene strategies (consistent routine, avoiding screens, optimizing sleep environment) and guidance on naps."
      },
      {
        "criterion_number": 5,
        "description": "The response should discuss potential causes for fatigue, including the effect of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple causes including chemotherapy, anemia, nutritional deficiencies, pain, emotional stress, and the cancer itself."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that light physical activity can improve fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that light activity can boost energy and gives examples (short walks, yoga, tai chi) with safety caveats."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend medication review.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions possible medications to manage fatigue and related symptoms, it does not recommend reviewing current medications for fatigue-inducing effects or interactions."
      }
    ],
    "question_number": 51,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:38:41.542265",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that alternative treatments like cannabis oil have not been proven to help patients with pancreatic cancer live longer or cure them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states there is no strong evidence from randomized controlled trials that cannabis oil cures or significantly extends life in pancreatic cancer and emphasizes alternatives are not proven to cure or replace standard therapies."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that cannabis oil is sometimes used to manage cancer-related symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes cannabis products may help with pain, nausea/vomiting, appetite loss, anxiety, insomnia, and depression, and references FDA-approved synthetic THC for symptom control."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing the use of cannabis oil with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A dedicated section advises talking to the oncologist to assess safety, recommend dosing/forms, and monitor interactions or side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe cannabis oil.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines cannabis oil, distinguishes CBD and THC, discusses psychoactivity, mentions forms (oils, edibles, tinctures), and common alternative names."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cannabis oil is not used as an anti-cancer treatment per guidelines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references ACS and NCI and states cannabis is not a substitute for proven treatments and should be integrated, not replace standard care, aligning with guideline-based positions."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe risks of using cannabis oil, including drug interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly warns cannabis can affect hepatic metabolism of other drugs, potentially reducing chemotherapy effectiveness or increasing toxicity."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe risks of using cannabis oil, including side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Side effects listed include dizziness, dry mouth, appetite and mood changes, hallucinations, paranoia, and dependence."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe risks of using cannabis oil, including variation in quality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights lack of regulation, variability in quality, purity, and dosage, and possible contaminants like pesticides and heavy metals."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe risks of using cannabis oil, including legal concerns.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes legality varies by location, distinguishes CBD vs THC status in the U.S., and mentions medical cannabis program access."
      }
    ],
    "question_number": 52,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:39:02.229295",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that lack of appetite is a common side effect of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes appetite loss is a common issue for cancer patients and discusses it specifically in the context of the husband\u2019s pancreatic cancer, effectively conveying that it is common."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the patient should consult with their oncologist, who may refer them to a registered dietitian, oncology nutritionist, and/or palliative care physician to address symptoms and optimize supportive care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends consulting the oncologist, a registered dietitian specializing in oncology, and a palliative care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme replacement can be pursued.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of pancreatic enzyme replacement therapy (e.g., pancrelipase/PERT)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the patient can try smaller meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends small meals, suggesting 5\u20136 small meals/snacks per day."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient can try more frequent meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically advises 5\u20136 small, frequent meals/snacks throughout the day."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient can try nutritional replacement shakes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests smoothies, milkshakes, protein shakes, and commercial supplements like Ensure or Boost."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that appetite stimulants can also be considered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions that the healthcare team may suggest appetite stimulants if appropriate."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that cancer itself can cause loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States that factors include the cancer itself as a cause of appetite loss."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that chemotherapy can cause nausea and loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies chemotherapy as a treatment that can contribute to appetite loss and discusses nausea management."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that bloating can decrease appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention bloating as a contributor to decreased appetite."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that pancreatic enzyme deficiency can cause decreased appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of pancreatic enzyme insufficiency or its impact on appetite."
      }
    ],
    "question_number": 53,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:39:39.771218",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that they can start with their primary doctor who can help refer to the most local community hospital with oncology services.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises starting with the local healthcare team and explicitly says to get a referral from the primary care doctor to the nearest oncology center/community hospital."
      },
      {
        "criterion_number": 2,
        "description": "State that if they are able to travel, then major cancer centers offer consultations which can also be done as telehealth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses traveling to high-volume cancer centers and separately emphasizes that many top centers offer virtual/telehealth consultations."
      },
      {
        "criterion_number": 3,
        "description": "State that patients can search for NCI-designated cancer centers to find the closest one to them, and explicitly mention that both oncologists and palliative care teams often offer virtual visits through telemedicine or telehealth consultations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides the NCI cancer center finder link for locating centers and explicitly notes telehealth availability for oncologists and that palliative care can be provided via telehealth."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly recommend reaching out to regional cancer centers, including examples or resources for finding such centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends high-volume/regional centers, names specific examples (Mayo, MD Anderson, MSK, Johns Hopkins), and provides the NCI center finder resource."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that specialists will often partner with local oncologists to coordinate care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes that local oncologists can coordinate basic care and that specialists can provide telehealth input, it does not explicitly state that specialists will partner with local oncologists to coordinate care."
      }
    ],
    "question_number": 54,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:40:08.987776",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should offer sympathy for the stressful situation dealing with insurance coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathy: expresses sorrow about the father's diagnosis and acknowledges the stress of insurance denials."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they can work with the hospital\u2019s financial counselor or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends using hospital social workers and financial counselors to assist with appeals and resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises obtaining a letter of medical necessity from the oncologist and discussing urgent/bridging options with the oncology team."
      },
      {
        "criterion_number": 4,
        "description": "The response should include contacting the insurance company to understand the reason for denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Instructs to review the insurer\u2019s denial letter for reasons and outlines initiating the insurer\u2019s internal appeal process (contact by phone/online/mail), which serves to clarify the denial basis."
      },
      {
        "criterion_number": 5,
        "description": "The response should state one option for remedy is filing an appeal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly details both internal and external (independent) appeals, including expedited appeals, and provides practical steps and expectations."
      }
    ],
    "question_number": 55,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:40:27.628528",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define high-volume centers as those performing at least 40 or 50 Whipple procedures per year.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states high-volume centers perform 20\u201350+ Whipple procedures and explicitly notes that some experts define this as 40+, which meets the \u226540\u201350 definition."
      },
      {
        "criterion_number": 2,
        "description": "State that high-volume centers have significantly lower mortality rates and higher overall survival rates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifies markedly lower in-hospital mortality (2\u20134% vs. 10\u201315%) and notes better overall survival at high-volume centers."
      },
      {
        "criterion_number": 3,
        "description": "State that high-volume centers have significantly lower complication rates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says high-volume centers have fewer complications such as infections, leaks, and bleeding."
      },
      {
        "criterion_number": 4,
        "description": "State that at a high-volume center, the surgeon is more likely to be a specialist in pancreas surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes surgeons at high-volume centers are often fellowship-trained specialists focusing on pancreatic/GI cancers and perform these operations frequently."
      },
      {
        "criterion_number": 5,
        "description": "State that high-volume centers often have access to clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states high-volume centers often participate in clinical trials, offering access to cutting-edge treatments."
      },
      {
        "criterion_number": 6,
        "description": "State that high-volume centers have access to the latest treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions access to cutting-edge treatments and advanced tools such as robotic-assisted surgery and intraoperative imaging."
      },
      {
        "criterion_number": 7,
        "description": "State disadvantages of going to a high-volume center, including travel time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response discusses the burden of travel to high-volume centers, sometimes out-of-state, compared with local proximity."
      },
      {
        "criterion_number": 8,
        "description": "State disadvantages of going to a high-volume center, including more complicated logistics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes logistical challenges (lodging, coordination, patient navigators) and contrasts them with the convenience of local care."
      }
    ],
    "question_number": 56,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:40:52.079227",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the Pancreatic Cancer Action Network as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions the Pancreatic Cancer Action Network (PanCAN), describes Patient Central, grants, and provides contact info (phone and website), framing it as a starting point for financial resources."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention CancerCare as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists CancerCare and states it offers limited financial grants for co-pays, transportation, and home care, with contact info, meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the American Cancer Society as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes the American Cancer Society (ACS), noting financial assistance programs such as Hope Lodge, transportation, and some medical costs, with contact details."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises connecting with \"Hospital Social Workers and Financial Navigators\" to help with financial planning and applying for aid."
      },
      {
        "criterion_number": 5,
        "description": "The response should offer sympathy for the stressful situation dealing with financial burden during cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Begins with empathetic language: \"I'm so sorry to hear about your loved one's pancreatic cancer diagnosis\u2014this is an incredibly challenging time, and the financial aspects can add significant stress.\""
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States, \"Ask your oncologist for a referral\" to social workers/financial navigators, indicating engagement of the oncology team for financial concerns."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing financial concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends: \"Seek Professional Advice: A financial counselor or patient advocate can help maximize benefits and minimize out-of-pocket costs.\""
      }
    ],
    "question_number": 57,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:41:16.196241",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions that depression is common among patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states depression is common and provides a prevalence range (33\u201370%) for pancreatic cancer patients."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing the patient\u2019s mood with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to start with the oncologist, mentions screening tools (e.g., PHQ-9), and coordinating care."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions support groups as helpful for patients with cancer experiencing depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends support groups and names PanCAN, ACS, and CancerCare."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions seeking immediate evaluation by a medical professional if the patient is experiencing thoughts of harming themself or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises immediate contact with the doctor or crisis resources if suicidal thoughts are present."
      },
      {
        "criterion_number": 5,
        "description": "The response offers the emergency department and calling 988 if the patient experiences thoughts of harming themself or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides 988 but does not explicitly mention going to the emergency department."
      },
      {
        "criterion_number": 6,
        "description": "The response points to published scientific studies describing the prevalence of depression in pancreatic cancer patients.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Cites studies and sources (e.g., The Lancet Oncology, NCCN, 2020 review in Supportive Care in Cancer) in support of prevalence data."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists persistent low mood, anhedonia, sleep/appetite changes, irritability, and self-harm thoughts."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing the patient\u2019s mood with a mental health professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends referral to a psychiatrist, psychologist, or oncology social worker."
      },
      {
        "criterion_number": 9,
        "description": "The response states that there are various treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple treatments including medication, therapy, and integrative approaches."
      },
      {
        "criterion_number": 10,
        "description": "The response states that there are both pharmacologic and non-pharmacologic treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions SSRIs (pharmacologic) and CBT, mindfulness, counseling (non-pharmacologic)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions lifestyle changes that support improvements in mental health.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests light physical activity, nutrition focus, sleep hygiene, and relaxation techniques."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that based on the ASCO guidelines, optimal care of depression should follow a stepped-care model.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention ASCO guidelines or a stepped-care model."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that Cognitive Behavioral Therapy (CBT), behavior therapy (BT), and behavioral activation (BA) are the most effective treatments for managing depressive symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions CBT but not BT/BA nor that these are the most effective per ASCO."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that exercise both during and after treatment can significantly reduce depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages light physical activity but does not state the ASCO-based finding that exercise during and after treatment significantly reduces depression."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that pharmacotherapy is not recommended as a first-line treatment for depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends SSRIs without noting that pharmacotherapy is not first-line per ASCO."
      }
    ],
    "question_number": 58,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:41:58.308878",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: 'Talk to Your Doctor... Share these questions with your oncologist' and notes the care team provides personalized insights."
      },
      {
        "criterion_number": 2,
        "description": "The response states that many aspects of a patient\u2019s health impact their prognosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple factors including age, overall health, tumor genetics, treatment response, lifestyle/support, and comorbidities affecting prognosis."
      },
      {
        "criterion_number": 3,
        "description": "The response defines overall survival as it is used in clinical research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines overall survival as the percentage alive after a certain time from diagnosis regardless of cause of death, which aligns with OS concept for lay readers."
      },
      {
        "criterion_number": 4,
        "description": "The response defines progression-free survival as it is used in clinical research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains PFS (grouped with DFS) as time without cancer returning or worsening, capturing the core idea of time until progression/recurrence."
      },
      {
        "criterion_number": 5,
        "description": "The response explains that overall survival and progression-free survival are typically reported as medians.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although 'median survival' is defined and examples are given, the response does not explicitly state that OS and PFS are typically reported as median times in studies."
      },
      {
        "criterion_number": 6,
        "description": "The response explains the above biostatistics terms (overall survival, progression-free survival, and median) in laymen\u2019s terms.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides clear, plain-language definitions for overall survival, relative survival, progression-free survival, and median survival."
      },
      {
        "criterion_number": 7,
        "description": "The response explains that survival data is best reported in terms of the stage of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States statistics are grouped by stage and provides stage-specific survival rates, noting resectability and type differences."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the limitations of applying reported statistics to patients\u2019 individual cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes that statistics are averages from past cohorts, not predictions; acknowledges variability by individual factors and evolving treatments."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions the difference between overall survival and progression-free survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Differentiates OS (alive regardless of cause of death) from PFS (time without return/worsening), making the distinction clear."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that survival is influenced by tumor characteristics such as genetic mutations (BRCA, KRAS), size, and location.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically references size, location, operability, and genetic mutations (KRAS, BRCA) as prognostic factors."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that survival depends on treatments received (chemotherapy, surgery, targeted therapy, no treatment, etc.) and treatment response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that surgery, chemotherapy, radiation, targeted drugs, immunotherapy, and treatment response significantly influence outcomes; provides examples."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that new treatments and advancements are being developed all the time, and these could potentially improve outcomes in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that statistics may not reflect recent advances, mentions improving survival, personalized/targeted therapies, immunotherapy, and clinical trials."
      }
    ],
    "question_number": 59,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:42:43.103595",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises that the oncology team can provide tailored details and explicitly suggests asking the doctors specific questions in the 'Next Steps' section."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that a liquid biopsy is a blood test.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that a liquid biopsy analyzes a sample of blood and compares it to traditional tissue biopsies."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that liquid biopsies involve analyzing circulating tumor DNA (ctDNA) from blood samples.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly defines ctDNA as bits of genetic material from cancer cells and describes analysis using techniques such as next-generation sequencing."
      },
      {
        "criterion_number": 4,
        "description": "The response explains there are many different tests which evaluate various things including circulating tumor DNA, circulating tumor cells, and proteins in the blood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists ctDNA, circulating tumor cells (CTCs), and other biomarkers such as proteins, exosomes, and RNA."
      },
      {
        "criterion_number": 5,
        "description": "The response says that liquid biopsies do not replace tissue biopsies in the diagnosis of cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states liquid biopsies are not a replacement for all traditional biopsies and can complement them."
      },
      {
        "criterion_number": 6,
        "description": "The response says the results of liquid biopsies must be interpreted by a medical professional.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it suggests discussing with doctors, it does not explicitly state that liquid biopsy results must be interpreted by a medical professional."
      },
      {
        "criterion_number": 7,
        "description": "The response says the results of liquid biopsies may be helpful when combined with imaging and pathology results.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes results are often used alongside imaging (CT scans) or tissue biopsies, indicating combination with imaging and pathology."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions there are liquid biopsies in various stages of development for different kinds of cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions FDA approvals for some cancers like lung and breast, and investigational/off-label use for pancreas, indicating varying stages across cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the limitations of liquid biopsies, including sensitivity, false positives, and cost.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses sensitivity limitations, possible false positives/negatives, and variability in availability and cost."
      },
      {
        "criterion_number": 10,
        "description": "The response says there are currently no FDA approved liquid biopsies for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states FDA approvals exist for some cancers (e.g., lung/breast) but for pancreas they are often investigational/off-label, implying no FDA-approved pancreatic indication."
      },
      {
        "criterion_number": 11,
        "description": "The response says health insurance may not pay for these tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that insurance coverage varies, indicating possible non-coverage."
      },
      {
        "criterion_number": 12,
        "description": "The response says liquid biopsies may be able to identify genetic mutations present in the cancer which can help to guide treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It describes identifying mutations like KRAS or BRCA and using that information to guide targeted therapies (e.g., PARP inhibitors)."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that liquid biopsies are noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions noninvasiveness and avoiding repeated surgeries, it does not specifically state expediting testing by avoiding retrieval of archival blocks or arranging a new biopsy."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not address limitations specific to detecting copy-number changes or gene fusions in cfDNA assays."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that this is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes liquid biopsies as an emerging tool, notes research stage and investigational use in pancreatic cancer, implying it is not standard of care for all patients."
      }
    ],
    "question_number": 60,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:43:34.911715",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response considers the costs of travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly factors in travel costs under Financial Considerations (includes travel, accommodations, and hidden fees)."
      },
      {
        "criterion_number": 2,
        "description": "The response considers the costs of healthcare abroad.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Details treatment-related costs (surgery, hospital stay, medications, follow-up), gives estimated ranges, and advises obtaining detailed quotes."
      },
      {
        "criterion_number": 3,
        "description": "The response considers logistics of travel, including the need for passports and/or visas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses medical visas and entry requirements (e.g., India\u2019s M-visa, Thailand\u2019s medical tourist visa) and related documentation."
      },
      {
        "criterion_number": 4,
        "description": "The response considers language and cultural barriers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses language access (English-speaking staff, translators) and cultural differences in care."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients receiving treatment for pancreatic cancer often require significant support from their family and friends.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes the need for companions/family support and references counseling and advocacy groups."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering if the patient is medically safe for travel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises medical clearance, \u2018fit to fly\u2019 certificate, consideration of symptoms/complications (e.g., clots, infections), and emergency preparedness."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends researching the quality of healthcare in the intended destination.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends high-volume centers, cites specific hospitals, emphasizes accreditation (JCI/ESMO), outcomes, and patient reviews."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing all travel plans with a medical professional prior to leaving.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Urges consultation with the oncologist and healthcare team, and obtaining clearance prior to travel."
      },
      {
        "criterion_number": 10,
        "description": "The response says that delaying the start of treatment for pancreatic cancer can be harmful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States treatments often need to start quickly and to factor in travel time, implying delay can be detrimental."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends researching pancreatic cancer outcomes in the intended destination as compared to her home country.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises reviewing success/survival statistics and comparing offerings abroad to local options."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends understanding the patient\u2019s treatment options, including clinical trials, which may be available in her home country before making travel plans.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions confirming availability of desired treatments and considering local clinical trials with resources like ClinicalTrials.gov."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention considerations related to insurance funding.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses health insurance coverage for international care, medical travel insurance, and potential funding sources."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to consider local accommodations when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifies planning lodging near the hospital (e.g., serviced apartments) and transportation."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention to consider challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Highlights need for post-treatment monitoring plans, return vs. stay decisions, and transfer of records/coordinating with local doctors."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that immunizations and infection prevention are important, especially for immunosuppressed patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise on immunizations or specific infection-prevention measures for immunosuppressed patients; only general references to infections/pandemics."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that telemedicine and remote support can be leveraged for follow-up, symptom management, and multidisciplinary care, reducing the need for frequent travel and facilitating access to expertise at high-volume centers.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions telemedicine for second opinions and as an alternative to travel, but does not specify its use for follow-up, symptom management, or multidisciplinary care."
      }
    ],
    "question_number": 61,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:44:33.344197",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that bowel changes, including diarrhea, nausea, and constipation, are common among patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that treatments often affect the bowels and explicitly lists diarrhea, constipation, and nausea as common side effects."
      },
      {
        "criterion_number": 2,
        "description": "The response mentions that chemotherapy, radiation therapy, surgery, and other treatments such as pain medications can impact the bowels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses chemotherapy, radiation, surgery (Whipple), and pain medications (opioids) causing bowel changes."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that bowel changes can also be due to infections.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists infections as a possible cause of bowel changes."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing specific concerns with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises contacting their doctor promptly and specifically mentions the oncologist as part of the care team."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping a log of events related to food intake, fluid intake, and bowel symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends tracking bowel symptoms but does not explicitly include logging food or fluid intake."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the above log with the patient\u2019s healthcare team.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that the symptom log will help the doctor pinpoint the issue, implying discussion with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends if the patient has not had a bowel movement in more than 24 hours and is not passing gas, their bowels may be obstructed, which is a medical emergency and requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions blockages needing urgent attention but does not provide the specific 24-hour/no gas guidance or explicitly recommend immediate ED evaluation."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends if the patient is nauseous and unable to keep any food or drink down without vomiting, this can quickly lead to severe dehydration, which requires urgent evaluation by a medical professional and potentially intravenous fluids and medicines.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly advise urgent evaluation and possible IV fluids if unable to keep food or liquids down."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends if the patient is experiencing severe abdominal pain, this may represent a medical emergency which requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not provide emergency guidance for severe abdominal pain."
      },
      {
        "criterion_number": 10,
        "description": "The response says patients with pancreatic cancer may experience pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes enzyme deficiency due to cancer/surgery and need for enzymes, which conveys pancreatic exocrine insufficiency."
      },
      {
        "criterion_number": 11,
        "description": "The response explains pancreatic insufficiency is related to a deficiency in the pancreatic enzymes which break down food and can cause diarrhea and bloating.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains reduced enzyme production leading to maldigestion with diarrhea (steatorrhea), bloating, and gas."
      },
      {
        "criterion_number": 12,
        "description": "The response explains there are supplementary pancreatic enzymes that can be taken to alleviate the symptoms of pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions pancreatic enzyme supplements (e.g., Creon) to manage malabsorption."
      },
      {
        "criterion_number": 13,
        "description": "The response explains if the bowel changes are due to chemotherapy, the treating oncologist can often prescribe additional medications to control these side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions medications like loperamide or laxatives but does not state that the oncologist can prescribe additional medications specifically for chemo-related side effects."
      },
      {
        "criterion_number": 14,
        "description": "The response says proper nutrition is an important part of cancer care outcomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Encourages small, frequent meals but does not explicitly state the importance of nutrition for cancer care outcomes."
      },
      {
        "criterion_number": 15,
        "description": "The response says it is important to remain hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises staying hydrated and increasing fluids."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that it is important to determine the cause of the bowel changes to manage them effectively.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes discussing with the care team for accurate assessment and determining the cause via tests."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that gastric outlet/duodenal obstruction can occur in up to 10% of patients with pancreatic cancer, leading to symptoms like early satiety, nausea, postprandial vomiting, and weight loss.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention gastric outlet/duodenal obstruction or the 10% statistic or the specific symptom cluster."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that patients with malignant ascites from pancreatic cancer may experience abdominal discomfort, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention malignant ascites or its symptoms."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that diet/nutrition changes can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists diet and nutrition changes as possible non-cancer/treatment causes of bowel changes."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that stress/anxiety can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly mentions stress and anxiety as potential contributors."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that pre-existing conditions can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions pre-existing conditions such as IBS as potential causes."
      }
    ],
    "question_number": 62,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:45:46.227681",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing with the oncologist/healthcare team and includes a section titled 'Consult His Doctor Immediately.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states that pancreatic cancer and its treatments may affect the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that chemotherapy for pancreatic cancer can impair driving and mentions symptoms from cancer and treatment affecting safety."
      },
      {
        "criterion_number": 3,
        "description": "The response states that pain medications may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes pain relievers can cause sedation and compound driving risks."
      },
      {
        "criterion_number": 4,
        "description": "The response states that symptoms such as fatigue, drowsiness, nausea, and vomiting may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists fatigue/drowsiness and nausea/vomiting as side effects that can impair driving."
      },
      {
        "criterion_number": 5,
        "description": "The response states that the patient\u2019s healthcare team may have resources to assist with transportation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides external transport resources (ACS Road to Recovery, rideshare, public transit) but does not state the healthcare team may have transportation resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that chemotherapy can cause fatigue that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions fatigue/drowsiness as common chemo side effects that impair alertness while driving."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that chemotherapy can cause vision changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes blurred vision and light sensitivity from certain drugs as potential driving impairments."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chemotherapy can cause neuropathy that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes neuropathy affecting grip on the steering wheel and use of pedals."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that chemotherapy can cause cognitive changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions 'chemo brain' with memory lapses, confusion, and slower reaction times affecting driving."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to avoid driving after the first chemotherapy session to see how your husband tolerates it.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises avoiding driving alone and being cautious after infusions, but does not specifically instruct to avoid driving after the first session to assess tolerance."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to plan for backup transportation, such as a taxi, friends/family, or public transportation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends arranging rides with family/friends, rideshare services, public transit, and community/volunteer driver programs."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the National Highway Traffic Safety Administration (NHTSA) provides information on medical conditions and driving safety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references NHTSA as a source of information on medical conditions and driving safety."
      }
    ],
    "question_number": 63,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:46:40.182530",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that the ability to work depends on individual circumstances such as the stage of cancer, overall health, and comorbidities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly notes variability by person and cites stage, overall health, and pre-existing conditions as determinants."
      },
      {
        "criterion_number": 2,
        "description": "The response states that the ability to work depends on the type of treatment (chemotherapy, radiation, surgery, targeted therapy) and related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions chemotherapy, radiation, surgery, targeted therapy, treatment cycles, and specific side effects affecting work."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the ability to work depends on the support available from friends, family, and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that a strong support system can help and includes family/caregiver support as a factor."
      },
      {
        "criterion_number": 4,
        "description": "The response states that the ability to work depends on job type and flexibility (working from home, reduced hours, workplace accommodations, scheduled breaks).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses office vs. manual work, remote options, flexible hours, reduced workload, and workplace accommodations."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pancreatic cancer and its treatment can cause symptoms which may make working challenging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists fatigue, weakness, nausea, digestive issues, neuropathy, and cognitive changes, explicitly linking them to work challenges."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises consulting the oncologist/healthcare team and involving them in work-related planning."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends workplace accommodations which may make working possible during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides specific accommodations (flexible scheduling, breaks, ergonomic setups, phased return) and references ADA."
      },
      {
        "criterion_number": 9,
        "description": "The response states the patient\u2019s ability to continue working should be continually reassessed as their medical condition changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests tracking symptoms, acknowledging fluctuations, and reassessing or taking breaks if side effects worsen."
      },
      {
        "criterion_number": 10,
        "description": "The response states that self-care is important while undergoing cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Emphasizes rest, nutrition, light exercise, and mental health support."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient may qualify for paid leave through their employer, the government, or both.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions short-term disability leave (employer) and disability benefits (government) alongside FMLA protections."
      },
      {
        "criterion_number": 12,
        "description": "The response states many patients with pancreatic cancer take time off of work during treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that others may need to take time off due to side effects/complications and that many patients choose to focus on treatment first."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that it is important for patients with pancreatic cancer to maintain their quality of life, and that work during treatment may be possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights palliative care for symptom relief/quality of life and states many do continue working when feasible."
      }
    ],
    "question_number": 64,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:47:28.446304",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing the use of medical marijuana with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises discussing with his oncologist/healthcare team and reiterates this in the 'How to Get Started' section."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that medical marijuana is not an effective alternative treatment for pancreatic cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Medical marijuana isn't a cure for cancer' and 'shouldn't replace standard treatments.'"
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions risks and side effects associated with medical marijuana, including psychoactive effects and potential interactions with other medications.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists dizziness, hallucinations, mood changes, impaired coordination, and interactions with blood thinners, painkillers, and chemotherapy, including potential liver strain."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly states that medical marijuana comes in various forms, such as oils, edibles, tinctures, and vaporizers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Names oils, edibles, tinctures, capsules, vaporizers, and topical creams."
      },
      {
        "criterion_number": 5,
        "description": "The response specifically mentions the risk of inhaled medical marijuana exposing patients to infectious organisms like fungi, particularly for those receiving certain chemotherapy treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions lung irritation and product contamination (including mold) but does not explicitly address infectious risks from inhalation or heightened risk during chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that medical marijuana may be used to control symptoms associated with pancreatic cancer and its treatments, such as nausea, vomiting, loss of appetite, and pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States it may help with pain, nausea/vomiting, appetite, and anxiety/sleep related to cancer and chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that there is mixed data on the benefit of medical marijuana for managing symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Says evidence is mixed and more studies are needed; also notes results vary in a cited review."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses potential legal challenges with obtaining and using medical marijuana, noting that these may vary based on the patient\u2019s location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers U.S. state variability, federal illegality, international differences, and insurance coverage."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends not driving or making important decisions while under the influence of marijuana.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not include an explicit recommendation to avoid driving or important decisions while impaired."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly recommends obtaining medical marijuana only from professionals licensed to sell it.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises choosing lab-tested products from licensed dispensaries, implying procurement from licensed sellers."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that medical marijuana refers to products derived from the cannabis plant or its extracts that contain active compounds such as THC (tetrahydrocannabinol), CBD (cannabidiol), or combinations thereof.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines medical marijuana as cannabis plant or extracts with THC and CBD and describes their properties."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that preliminary data reports poor clinical outcomes in adults receiving immunotherapy while using cannabis and/or cannabinoids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of immunotherapy outcomes with cannabis use."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that CBD presents risks for hepatotoxicity, with a meta-analysis reporting a nearly 6-fold increase in liver enzyme elevation and drug-induced liver injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions possible liver strain and interactions but not CBD-specific hepatotoxicity or the meta-analysis finding."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cannabis and/or cannabinoids are one of several pharmacologic options for adults with cancer experiencing refractory nausea and vomiting despite optimal prophylaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes FDA-approved synthetic cannabinoids for chemotherapy-induced nausea but does not specify 'refractory despite optimal prophylaxis' or 'one of several options.'"
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce polypharmacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address polypharmacy reduction."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce opioid requirements for cancer-related pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention opioid-sparing research; instead suggests cannabis may be as effective as opioids for some pain."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of chemotherapy-induced peripheral neuropathy or related research needs."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that further research is needed to determine the effects of cannabis on pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States evidence is mixed in general but does not explicitly state that further research is needed regarding cannabis' effects on pain specifically."
      }
    ],
    "question_number": 65,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:49:01.817565",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends consulting with the patient\u2019s oncologist or healthcare team, including specific roles such as nurse practitioner or palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting the medical team and specifically mentions the oncologist and palliative care specialist to explain options to the whole family."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that the healthcare team may have a social worker available to assist with family discussions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that hospitals often have oncology social workers who can mediate discussions, indicating availability through the care setting to assist with family discussions."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends involving a neutral third party, such as a social worker, spiritual care worker, counselor, or patient advocate, to facilitate family discussions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a neutral third party (family therapist or mediator) and also suggests involving a counselor or social worker to mediate discussions."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly provides online resources for cancer patients and their families, including specific organizations like PANCAN, NCI, or ACS.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites PanCAN, NCI, and the American Cancer Society, as well as CancerCare and ASCO\u2019s Cancer.Net."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend scheduling a family meeting to discuss goals of care and important treatment decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends scheduling a family meeting with ground rules and also suggests a family conference with the doctor to align decisions."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that understanding your mother\u2019s specific goals should shape conversations about goals of care and treatment recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that her wishes should guide decisions and notes treatment depends on her goals, emphasizing goal-concordant care."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that your mother\u2019s wishes related to treatment, belief systems, and personal ways of coping should be respected by their families, cancer care team, and others who support them through the cancer experience.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it emphasizes honoring the patient\u2019s autonomy and acknowledges cultural differences, it does not explicitly state that the care team and others should respect her belief systems and personal coping styles."
      }
    ],
    "question_number": 66,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:50:00.522221",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests talking to a doctor and mentions palliative care teams, but does not specifically recommend discussing concerns with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual care worker, palliative care professional, or counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends professional counseling and notes that many hospitals have palliative care teams including social workers or psychologists."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends support groups and other online resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups (online or in-person) and references organizations with resources tailored to pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response states that depression is highly prevalent in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions depression and anxiety are common in cancer patients generally but does not state that depression is highly prevalent in pancreatic cancer specifically."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms of depression (e.g., persistent sadness, anhedonia, sleep/appetite changes, hopelessness) are reviewed."
      },
      {
        "criterion_number": 6,
        "description": "The response states that if the patient is experiencing thoughts of harming themselves or others, they should seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no guidance about urgent action for suicidal or homicidal ideation."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that it\u2019s important to have open and honest conversations about their concerns, including feeling like a burden to their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises starting an open, honest conversation and provides example language addressing feelings of being a burden."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage the patient to express their fears and anxieties about the impact of their illness on their loved ones, and acknowledge and validate their feelings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages expressing worries, active listening, and validation without dismissing concerns."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to ask about the patient\u2019s preferences and personal goals of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends involving the patient in decisions, it does not explicitly mention asking about preferences and personal goals of care."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention it is important to emphasize working together to manage the challenges.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes families as teams, sharing responsibilities, and distributing caregiving tasks to manage the burden together."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention support networks such as PanCAN, CancerCare, ASCO.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions PanCAN, CancerCare, and the American Cancer Society, and provides the PanCAN Patient Central hotline."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that professional counseling can help process these emotions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that a therapist or counselor specializing in oncology can help process these emotions."
      }
    ],
    "question_number": 67,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:51:17.271374",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states targeted therapies work against cancer with specific genetic mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that targeted therapy attacks specific molecules/genes/pathways and notes tumors are driven by specific genetic changes; therapy is matched if a targetable mutation is found."
      },
      {
        "criterion_number": 2,
        "description": "The response states that not all pancreatic cancers will have mutations for which targeted therapy can be used.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states not every pancreatic cancer patient is a candidate and eligibility depends on tumor genetics and other factors."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of targetable mutations in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions BRCA1/2 mutations (PARP inhibitors), NTRK gene fusions (TRK inhibitors), KRAS (investigational), and MSI-high context."
      },
      {
        "criterion_number": 4,
        "description": "The response states targeted therapies can be given alone or sometimes in combination with chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes EGFR inhibitor erlotinib is often combined with gemcitabine and asks how therapy will be combined, but does not explicitly state that targeted therapies can also be given alone."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly recommends consulting the oncologist and provides specific questions to ask at the next appointment."
      },
      {
        "criterion_number": 6,
        "description": "Mentions targeted therapy targets proteins, genes, or pathways of cancer cells with potentially less damage to normal cells vs chemotherapy or radiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes targeting proteins/genes/pathways and contrasts with chemotherapy, noting potential for fewer side effects and sparing normal cells."
      },
      {
        "criterion_number": 7,
        "description": "Mentions that while targeted therapy is an option, it is important to consider all potential treatment options, outcomes, and adverse events to make an informed decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses benefits, side effects, testing results, clinical trial considerations, success rates, and costs\u2014encouraging informed decision-making with the care team."
      },
      {
        "criterion_number": 8,
        "description": "Mentions examples of targeted therapies such as those listed (e.g., dabrafenib+trametinib, larotrectinib, entrectinib, selpercatinib, rucaparib, olaparib, adagrasib, sotorasib, erdafitinib, trastuzumab deruxtecan, zenocutuzumab).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including larotrectinib, entrectinib (NTRK), olaparib (PARP), and sotorasib (KRAS), which are among the listed examples."
      },
      {
        "criterion_number": 9,
        "description": "Negative points if targeted therapies not approved for pancreatic cancer are discussed (e.g., osimertinib, regorafenib, mTOR inhibitors).",
        "score_given": 0,
        "max_points": 0,
        "justification": "Does not mention disallowed agents such as osimertinib, regorafenib, or mTOR inhibitors; no penalty applied."
      }
    ],
    "question_number": 68,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:52:10.977569",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing integrative medicine with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises to consult the oncology team before starting any new therapies and to talk to the oncology team about integrative programs and referrals."
      },
      {
        "criterion_number": 2,
        "description": "The response states integrative medicine is not as effective as standard of care treatments for pancreatic cancer like chemotherapy, radiation, surgery, and targeted therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states integrative methods are not a cure, not meant to replace standard treatments, and there is no strong evidence they shrink tumors or extend survival on their own."
      },
      {
        "criterion_number": 3,
        "description": "The response states integrative medicine can be a helpful adjunct to standard of care treatments for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States integrative medicine can be valuable for symptom relief and quality of life and is meant to complement standard treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response defines integrative medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a definition: combining conventional treatments with evidence-based complementary approaches to improve well-being and manage symptoms."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of integrative medicine interventions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gives multiple examples: nutrition/diet, acupuncture, mind-body practices (meditation, yoga, tai chi), exercise, massage therapy, and herbal supplements."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends telling the patient\u2019s oncologist if they plan to include integrative medicine interventions into their care plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to consult the oncology team before starting any new therapies and to work with a multidisciplinary team to build a plan."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends telling the patient\u2019s oncologist about all supplements they are taking.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it warns about supplement interactions and suggests supervision, it does not explicitly instruct telling the oncologist about all supplements being taken."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with the treatments being prescribed for their pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions interactions such as St. John\u2019s wort interfering with chemotherapy and high-dose antioxidants potentially reducing chemotherapy effectiveness."
      },
      {
        "criterion_number": 9,
        "description": "The response states there is data to support some integrative medicine interventions for specific uses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes scientific backing for symptom management and cites evidence for acupuncture, mind-body practices, and exercise improving quality of life or specific symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that safety concerns and risks related to integrative medicine approaches are heightened with self-prescription or use of non-standardized products.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Warns against unproven therapies, advises against using herbal supplements without oversight, and recommends choosing high-quality, USP-verified products, addressing risks of self-prescription and non-standardized products."
      }
    ],
    "question_number": 69,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:52:48.393019",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the skin changes with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing with the oncologist/healthcare team and to contact the oncologist or nurse right away."
      },
      {
        "criterion_number": 2,
        "description": "The response states that skin changes are a common side effect of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that skin changes are a relatively common side effect of chemotherapy, especially for treatments used in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response states that skin changes related to treatment for pancreatic cancer can range from mild to life-threatening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that some changes can be more serious and require immediate attention, it does not explicitly state that they can be life-threatening."
      },
      {
        "criterion_number": 4,
        "description": "The response provides at least two examples of skin changes, including hand-foot syndrome, allergic reactions, or infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple examples are provided, including rash/redness, dryness/itching, photosensitivity, hyperpigmentation, hand-foot syndrome, and nail changes; it also mentions allergic reactions and infection as concerns."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate evaluation by a healthcare provider if the patient shows signs of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises seeking medical attention immediately if there are signs such as fever, blistering, swelling, or signs of infection."
      },
      {
        "criterion_number": 6,
        "description": "The response provides at least one example of signs and symptoms of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists examples: fever, pus, and warmth as signs of infection."
      },
      {
        "criterion_number": 7,
        "description": "The response states that skin changes related to treatment for pancreatic cancer should be treated by a healthcare professional experienced in caring for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response directs the reader to the oncologist and oncology team to evaluate and manage the skin changes, implying treatment by cancer-experienced professionals."
      },
      {
        "criterion_number": 8,
        "description": "The response states that skin changes related to treatment for pancreatic cancer often require specific interventions or escalation of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes clinicians may prescribe creams, ointments, or oral medications and may adjust treatment; also recommends immediate medical attention for severe symptoms, indicating potential escalation."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions at least three specific manifestations of skin changes related to chemotherapy, such as new or worsening skin lesions, itch, acne-like symptoms, bullous dermatoses, allergic reactions, hand-foot syndrome, nail changes, or inflammatory dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions rash/acne-like bumps, hives, dryness/itching, photosensitivity, hyperpigmentation, hand-foot syndrome, and nail changes\u2014well over three manifestations."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that skin changes could also be due to other conditions, such as infection, other medications, or unrelated skin disorders.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes skin changes could be due to other causes like infection or medication interactions, and mentions allergic reactions."
      },
      {
        "criterion_number": 12,
        "description": "The response states the importance of correctly identifying skin changes to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it emphasizes reporting and appropriate assessment, it does not state the importance of correct identification to avoid unnecessary discontinuation of effective therapy."
      }
    ],
    "question_number": 70,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:53:48.592182",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response suggests asking about the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly asks: 'What stage is the cancer, and what does that mean in terms of how far it has spread?'"
      },
      {
        "criterion_number": 2,
        "description": "The response suggests asking about available treatment options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists questions about recommended treatment options, surgery, chemotherapy, radiation, immunotherapy, and targeted drugs."
      },
      {
        "criterion_number": 3,
        "description": "The response suggests asking about prognosis if the patient wants to know this information.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'What is the expected prognosis or survival rate based on her stage and health?'"
      },
      {
        "criterion_number": 4,
        "description": "The response suggests asking about potential side effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'What side effects should we expect from the recommended treatments, and how can we manage them...?'"
      },
      {
        "criterion_number": 5,
        "description": "The response suggests asking about when the patient should follow up next.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under 'Next Steps and Follow-Up' asks: 'How often will we have appointments...?'"
      },
      {
        "criterion_number": 6,
        "description": "The response recommends writing down questions ahead of time and bringing them to the appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises: 'Writing down your questions in advance...'"
      },
      {
        "criterion_number": 7,
        "description": "The response suggests asking about symptoms affecting the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses pain, jaundice, digestive problems, weight loss, and pain management options."
      },
      {
        "criterion_number": 8,
        "description": "The response suggests asking about clinical trial availability.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks: 'Are there clinical trials available that might be a good fit? How can we learn more or enroll?'"
      },
      {
        "criterion_number": 9,
        "description": "The response suggests asking about how palliative care can help with the patient\u2019s care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'What would palliative or supportive care look like?' and identifies palliative care specialist on the team."
      },
      {
        "criterion_number": 10,
        "description": "The response suggests asking if genetic testing is available for germline inheritable cancer predisposition syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks: 'Is there a genetic component? Should we consider genetic testing for her or our family?'"
      },
      {
        "criterion_number": 11,
        "description": "The response suggests asking about nutrition and if a nutritionist is available to help with dietary recommendations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions nutrition management and specifically working with a dietitian."
      },
      {
        "criterion_number": 12,
        "description": "The response suggests asking about support groups for patients with pancreatic cancer and their families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks for referrals to support groups, counselors, or patient navigators."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests asking about how to contact the oncology team in case of questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: 'Who do we contact in an emergency or for questions outside of appointments?'"
      },
      {
        "criterion_number": 14,
        "description": "The response suggests asking if lifestyle changes need to be made.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses dietary changes, exercise/physical therapy, daily activities, and infection precautions."
      },
      {
        "criterion_number": 15,
        "description": "The response suggests asking about mental health and resources for mental health support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions emotional side effects (anxiety/depression) and referrals to counselors/support groups."
      },
      {
        "criterion_number": 16,
        "description": "The response recommends writing down important information during the appointment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests bringing a notebook or recording device to jot down answers."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention to ask questions related to goals of treatment (palliative, curative, etc).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses palliative/supportive care versus aggressive treatment and advance care planning, reflecting goals-of-care discussions."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention bringing a family member or a friend to help listen and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends bringing a trusted family member or friend to help listen and take notes."
      }
    ],
    "question_number": 71,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:54:55.497793",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises consulting the oncologist and healthcare team, including scheduling a dedicated appointment and considering a second opinion."
      },
      {
        "criterion_number": 2,
        "description": "The response states quality of life is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Quality of life is emphasized multiple times, including prioritizing quality time and relief from treatment side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends considering the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly prompts discussion of goals (e.g., more time vs. better quality time) and aligning choices with those goals."
      },
      {
        "criterion_number": 4,
        "description": "The response states pancreatic cancer is an aggressive cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that pancreatic cancer is often aggressive."
      },
      {
        "criterion_number": 5,
        "description": "The response states stopping treatment without consulting the treating oncologist is dangerous.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it urges consultation with the oncologist, it does not explicitly state that stopping treatment without consulting the oncologist is dangerous."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering access to emergency care at the travel destination.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises researching hospitals/clinics at the destination and notes that accessing care abroad could be challenging, also mentioning potential emergencies."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends refilling all prescription medications prior to travel.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It recommends packing medications but does not explicitly advise refilling prescriptions prior to travel."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends considering if travel is safe.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It recommends assessing feasibility, obtaining a 'fit to travel' letter, and choosing less strenuous trips, which directly addresses travel safety."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends considering if the patient is strong enough to travel.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly asks whether the patient can handle flights, walking, and activities, which assesses their strength and endurance for travel."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly clarify what \u201cstopping treatment\u201d means, such as stopping all therapies, only chemotherapy, or supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clarifies that stopping treatment could range from pausing chemotherapy to entering hospice, and distinguishes active cancer treatment (chemo/radiation) from palliative care."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly discuss the effects of a (temporary) treatment break on the prognosis of the cancer, symptoms, and other risks involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses prognosis with and without treatment, notes that stopping may lead to faster progression and complications (pain, jaundice, blockages), and mentions temporary treatment pauses."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that stopping treatment may affect the patient\u2019s medical stability, ability to travel safely, and access to care and support while away.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that stopping treatment can lead to complications that may cut a trip short or require emergency care, discusses unpredictably worsening symptoms affecting safe travel, and notes challenges accessing care abroad and arranging support."
      }
    ],
    "question_number": 72,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:55:55.497263",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit recommendation: \"Please consult his oncologist or healthcare team immediately...\" and later reiterates involving the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response states that if there are signs or symptoms of infection at the port site, to seek immediate evaluation by a healthcare professional.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States: \"If the port problems are causing pain or signs of infection (fever, redness, swelling), seek emergency care.\""
      },
      {
        "criterion_number": 3,
        "description": "The response offers examples of signs or symptoms of infection, including fever, chills, redness or pain at the port site, and pus coming from the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides fever, redness, swelling, and pain but does not include chills or pus. Binary grading requires inclusion of the listed examples."
      },
      {
        "criterion_number": 4,
        "description": "The response states many chemotherapy drugs must be given through central venous catheters.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions that many regimens are IV-based and that some drugs irritate veins, but does not state that many chemotherapy drugs must be administered through central venous catheters."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of central venous catheters.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists PICC lines, tunneled central venous catheters (Hickman, Broviac, Groshong), and non-tunneled central venous catheters (jugular/subclavian)."
      },
      {
        "criterion_number": 6,
        "description": "The response states different central venous catheters have pros and cons.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides pros and cons for PICC, tunneled, and non-tunneled central lines, explicitly contrasting benefits and risks."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends asking the patient\u2019s oncologist about alternative treatment regimens that may not require administration through a central venous catheter.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests oral chemotherapy (e.g., capecitabine) as a possibility and advises: \"Discuss this with his doctor to see if it's feasible.\""
      },
      {
        "criterion_number": 8,
        "description": "The response recommends avoiding touching, rubbing, and bumping the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice provided about avoiding touching, rubbing, or bumping the port site."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include peripherally inserted central catheters (PICC lines).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly mentions and describes PICC lines as an alternative."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a tunneled central venous catheter (Hickman, Broviac, Groshong).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists tunneled catheters and examples (Hickman, Broviac, Groshong)."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a non-tunneled central venous catheter (jugular or subclavian line).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names non-tunneled central venous catheters (internal jugular or subclavian) as an option."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include oral chemotherapy such as capecitabine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions capecitabine explicitly as an oral option."
      },
      {
        "criterion_number": 14,
        "description": "The response should not mention that chemotherapy for pancreatic cancer can be given via subcutaneous injection.",
        "score_given": -10,
        "max_points": 0,
        "justification": "States: \"Other options like subcutaneous injections are rare for pancreatic chemo,\" which implies SC administration is an option; this violates the criterion."
      }
    ],
    "question_number": 73,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:57:08.033642",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises to consult the oncology team for personalized advice and to work closely with the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends avoiding people who have signs or symptoms of an infectious illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States to limit contact with sick people and asks friends and family to stay away if they have colds, flu, or infections."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends frequent hand washing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends washing hands frequently for at least 20 seconds or using alcohol-based sanitizer."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends wearing a face mask while in crowds.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises wearing a well-fitting mask (e.g., N95) if outings are necessary and to avoid crowds."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing asking the patient\u2019s healthcare team about which vaccinations are recommended.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends staying up-to-date on vaccines and to discuss timing with the doctor, implying consultation about vaccination recommendations."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reporting signs and symptoms of infection to the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages having oncology team emergency contacts and knowing when to go to the ER; also says to report cuts, sores, or rashes to the doctor immediately."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of signs and symptoms of infection, including fever, chills, cough, runny nose, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists fever, chills, cough, vomiting, and others but does not include runny nose or nausea as examples."
      },
      {
        "criterion_number": 8,
        "description": "The response states the patient\u2019s oncologist may prescribe antibiotics, antivirals, and antifungals to prevent infection.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that doctors sometimes prescribe antibiotics, antivirals, or antifungals preventively during chemotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response instructs the patient to take all medications as prescribed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to follow prophylactic medications exactly as directed."
      },
      {
        "criterion_number": 10,
        "description": "The response states some treatments for pancreatic cancer can lower white blood cell counts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes treatments can cause immunosuppression/neutropenia and mentions growth factors to boost white blood cells."
      },
      {
        "criterion_number": 11,
        "description": "The response states white blood cells fight off infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not explicitly state the role of white blood cells in fighting infection."
      },
      {
        "criterion_number": 12,
        "description": "The response states a low white blood cell count can increase the risk of infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that immunosuppression/neutropenia makes the body more susceptible to infections and references periods of low white blood cell counts."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that prevention includes vaccination for COVID-19 and flu for the patient and household members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions flu and COVID-19 vaccines for the patient and recommends household members be vaccinated."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention includes avoiding exposure to fungal spores (e.g., construction/demolition sites, intensive soil exposure, household renovation).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions soil handling with gloves and cleaning humidifiers but does not explicitly advise avoiding high\u2013fungal-spore environments like construction/demolition or household renovations."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not include guidance that antimicrobial prophylaxis is generally not needed for most solid tumors when neutropenia is brief/low risk."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to lack of evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state these interventions lack evidence; instead recommends a low-microbial (neutropenic) diet during neutropenia."
      }
    ],
    "question_number": 74,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:58:06.833752",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines precision medicine as tailoring treatment based on unique tumor characteristics (genetic/molecular) to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains precision medicine as customizing care based on tumor genetics and other factors and notes potential for improved effectiveness and fewer side effects."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing details with the father\u2019s oncologist/precision oncology specialist."
      },
      {
        "criterion_number": 3,
        "description": "Mentions testing the tumor for genetic mutations which can be targeted with certain therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes tumor genomic profiling (biopsy or liquid biopsy) to identify actionable mutations and guide therapy."
      },
      {
        "criterion_number": 4,
        "description": "States PARP inhibitors may be used in patients with mutations in the BRCA gene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions PARP inhibitors (e.g., olaparib) for BRCA mutations."
      },
      {
        "criterion_number": 5,
        "description": "States immunotherapy may be used in patients if their tumors have MSI-high.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pembrolizumab for MSI-high or TMB-high tumors."
      },
      {
        "criterion_number": 6,
        "description": "Mentions testing the tumor for expression of certain proteins which can be targeted with certain therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions testing for proteins among biomarkers and that actionable targets can be matched to drugs, implying protein expression testing."
      },
      {
        "criterion_number": 7,
        "description": "Provides examples of targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including PARP inhibitors for BRCA, immunotherapy for MSI-high/TMB-high, and KRAS-targeted agents."
      },
      {
        "criterion_number": 8,
        "description": "Provides examples of therapies targeting protein expression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit examples of therapies targeting protein expression (e.g., HER2-, CLDN18.2-, or others) were provided."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that not every patient will have genetic mutations or protein expression which can be targeted with precision medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that not all pancreatic tumors have actionable mutations and quantifies an estimated proportion."
      },
      {
        "criterion_number": 10,
        "description": "States precision medicine helps the oncologist identify treatments which will not be helpful.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that testing can rule out ineffective treatments."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that comprehensive genomic profiling using NGS is now standard for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention NGS-based comprehensive genomic profiling being standard of care."
      },
      {
        "criterion_number": 12,
        "description": "Mentions that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even without family history.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses genetic counseling mainly if there is family history and does not state universal germline and somatic testing recommendations."
      },
      {
        "criterion_number": 13,
        "description": "Mentions that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention TRK inhibitors or NTRK fusions."
      }
    ],
    "question_number": 75,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:58:52.077180",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to talk to the oncology team immediately and to consult her oncologist for personalized advice."
      },
      {
        "criterion_number": 2,
        "description": "The response states mouth sores are a common side effect of some chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that oral mucositis from chemotherapy is a common side effect."
      },
      {
        "criterion_number": 3,
        "description": "The response states drugs like 5-FU and capecitabine can cause mouth sores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific chemotherapy agents (e.g., 5-FU, capecitabine) are named."
      },
      {
        "criterion_number": 4,
        "description": "The response states these are sometimes related to having low white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention low white blood cell counts (neutropenia) as related to mucositis."
      },
      {
        "criterion_number": 5,
        "description": "The response states that having low white blood cell counts can increase the likelihood of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infection risk is mentioned, but not in relation to low white blood cell counts."
      },
      {
        "criterion_number": 6,
        "description": "The response states mouth sores in patients on chemotherapy can also be related to infections from viruses or bacteria.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes possible thrush (fungal) and bacterial issues, but does not state that sores can be related to infections from viruses or bacteria."
      },
      {
        "criterion_number": 7,
        "description": "The response states the patient\u2019s healthcare team may swab the mouth sores to test them for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of swabbing or diagnostic testing of sores."
      },
      {
        "criterion_number": 8,
        "description": "The response states there are medications which can help prevent and improve mouth sores in the form of both topical drugs and specialized mouthwashes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions prescription mouth rinses, 'magic mouthwash,' topical agents (e.g., lidocaine, steroids), and protective coatings like sucralfate."
      },
      {
        "criterion_number": 9,
        "description": "The response states there are medications which can improve symptoms related to mouth sores, like pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends analgesics (acetaminophen/ibuprofen), topical anesthetics (benzocaine, lidocaine), and stronger prescription pain medications."
      },
      {
        "criterion_number": 10,
        "description": "The response instructs the patient to immediately seek evaluation by a healthcare provider if they are experiencing a fever or other signs or symptoms of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises that fever and signs of infection 'need prompt medical attention' and to contact the doctor right away for concerning symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends gentle oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed gentle oral care guidance (soft-bristled brush, salt/baking soda rinses, avoid alcohol-containing mouthwashes)."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations due to lack of efficacy and potential for adverse effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Chlorhexidine is not discussed."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical anesthetics (lidocaine viscous, 2% solution) and mixed medication mouthwashes (\u201cmagic mouthwash\u201d) may be used for pain control, though evidence for specific formulations is variable.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions lidocaine and 'magic mouthwash' for pain, but does not specify viscous 2% formulation nor comment on variable evidence for formulations."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Gabapentin may be considered for mucositis-related pain, often in combination with other analgesics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gabapentin is not mentioned."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that topical and systemic antifungals (e.g., clotrimazole troches, systemic fluconazole) are indicated for secondary candidiasis, which is common in the setting of mucositis and xerostomia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Antifungals and thrush are referenced, but no mention of topical vs systemic options, examples (clotrimazole/fluconazole), or indication for secondary candidiasis."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address antibiotic use or criteria for initiation."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen, but that stronger prescription medicines may be indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends acetaminophen/ibuprofen and notes that stronger prescription pain medications may be necessary."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages involvement of oncologist, dentist with oncology expertise, palliative care, and dietitian, emphasizing supportive care."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, nutritional support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed dietary advice: soft/bland foods, nutrition supplements, hydration, and small frequent meals."
      }
    ],
    "question_number": 76,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T14:59:44.028255",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing specifics with the oncologist and trial coordinators; later reiterates to discuss with the oncologist and trial PI."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the design of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers randomization, blinding vs open-label, control/active comparator, crossover, data monitoring, and early stopping, providing a clear overview of trial design."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the four phases of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes Phases I\u2013IV with focus (safety/dosing, efficacy, comparison to standard, post-approval)."
      },
      {
        "criterion_number": 4,
        "description": "The response defines placebo.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines placebo as an inactive substance that looks identical to the real treatment and has no therapeutic effect."
      },
      {
        "criterion_number": 5,
        "description": "The response states that patients in clinical trials for cancer are seldom given a placebo, as this may cause harm.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States placebos are uncommon in cancer trials and explains ethical concerns about giving only placebo in life-threatening disease, emphasizing standard of care is typically provided."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews informed consent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises reviewing the informed consent form, notes it details placebo involvement, randomization odds, and control therapy, and mentions the right to withdraw at any time."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the placebo effect.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains improvements can be due to the 'placebo effect,' where belief in treatment helps."
      },
      {
        "criterion_number": 8,
        "description": "The response states that patients in the control arm of clinical trials often receive the standard of care treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states control groups typically receive standard of care and describes designs with placebo plus standard treatment vs experimental plus standard treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to discover new, effective treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States trials test new treatments to see if they are safe and effective and are essential for advancing medicine."
      },
      {
        "criterion_number": 10,
        "description": "The response states clinical trials are designed to minimize patient harm.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes strict ethical oversight, IRB review, safety monitoring, and early stopping for safety, indicating harm minimization."
      },
      {
        "criterion_number": 11,
        "description": "The response states that patients participating in clinical trials are monitored closely for side effects from the disease and the treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions close monitoring, regular check-ins, and scans for participants."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends researching clinical trials before participating.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages reviewing trial details, asking questions, and weighing pros and cons before enrolling."
      },
      {
        "criterion_number": 13,
        "description": "The response offers resources for researching clinical trials, including ClinicalTrials.gov.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides ClinicalTrials.gov and PanCAN as resources for finding trials."
      },
      {
        "criterion_number": 14,
        "description": "The response states clinical trials are designed to be ethical and are monitored closely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions strict ethical guidelines, IRB oversight, and data monitoring committees."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States trials are essential for advancing medicine and notes participation can help future patients."
      }
    ],
    "question_number": 77,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:00:41.816135",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states the oncologist is the best source for details and encourages asking them for clarification; later reiterates to reach out to the oncologist or a specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response states there are many different types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple treatment modalities and notes that combination therapy uses two or more types, indicating several treatment types are available."
      },
      {
        "criterion_number": 3,
        "description": "The response includes surgery, chemotherapy, immunotherapy, targeted therapy, and radiation therapy as types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contains dedicated sections mentioning chemotherapy, radiation therapy, surgery, targeted therapy, and immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response states combination therapy may mean two or more different types of treatment or two or more chemotherapy medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines combination therapy as using two or more types of treatment and also provides examples of multi-drug chemotherapy regimens (e.g., FOLFIRINOX, gemcitabine plus nab-paclitaxel)."
      },
      {
        "criterion_number": 5,
        "description": "The response gives the example of FOLFIRINOX.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists FOLFIRINOX as a common regimen."
      },
      {
        "criterion_number": 6,
        "description": "The response states that FOLFIRINOX is a combination chemotherapy regimen which contains 5-FU, leucovorin, irinotecan, and oxaliplatin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines FOLFIRINOX as four drugs: folinic acid (leucovorin), fluorouracil (5-FU), irinotecan, and oxaliplatin."
      },
      {
        "criterion_number": 7,
        "description": "The response states the treatment plan for patients with pancreatic cancer is individualized to their overall health and the cancer\u2019s type, stage, and genetic signature.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States treatments are highly personalized and dependent on stage, overall health, and genetic factors; also mentions tumor location/size/spread."
      },
      {
        "criterion_number": 8,
        "description": "The response states the decision to use any cancer treatment weighs the likelihood of benefit with the risk of side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists benefits and potential side effects, it does not explicitly state that treatment decisions weigh benefits versus risks."
      },
      {
        "criterion_number": 9,
        "description": "The response states the goal of combination therapy is to achieve the best anti-cancer effect.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the goal is to improve effectiveness, shrink tumors, control symptoms, and extend survival\u2014capturing the intent to maximize anti-cancer effect."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that examples of combination therapy include chemoradiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions chemoradiation (radiation combined with chemotherapy)."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that examples of combination therapy include chemotherapy and surgery, with neoadjuvant chemotherapy given before surgery and adjuvant chemotherapy given after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes surgery can be combined with chemotherapy before or after surgery; elsewhere defines neoadjuvant (before surgery) and adjuvant (after surgery) therapy, satisfying the example."
      }
    ],
    "question_number": 78,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:02:09.935015",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises looping in the doctor/oncologist and working with the care team to address pre-authorization issues."
      },
      {
        "criterion_number": 2,
        "description": "The response states oncology practices often have team members who help patients with insurance issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes many cancer centers have financial navigators or social workers who specialize in insurance and can submit appeals or negotiate."
      },
      {
        "criterion_number": 3,
        "description": "The response states pre-authorization issues are not uncommon in oncology care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \"You're not alone... many families face similar hurdles,\" indicating these issues are common in this context."
      },
      {
        "criterion_number": 4,
        "description": "The response states that denials should be appealed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises to file an appeal promptly and describes internal and external appeals."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends contacting the insurance company.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to contact the insurance provider immediately, ask for reasons, and request information in writing."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends understanding the patient\u2019s insurance plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises reviewing the plan\u2019s summary of benefits for pre-authorization requirements, appeals processes, and timelines."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends understanding the insurance company\u2019s denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking for the exact reason for delay/denial and requesting that information in writing."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends contacting patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends seeking help from patient advocacy organizations for insurance navigation and appeals."
      },
      {
        "criterion_number": 9,
        "description": "The response offers examples of patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN, CancerCare, and the Patient Advocate Foundation with contact info."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends clearly documenting all communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to keep a detailed log of all communications, including dates, times, and discussion points."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends obtaining written documentation for all approved pre-authorizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises requesting the reason for denial in writing and logging calls, but does not specifically recommend obtaining written documentation for approved authorizations."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that prior authorization is a process in which payers require clinicians to obtain approval before a medication is covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit definition of prior authorization as payer-required approval before coverage of a medication is provided."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that the appeal process involves submitting a formal appeal with supporting evidence, such as clinical guidelines, published trial data, and, for targeted or off-label therapies, molecular profiling results.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions including NCCN guidelines and medical records, it does not mention published trial data or molecular profiling results for targeted/off-label therapy appeals."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention that if appeals are unsuccessful or delays persist, alternative access strategies should be pursued, including patient assistance programs, manufacturer co-pay cards, and foundation grants, which require application and documentation of financial need.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions patient assistance programs and foundations but does not explicitly include manufacturer co-pay cards or note that these programs require applications with documentation of financial need."
      },
      {
        "criterion_number": 15,
        "description": "The response must specifically mention patient advocacy organizations such as PanCAN and CancerCare as resources.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly cites PanCAN and CancerCare as resources and provides their contact details."
      }
    ],
    "question_number": 79,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:02:56.820856",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to contact his oncologist or primary care physician right away and to discuss with his healthcare team for proper evaluation."
      },
      {
        "criterion_number": 2,
        "description": "The response states that infections can cause cognitive changes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States infections during treatment can lead to imbalances affecting brain function."
      },
      {
        "criterion_number": 3,
        "description": "The response states that cancer and its treatments may cause symptoms that can mimic cognitive changes, including fatigue, pain, poor sleep, dehydration, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes fatigue, pain, depression/anxiety from illness can mimic cognitive problems and cites dehydration as a contributor. Although poor sleep is not explicitly mentioned, the core concept and multiple specified examples are included."
      },
      {
        "criterion_number": 4,
        "description": "The response states sudden changes in cognition may be a medical emergency and to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specifically mention that sudden cognitive changes are a medical emergency or instruct immediate evaluation in that scenario."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate medical evaluation if the patient has stroke symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stroke symptoms or the need for immediate evaluation if present."
      },
      {
        "criterion_number": 6,
        "description": "The response states if the patient has a fever or other signs or symptoms of infection, to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While infections are discussed, there is no explicit directive to seek immediate evaluation for fever or infection symptoms."
      },
      {
        "criterion_number": 7,
        "description": "The response states patients commonly experience mental fogginess, or \u201cchemo brain.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions chemotherapy-related cognitive impairment ('chemo brain') and describes mental fogginess."
      },
      {
        "criterion_number": 8,
        "description": "The response states that cognitive changes from cancer treatment may improve if the treatment is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that stopping treatment may improve cognitive changes; instead notes effects can persist."
      },
      {
        "criterion_number": 9,
        "description": "The response states if treatment side effects are severe enough, the patient\u2019s oncologist may choose to decrease the dose of the treatment so it is better tolerated or switch to a different therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests treatment plan adjustments including switching medications, which addresses switching therapy (though dose reduction is not explicitly mentioned)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends tracking the cognitive changes and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises keeping a symptom journal and sharing patterns with doctors."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that cancer treatment (including radiation, chemotherapy, and pain medications such as opioids) can affect a person\u2019s cognitive functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions chemotherapy, radiation (indirect effects), and opioids as contributors to cognitive changes."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that other factors unrelated to treatment could also cause cognitive changes, such as cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses cancer-related causes such as metastasis, paraneoplastic syndromes, and metabolic issues, indicating non-treatment factors."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that stress/anxiety can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions anxiety and depression as factors that can mimic or exacerbate cognitive problems."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pre-existing conditions can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "References underlying conditions such as thyroid issues or early dementia as possible contributors."
      }
    ],
    "question_number": 80,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:03:37.741429",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises making decisions with her oncology team and later says to talk to her oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states feeding tubes can help patients get the nutrition and hydration they need when they are unable to eat or drink on their own.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses providing liquid nutrition when eating by mouth is difficult but does not explicitly mention hydration or inability to drink."
      },
      {
        "criterion_number": 3,
        "description": "The response states the most common types of feeding tubes are placed through the skin of the abdomen and into the stomach or small bowel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies PEG (percutaneous) and jejunostomy tubes placed into the stomach or small intestine for long-term use, indicating percutaneous abdominal placement."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the patient is not eating or drinking enough because they do not want to, this may be the body\u2019s way of signaling that the patient is nearing the end of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that reduced desire to eat/drink may be a natural sign of approaching end of life."
      },
      {
        "criterion_number": 6,
        "description": "The response states studies have shown that in the absence of a bowel obstruction, feeding tubes do not typically increase survival in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of survival impact or lack of benefit in the absence of obstruction."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends considering hospice care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is not mentioned; only palliative care is suggested."
      },
      {
        "criterion_number": 8,
        "description": "The response states that malnutrition is common in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that up to 80% of pancreatic cancer patients experience significant weight loss and cachexia, indicating malnutrition is common."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of feeding tubes, including discomfort and infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists infection at the tube site and discomfort, along with diarrhea and aspiration."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends discussing the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly references goals of care (curative vs. palliative) and suggests involving palliative care to discuss goals."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked bile duct.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It notes that tumors can block the bile ducts."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked stomach.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It mentions duodenal obstruction and stomach-related complications but does not explicitly state stomach blockage."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to low levels of digestive enzymes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states pancreatic cancer often reduces enzyme production leading to malabsorption (pancreatic insufficiency)."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It mentions decreased appetite and early satiety related to the disease and treatments."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to cancer-related pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists severe pain as a factor affecting eating and digestion."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that nutritional counseling is recommended for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends involvement of a registered dietitian specializing in oncology and discusses nutritional screening."
      }
    ],
    "question_number": 81,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:04:27.467643",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references doctors and the treatment center\u2019s social worker but does not explicitly recommend discussing the plan for talking to children with the patient\u2019s oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends involving a professional who can help with these challenging conversations, like a social worker or spiritual counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends consulting a counselor, social worker, child life specialist, and a family therapist, and notes many hospitals offer these services."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends online resources for patients with cancer, including cancer.org.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists several online resources including the American Cancer Society (cancer.org), CancerCare, KidsHealth, and Pancreatic Cancer Action Network."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends clear and honest language.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises being honest but hopeful, using the word 'cancer' directly, and avoiding euphemisms that could confuse children."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tailoring the conversation to the children\u2019s ages.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides age-specific guidance for young children, school-age kids, and teens with examples tailored to each developmental stage."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention to avoid overwhelming the child with too much information at once; provide information in small doses, stopping frequently to check for comprehension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it cautions against overwhelming with jargon or worst-case scenarios and encourages questions, it does not explicitly advise giving information in small doses or stopping frequently to check comprehension."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention to arrange for an appropriate location for the conversation and ensure there is enough time to give the information and answer questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends choosing a quiet, comfortable time and setting when everyone is relaxed and not rushed, and avoiding times like right before bedtime or school."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention to provide information that is relevant to what the child wants to know.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests encouraging questions such as 'What do you think about this?' and responding accordingly, indicating responsiveness to what the child wants to know."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to respond empathically to the child\u2019s emotions and acknowledge their feelings throughout the conversation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends validating feelings, stating it\u2019s okay to feel sad, angry, or scared, and to listen without interrupting."
      }
    ],
    "question_number": 82,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:04:53.820143",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that sleep patterns can be disturbed by cancer and its treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that sleep disturbances are common in cancer (including pancreatic cancer) and that treatments like chemotherapy, opioids, and steroids can disrupt sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response states that sleep patterns can be disturbed by symptoms like fatigue, pain, and nausea.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly attributes sleep issues to pain, cancer-related fatigue, and digestive issues such as nausea, bloating, and indigestion."
      },
      {
        "criterion_number": 3,
        "description": "The response states that sleep patterns can be a symptom of anxiety and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies anxiety and depression (as well as stress/fear) as emotional factors that can prevent restful sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises bringing the issue to the oncologist, palliative care specialist, or primary care physician and mentions potential referral to a sleep specialist."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tracking the sleep disturbances and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends keeping a sleep diary and using it to help the healthcare team identify triggers."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends sleep hygiene techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests sleep hygiene strategies including a bedtime routine, limiting caffeine, optimizing the sleep environment, and light daytime exercise."
      },
      {
        "criterion_number": 7,
        "description": "The response states other options for treatment may include supplements like melatonin, cognitive behavioral therapy, or prescribed medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions melatonin, prescription sleep aids (with medical supervision), and CBT-I as options."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends seeking immediate medical evaluation if the changes in sleep patterns are sudden or severe.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises urgent medical attention for sudden or severe symptoms such as confusion, extreme lethargy, or breathing issues."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that non-pharmacological interventions like relaxation techniques, cognitive behavioral therapy for insomnia, and mindfulness can be beneficial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically endorses CBT-I as effective for cancer patients; although mindfulness/relaxation are not named explicitly, CBT-I is a non-pharmacological intervention noted as beneficial."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that addressing underlying causes of sleep disruption, such as pain management or treatment of anxiety/depression, is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes assessing and addressing underlying causes (e.g., uncontrolled pain, medication side effects) and recommends adjusting pain management; also identifies anxiety/depression as contributing factors."
      }
    ],
    "question_number": 83,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:05:31.220594",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing complementary therapies with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly urges consultation with the oncology team before starting acupuncture or any complementary therapy and to discuss within clinical trial protocols."
      },
      {
        "criterion_number": 2,
        "description": "The response states complementary therapies like acupuncture may improve symptoms related to cancer and its treatments and may improve cancer patients\u2019 quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes acupuncture can help with nausea, vomiting, pain, fatigue, anxiety, appetite/digestive issues and states it may improve quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response states complementary therapies are not a safe alternative to standard cancer treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly defines complementary therapies as used alongside standard treatments and states they are not meant to replace standard care; warns against claims that acupuncture can cure cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response states complementary therapies are not as effective as standard of care cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it says complementary therapies should not replace standard care, it does not explicitly state they are less effective than standard-of-care cancer treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response defines complementary therapies and provides examples, including acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly defines complementary therapies and lists examples (acupuncture, massage, meditation, yoga, herbal supplements)."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends informing the patient\u2019s oncologist of any supplements the patient starts taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to disclose everything to the doctor and specifically cautions about supplements and interactions."
      },
      {
        "criterion_number": 7,
        "description": "The response states supplements are not regulated by the FDA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention is made of FDA regulation or the lack thereof for supplements."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with certain treatments for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly warns that supplements like turmeric or ginger can interact with chemotherapy drugs or affect liver function."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of acupuncture, including bleeding and infection, which may be increased in patients receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses infection risk (especially with neutropenia) and bleeding/bruising risk with low platelets from chemotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends utilizing a practitioner licensed in acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises choosing a licensed practitioner, citing credentialing bodies and experience with oncology patients."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that acupuncture is generally safe for cancer patients, with no increased risk of serious adverse events compared to sham or standard care, though mild side effects such as bruising, soreness, or transient discomfort may occur.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it states acupuncture is generally safe and serious complications are uncommon, it does not state there is no increased risk compared to sham/standard care and does not clearly note typical mild side effects like soreness or transient discomfort."
      }
    ],
    "question_number": 84,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:06:01.941512",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing balance problems with the patient\u2019s oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises to discuss with his oncologist or healthcare team 'as soon as possible' and later states 'Contact his doctor immediately,' meeting the requirement for an immediate recommendation."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that symptoms from pancreatic cancer and its treatment, such as fatigue, headache, muscle weakness, and peripheral neuropathy, may contribute to sensations of imbalance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links treatment-related fatigue, muscle weakness, anemia, and peripheral neuropathy to unsteadiness/balance problems. While headache is only mentioned in symptom tracking, the response clearly connects multiple relevant symptoms to imbalance."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that chemotherapy can cause peripheral neuropathy, fatigue, anemia, and generalized weakness, which can all cause instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explicitly attributes peripheral neuropathy to chemotherapy, but fatigue, anemia, and weakness are attributed to 'treatments' in general rather than chemotherapy specifically. The criterion requires explicit attribution to chemotherapy for all listed effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that pancreatic cancer itself increases the risk of thromboembolic events, including cerebral ischemic strokes, which may present with acute balance disturbances or ataxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of thromboembolic events or ischemic strokes. Neurologic causes discussed include metastases and paraneoplastic syndromes, but not stroke risk."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly instructs seeking immediate medical evaluation if symptoms are abrupt, severe, or accompanied by other neurologic deficits.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it advises to contact the doctor immediately, it does not explicitly condition urgent evaluation on abrupt/severe onset or additional neurologic deficits."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that balance problems can lead to falls.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'Balance issues can increase the risk of falls and injuries,' which directly meets the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends ensuring the patient drinks plenty of fluids.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises 'Encourage hydration,' which is an explicit recommendation to ensure adequate fluid intake."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends the patient stand and walk with assistance until they can be evaluated by their healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests using assistive devices like a cane or walker but does not explicitly state to stand and walk with assistance until evaluation."
      }
    ],
    "question_number": 85,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:06:29.248511",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends reviewing the pathology report with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises: 'it's essential to review them with her oncologist or healthcare team for personalized interpretation.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states that pathology reports are written by doctors called pathologists who view tissue under the microscope to diagnose diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it says reports are 'prepared by pathologists after examining tissue samples' and later mentions 'Microscopic Description,' it does not explicitly state that doctors called pathologists view tissue under a microscope to make diagnoses."
      },
      {
        "criterion_number": 3,
        "description": "The response states the pathology report will contain a tumor type.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Section 'Diagnosis and Tumor Type' clearly describes that the report includes tumor type (e.g., pancreatic ductal adenocarcinoma, neuroendocrine tumor, etc.)."
      },
      {
        "criterion_number": 4,
        "description": "The response states the pathology report may contain a stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated 'Staging (TNM System)' section explains that staging is reported and used to determine overall stage."
      },
      {
        "criterion_number": 5,
        "description": "The response states the pathology report may contain a tumor size.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under 'Tumor Size, Location, and Grade,' it notes size in centimeters and provides examples."
      },
      {
        "criterion_number": 6,
        "description": "The response states the pathology report may contain a tumor grade.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes grading (G1\u2013G3) and its implications."
      },
      {
        "criterion_number": 7,
        "description": "The response states the pathology report may mention vascular invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions 'lymphovascular invasion' under 'Lymph Node and Vascular/Perineural Invasion.'"
      },
      {
        "criterion_number": 8,
        "description": "The response states the pathology report may mention perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly references 'perineural invasion' and explains its significance."
      },
      {
        "criterion_number": 9,
        "description": "The response states the pathology report may contain special stains which can sometimes be used to determine additional treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions immunohistochemistry (IHC) as confirming diagnosis and lists markers (e.g., synaptophysin), but does not state that special stains can guide additional treatment options."
      },
      {
        "criterion_number": 10,
        "description": "The response states the final stage ranges from I to IV and is a sum of a tumor (T) score, a node (N) score, and a metastasis (M) score.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines T, N, and M components and states that 'Overall Stage combines TNM into a stage (I-IV).' "
      },
      {
        "criterion_number": 11,
        "description": "The response states the pathology report helps the oncologist determine which treatment may be the most effective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple sections tie findings (type, stage, grade, molecular profile) to treatment decisions and advise discussing with the oncologist."
      },
      {
        "criterion_number": 12,
        "description": "The response states the pathology report may include results from genetic testing of the tumor which may help in identifying targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The 'Molecular and Genetic Testing' section mentions BRCA, MSI, etc., and links them to targeted therapy (e.g., PARP inhibitors) and immunotherapy."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention margin status, including the presence of the tumor at or within 1 mm of any resection margin (R1), and its impact on prognosis and adjuvant therapy decisions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Margins are discussed (negative, positive, close) with implications for additional treatment, but it does not define R1 as tumor at/within 1 mm nor explicitly tie margin status to prognosis and adjuvant therapy decisions."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the importance of the number of lymph nodes examined and number positive, and explicitly link perineural and vascular invasion to higher recurrence risk.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights 'number examined and number positive' and states 'Positive nodes or invasion indicate higher risk of spread and recurrence,' linking both perineural and lymphovascular invasion to recurrence risk."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention tumor location (head, body, tail) as required for accurate pathologic staging (pT), and reference the AJCC staging system using pT, pN, pM nomenclature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Location (head/body/tail) is mentioned, but there is no reference to AJCC or use of pT, pN, pM nomenclature."
      }
    ],
    "question_number": 86,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:07:08.856202",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the case with an oncologist to review the trial details and discuss the pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing with their oncologist/specialist and engaging the trial team before deciding; emphasizes tailored guidance and questions to ask."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that there are no FDA-approved cancer vaccines for pancreatic cancer and that all vaccines for pancreatic cancer are experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States vaccines are 'mostly experimental' and 'not yet standard treatment' but does not explicitly state there are no FDA-approved pancreatic cancer vaccines or that all are experimental."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how a cancer vaccine works.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes therapeutic vaccines that train the immune system to recognize and attack cancer cells and target tumor proteins/mutations."
      },
      {
        "criterion_number": 4,
        "description": "The response states clinical trials are how treatments are tested for diseases like pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Outlines trial phases specifically focused on assessing safety and effectiveness, effectively conveying that trials are the mechanism for testing treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the four phases of clinical trials.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly describes Phases 1\u20134 with purpose and scope."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends researching clinical trials prior to enrolling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages searching ClinicalTrials.gov, contacting PanCAN, and preparing questions before deciding, which constitutes researching trials prior to enrollment."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends ClinicalTrials.gov as a resource.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically recommends ClinicalTrials.gov and how to search it."
      },
      {
        "criterion_number": 8,
        "description": "The response states patients should consider all of their treatment options prior to enrolling in a clinical trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses weighing risks/benefits and effects on the current plan, but does not explicitly instruct patients to consider all treatment options prior to enrolling."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to minimize patient harm and closely follow ethical standards.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions informed consent and safety monitoring, but does not explicitly state that trials are designed to minimize harm or that they closely follow ethical standards."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential benefits and risks of clinical trial participation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides clear lists of benefits (access to cutting-edge care, monitoring, contribution to research) and risks (side effects, uncertainty/placebo, time burden, emotional toll)."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends discussing with the clinical trial research team about costs to the patient for participating in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a specific question to ask the trial coordinator about what costs are covered and a section on costs/insurance."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention that vaccine clinical trials in pancreatic cancer are designed to address the poor response of this malignancy to standard immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention pancreatic cancer\u2019s poor response to standard immunotherapy as a rationale for vaccine trials."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that vaccine trials aim to stimulate tumor-specific T cell (immune cell) responses to enhance the immune system\u2019s effectiveness in killing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes training the immune system to recognize and attack cancer but does not explicitly reference tumor-specific T cell responses."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention at least two of the following vaccine platforms: peptide-based vaccines targeting defined tumor antigens, dendritic cell vaccines loaded with tumor lysates, or personalized mRNA/neoantigen vaccines that encode patient-specific tumor mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions mRNA-based and GVAX (whole-cell), but does not include peptide-based vaccines or dendritic cell vaccines loaded with tumor lysates; thus only one listed platform matches."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention that safety data from recent trials indicate that most vaccine regimens are well-tolerated, with adverse events generally limited to mild-to-moderate injection site reactions, flu-like symptoms, or transient fever.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists common side effects but does not attribute them to recent trial safety data or state that regimens are generally well-tolerated."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that most data on vaccine trials in pancreatic cancer are derived from early-phase studies with small sample sizes and limited long-term follow-up.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that many trials are Phase 1 or 2 but does not mention small sample sizes or limited long-term follow-up."
      },
      {
        "criterion_number": 17,
        "description": "The response must explicitly define clinical trials as research studies that explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes the phases and their aims but does not explicitly define clinical trials as research studies exploring safety and effectiveness for humans."
      },
      {
        "criterion_number": 18,
        "description": "The response must explicitly state that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that clinical trials are essential for optimizing current and future cancer therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response must mention that the patient will be informed, verbally and in writing, if a placebo is part of a clinical trial before they enroll.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the possibility of placebo and informed consent generally but does not state that patients will be informed verbally and in writing about placebo use before enrollment."
      }
    ],
    "question_number": 87,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:08:31.976792",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing care coordination concerns directly with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises to designate a lead physician and specifically notes this is typically the primary oncologist, encouraging the user to ask the current doctor to serve in this role or recommend someone. It also suggests ensuring the oncologist and surgeon communicate directly, which implies discussing coordination with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that the medical oncologist typically serves as the coordinating physician among the different specialists on the healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response states the lead is typically the primary oncologist \"(medical or surgical).\" It does not clearly state that the medical oncologist specifically is typically the coordinating physician."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a patient navigator or social worker.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends using nurse navigators, case managers, or patient advocates for coordination and, if unavailable, asking about social workers or patient liaisons."
      },
      {
        "criterion_number": 4,
        "description": "The response states that most oncology clinics have nurses who specialize in helping patients coordinate care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response says \"many hospitals and cancer centers offer nurse navigators,\" but does not state that most oncology clinics have such nurses."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends trying to schedule multiple appointments on one day to limit life interruptions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it suggests joint appointments or virtual meetings for care coordination, it does not explicitly advise scheduling multiple appointments on a single day to reduce disruptions."
      },
      {
        "criterion_number": 6,
        "description": "The response states that the different specialists will communicate with one another and document their assessments in the electronic medical record.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends tumor boards and direct communication between specialists and emphasizes use of EHR/patient portals to access \"test results, notes, and messages from all providers,\" and ensuring all specialists use the same system, indicating documentation and information sharing."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends asking about a multidisciplinary meeting with the involved specialists, sometimes called a \u201cTumor Board.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends that the case be presented at a tumor board to create a unified treatment plan."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention a structured multidisciplinary approach for coordinating care among multiple specialists for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states pancreatic cancer requires a \"multidisciplinary approach\" and discusses structured elements such as a lead physician, nurse navigators, tumor boards, and integrated teams at high-volume centers."
      },
      {
        "criterion_number": 9,
        "description": "The response must list all required specialists: surgical oncology, medical oncology, radiation oncology, gastroenterology, genetics, nutrition, and palliative care, and mention their distinct roles in diagnosis, staging, treatment, and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists surgical, medical, and radiation oncology, gastroenterology, nutrition, and palliative care, it omits genetics and does not describe distinct roles in diagnosis, staging, treatment, and supportive care."
      },
      {
        "criterion_number": 11,
        "description": "The response must emphasize the necessity of clear patient-centered communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes proactive communication, preparing questions, advocating for needs, using written summaries, and centralized communication, all oriented around the patient and caregiver involvement."
      }
    ],
    "question_number": 88,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:09:15.047312",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing with the oncology team multiple times (e.g., \u201cplease discuss this with your loved one's oncology team\u2026,\u201d and \u201cPlease reach out to your medical team right away\u2026\u201d)."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews common medical emergencies experienced by patients with pancreatic cancer, including biliary obstruction and bowel obstruction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers severe pain crises, biliary obstruction, GI blockages/obstruction, bleeding, infections/sepsis, VTE, metabolic derangements, respiratory distress, and treatment-related emergencies."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends having an Advance Directive or Living Will in place to guide the patient\u2019s care if they are unable to speak for themselves.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions including advance directives (e.g., DNR) in emergency contacts and legal preparations (wills, powers of attorney, healthcare proxies)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends seeking help from a professional in talking about these challenging questions, like a social worker, spiritual worker, or palliative care professional.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends palliative care involvement and counseling/support groups; palliative care professionals are explicitly noted."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends ensuring supportive care medications are refilled for symptoms like pain and nausea.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises keeping pain relievers, anti-nausea meds, laxatives, and emergency drugs on hand; also discusses breakthrough pain options."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States emergencies/complications can arise from the cancer itself (tumor), spread, and treatment side effects, and notes comorbidities that increase risks\u2014conveying high risk conceptually."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that biliary obstruction presents with jaundice, dark urine, and pruritus.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions jaundice, dark urine, pale stools, and specifically lists severe itching (pruritus) as a warning sign."
      },
      {
        "criterion_number": 9,
        "description": "The response must describe gastric outlet obstruction as persistent vomiting, inability to tolerate oral intake, and abdominal distension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Includes persistent vomiting and bloating but does not explicitly state inability to tolerate oral intake; abdominal distension is implied as bloating but the full triad is not clearly described."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention VTE and include symptoms like sudden leg swelling, pain, shortness of breath, or chest pain, and state that pulmonary embolism is a leading cause of death after cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes DVT/PE symptoms (leg swelling/pain, chest pain, shortness of breath) but does not state that PE is a leading cause of death after cancer itself."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention febrile neutropenia as a life-threatening complication of chemotherapy, characterized by fever and signs of infection in the context of neutropenia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions infections/sepsis and low blood counts from chemotherapy but does not explicitly identify febrile neutropenia or describe it as a life-threatening neutropenic fever."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention metabolic derangements such as hypercalcemia (confusion, weakness, constipation) or hyponatremia (confusion, seizures).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions hypercalcemia and associated symptoms (confusion, weakness) and also notes seizures in the context of metabolic/electrolyte imbalances."
      },
      {
        "criterion_number": 13,
        "description": "The response must describe bowel obstruction as presenting with abdominal pain, vomiting, and constipation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists vomiting and severe constipation but does not explicitly include abdominal pain as a symptom of bowel obstruction."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention spinal cord compression and its symptoms, such as new-onset weakness, sensory changes, or loss of bowel/bladder control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Spinal cord compression and its hallmark symptoms are not mentioned."
      }
    ],
    "question_number": 89,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:09:57.059518",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the hearing changes with his oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: \"Contact his doctor immediately: Report these changes to his oncologist or primary care physician right away.\""
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments, like oxaliplatin, which is frequently used in treating pancreatic cancer as part of combination chemotherapy, can cause hearing changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions oxaliplatin as part of platinum-based drugs and notes it can cause hearing changes/ototoxicity."
      },
      {
        "criterion_number": 3,
        "description": "The response states that platinum-based chemotherapy, such as cisplatin, is well-known to cause hearing loss (ototoxicity).",
        "score_given": 5,
        "max_points": 5,
        "justification": "States \"Platinum-based drugs... like oxaliplatin or cisplatin\" and that they are known to cause ototoxicity."
      },
      {
        "criterion_number": 4,
        "description": "The response states the hearing changes may be related to other conditions like fatigue, infection, dehydration, malnutrition, or metabolic abnormalities from the cancer or its treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists non-treatment causes including \"Malnutrition, dehydration, infections, anemia, or electrolyte imbalances\" as potential contributors."
      },
      {
        "criterion_number": 5,
        "description": "The response states it is important for the patient\u2019s oncologist to know about new symptoms because they may need to adjust the dose of the chemotherapy or consider a different treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes the oncologist may recommend \"dose reductions or switching drugs if ototoxicity is suspected.\""
      },
      {
        "criterion_number": 6,
        "description": "The response states that treatment-related side effects may become worse or permanent if changes are not made to the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions hearing changes can be temporary or permanent and are dose-dependent, but does not explicitly state that failure to change treatment could lead to worsening or permanent side effects."
      },
      {
        "criterion_number": 7,
        "description": "The response states hearing changes may be related to cancer spreading to the brain if there are other neurologic symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States metastasis to the brain could affect hearing and advises monitoring neurologic symptoms such as dizziness, balance issues, and headaches."
      },
      {
        "criterion_number": 8,
        "description": "The response states the hearing changes may be related to normal age-related hearing loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions \"Age-related hearing loss (presbycusis)\" as a possibility."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the risk of hearing loss increases with cumulative doses and patient age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States ototoxicity is \"dose-dependent\" and \"more pronounced in older adults,\" addressing cumulative dose and age."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that other therapies, including aminoglycoside antibiotics, loop diuretics, and radiation to the head/neck, can also contribute to hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions radiation to head/neck and generically references antibiotics and diuretics, but does not specifically identify aminoglycoside antibiotics or loop diuretics as contributors."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that referral for audiologic evaluation is advised.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises a hearing test (audiogram) and referral to an ENT specialist, which constitutes audiologic evaluation."
      }
    ],
    "question_number": 90,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:10:37.774948",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states proton therapy is a type of radiation therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says, 'Proton therapy, also known as proton beam therapy, is an advanced form of radiation therapy.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states proton therapy uses protons rather than photons to deliver highly conformal radiation doses to tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It contrasts protons with traditional X-rays/photons and explains the Bragg peak and precise targeting, indicating conformal dose delivery."
      },
      {
        "criterion_number": 3,
        "description": "The response states proton therapy may be more precise in its target field compared to traditional radiation therapy techniques, which may reduce treatment-related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'This precision can reduce side effects compared to conventional radiation,' directly addressing improved precision and reduced side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response states proton therapy is a safe and feasible option for select patients with locally advanced or recurrent pancreatic cancer, especially when minimizing toxicity to surrounding organs is critical.",
        "score_given": 5,
        "max_points": 5,
        "justification": "For pancreatic cancer, it notes proximity to vital organs and says proton therapy 'may be considered' for unresectable/locally advanced cases, implying feasibility when minimizing toxicity is important."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use proton therapy is influenced by the cancer\u2019s stage, location, size, proximity to other organs, among others.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists factors: 'The stage and location of the cancer\u2026 whether the tumor is resectable\u2026 overall health,' and discusses proximity to critical organs."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a Radiation Oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically recommends discussion with 'a radiation oncologist who specializes in gastrointestinal cancers.'"
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to 'discuss this with your mother's oncologist.'"
      },
      {
        "criterion_number": 8,
        "description": "The response states proton therapy has proven benefit in some cancers, like head and neck cancer, though has unclear benefit over traditional radiation therapy and is considered experimental in most types of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists several cancers (including head and neck) and notes it's 'not proven to be superior for all cancers,' it does not state that proton therapy is considered experimental in most cancer types."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all cancer centers have the capability to provide proton therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says, 'Not every hospital offers it,' and mentions specialized centers, fulfilling this criterion."
      },
      {
        "criterion_number": 10,
        "description": "The response states proton therapy still carries the risk of side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states 'Side effects can still occur (e.g., fatigue, skin reactions, or gastrointestinal issues).' "
      },
      {
        "criterion_number": 11,
        "description": "The response states proton therapy is often used in combination with chemotherapy (such as gemcitabine) as part of concurrent chemoradiation protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes use 'as part of a multimodal approach (combined with chemotherapy, like gemcitabine or FOLFIRINOX),' indicating concurrent/combined chemoradiation use."
      },
      {
        "criterion_number": 12,
        "description": "The response states proton therapy can be used for locally advanced, unresectable, or recurrent disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions 'unresectable (inoperable) pancreatic tumors' and 'locally advanced cases where surgery isn't possible,' meeting the criterion (recurrent not required as it's 'or')."
      }
    ],
    "question_number": 91,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:11:07.931690",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist, as they likely have financial experts who are knowledgeable in this area.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises speaking with the oncologist, hospital social worker, patient navigator, and a financial counselor at the treatment center for assistance."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends learning about the patient\u2019s insurance plan, including out-of-pocket costs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions having insurance information ready and references copay/premium assistance but does not explicitly recommend learning about the plan\u2019s out-of-pocket costs."
      },
      {
        "criterion_number": 3,
        "description": "The response states pharmaceutical companies have programs to help patients cover the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states manufacturers offer assistance and provides multiple program examples (Lilly Cares for Gemzar, BMS Access Support for Abraxane, Genentech Access Solutions for Tarceva, AstraZeneca Access 360 for Lynparza)."
      },
      {
        "criterion_number": 4,
        "description": "The response states large hospital systems and cancer centers may have assistance programs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests contacting oncology teams and financial counselors but does not explicitly state that hospital systems/cancer centers have their own assistance programs."
      },
      {
        "criterion_number": 5,
        "description": "The response states patient assistance programs may cover all or most of the cost of medications for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States programs can provide free or low-cost medications, implying coverage of all or most costs."
      },
      {
        "criterion_number": 6,
        "description": "The response states government programs may offer assistance with the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cites Medicare/Medicaid (including Extra Help), and State Pharmaceutical Assistance Programs as options."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of non-profit organizations with patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including PAN Foundation, HealthWell Foundation, CancerCare, and The Assistance Fund."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of pancreatic cancer-specific patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names PanCAN (Patient Central) and the Hirshberg Foundation as pancreatic cancer-specific resources."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends applying for assistance early as the process may take time and delay treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to \u201cApply Quickly\u201d and notes waiting lists and limited funds, which implies time sensitivity."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention federal, state, manufacturer, and independent charity options for medication cost assistance for pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes federal (Medicare/Medicaid, Extra Help), state (SPAPs), manufacturer PAPs, and independent charities (PAN, HealthWell, TAF, CancerCare)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that Medicaid offers comprehensive prescription drug coverage with minimal co-payments and is the most effective public program for low-income patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions Medicaid may fully cover medications but does not explicitly state comprehensive coverage with minimal co-pays nor that it is the most effective public program for low-income patients."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention that manufacturer-sponsored assistance programs provide free or discounted medications to eligible uninsured or underinsured patients, requiring proof of financial hardship and doctor certification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that manufacturers offer free meds or copay cards to uninsured/underinsured, but does not state requirements for proof of financial hardship and doctor certification."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that independent nonprofits like HealthWell and PAN Foundation offer co-pay and premium assistance to insured patients with incomes below 400-500% of the federal poverty level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions copay and premium assistance from these nonprofits but does not specify the insured status requirement or the 400\u2013500% FPL income thresholds."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the complexity of accessing assistance programs and disparities among non-English speakers and some ethnic groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss complexity-related disparities or barriers for non-English speakers or specific ethnic groups."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention financial navigators and online tools such as NeedyMeds or RxAssist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Refers to patient navigators and financial counselors and explicitly lists NeedyMeds and RxAssist as online tools."
      }
    ],
    "question_number": 92,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:11:40.421142",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises discussing details with the oncologist in multiple places (e.g., 'It's always best to discuss this directly with his oncologist' and 'I strongly recommend talking to his oncologist about the details tailored to his case')."
      },
      {
        "criterion_number": 2,
        "description": "The response states maintenance therapy is typically used in pancreatic cancer after the initial induction therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines maintenance therapy as treatment given after the initial, more intensive phase and specifically applies this to pancreatic cancer (e.g., olaparib after platinum-based chemotherapy), satisfying the 'after induction therapy' context."
      },
      {
        "criterion_number": 3,
        "description": "The response states maintenance therapy typically involves fewer anti-cancer drugs with the goal of limiting side effects.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions lower doses and less aggressive treatment to minimize side effects, it does not state that maintenance typically uses fewer drugs/agents specifically."
      },
      {
        "criterion_number": 4,
        "description": "The response states the oncologist will continue to monitor the cancer closely while the patient is on maintenance therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes ongoing monitoring with regular scans and blood tests to assess effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the cancer grows while on maintenance therapy, combination therapy may be reintroduced to get the cancer back under control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention reintroducing combination therapy upon disease progression while on maintenance."
      },
      {
        "criterion_number": 6,
        "description": "The response states chemotherapy side effects are typically cumulative, so using maintenance therapy may help the patient tolerate treatment for a longer period of time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it discusses minimizing side effects and tolerability, it does not mention cumulative toxicity or the rationale that maintenance may enable longer-term tolerability."
      },
      {
        "criterion_number": 7,
        "description": "The response states maintenance therapy may involve chemotherapy, targeted therapy, or immunotherapy depending upon the characteristics of the patient\u2019s tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists chemotherapy, targeted therapy (e.g., PARP inhibitors), and immunotherapy in select cases, and ties choices to tumor genetics (e.g., BRCA mutations)."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the decision to initiate maintenance therapy should be individualized, considering disease response, cumulative toxicities, patient preference, and goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes individualized decision-making and considers disease response and patient preferences, but does not explicitly mention cumulative toxicities or goals of care."
      }
    ],
    "question_number": 93,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:12:11.927820",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: 'speak with their oncologist about medications, referrals to a psycho-oncologist, or hospital-based support services,' and also to consult the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a licensed mental health care provider.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends counseling with oncology social workers, referrals to a psycho-oncologist, and provides therapist directories (ADAA, SAMHSA), indicating engagement with licensed mental health professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response instructs the patient to seek immediate medical evaluation if they are experiencing thoughts of harming themselves or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides 988 crisis line information but does not explicitly instruct immediate medical evaluation for suicidal or homicidal thoughts."
      },
      {
        "criterion_number": 4,
        "description": "The response states anxiety is a common occurrence in patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'you're not alone' and references 'cancer-related anxiety' affecting patients and caregivers, conveying that it is common."
      },
      {
        "criterion_number": 5,
        "description": "The response states treatments like cognitive behavioral therapy may help to control anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'cognitive behavioral techniques' as tools for managing treatment-related anxiety, which reflects CBT approaches."
      },
      {
        "criterion_number": 6,
        "description": "The response states medications may help to control anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing 'medications' with the oncologist for severe anxiety, implying pharmacologic options may help."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention psychotherapy, psychoeducation, supportive therapy, and integrative modalities as available resources for treatment-related anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions integrative therapies (yoga, acupuncture, art therapy) but does not explicitly use the terms 'psychotherapy,' 'psychoeducation,' or 'supportive therapy.'"
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention mindfulness-based interventions or mindfulness-based stress reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions mindfulness and meditation apps, but does not explicitly reference 'mindfulness-based interventions' or 'mindfulness-based stress reduction (MBSR)'."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends mindfulness and relaxation techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends mindfulness, guided meditation (Calm, Headspace), breathing exercises, yoga, and stress management."
      },
      {
        "criterion_number": 11,
        "description": "The response offers pancreatic cancer-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PanCAN (Patient Central, Survivor and Caregiver Network) and the Hirshberg Foundation with contact details."
      },
      {
        "criterion_number": 12,
        "description": "The response offers mental health-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists ADAA, NAMI, 988 Suicide & Crisis Lifeline, and SAMHSA treatment locator."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends participation in cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights PanCAN support groups, CancerCare pancreatic cancer-specific groups, ACS online communities, and caregiver support groups."
      }
    ],
    "question_number": 94,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:12:45.091155",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing with the oncology team and, in Next Steps, to discuss thoroughly with the oncologist, surgeon, or interventional radiology specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response states cryotherapy is a procedure that uses metal instruments cooled to subzero temperatures in order to kill tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes insertion of a cryoprobe that delivers liquid nitrogen/argon to reach \u221240\u00b0C, forming ice crystals to kill cells. While not explicitly saying 'metal', it correctly describes a cryoprobe cooled to subzero temperatures to destroy tumor tissue."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that cryotherapy (also called cryoablation) is a minimally invasive locoregional treatment that destroys tumor tissue by freezing it, typically using probes inserted through the skin (percutaneously) or intraoperatively under imaging guidance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Calls it cryotherapy/cryoablation, a minimally invasive ablation; explains freezing destroys tumor tissue; specifies percutaneous or laparoscopic approaches and imaging guidance (ultrasound/CT/MRI)."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use cryotherapy involves the cancer\u2019s size, location, proximity to other organs, among other things.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes appropriateness depends on stage and health; specifically mentions increased risk if tumor is large or near major blood vessels (proximity) and other factors."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the benefits and risks of this procedure with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages thorough discussion with oncologist/surgeon/interventional radiology and outlines benefits/risks, implying discussion of these with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response states cryotherapy may be used in conjunction with other treatment modalities like chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it may be used in combination with other treatments, such as chemotherapy or radiation."
      },
      {
        "criterion_number": 8,
        "description": "The response states cryotherapy is not typically used to cure cancer but may be used to debulk tumors that are not operable.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states it is not considered curative on its own and describes use in unresectable tumors with goals like shrinkage/debulking and palliation."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all patients benefit from cryotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Not suitable for everyone' and notes it may not eliminate all cancer cells, particularly in advanced disease."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in pancreatic cancer, cryotherapy is not a standard first-line therapy but is considered for patients with unresectable, locally advanced, or metastatic disease who are not candidates for surgical resection or have failed systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly says it is not first-line/standard for pancreatic cancer and indicates consideration for unresectable tumors and those with advanced disease or poor surgical candidacy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that its primary role is palliative, aiming to reduce tumor burden, alleviate pain, and potentially improve quality of life and local disease control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes use as a palliative option to relieve symptoms (pain, obstruction) and notes tumor shrinkage; conveys non-curative role focused on symptom relief and local control."
      }
    ],
    "question_number": 95,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:13:23.561283",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends discussing with the oncologist and a pancreatic cancer specialist and states they can interpret and order appropriate tests."
      },
      {
        "criterion_number": 2,
        "description": "The response states CA 19-9 is the tumor marker most commonly used to track disease status in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states CA 19-9 is the most commonly used marker for pancreatic cancer and discusses its use in monitoring response, recurrence, and progression."
      },
      {
        "criterion_number": 3,
        "description": "The response states other tumor markers, like CEA and CA 125, are less reliable than CA 19-9 for disease monitoring in pancreatic cancer and are used more frequently in other gastrointestinal or genitourinary cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes CEA and CA125 are less specific and not as routinely used as CA19-9, and highlights their associations with other cancers (e.g., colorectal for CEA and ovarian for CA125), fulfilling the intent of this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response states tumor markers may be used to monitor the course of disease in patients with pancreatic cancer, along with imaging studies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says markers are used to monitor treatment response, recurrence, and progression and emphasizes interpretation alongside imaging such as CT and MRI."
      },
      {
        "criterion_number": 5,
        "description": "The response states tumor markers are not reliable markers of disease in all patients with pancreatic cancer, as not all tumors secrete the markers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions they are not perfect, can be normal in some cancer cases, and that 10\u201320% do not produce CA19-9 due to Lewis antigen status."
      },
      {
        "criterion_number": 6,
        "description": "The response states circulating tumor DNA (ctDNA) is an emerging technology aimed at detecting early cancer progression and recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies ctDNA as part of liquid biopsy approaches being studied for more precise monitoring, aligning with its emerging role in detecting progression/recurrence."
      },
      {
        "criterion_number": 7,
        "description": "The response states circulating tumor DNA (ctDNA) is not FDA approved for disease monitoring in pancreatic cancer and remains experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes ctDNA is not standard and is being studied, it does not explicitly state that it is not FDA-approved for disease monitoring in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that CEA is elevated in 30-60% of pancreatic cancer cases and is particularly useful in Lewis-negative patients who do not secrete CA19-9.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not provide the 30\u201360% prevalence range for CEA elevation nor state that CEA is particularly useful in Lewis-negative patients."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that both CEA and CA125 have demonstrated value for diagnosis, prognosis, and monitoring, especially when CA19-9 is not informative. CA125, when combined with CA19-9, improves diagnostic accuracy and is associated with tumor burden and metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss diagnostic/prognostic value explicitly, does not state that CA125 combined with CA19-9 improves diagnostic accuracy, and does not mention CA125\u2019s association with tumor burden/metastasis."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that emerging markers such as LAMC2, POSTN are not yet standard in routine clinical practice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions other investigational markers (e.g., TIMP-1, osteopontin), it does not mention LAMC2 or POSTN or their non-standard status."
      }
    ],
    "question_number": 96,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:13:56.335368",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that hand-foot syndrome is a common side effect of some chemotherapy drugs used to treat pancreatic cancer, including capecitabine and 5-FU.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly identifies HFS as a common side effect and specifically names capecitabine (Xeloda) and 5-FU as causative agents."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist and healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to contact the oncology team immediately and emphasizes early reporting and tailored recommendations."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the patient\u2019s oncologist may recommend reducing the chemotherapy dose.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions dose reduction or delay for moderate to severe HFS."
      },
      {
        "criterion_number": 4,
        "description": "The response instructs the patient to seek immediate medical evaluation if the patient experiences fever, chills, blisters, or pus draining from the affected area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends urgent care for blisters, open sores, infection signs like pus, or fever."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s oncology team will grade the severity of the hand-foot syndrome, which will determine the recommended treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes grading severity (1\u20133) and that this guides management decisions."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends hand hygiene with a gentle soap.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises gentle bathing with lukewarm water and mild, fragrance-free soap."
      },
      {
        "criterion_number": 7,
        "description": "The response states pain may be controlled with over-the-counter medications like Tylenol or ibuprofen, though the patient should check with their healthcare team first.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions acetaminophen or ibuprofen for pain and to check with the doctor first."
      },
      {
        "criterion_number": 8,
        "description": "The response states oral or topical prescription pain medications may be needed if pain is severe.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States stronger prescription medications or topical anesthetics may be needed for severe pain."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends utilizing topical moisturizers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends frequent use of thick emollient creams, including urea-containing products."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends skin protection with loose clothing and soft shoe soles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises wearing loose, soft cotton gloves/socks and using padded insoles or soft-soled shoes."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends cooling the skin with cold compresses.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests cool compresses or ice packs wrapped in cloth for symptomatic relief."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends avoiding hot showers and activities that cause rubbing on the skin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically advises avoiding hot showers/saunas and activities that cause pressure or rubbing."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention strategies include celecoxib and urea cream.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions celecoxib as a preventive option but does not identify urea cream as a prevention strategy (urea is discussed for symptom care, not prevention)."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cooling procedures, such as frozen gloves or socks applied during taxane infusions, may prevent or reduce HFS severity and are recommended by the Oncology Nursing Society for taxane-based regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention frozen gloves/socks during taxane infusions or ONS recommendations."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that prevention strategies such as Pyridoxine (vitamin B6) and lactic acid have not shown consistent benefit for prevention or treatment of HFS in randomized trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes pyridoxine with variable evidence but does not state lack of consistent benefit in randomized trials and does not mention lactic acid."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that omeprazole (a proton pump inhibitor) and tipiracil (a thymidine phosphorylase inhibitor) may have prophylactic effects, but these are not yet standard practice.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of omeprazole or tipiracil as potential prophylactic agents."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that management of established HFS includes topical urea and corticosteroids.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends urea-containing creams and includes corticosteroids (e.g., dexamethasone) as part of management."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Photobiomodulation (low-level laser therapy) has shown promise as an adjunct for pain and symptom control.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention photobiomodulation or low-level laser therapy."
      }
    ],
    "question_number": 97,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:14:48.737078",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The decision between a cancer center and community oncology is often based on the type and stage of cancer, the patient\u2019s insurance, location, and preference.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states the decision depends on stage/type, location/travel feasibility, insurance coverage, and personal preferences."
      },
      {
        "criterion_number": 2,
        "description": "Cancer centers may have access to more advanced therapies and clinical trials than community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights access to clinical trials and advanced treatments at cancer centers, citing examples like PARP inhibitors and other novel therapies."
      },
      {
        "criterion_number": 3,
        "description": "Pancreatic cancer requires multidisciplinary care involving medical oncology, radiation oncology, and surgical oncology, which may be more readily available at a large cancer center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes multidisciplinary tumor boards and lists relevant specialties, noting this is a key feature of cancer centers."
      },
      {
        "criterion_number": 4,
        "description": "Cancer centers may be more equipped to handle complex care for advanced disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that for aggressive or advanced disease, cancer centers' resources and expertise can be \"game-changing,\" indicating greater capacity for complex care."
      },
      {
        "criterion_number": 5,
        "description": "Community oncology programs may be more convenient and closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes community oncology is closer to home with easier access for frequent visits and support, highlighting convenience."
      },
      {
        "criterion_number": 6,
        "description": "There may be differences in cost between cancer centers and community oncology programs based on the patient\u2019s insurance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses potential higher out-of-pocket costs and wait times at cancer centers, notes insurance considerations, and mentions community settings may be more affordable."
      },
      {
        "criterion_number": 7,
        "description": "Cancer centers may offer more support services to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists support services at cancer centers including genetic counseling, pain management, psychological support, and survivorship programs."
      },
      {
        "criterion_number": 8,
        "description": "Most standard cancer care can be delivered at community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states community programs provide evidence-based standard treatments (e.g., FOLFIRINOX, gemcitabine, radiation, surgery) following NCCN guidelines."
      },
      {
        "criterion_number": 9,
        "description": "Cancer centers include NCI-designated comprehensive cancer centers and academic medical centers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response defines cancer centers, references NCI-designated comprehensive cancer centers, and notes affiliations with major universities/academic hospitals."
      },
      {
        "criterion_number": 10,
        "description": "Cancer centers are often located in major cities, which can mean longer travel times, more complex scheduling, and larger, busier environments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses travel burden to cancer centers and describes a large-scale environment that can feel less personal, implying busier settings and logistical complexity."
      },
      {
        "criterion_number": 11,
        "description": "In some cases, initial treatment planning can be done at a cancer center, and follow-up care can be done at a community center closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly recommends a hybrid approach: start at a cancer center for diagnosis/planning and continue treatment locally with collaboration."
      }
    ],
    "question_number": 98,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:15:24.465422",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises talking to the healthcare team: 'Talk to their healthcare team: Oncologists, nurses, or palliative care specialists...' and notes they can address safe sex, libido, and pain."
      },
      {
        "criterion_number": 2,
        "description": "States patients undergoing treatment for pancreatic cancer may experience a decrease in libido related to symptoms from treatment or the cancer itself, like fatigue, nausea, pain, malnutrition, anxiety, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links treatment/cancer effects to reduced libido: mentions fatigue, nausea, pain, digestive changes, hormonal shifts 'that lower sex drive.'"
      },
      {
        "criterion_number": 3,
        "description": "Specifically mentions at least one of the following changes in intimacy: decreased desire, arousal disorders, pain, erectile dysfunction, altered body image, or emotional distress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions decreased libido (decreased desire), pain, erectile dysfunction, altered body image, and emotional well-being concerns."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a dedicated section 'Start with Open Communication' with practical tips and 'I' statements."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends seeking input from a professional trained in intimacy problems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends 'a couples counselor, sex therapist, or oncology social worker' for tailored advice."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages joining support groups and cites PanCAN.org and CancerCare.org."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly mentions at least one of the following interventions: psychosocial therapy, psychosexual therapy, or couples-based therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests 'couples counselor' (couples-based therapy) and 'sex therapist' (psychosexual therapy), meeting the intervention criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least one of the following referral options: medical sexologist, psycho-sexologist, social worker, or psychologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions 'oncology social worker' and 'sex therapist' as referral options."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly states that concerns about intimacy during treatment for a loved one with pancreatic cancer are common.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is 'completely normal for intimacy to be a concern,' normalizing the issue."
      }
    ],
    "question_number": 99,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:15:53.438699",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines radiofrequency ablation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines RFA as a minimally invasive procedure using heat from radiofrequency energy to destroy tumor tissue; describes it as thermal ablation that 'cooks' tumor tissue."
      },
      {
        "criterion_number": 2,
        "description": "The response states radiofrequency ablation is minimally invasive and typically does not require surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states RFA is 'minimally invasive' and can kill tumor tissue 'without needing major surgery.'"
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing specifics with the medical team and specifically recommends speaking with the oncologist or an interventional radiology specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response states not all patients with pancreatic cancer benefit from radiofrequency ablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that RFA is not always effective (e.g., for larger or metastatic tumors) and suitability depends on multiple factors, indicating not all patients benefit."
      },
      {
        "criterion_number": 5,
        "description": "The response considers the potential risks and benefits of radiofrequency ablation for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear list of benefits (minimally invasive, symptom relief, QoL) and risks (pain, infection, bleeding, pancreatitis, injury to adjacent structures) with context."
      },
      {
        "criterion_number": 6,
        "description": "The response states radiofrequency ablation is typically used in a multidisciplinary treatment plan along with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States RFA is often combined with other treatments such as chemotherapy or radiation and is typically part of a broader treatment plan."
      },
      {
        "criterion_number": 7,
        "description": "The response states radiofrequency ablation is a procedure performed by specially trained Interventional Radiologists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions consulting a 'specialist in interventional radiology (they often perform RFA),' indicating it is performed by interventional radiologists."
      },
      {
        "criterion_number": 8,
        "description": "The response states this is typically an outpatient procedure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States it is 'often done on an outpatient basis' with same-day discharge in many cases."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that in pancreatic cancer, RFA is most commonly delivered via endoscopic ultrasound guidance (EUS-RFA), allowing precise targeting of the tumor while minimizing injury to surrounding structures.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions endoscopic approaches generally but does not specify endoscopic ultrasound guidance (EUS-RFA) or note it as the most common method in pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that radiofrequency ablation is used in pancreatic cancer primarily for unresectable or inoperable tumors as a palliative or adjunctive therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States RFA is considered when tumors cannot be surgically removed and for palliative goals; also frames it as adjunctive with other treatments."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA is not a substitute for surgery or systemic therapy in resectable disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes RFA is used when surgery isn't an option and is not a cure, it does not explicitly state that RFA is not a substitute for surgery or systemic therapy in resectable disease."
      }
    ],
    "question_number": 100,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:16:25.754971",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting her healthcare team and oncologist, e.g., \"You should always consult her healthcare team for specifics,\" \"Ask her oncologist, pharmacist, or a palliative care specialist,\" and \"contact her doctor right away.\""
      },
      {
        "criterion_number": 2,
        "description": "The response states it is normal for patients with pancreatic cancer to be on multiple medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states it is common/normal to be on many medications: \"Yes, it's quite common and often necessary for people with pancreatic cancer to be on multiple medications.\""
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may need medications for symptom control, including acid reflux, nausea, pain, diarrhea, and enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Includes acid reflux (PPIs/antacids), nausea (antiemetics), pain (opioids, non-opioids), and enzyme replacement (Creon/Pancreaze), but does not mention diarrhea or anti-diarrheal medications."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends utilizing a pill organizer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends using a pill organizer: \"Use a pill organizer (weekly or monthly).\""
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping an updated medication list with administration times.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises keeping a detailed list including doses, times, and purposes, and sharing with all doctors."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reviewing the patient\u2019s medication list with the healthcare team to identify strategies to make handling the medications easier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends medication reconciliation with oncologist/pharmacist/palliative care to streamline meds and consider extended-release options."
      }
    ],
    "question_number": 101,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:16:41.096024",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing yoga with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises consulting the oncologist/healthcare team and getting medical clearance before starting yoga."
      },
      {
        "criterion_number": 2,
        "description": "The response states yoga may improve a cancer patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States yoga can complement care by improving quality of life and lists domains of QoL improvement."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends gentle and slow yoga practice to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle/modified forms (restorative, chair, gentle hatha/yin), avoiding vigorous styles, and starting slowly (10\u201320 minutes)."
      },
      {
        "criterion_number": 4,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions fatigue and pain, but does not explicitly mention malnutrition or dehydration as injury risks."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not recommend joining cancer support groups; mentions classes and integrative services but not support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References research and sources by name (Journal of Clinical Oncology, Integrative Cancer Therapies, 2020 study in Supportive Care in Cancer, Cancer Nursing meta-analysis, ACS, NCI)."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are yoga classes specifically for cancer patients and provides resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies oncology-specific yoga and provides concrete resources (Yoga4Cancer, Livestrong at the YMCA) and guidance to find classes."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that yoga is generally safe for people with cancer, including those undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states yoga can generally be safe for people with pancreatic cancer and for most cancer patients when adapted."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that yoga may help reduce cancer-related fatigue, anxiety, and depression, and improve emotional well-being during and after treatment, though effects are typically small to moderate and the certainty of evidence is low to moderate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses benefits (fatigue, anxiety, emotional well-being) but does not qualify that effect sizes are typically small to moderate or that evidence certainty is low to moderate."
      }
    ],
    "question_number": 102,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:17:09.772991",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"I strongly recommend discussing these with his doctors\" and \"Please talk to your husband's oncologist, surgeon, or a palliative care specialist soon...\""
      },
      {
        "criterion_number": 2,
        "description": "The response states many side effects from cancer treatment improve and disappear once treatment stops.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes some effects \"improve within months\" but does not explicitly state that many side effects disappear once treatment stops."
      },
      {
        "criterion_number": 3,
        "description": "The response states some side effects like peripheral neuropathy may become permanent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states: neuropathy \"can last months to years... but in some cases, it's permanent.\""
      },
      {
        "criterion_number": 4,
        "description": "The response states some side effects from treatment may take time to improve or disappear, as long as many months.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes time course: neuropathy \"can last months to years\" and \"Some side effects (like fatigue) ... improve within months.\""
      },
      {
        "criterion_number": 5,
        "description": "The response states many side effects from treatment can be controlled with medications, for example pancreatic enzyme supplementation for pancreatic insufficiency or vitamins for malabsorption after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples: pancreatic enzyme supplements (e.g., Creon) for exocrine insufficiency; vitamin supplementation for deficiencies; also states many side effects can be managed with medical support."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews potential side effects of surgery for pancreatic cancer (e.g., Whipple procedure).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers surgical effects: exocrine/endocrine insufficiency (including diabetes), digestive changes, nutritional deficiencies, pain/adhesions, prolonged recovery and fatigue."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews potential side effects of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details chemo effects: peripheral neuropathy, fatigue, cognitive changes, heart/kidney issues, secondary cancers, fertility issues."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the potential for long-term heart or kidney damage and fertility issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions \"long-term heart damage or reduced kidney function\" and notes fertility issues as potential long-term effects."
      },
      {
        "criterion_number": 9,
        "description": "The response states the treating team will work within the patient\u2019s goals of care to maximize treatment efficacy while limiting side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests involving oncologist/palliative care and survivorship planning, it does not explicitly state alignment with the patient's goals of care to balance efficacy and side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential side effects of radiation therapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists radiation effects: GI problems (diarrhea, urgency, bleeding), fibrosis/scarring, secondary cancers, fatigue, skin changes."
      },
      {
        "criterion_number": 11,
        "description": "The response states some cancer treatments can increase the likelihood of developing second cancers in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions for chemotherapy: \"Secondary Cancers: A small increased risk of other cancers years later\" and also notes this risk for radiation."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends open communication with the patient\u2019s healthcare team about symptoms and symptom control to limit the long-term effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages communication: \"Please talk to your husband's oncologist...\" provides specific questions to ask and suggests a survivorship care plan and regular follow-ups, which support symptom reporting and control."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that long-term side effects are common in patients treated for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists \"the most common long-term side effects,\" it does not explicitly state that long-term side effects are common among patients treated for pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the cumulative impact of surgery, chemotherapy, radiation, and the underlying disease as sources of long-term side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses all sources: separate sections for surgery, chemotherapy, radiation, and a \"General Long-Term Effects Across Treatments\" section that includes issues from the cancer itself (e.g., chronic pain, weight/nutrition challenges), reflecting combined contributions."
      }
    ],
    "question_number": 103,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:17:53.034381",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response offers recommendations for organizations and includes key initiatives of the organizations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends multiple organizations (PanCAN, Lustgarten Foundation, Hirshberg Foundation, SU2C, ACS) and details key initiatives for each (e.g., PanCAN\u2019s Precision Promise, Lustgarten\u2019s collaborations with CSHL/Johns Hopkins, Hirshberg\u2019s seed grants and symposium, SU2C Dream Teams, ACS research and patient support)."
      },
      {
        "criterion_number": 2,
        "description": "The response includes Charity Navigator ratings for the mentioned organizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Charity Navigator ratings are provided for PanCAN, Lustgarten, SU2C, and ACS, but not explicitly for the Hirshberg Foundation (it only states 'Highly rated for transparency' without a Charity Navigator star rating). Since ratings are not included for all mentioned organizations, full credit cannot be awarded."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response discusses donations funding innovative studies and highlights nonprofit organizations, it does not explicitly state that nonprofit organizations are vital for supporting innovative pancreatic cancer research."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that donations to nonprofit organizations can support research, clinical trials, and patient support initiatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that donating can fund innovative studies and clinical trials and describes programs such as patient resources and support (e.g., PanCAN patient resources, ACS patient support) that donations help sustain, thereby covering research, clinical trials, and patient support initiatives."
      }
    ],
    "question_number": 104,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:18:23.784764",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s oncologist immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"It's crucial that he discusses this with his oncologist or healthcare team right away\" and later, \"Contact his doctor immediately.\""
      },
      {
        "criterion_number": 2,
        "description": "The response instructs the patient to seek immediate medical evaluation if the vision changes are abrupt in onset, severe, or accompanied by other symptoms including dizziness, pain, confusion, fever, or other neurologic symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States: \"Sudden or severe changes could indicate something urgent... so don't delay,\" clearly instructing immediate evaluation for abrupt/severe changes (even though it does not list all associated symptoms)."
      },
      {
        "criterion_number": 3,
        "description": "The response states vision changes related to treatment are not typical, though can be related to dry eyes or peripheral neuropathy from chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes treatment-related ocular effects are \"not extremely common\" and mentions dry eyes and neuropathy affecting the optic nerve as potential mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that chemotherapy can cause vision changes (ocular toxicity). For example, gemcitabine and 5-fluorouracil have been associated with retinal findings including cotton-wool spots and other visual disturbances.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes ocular toxicity from chemotherapy, citing 5-FU, irinotecan (eye irritation/blurred vision), taxanes (cystoid macular edema/retinal changes), and gemcitabine (conjunctivitis/blur). While cotton-wool spots are not named, chemo-related ocular toxicity is clearly addressed with relevant examples."
      },
      {
        "criterion_number": 5,
        "description": "The response states the oncologist may recommend dose reducing treatment or changing to a different treatment if the vision changes are felt to be treatment-related.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Says side effects may improve with \"dose adjustments\" and that the team might \"adjust his regimen,\" indicating dose reduction or changing therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response states vision changes may be related to metastasis to the brain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions metastases to the brain can affect the optic pathways/visual centers and impact vision."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that ocular metastases may cause vision changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pancreatic cancer can spread \"rarely [to] the eyes themselves,\" implying ocular metastases as a cause of vision changes."
      },
      {
        "criterion_number": 8,
        "description": "The response states vision changes may be related to paraneoplastic processes and explains what this is.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains paraneoplastic syndromes as \"rare immune responses triggered by the cancer\" that can affect vision, giving the example of cancer-associated retinopathy."
      },
      {
        "criterion_number": 10,
        "description": "The response states the patient\u2019s oncologist may prescribe medications to improve the vision changes, including eye drops, steroids, or antibiotics.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States the team might \"prescribe eye drops\" and recommend artificial tears. While steroids/antibiotics are not named, medications (eye drops) to improve symptoms are explicitly mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient\u2019s vision changes may be due to infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state infection as a cause of vision changes. Conjunctivitis is mentioned as a drug side effect but not framed as infectious."
      },
      {
        "criterion_number": 12,
        "description": "The response states the patient\u2019s vision changes may be due to age-related vision changes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists age-related conditions (cataracts, glaucoma, macular degeneration) as possible coincident causes of vision changes."
      }
    ],
    "question_number": 105,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:19:00.533348",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "States that telehealth appointments are generally as effective as in-person visits for many aspects of care for patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states telehealth can be as effective as in-person for many aspects of oncology care and notes for pancreatic cancer specifically a hybrid approach is often recommended; cites evidence and a Pancreatology review supporting effectiveness for survivorship/symptom monitoring."
      },
      {
        "criterion_number": 2,
        "description": "Reviews the potential benefits of telehealth appointments, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions reduced exposure to infections, saves time and money on travel, allows family involvement, and improves access to specialists (especially in rural areas)."
      },
      {
        "criterion_number": 3,
        "description": "Reviews the potential downsides of telehealth appointments, including potential differences in insurance reimbursement and challenges with physical examination.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly notes limitations of physical examination via telehealth and advises checking insurance coverage policies/state-specific rules (implying potential reimbursement differences)."
      },
      {
        "criterion_number": 4,
        "description": "States it can be challenging for a doctor to fully evaluate a patient via telehealth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that telehealth cannot fully replicate hands-on assessments and that subtle changes may be missed, making full evaluation challenging."
      },
      {
        "criterion_number": 5,
        "description": "States telehealth can be a convenient alternative to in-office visits and may be helpful if the patient has mobility or transportation issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes telehealth as convenient, reducing travel burden and being helpful for those in rural areas or with mobility issues."
      },
      {
        "criterion_number": 6,
        "description": "States in-office visits may be more appropriate in certain situations, including for initial visits or when there are big changes to the patient\u2019s health or treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies in-person is needed for initial diagnosis/staging and for emergencies/complex symptoms and treatment delivery, indicating appropriateness when health status changes."
      },
      {
        "criterion_number": 7,
        "description": "Recommends discussing telehealth options with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises asking her oncologist about telehealth policies and integration into the care plan."
      },
      {
        "criterion_number": 8,
        "description": "States not all oncologists offer telehealth appointments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that not all oncologists offer telehealth; only suggests asking about policies."
      },
      {
        "criterion_number": 9,
        "description": "Offers tips for making the most out of a telehealth appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides concrete tips: prepare records and symptom lists, test technology, use home monitoring devices, consider hybrid scheduling, and check insurance."
      },
      {
        "criterion_number": 10,
        "description": "States medical emergencies are not appropriate for telehealth evaluations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly indicates emergencies or severe/complex symptoms require in-person evaluation to avoid delays in care."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that telehealth may be less suitable for sensitive discussions, such as new diagnosis or end-of-life care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state telehealth is less suitable for sensitive discussions; in fact, suggests palliative care discussions can work well via telehealth."
      },
      {
        "criterion_number": 12,
        "description": "Mentions that limitations of telehealth include technology barriers and occasional concerns about reduced personal connection or quality of interaction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes technical issues, privacy concerns, and lack of non-verbal cues making telehealth feel less personal, addressing both technology and interpersonal limitations."
      }
    ],
    "question_number": 106,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:19:42.218619",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises talking to the oncologist or oncology nurse for personalized guidance and next steps."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments for pancreatic cancer can cause hair loss, for example, FOLFIRINOX or gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions gemcitabine (\u00b1 nab-paclitaxel) and FOLFIRINOX and discusses their association with hair loss."
      },
      {
        "criterion_number": 3,
        "description": "The response provides reported estimates of hair loss with FOLFIRINOX and gemcitabine and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response gives estimates (e.g., 10\u201350% for gemcitabine regimens, 50\u201380% for FOLFIRINOX), it does not cite any sources."
      },
      {
        "criterion_number": 4,
        "description": "The response states hair typically grows back once the causative treatment is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states hair loss is typically temporary and regrowth begins 1\u20133 months after treatment ends."
      },
      {
        "criterion_number": 5,
        "description": "The response states cold caps are sometimes used to reduce hair loss but they can be expensive.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes cold caps/scalp cooling, notes variable effectiveness and availability, and mentions costs and insurance coverage issues."
      },
      {
        "criterion_number": 6,
        "description": "The response states hair loss from chemotherapy is a common and distressing side effect in patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It frames hair loss as a common concern and notes it can be distressing, affecting self-image, in the context of pancreatic cancer chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response states other chemotherapy regimens or immunotherapy or targeted therapy cause hair loss at lower rates or not at all.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that other options like FOLFOX or targeted therapies (e.g., erlotinib) may have lower risks of hair loss."
      },
      {
        "criterion_number": 8,
        "description": "The response states many cancer patients wear hats or wigs to help with appearances and self-esteem.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends wigs, scarves, hats, or turbans and notes they can help with appearance and are sometimes covered by insurance."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests counseling through cancer support groups and cites organizations like PanCAN and ACS."
      },
      {
        "criterion_number": 10,
        "description": "The response reports expected timelines for hair loss after starting chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes hair loss typically starts 2\u20134 weeks after the first chemo session and describes the pattern and regrowth timeline."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the severity and risk of hair loss is higher with multi-agent and taxane-containing protocols, and female patients are at increased risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it indicates higher risk with multi-agent regimens and with drugs like paclitaxel, it does not mention that female patients are at increased risk."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that most cases of hair loss are reversible, with regrowth expected within 3-6 months after cessation of chemotherapy, but persistent or permanent alopecia can occur, especially after repeated or high-dose regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It provides the typical regrowth timeline (1\u20133 months to start, full recovery 3\u20136 months) but does not mention the possibility of persistent or permanent alopecia."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that eyebrow and eyelash loss may also be seen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that eyebrows and eyelashes may also be affected, along with other body hair."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that topical minoxidil may aid regrowth post-chemotherapy, though evidence for prevention is limited.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of topical minoxidil or its role in post-chemotherapy regrowth."
      }
    ],
    "question_number": 107,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:20:10.034749",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines oligometastatic disease in pancreatic cancer as a state where the cancer has spread to a limited number of sites, typically involving a single organ (e.g., liver or lung) and a small number of lesions, commonly defined as \u22643 to \u22645 metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that oligometastatic disease refers to cancer that has spread to a small number of places, explicitly noting 'typically 1 to 5 metastatic sites,' and provides organ examples. This captures the limited-number concept and common numerical definition."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises talking to the oncologist for clarification and suggests considering a second opinion at a major cancer center."
      },
      {
        "criterion_number": 3,
        "description": "Discusses the potential impact oligometastatic disease may have on treatment options, including the possibility of aggressive multimodal therapy such as systemic chemotherapy followed by local treatments like surgery, ablation, or stereotactic radiotherapy, if there is a good response to initial therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response describes broader treatment options including surgery, SBRT, chemotherapy, and ablation; it also notes candidacy may depend on response to initial treatments, aligning with the concept of systemic therapy followed by local consolidation."
      },
      {
        "criterion_number": 4,
        "description": "Contrasts oligometastatic disease to localized disease and widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly distinguishes oligometastatic disease from localized disease (no spread) and widespread metastatic disease (many areas)."
      },
      {
        "criterion_number": 5,
        "description": "Mentions that patients with oligometastatic disease have the potential for an improved prognosis compared to widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that patients with oligometastatic pancreatic cancer may respond better than those with more extensive spread and mentions the possibility of longer-term control or remission, indicating a relatively improved prognosis."
      }
    ],
    "question_number": 108,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:20:44.685666",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states it is common for patients to have low blood counts due to chemotherapy used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that low blood counts and related treatment delays are common in pancreatic cancer patients receiving chemotherapy and cites prevalence (50\u201370%)."
      },
      {
        "criterion_number": 2,
        "description": "The response states treatment delays due to low blood counts are enacted to ensure the patient\u2019s safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly explains that oncologists delay treatment to prevent serious complications (e.g., severe infections), emphasizing safety."
      },
      {
        "criterion_number": 3,
        "description": "The response states the oncologist may recommend dose reducing the chemotherapy or changing to a different treatment if the blood counts remain low.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response mentions dose reductions and schedule modifications to minimize side effects, satisfying the criterion (includes \u2018dose reduction\u2019)."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of chemotherapy known to cause low blood counts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specific regimens (FOLFIRINOX, gemcitabine, combinations) are named as examples that can suppress counts."
      },
      {
        "criterion_number": 5,
        "description": "The response lists the different types of low blood counts that may impact treatment, including anemia, neutropenia, thrombocytopenia, and low total white blood cell count, and explains why these cells are important in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists low white blood cells (neutropenia), anemia, and thrombocytopenia, and explains infection risk, fatigue, and bleeding risk in lay terms. \u2018Low white blood cells (neutropenia)\u2019 covers low WBC count for lay readers."
      },
      {
        "criterion_number": 6,
        "description": "The response states the oncologist may prescribe an injection medication (e.g., G-CSF) to help increase the neutrophil count.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions growth factors (filgrastim, pegfilgrastim) to boost white blood cell production, which are G-CSF agents to raise neutrophils."
      },
      {
        "criterion_number": 7,
        "description": "The response states if the red blood cell or platelet counts get too low, the oncologist may order a transfusion of red blood cells or platelets to keep these at safe levels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that blood transfusions or platelet infusions can help in severe cases, aligning with transfusion support."
      },
      {
        "criterion_number": 8,
        "description": "The response instructs the patient to seek immediate medical evaluation if they have low blood counts and experience fever, chest pain, shortness of breath, leg swelling, blood in the urine, blood in the stool, or other uncontrollable bleeding.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit urgent warning or symptom list (e.g., fever, chest pain, dyspnea, bleeding) advising immediate evaluation is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends ensuring good nutrition to ensure the bone marrow can produce the required blood cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends ensuring good nutrition as part of supporting recovery, which implies supporting marrow production."
      },
      {
        "criterion_number": 10,
        "description": "The response must strongly recommend consulting with an oncologist or care team, providing specific questions or topics to discuss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It strongly recommends discussing with the oncologist and provides specific questions (reason for low counts, duration of delay, supportive meds, effect on treatment effectiveness)."
      }
    ],
    "question_number": 109,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:21:11.404604",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing the treatment with the father's oncologist and oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explains hyperthermia treatment for cancer in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Hyperthermia is clearly described as controlled heating of tissues to damage cancer cells and enhance other treatments, using accessible language and examples."
      },
      {
        "criterion_number": 3,
        "description": "The response specifies that hyperthermia treatment involves heating tumor tissue to a temperature range of 39-43\u00b0C to enhance the cytotoxic effects of chemotherapy and/or radiotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it states that hyperthermia enhances chemo/radiation, it gives a temperature range of 40\u201345\u00b0C, not the required 39\u201343\u00b0C."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions all three delivery methods: regional (including \u2018deep regional\u2019), intraoperative, and whole-body hyperthermia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions local, regional, and whole-body approaches but does not mention intraoperative hyperthermia or specify deep regional."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews potential benefits and risks of hyperthermia treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response outlines potential benefits (treatment enhancement, possible improved response/pain relief) and risks (skin burns, discomfort, systemic effects with whole-body, rare serious events) with good balance."
      },
      {
        "criterion_number": 6,
        "description": "The response states hyperthermia is not an effective alternative to standard of care treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states hyperthermia is an adjunct/enhancer, not a replacement for standard care."
      },
      {
        "criterion_number": 7,
        "description": "The response states hyperthermia is not a standard first-line therapy for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that hyperthermia for pancreatic cancer is experimental and not a standard first-line treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response states there is not robust evidence for the use of hyperthermia treatment in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states the evidence is limited and mixed and that large, definitive studies are lacking."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that hyperthermia is used in pancreatic cancer as an adjunct to standard chemoradiotherapy for patients with locally advanced, unresectable, or metastatic disease, especially when conventional therapies have limited efficacy or are refractory.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it describes use as an add-on to chemotherapy and/or radiation and mentions metastatic disease, it does not specify locally advanced or unresectable disease, nor does it mention refractory cases or explicitly frame it as adjunct to chemoradiotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that adding hyperthermia to chemoradiotherapy may improve overall response rates and median survival compared to standard therapy alone, with acceptable safety profiles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions some studies suggest improved tumor response or survival when added to standard care, but does not specifically reference overall response rates, median survival, comparison to standard therapy alone, or acceptable safety profiles in this context."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that the quality of evidence for hyperthermia is limited, it remains investigational, and there are ongoing trials evaluating its efficacy and optimal integration into multimodal treatment regimens.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It states the evidence is limited and describes ongoing trials, and calls it experimental, but does not explicitly mention that trials are evaluating optimal integration into multimodal regimens."
      }
    ],
    "question_number": 110,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:21:50.678144",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises involving the oncologist: it states that the mother's oncologist can review results and integrate findings into treatment decisions, and suggests seeking a specialist at an NCI-designated center."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Genetic counselors are highlighted as the primary professionals to interpret results, assess inherited risk, and guide family screening, with instructions on how to find one via the NSGC directory and testing labs."
      },
      {
        "criterion_number": 4,
        "description": "The response explains genetic testing and why it is done in cancer treatment, using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly explains that genetic testing informs inherited risk, treatment options, and implications for family members, describes report elements (genes tested, variant classifications), and uses accessible language about how results can affect therapy and clinical trial options."
      },
      {
        "criterion_number": 5,
        "description": "The response includes in its explanation that certain genetic mutations like BRCA2 may be targets for targeted cancer therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that BRCA gene mutations may make a patient eligible for PARP inhibitors, a targeted therapy, directly addressing targeted treatment implications."
      },
      {
        "criterion_number": 6,
        "description": "The response states that certain genetic mutations are associated with inherited cancer predisposition syndromes which may affect the patient\u2019s relatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses inherited syndromes (e.g., BRCA, Lynch), family risk assessment, and guidance on family screening and preventive measures, including prompting questions about relatives' implications."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that board-certified genetic counselors, medical geneticists, and oncologists can help determine the clinical significance of identified variants, discuss implications for surveillance, prevention, and treatment, and provide guidance for at-risk family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names genetic counselors, medical geneticists, and oncologists and describes their roles in interpreting variants, integrating findings into treatment, advising on surveillance/prevention, and guiding family screening."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that pathogenic variants in genes such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, and others may influence both therapeutic decisions and recommendations for family screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists BRCA1/2, PALB2, and ATM as commonly tested pancreatic cancer genes, notes implications for targeted therapy (e.g., PARP inhibitors) and explicitly mentions guiding family screening; while CDKN2A is not named, the criterion uses \"such as,\" and the response meets the spirit by naming multiple relevant genes and linking them to therapy and family screening."
      }
    ],
    "question_number": 111,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:22:13.651214",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises consulting the healthcare team, including an oncologist and a registered dietitian, for personalized advice."
      },
      {
        "criterion_number": 2,
        "description": "The response states changes in taste are a common side effect of some chemotherapies used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states taste changes are common in pancreatic cancer and identifies chemotherapy as a potential cause, fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends trying different foods and drinks to identify flavor profiles that are appealing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises keeping a food diary and experimenting with seasonings, tart/sour foods, and temperature to find appealing options."
      },
      {
        "criterion_number": 4,
        "description": "The response states cold intolerance is a common side effect of oxaliplatin, so patients should avoid cold foods and drinks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of oxaliplatin or cold intolerance; in fact, it suggests cold foods might be better for some."
      },
      {
        "criterion_number": 5,
        "description": "The response states changes in taste typically improve or disappear entirely when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that dysgeusia typically improves or resolves once the causative medication is stopped."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of maintaining proper nutrition and hydration while undergoing treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It stresses nutrition is crucial for strength during treatment and encourages hydration with specific tips (e.g., sipping fluids, ice chips)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends nutritional supplements to ensure the patient is achieving their needs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends high-calorie, high-protein shakes and commercial supplements such as Ensure or Boost."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that improved oral hygiene and active swallowing exercises may also promote taste recovery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it provides detailed oral hygiene advice, it does not mention active swallowing exercises."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that a referral to a registered dietitian is recommended for tailored nutritional strategies, as taste changes often lead to reduced appetite, altered food preferences, and risk of malnutrition.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends consulting a registered/oncology dietitian for personalized advice and notes risks like weight loss and poor nutrition."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that dietitians can assist with food texture modification, flavor enhancement, and strategies to maintain adequate caloric and protein intake.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it notes dietitians can recommend enzyme supplements/fortified foods, it does not explicitly mention assistance with food texture modification or flavor enhancement."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pharmacological and supplement-based interventions have been explored with mixed results. Further research is needed to establish standardized, effective interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions potential use of mouth rinses and checking zinc but does not state that evidence is mixed or that further research is needed."
      }
    ],
    "question_number": 112,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:22:46.863509",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the exercise plan with the patient\u2019s oncologist or healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly advises consulting the oncologist/healthcare team before starting exercise and mentions obtaining doctor clearance post-surgery and referrals to oncology physical therapy."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends gentle and slow exercise to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends low-impact, gentle activities, starting small (e.g., 10\u201315 minutes), avoiding high-intensity exercise, and stopping with pain/dizziness, which aligns with gentle/slow progression."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions fatigue, pain, weight loss/cachexia, and hydration, it does not explicitly state increased injury risk due to fatigue, malnutrition, dehydration, and pain."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends connecting with pancreatic cancer communities and cites PanCAN (pancan.org)."
      },
      {
        "criterion_number": 5,
        "description": "The response states gentle exercise participation may improve a cancer patient\u2019s quality of life and offers published research studies as evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it states exercise may improve quality of life, it does not offer or reference any specific published research studies as evidence."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions that research and studies show benefits but does not cite any specific studies; only organizations (ACS, ACSM, NCCN) are referenced."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are exercise classes specifically for cancer patients and provides resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references the Livestrong at the YMCA program for cancer survivors and mentions oncology-specific resources (ACS/MSKCC virtual programs), meeting the requirement."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention that The American Society of Clinical Oncology recommends both aerobic and resistance exercise as safe and beneficial for patients with pancreatic cancer during chemotherapy, chemoradiotherapy, or neoadjuvant therapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "ASCO is not mentioned, and no explicit statement of ASCO\u2019s recommendation for aerobic and resistance exercise during chemotherapy/chemoradiotherapy/neoadjuvant therapy is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response must clearly state that physical activity should be tailored to individual capacity and comorbidities, using terms like \u201cindividual capacity,\u201d \u201cpersonalized,\u201d or \u201ctailored.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states advice should be personalized and includes having a physical therapist create a tailored plan, and notes exercise depends on individual factors (stage, health, treatment, energy)."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that aerobic exercise (e.g., walking, cycling, swimming) and resistance training (e.g., weights, resistance bands) improve cardiorespiratory fitness, physical function, and reduce symptoms like fatigue and mood disturbances.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although benefits like reduced fatigue and improved mood are mentioned, the response does not explicitly state that aerobic and resistance training improve cardiorespiratory fitness and physical function as specified."
      }
    ],
    "question_number": 113,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:23:17.307775",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises regular check-ins with the oncologist and to discuss with the care team; multiple mentions of contacting the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends reporting any new symptoms to the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States, \u201cIf you notice any of these, contact their healthcare team right away,\u201d which clearly instructs reporting new symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response states it is important to separate side effects of treatment from progression of disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that symptoms can overlap with treatment side effects and advises not to assume the worst without professional evaluation."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of new or worsening pain, jaundice, unintentional weight loss, and appetite changes as symptoms that may signify progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists increasing/new pain (abdominal/back), jaundice, significant unintentional weight loss, and appetite loss."
      },
      {
        "criterion_number": 5,
        "description": "The response states metastases to other sites in the body can have various symptoms and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a specific section on metastasis with examples for lungs, bones, liver, and brain."
      },
      {
        "criterion_number": 6,
        "description": "The response instructs the patient to seek immediate medical evaluation if they experience severe pain, jaundice, severe constipation, confusion, or neurologic changes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises ER visit for intense pain, severe vomiting, confusion, or breathing difficulties, but does not include jaundice or severe constipation as immediate red flags, and does not explicitly link neurologic changes (beyond confusion) to immediate evaluation."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention at least 10 of the following signs and symptoms indicating disease progression in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions \u226510: jaundice, dark urine, pale stools, pruritus (itching), abdominal pain, back pain, weight loss, anorexia (loss of appetite), fatigue/weakness, nausea/vomiting, diarrhea, and new or worsening diabetes."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention gastrointestinal bleeding or rapidly declining performance status as alarm symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of GI bleeding or rapidly declining performance status."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state the importance of close monitoring of symptoms for timely intervention and supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes tracking symptoms, keeping a journal, and contacting the team right away for early intervention; references supportive/palliative care."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention early integration of supportive care to optimize quality of life and address complications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends asking about palliative care options early to manage symptoms and improve quality of life."
      }
    ],
    "question_number": 114,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:24:03.206863",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoadjuvant therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly defines neoadjuvant therapy as treatment given before the primary/main treatment to make it more effective."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that neoadjuvant treatment is given before the main treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states it is given before the primary or main treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that neoadjuvant therapy usually occurs before surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that the main treatment is often surgery and discusses use prior to procedures like the Whipple."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that neoadjuvant therapy is usually chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it usually includes chemotherapy and gives examples such as FOLFIRINOX and gemcitabine-based regimens."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that radiation therapy can sometimes be used for neoadjuvant therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions radiation therapy and chemoradiation as neoadjuvant options."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that oncologists often evaluate the response of a person\u2019s cancer after neoadjuvant therapy to determine the next steps.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains reassessment after therapy with scans/tests to decide if surgery is next and to guide further treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the main goals of neoadjuvant therapy are to treat micrometastases early, improve chances of margin-negative (R0) resection, downstage advanced tumors, and ensure patients receive systemic therapy, as many can\u2019t complete adjuvant treatment after surgery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Covers treating micrometastases, downstaging to enable surgery, and facilitating more complete resection, but does not mention the goal of ensuring delivery of systemic therapy because many patients cannot complete adjuvant therapy after surgery."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that patient selection, multidisciplinary coordination, and management of therapy-related toxicities are critical, as attrition during neoadjuvant therapy can preclude surgery.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions side effects and that doctors monitor/manage them and implies patient selection, but does not emphasize multidisciplinary coordination or the risk that attrition during neoadjuvant therapy can preclude surgery."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing with his oncologist/oncology team and a pancreatic cancer specialist."
      }
    ],
    "question_number": 115,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:24:25.375369",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that music therapy can help with symptoms associated with pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Clearly states music therapy can help manage symptoms during pancreatic cancer treatment and references symptom management broadly and specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that music therapy can help with anxiety.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicit section on reducing anxiety and stress with supporting evidence."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that music therapy can improve quality of life.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions improved quality of life and cites a Journal of Clinical Oncology study (though without a link)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that music therapy can help with depression.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes depression as a common issue and indicates music therapy helps with emotional well-being; implies benefit for depression and mood."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that music therapy can help with pain.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Dedicated pain management section stating music therapy can decrease pain intensity and referencing Cochrane."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that music therapy can help with fatigue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly includes alleviating fatigue as a potential benefit."
      },
      {
        "criterion_number": 7,
        "description": "The response states that music therapy is anti-cancer therapy.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Does not claim anti-cancer effects; explicitly states it is not a cure and is a complementary approach."
      },
      {
        "criterion_number": 8,
        "description": "The response should cite peer-reviewed publications with links.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions journals and organizations but provides no links to peer-reviewed publications."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that ASCO and SIO recommend music therapy as a safe, non-invasive adjunct for managing anxiety and depression in adults with cancer, including those undergoing active treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "References ASCO generally but does not mention SIO or the joint recommendation."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that emerging evidence suggests music therapy may also modulate immune responses and support overall treatment outcomes, but further research is needed.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No discussion of immune modulation or effects on treatment outcomes beyond symptom relief/QOL."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends discussing with the oncologist or palliative care team and suggests referral to a certified music therapist."
      }
    ],
    "question_number": 116,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:24:47.742322",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that pancreatic cancer is not contagious.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states pancreatic cancer is not contagious or transmissible to pets or people and that pets cannot catch it."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that chemotherapy can weaken the immune system and make someone at increased risk of infection.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States that cancer and its treatments can weaken the immune system, making the person more susceptible to infections."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pets can carry infections that could be harmful to immunocompromised persons.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Notes pets can carry zoonotic diseases that pose higher risk to someone with a compromised immune system."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient discuss precautions related to chemotherapy excretion with a pharmacist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises consulting the oncologist and a veterinarian, but does not mention a pharmacist."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some chemotherapy drugs are excreted in urine.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically lists urine among bodily fluids in which chemo drugs can be excreted."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that some chemotherapy drugs are excreted in stool.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention stool among excreted bodily fluids."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that some chemotherapy drugs are excreted in saliva.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically lists saliva among bodily fluids in which chemo drugs can be excreted."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some chemotherapy drugs are excreted in vomit.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically lists vomit among bodily fluids in which chemo drugs can be excreted."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that pets should avoid contact with excreted medications.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explains risk if pets contact bodily fluids containing chemo residues and advises prompt cleanup, washing bedding, and limiting close contact after chemo\u2014effectively advising avoidance of excreted medications."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that pets should avoid contact with chemotherapy medications.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Discusses avoiding contact with bodily fluids containing residues but does not explicitly state pets should avoid contact with chemotherapy medications themselves."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that pets should avoid contact with all medications.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Does not mention avoiding contact with all medications."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pets provide significant emotional and psychological benefits to cancer patients.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States pets can be a great source of companionship and mentions comfort from pet therapy and emotional support."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that to reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on their pets.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends precautions such as cleaning accidents, washing bedding, and limiting close contact after chemo; notes potential restrictions after internal radiation."
      },
      {
        "criterion_number": 14,
        "description": "After chemotherapy, surfaces\u2014especially in bathrooms\u2014can remain contaminated for at least 48 hours, so thorough cleaning is advised.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States chemo drugs can be excreted for 48\u201372 hours and advises cleaning bedding/areas and prompt cleanup of accidents, capturing the 48-hour contamination timeframe and cleaning advice."
      },
      {
        "criterion_number": 15,
        "description": "Hand hygiene is essential after contact with patient waste or contaminated areas.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Promotes handwashing after handling pets but does not explicitly state hand hygiene after contact with patient waste or contaminated areas."
      },
      {
        "criterion_number": 16,
        "description": "Immunocompromised patients should practice good hand hygiene after handling pets.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly advises washing hands after handling pets."
      },
      {
        "criterion_number": 17,
        "description": "Immunocompromised patients should avoid contact with pet waste.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Suggests cleaning litter boxes with gloves but does not advise immunocompromised patients to avoid contact with pet waste."
      },
      {
        "criterion_number": 18,
        "description": "Immunocompromised patients should prevent pets from licking open wounds.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Specifically states to avoid letting pets lick open wounds or the face."
      },
      {
        "criterion_number": 19,
        "description": "There is no strong evidence that pet ownership increases cancer risk or that pets need to be removed from the home during treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it highlights benefits of pets and suggests precautions, it does not explicitly state there is no evidence pets increase cancer risk or that pets do not need to be removed."
      },
      {
        "criterion_number": 20,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets, and seek assistance with pet care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention avoiding young animals, reptiles, or exotic pets; assistance with pet care is discussed generally but not in the context of severe immunosuppression."
      },
      {
        "criterion_number": 21,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explicitly recommends consulting the oncologist for personalized advice."
      }
    ],
    "question_number": 117,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:25:43.500714",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define adjuvant therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines adjuvant therapy as additional treatment given after the primary treatment to address microscopic disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should state the goal of adjuvant therapy is to prevent cancer recurrence.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states the goal is to reduce the risk of the cancer returning (recurrence)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that adjuvant therapy usually occurs after surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States adjuvant therapy is given after primary treatment and notes primary treatment is usually surgery; also mentions starting 4\u20138 weeks after surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include adjuvant therapy can be chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists chemotherapy (e.g., gemcitabine, FOLFIRINOX) as a common form of adjuvant therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should include adjuvant therapy can be radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions radiation therapy and chemoradiation as potential adjuvant options."
      },
      {
        "criterion_number": 6,
        "description": "The response states that guidelines recommend all patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy, unless there are medical or surgical contraindications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state the specific guideline recommending 6 months of adjuvant chemotherapy for all eligible resected patients without preoperative therapy."
      },
      {
        "criterion_number": 7,
        "description": "The response states that adjuvant systemic therapy significantly improves survival compared to surgery alone.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes that studies have shown adjuvant chemotherapy can improve survival rates, implying benefit over surgery alone."
      },
      {
        "criterion_number": 8,
        "description": "The response states that the choice of adjuvant regimen should be individualized based on patient fitness and risk of toxicity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States that the decision depends on overall health, stage, surgical results, and genetic markers, and discusses side effects, reflecting individualization based on fitness and toxicity risk."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends that the user discuss this case with an oncologist or cancer specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing specifics with the oncologist and provides suggested questions."
      }
    ],
    "question_number": 118,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:26:10.777737",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing constipation with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises consulting the healthcare team, explicitly naming the oncologist, before making changes and to work closely with the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing pain medications with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a medication review and possible opioid rotation or addition of non-opioids with the doctor and emphasizes consultation with the oncology/palliative care team before changes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that constipation is a side effect of opioid pain medications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states opioid-induced constipation is common with opioids such as morphine and oxycodone."
      },
      {
        "criterion_number": 4,
        "description": "Recommend a bowel regimen including stimulant laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Stimulant laxatives (senna, bisacodyl) are recommended as part of the management plan."
      },
      {
        "criterion_number": 5,
        "description": "Recommend a bowel regimen including osmotic laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Osmotic laxatives (polyethylene glycol, lactulose) are recommended and described."
      },
      {
        "criterion_number": 6,
        "description": "Recommend a bowel regimen including stool softeners.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Stool softeners such as docusate are recommended as part of management for OIC."
      },
      {
        "criterion_number": 7,
        "description": "State that a combination of these treatments is sometimes needed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes interventions can be very effective when combined and suggests preventive laxative regimens, implying combination therapy may be needed."
      },
      {
        "criterion_number": 8,
        "description": "State that there are prescription medications that can directly target opioid-associated constipation.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It names methylnaltrexone and naloxegol as prescription options that block opioid effects in the gut without affecting analgesia."
      },
      {
        "criterion_number": 9,
        "description": "Recommend hydration to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends increasing fluid intake with specific targets and examples of appropriate fluids."
      },
      {
        "criterion_number": 10,
        "description": "Recommend physical activity to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends gentle movement such as short walks and chair exercises to stimulate bowel function."
      },
      {
        "criterion_number": 11,
        "description": "Mention that OIC is due to reduced gut motility and that agents increasing water content or stimulating peristalsis address this.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains opioids reduce gut motility and describes osmotics pulling water into the intestines and stimulants triggering bowel contractions, aligning treatments with the pathophysiology."
      },
      {
        "criterion_number": 12,
        "description": "Mention AGA recommends PEG and lactulose as effective osmotic agents improving stool vs placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While PEG and lactulose are mentioned, there is no reference to AGA recommendations or comparative efficacy versus placebo."
      },
      {
        "criterion_number": 13,
        "description": "State that soluble fiber is only for fiber-deficient diets and has limited efficacy in OIC due to limited effect on colonic motility.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response recommends fiber cautiously but does not state its limited efficacy in OIC or restrict it to fiber-deficient diets."
      },
      {
        "criterion_number": 14,
        "description": "Mention that enemas are reserved for rescue therapy and not for regular use.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It advises enemas/suppositories for severe cases for quick relief and only under medical guidance, indicating rescue rather than regular use."
      }
    ],
    "question_number": 119,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:26:43.377610",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that meditation and mindfulness can improve quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly addresses quality-of-life benefits under 'Improving Quality of Life and Symptom Management' and notes better sleep, reduced fatigue, improved mood, and enhanced coping."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that meditation and mindfulness are not anti-cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states 'These are not treatments for cancer itself' and 'won't treat or cure pancreatic cancer,' emphasizing complementary use alongside standard therapies."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that meditation and mindfulness can help emotional well-being.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights reductions in stress, anxiety, and depression; mentions improved mood and better emotional function, demonstrating support for emotional well-being."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that meditation and mindfulness demonstrate moderate improvements in anxiety, depression, cancer-related fatigue, and overall quality of life in oncology populations, with effects maintained for at least several months post-intervention.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it describes improvements in anxiety, depression, fatigue, and quality of life, it does not state that effects are maintained for several months post-intervention, which is required for full credit."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that meditation and mindfulness are safe, feasible, and can be integrated alongside standard cancer care to help manage both physical and psychological symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes they are generally safe and low-risk, can be used alongside conventional treatments, and can help with physical symptoms (pain, nausea, appetite) and psychological symptoms (anxiety, depression)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises discussing with the oncology team and specifically to talk to his oncologist or a palliative care specialist."
      }
    ],
    "question_number": 120,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:27:08.484841",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing concerns with an oncology nutritionist or dietitian",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises working with a registered dietitian specializing in oncology and suggests asking for a referral to oncology dietitians."
      },
      {
        "criterion_number": 2,
        "description": "State that pancreatic enzyme supplements can help with digestion when there is pancreatic enzyme deficiency",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states doctors may prescribe pancreatic enzymes (e.g., Creon) for trouble digesting fats and to take them with meals."
      },
      {
        "criterion_number": 3,
        "description": "State that nutrition is important for maintaining strength or energy",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response says nutrition supports strength and energy, e.g., 'supporting her strength' and 'maintains energy.'"
      },
      {
        "criterion_number": 4,
        "description": "State that nutrition is important for supporting the immune system",
        "score_given": 4,
        "max_points": 4,
        "justification": "It notes weakened immunity as an issue and later states 'nutrition can help... support immunity.'"
      },
      {
        "criterion_number": 5,
        "description": "State that nutrition is important for maintaining weight",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly lists maintaining weight as a goal and recommends monitoring weight weekly."
      },
      {
        "criterion_number": 6,
        "description": "State reasons for nutrition challenges in pancreatic cancer, including poor appetite",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists poor appetite among common issues."
      },
      {
        "criterion_number": 7,
        "description": "State reasons for nutrition challenges in pancreatic cancer, including digestion difficulties",
        "score_given": 3,
        "max_points": 3,
        "justification": "It describes difficulty digesting fats (steatorrhea) and the role of enzyme replacement."
      },
      {
        "criterion_number": 8,
        "description": "State reasons for nutrition challenges in pancreatic cancer, including treatment side effects like nausea",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists nausea, vomiting, diarrhea, and constipation as treatment-related issues."
      },
      {
        "criterion_number": 9,
        "description": "State they should focus on protein intake",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends high-protein intake with specific targets (1.2\u20132 g/kg) and examples of protein sources."
      },
      {
        "criterion_number": 10,
        "description": "State they should focus on calorie intake",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends high-calorie intake with targets (25\u201330 kcal/kg) and strategies to boost calories."
      },
      {
        "criterion_number": 11,
        "description": "Recommend trying to manage nausea",
        "score_given": 6,
        "max_points": 6,
        "justification": "It provides nausea management strategies (bland foods, ginger tea, avoiding strong smells)."
      },
      {
        "criterion_number": 12,
        "description": "Recommend hydration",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends 8\u201310 cups of fluids daily and suggests water, herbal teas, broths, and electrolyte drinks."
      },
      {
        "criterion_number": 13,
        "description": "Mention high risk of malnutrition/cachexia/weight loss requiring early and ongoing nutritional assessment/intervention",
        "score_given": 0,
        "max_points": 9,
        "justification": "While it mentions malnutrition and common weight loss and suggests working with a dietitian and monitoring weight, it does not mention cachexia nor explicitly emphasize early and ongoing formal nutritional assessment and intervention."
      },
      {
        "criterion_number": 14,
        "description": "Prioritize enteral over parenteral nutrition when oral intake is inadequate",
        "score_given": 0,
        "max_points": 7,
        "justification": "It lists oral supplements, tube feeding, or IV nutrition as options but does not state a preference for enteral over parenteral nutrition."
      },
      {
        "criterion_number": 15,
        "description": "Mention that oral nutritional supplements enriched with omega-3 fatty acids are beneficial for weight and lean mass",
        "score_given": 0,
        "max_points": 3,
        "justification": "Oral supplements are suggested (Ensure/Boost), but there is no mention of omega-3\u2013enriched formulas or benefits to weight/lean body mass."
      },
      {
        "criterion_number": 16,
        "description": "Emphasize a plant-enriched diet for overall health and cancer risk reduction",
        "score_given": 0,
        "max_points": 3,
        "justification": "It advises including fruits, vegetables, and whole grains for micronutrients, but does not explicitly emphasize a plant-enriched dietary pattern or link it to overall health and cancer risk reduction."
      },
      {
        "criterion_number": 17,
        "description": "State that current evidence does not support ketogenic diets for treatment",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response does not address ketogenic diets."
      }
    ],
    "question_number": 121,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:27:58.960726",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that memory issues can be associated with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly describes 'chemo brain' and notes that chemotherapy regimens used in pancreatic cancer can cause cognitive impairment."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing memory concerns with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to discuss with the oncology team and to bring concerns up with the oncologist or primary care provider as soon as possible."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that memory issues can be associated with pain medications.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states that pain medications (like opioids) can impair memory and concentration and cause sedation/confusion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that memory issues can be associated with poor nutrition.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It links malnutrition due to digestive problems to effects on brain function and recommends nutritional support."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that memory issues can be associated with dehydration.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While it recommends staying hydrated, it does not explicitly state that dehydration is associated with memory issues."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that memory issues can be associated with anxiety.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states that anxiety can mimic or worsen memory issues."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that memory issues can be associated with depression.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states that depression can mimic or worsen memory issues."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that memory issues can be associated with fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that significant fatigue can impair cognitive function."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that memory issues can be associated with stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifies that stress from the diagnosis can mimic or worsen memory issues."
      },
      {
        "criterion_number": 10,
        "description": "The response should cite peer-reviewed articles with links.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No peer-reviewed articles with links are provided; only general references to organizations (ACS, NCI) without citations."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that memory issues in pancreatic cancer patients are frequently related to cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states treatment can cause cognitive issues and cites that up to 75% of cancer patients experience cognitive changes during chemotherapy, implying frequent association."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that biological mechanisms underlying chemotherapy-induced cognitive changes include direct neurotoxic effects of chemotherapy, neuroinflammation, changes in brain structure and connectivity, and involvement of specific biomarkers and genetic predispositions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions inflammation, oxidative stress, and direct effects on brain cells but does not mention changes in brain structure/connectivity or biomarkers/genetic predispositions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that cognitive impairment may also be influenced by the cancer itself, paraneoplastic effects, and other factors such as age, comorbidities, and emotional distress.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It discusses the cancer itself (metabolic/electrolyte issues, metastasis), paraneoplastic syndromes, age/comorbidities, and emotional factors (anxiety, depression, stress)."
      }
    ],
    "question_number": 122,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:28:30.171065",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ablative techniques in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines ablation as minimally invasive procedures that destroy tumor cells using energy sources and applies this to pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that ablative techniques in pancreatic cancer are used when surgery isn\u2019t possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states ablation is considered when surgery isn't feasible, such as tumors near critical vessels."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including radiofrequency ablation (RFA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated section on RFA with an explanation of mechanism and approach."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including microwave ablation (MWA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes MWA with description of how it works and its potential advantages."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that ablative techniques are not curative.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that ablation is not a cure for advanced cases, conveying non-curative intent in typical pancreatic cancer use."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that ablative techniques in pancreatic cancer are used to manage symptoms.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes palliative use to relieve symptoms such as pain, jaundice, and blockages."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including cryoablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cryoablation and its mechanism (freezing/thawing), noting limited use in pancreas."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these techniques are typically considered after or in conjunction with systemic chemotherapy, which remains the first-line treatment for locally advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions ablation is usually combined with chemotherapy/radiation, it does not state chemotherapy remains first-line for locally advanced disease and even suggests ablation can be used as primary treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including irreversible electroporation (IRE).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear description of IRE (NanoKnife) and its non-thermal mechanism."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including high-intensity focused ultrasound (HIFU).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes HIFU and notes it is non-invasive and less commonly used in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA delivers thermal energy via a probe to induce coagulative necrosis of tumor cells. RFA can be performed percutaneously, surgically, or via endoscopic ultrasound (EUS) guidance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions probe-delivered heat and percutaneous/endoscopic approaches, but does not specify 'coagulative necrosis' nor include surgical/EUS guidance explicitly."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that RFA is the most studied thermal technique and has demonstrated feasibility and safety, with some evidence of improved survival and immune modulation.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Calls RFA 'one of the more established methods' but does not state it is the most studied, nor mention survival benefit or immune modulation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that MWA uses electromagnetic waves to generate heat and destroy tumor tissue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States MWA uses microwave energy to generate heat; within the ablation context it implies tumor destruction."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that MWA is emerging as an alternative to RFA, with potential advantages in speed and ablation volume, but clinical data remain limited.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes faster treatment and growing popularity but does not mention increased ablation volume or that clinical data remain limited."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that IRE is a non-thermal technique that uses high-voltage electrical pulses to create permanent nanopores in cell membranes, leading to apoptosis.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Describes non-thermal high-voltage pulses causing 'tiny holes' and 'cell death' but does not mention permanent nanopores or apoptosis."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that IRE is particularly attractive for tumors near critical structures, as it spares connective tissue and vessels. It is increasingly used in locally advanced pancreatic cancer and is under investigation in randomized trials.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes suitability near vessels/nerves and experimental status, but does not mention sparing connective tissue/vessels explicitly, increasing use, or ongoing randomized trials."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that HIFU delivers focused ultrasound waves to induce thermal and mechanical destruction of tumor cells.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions heating and destruction but omits mechanical destruction."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that HIFU is less commonly used but has shown feasibility in clinical studies.",
        "score_given": 0,
        "max_points": 4,
        "justification": "States HIFU is less commonly used but does not mention feasibility demonstrated in clinical studies."
      },
      {
        "criterion_number": 19,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly advises discussing specifics with the oncology team and asks to consult doctors about type and suitability."
      }
    ],
    "question_number": 123,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:29:23.622002",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends that the patient or family discuss goals of care (e.g., treatment goals, quality of life preferences, advanced care planning) with their oncologist or oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response encourages working closely with the healthcare team, asking for QoL assessments, and setting realistic goals, it does not explicitly recommend a goals-of-care or advance care planning discussion with the oncologist/oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing symptom management (e.g., pain, nausea, fatigue) with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to work with the doctor on pain management, have regular check-ins with the oncologist to address issues like malnutrition/enzyme deficiency, keep a journal to discuss with the team, and contact the doctor if symptoms worsen\u2014explicitly directing symptom management discussions to the care team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly includes information about palliative care (e.g., mentions \u201cpalliative care,\u201d \u201csupportive care,\u201d or \u201cpalliative care specialists\u201d as a resource for symptom or quality of life management).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is explicitly highlighted, including early involvement, focus on symptom relief, pain management, and integrative therapies."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states or clearly implies that mental health professionals (e.g., counselor, psychologist, psychiatrist, mental health provider) can help patients deal with the emotional or psychological burden of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends counseling/therapy with a psychologist or counselor experienced in oncology to address anxiety, depression, and fear."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends discussing side effect management (e.g., side effects of treatment, managing adverse effects) with the oncology team or oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directs readers to work with the doctor on pain (a treatment side effect) and to have regular check-ins with the oncologist for issues like malnutrition; it also advises discussing patterns with the team, which constitutes explicit recommendation to discuss side effect management with clinicians."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy associated with a high symptom burden, including pain, gastrointestinal symptoms, fatigue, and significant psychological distress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although the response lists common symptoms (pain, fatigue, nausea, digestive issues, emotional distress), it does not state that pancreatic cancer is an aggressive malignancy; thus it does not fully meet the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that palliative care is not synonymous with hospice; rather, it is an active, multidisciplinary approach to symptom management and psychosocial support that can be provided at any stage of disease, including during active cancer-directed therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states, \u201cDon\u2019t wait until the end stages\u2014palliative care can start right away\u2026 regardless of the treatment stage,\u201d which conveys that palliative care is distinct from hospice and available during active treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that multidisciplinary collaboration can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It includes a dedicated section on involving a multidisciplinary care team (palliative care specialists, oncologists, dietitian, gastroenterologist) to address QoL issues."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that advance care planning can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advance care planning (e.g., advance directives, healthcare proxy, POLST, formal goals-of-care discussions) is not mentioned."
      }
    ],
    "question_number": 124,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:29:57.026296",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the Pancreatic Cancer Action Network (PanCAN) as a major pancreatic cancer advocacy organization.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PanCAN is explicitly listed as the first major US-based organization, with details on its advocacy focus and how to connect."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing advocacy options with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no recommendation to discuss advocacy options with the oncology team or healthcare providers."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PanCAN is a leading national organization dedicated to patient advocacy, support, research funding, and public policy initiatives for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response calls PanCAN a leading organization and mentions patient support and lobbying (public policy), it does not state that PanCAN provides research funding; it only references 'research advocacy.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that PanCAN offers structured opportunities for patients and families to engage in advocacy, including legislative outreach, awareness campaigns, and peer support programs such as the Patient and Liaison Services (PALS) program.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response describes PanCAN\u2019s legislative outreach (Advocacy Day, lobbying), awareness campaigns (Wage Hope, PurpleStride), and a peer support resource (Patient Central). Although PALS is not named, the elements of structured opportunities are clearly included."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology\u2019s patient-facing website, Cancer.Net, provides information on advocacy opportunities and connects patients to broader cancer advocacy networks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cancer.Net is not mentioned; only NCI, ACS, and ClinicalTrials.gov are referenced."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that both PanCAN and Cancer.Net are specifically recommended by the American Society of Clinical Oncology in its clinical practice guidelines as key resources for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of ASCO clinical practice guidelines or ASCO recommending PanCAN or Cancer.Net."
      }
    ],
    "question_number": 125,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:30:18.590539",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, \u201ctreatment depends on factors like the stage ...,\u201d satisfying the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include surgery.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes multiple modalities and notes surgery often combined with other treatments, meeting the multimodality criterion including surgery."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include chemotherapy.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Provides a dedicated chemotherapy section and discusses its role alongside other treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include radiation.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Includes a radiation therapy section and its integration with chemotherapy (chemoradiation)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that chemotherapy can be used before or after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states chemotherapy is used before (neoadjuvant) or after surgery (adjuvant)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer management should involve a multidisciplinary team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises asking about the multidisciplinary team reviewing her case and suggests high-volume centers, clearly endorsing MDT involvement."
      },
      {
        "criterion_number": 7,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe the Whipple procedure.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists Whipple (pancreaticoduodenectomy) and describes structures removed and indications (tumors in the head)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe distal pancreatectomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes distal pancreatectomy as removal of the body/tail and often spleen for tumors in those areas."
      },
      {
        "criterion_number": 9,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe total pancreatectomy.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions total pancreatectomy, removal of the entire pancreas, and the consequence of diabetes/digestive issues."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that surgical resection is the only potentially curative option for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Says surgery offers the best chance and can potentially cure but does not state it is the only potentially curative option."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that deciding on surgery requires multidisciplinary evaluation and mention anatomical, biological, or patient factors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises multidisciplinary team review and discusses anatomical (major blood vessels, location), biological (spread), and patient factors (age, overall health)."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends discussing options with her oncology team and seeking a specialist second opinion."
      }
    ],
    "question_number": 126,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:30:49.175654",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links treatment with stage: \u201cStages and Treatment: Staging determines the extent (e.g., localized, regional, or metastatic). Treatments may include\u2026,\u201d implying treatment decisions are stage-dependent."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention that anatomic location within the pancreas (e.g., head vs body/tail) affects treatment decisions."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists multiple modalities and includes surgery: \u201cTreatments may include surgery (e.g., Whipple procedure\u2026), chemotherapy, radiation\u2026,\u201d satisfying multimodality including surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Chemotherapy is explicitly included among treatment modalities."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Radiation is explicitly listed as a treatment modality."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that early, multidisciplinary management is essential to optimize outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends a multidisciplinary team and early palliative care, it does not state that early multidisciplinary management is essential to optimize outcomes."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that care is best coordinated at high-volume centers with expertise in pancreatic malignancies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises second opinions at high-volume centers and notes better outcomes: \u201censure it's at a center with experienced surgeons (outcomes are better at high-volume facilities).\u201d"
      },
      {
        "criterion_number": 8,
        "description": "The response should state that symptom management is an important part of the care of patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes symptom control via palliative care and suggests asking about managing symptoms/pain."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the basics of pancreatic cancer, including that the most common type is pancreatic adenocarcinoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states, \u201cThe most common is pancreatic adenocarcinoma (about 95% of cases).\u201d"
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how pancreatic cancer is staged based on the NCCN guidelines (version 2.2025) TNM staging and AJCC prognostic groups.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Only general staging terms (localized, regional, metastatic) are provided; no TNM detail or AJCC stage group descriptions."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy with a poor prognosis, often presenting at an advanced stage.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes late presentation and poor survival: \u201coften doesn't show symptoms until it's advanced\u201d and \u201coverall 5-year survival rate is around 10\u201312%.\u201d"
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend writing down questions in advance to ensure that all concerns are addressed during consultations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit recommendation: \u201cWrite down questions in advance,\u201d with example questions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that advocacy for comprehensive testing is important, including somatic and germline genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises genetic testing (e.g., BRCA\u2014germline) and references PanCAN\u2019s \u201cKnow Your Tumor\u201d program for personalized testing (tumor molecular/somatic profiling), covering both."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to inquire about clinical trial opportunities, as participation may provide access to novel therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clinical trials are recommended in questions and resources, with guidance to search trial databases."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information, support services, and advocacy opportunities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "PanCAN is highlighted, but cancer.net is not mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends consulting healthcare professionals and explicitly includes an oncologist in the multidisciplinary team; also suggests second opinions at expert centers."
      }
    ],
    "question_number": 127,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:31:29.506701",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic neuroendocrine tumors (pNETs) are usually sporadic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that most PNETs (about 80\u201390%) are sporadic."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that pancreatic neuroendocrine tumors (pNETs) do tend to have a genetic component in a significant minority of cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that around 10\u201320% are associated with hereditary syndromes, indicating a significant minority."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that some cases of pancreatic neuroendocrine tumors (pNETs) are associated with hereditary syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that a portion of PNETs are linked to hereditary syndromes."
      },
      {
        "criterion_number": 4,
        "description": "The response should include multiple endocrine neoplasia type 1 (MEN1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "MEN1 is named, described, and contextualized as the most common syndrome associated with PNETs."
      },
      {
        "criterion_number": 5,
        "description": "The response should include von Hippel-Lindau disease (VHL).",
        "score_given": 3,
        "max_points": 3,
        "justification": "VHL is named, its gene is identified, and association with PNETs is described."
      },
      {
        "criterion_number": 6,
        "description": "The response should include neurofibromatosis type 1 (NF1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "NF1 is explicitly mentioned as a less common associated syndrome."
      },
      {
        "criterion_number": 7,
        "description": "The response should include tuberous sclerosis complex (TSC).",
        "score_given": 3,
        "max_points": 3,
        "justification": "TSC (TSC1/TSC2) is named and its association with PNETs is noted."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that genetic testing is available for pancreatic neuroendocrine tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that germline and somatic (tumor) genetic testing are available and describes processes."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that they have concerns about the risk of cancer, they should talk with a genetic counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends consultation with a genetic counselor and provides resource (NSGC)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 10\u201317% of pancreatic neuroendocrine tumors (pNETs) are associated with inherited syndromes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that 10\u201320% are hereditary; while slightly broader, it conveys the approximate magnitude consistent with the 10\u201317% range."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that these inherited syndromes often present at a younger age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes hereditary cases tend to be diagnosed earlier, often before age 50."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that germline mutations are also found in sporadic-appearing pancreatic neuroendocrine tumors (pNETs), including mutations in DNA repair genes such as MUTYH, CHEK2, and BRCA2, as well as MEN1 and VHL.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention germline findings in sporadic-appearing cases or DNA repair genes (MUTYH, CHEK2, BRCA2); discusses somatic tumor mutations instead."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that multigene panel testing is recommended, as it can identify both syndromic and non-syndromic germline variants relevant for familial risk assessment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions panels for hereditary syndromes but does not recommend multigene panel testing to capture both syndromic and non-syndromic germline variants."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the user discuss this case with a medical professional.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Clearly advises consulting a healthcare professional (oncologist, genetic counselor) and reiterates this in the next steps."
      }
    ],
    "question_number": 128,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:32:12.247788",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions the Pancreatic Cancer Action Network (PanCAN) as a source for survivor stories.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly references PanCAN, notes a 'Survivor Stories' section, and provides the helpline (877-2-PANCAN)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends asking the oncology team for additional support group recommendations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests joining support groups and discussing clinical trials with an oncologist, it does not explicitly recommend asking the oncology team for support group recommendations."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions Cancer Support Community (CSC) as a resource for support or survivor stories.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'Cancer Support Community' directly and references Gilda\u2019s Club/Cancer Support Community for groups."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions Let\u2019s Win! Pancreatic Cancer survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Let\u2019s Win! Pancreatic Cancer is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the American Society of Clinical Oncology\u2019s patient-facing website (www.cancer.net) as a source for stories of hope.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically cites Cancer.Net (ASCO) and its 'Personal Stories' area."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that organizations provide patient and survivor stories, peer support networks, and opportunities to connect with others who have faced similar diagnoses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes PanCAN survivor stories and its one-on-one network, ACS forums, and Inspire groups\u2014clearly indicating stories, peer networks, and ways to connect."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that peer support and shared experiences are recognized as powerful tools for maintaining motivation and a sense of hope during the cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that hearing from others provides strength and that sharing/hearing stories can be 'incredibly empowering,' supporting hope and motivation."
      }
    ],
    "question_number": 129,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:32:37.149932",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define stage IV pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states stage IV pancreatic cancer \"has spread to distant organs,\" which is a correct definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that the disease is not curable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States the goal is to extend life and manage symptoms \"rather than aiming for a cure,\" clearly conveying that it is not curable."
      },
      {
        "criterion_number": 3,
        "description": "The response should include the goal of treatment is to control the cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions extending life and shrinking tumors, it does not explicitly state that a treatment goal is to control the cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include the goal of treatment to improve symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly emphasizes symptom management and relief (e.g., pain, nausea, digestive issues), meeting the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the cornerstone of treatment for stage IV pancreatic cancer is systemic chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States chemotherapy is \"often the mainstay for stage IV,\" which aligns with chemotherapy being the cornerstone."
      },
      {
        "criterion_number": 6,
        "description": "The response should include chemotherapy regimens listed in NCCN guidelines (version 2.2025) for treatment of metastatic pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists FOLFIRINOX and gemcitabine plus nab-paclitaxel, both NCCN-recommended regimens for metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response should discuss that clinical trials are another option.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Thoroughly discusses clinical trials and provides specific resources (ClinicalTrials.gov, PanCAN, NCI)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there may be targeted treatments based on genetic mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes targeted options like olaparib for BRCA mutations and larotrectinib for NTRK fusions; also mentions pembrolizumab for MSI-H."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the tumor have genetic testing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends early genetic testing (including tumor/l liquid biopsy) to guide treatment and assess hereditary risk."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that early palliative care referral is recommended at diagnosis to optimize symptom management, psychological support, and advance care planning.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises palliative/supportive care can start alongside active treatment and discusses advance care planning, aligning with early referral principles."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that aggressive symptom management, such as management of pain, fatigue, nausea, and gastrointestinal symptoms is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions comprehensive symptom management including pain, nausea, fatigue, weight loss, and digestive problems."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic enzyme replacement therapy should be considered for exocrine insufficiency, and nutritional support is important for maintaining weight and strength.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends pancreatic enzyme supplements (e.g., Creon) and provides detailed nutritional strategies to maintain weight and strength."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that psychosocial support, including counseling and peer support, is critical for both patients and families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses counseling, support groups, caregiver support, and stress management resources for patients and families."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises discussing options with the oncology team and suggests second opinions at major cancer centers."
      }
    ],
    "question_number": 130,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:33:28.601055",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that management of pancreatic tumors involves a multidisciplinary team of surgeons, medical oncologists, and radiation oncologists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that pancreatic cancer requires a multidisciplinary team, including surgical oncologists, medical oncologists, and radiation oncologists."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response links better outcomes to high-volume experience (e.g., surgeons performing many Whipple procedures have better outcomes) and emphasizes care at academic/high-volume hospitals with multidisciplinary teams, satisfying the intent of improved outcomes at high-volume multidisciplinary centers."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "PanCAN is named with actionable details, including the helpline (877-573-9971) and website (pancan.org), and mentions Patient Central."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide information for the American Cancer Society (ACS).",
        "score_given": 3,
        "max_points": 3,
        "justification": "The American Cancer Society is included with its website (cancer.org) and a description of available support."
      },
      {
        "criterion_number": 5,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response provides the NCI link to find centers: cancer.gov/about-cancer/managing-care/find-center."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that high-volume centers\u2014defined as institutions performing at least 15 pancreatic resections annually\u2014demonstrate superior survival rates, lower postoperative morbidity, improved lymphadenectomy, shorter hospital stays, and better access to adjuvant therapies.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it mentions that high-volume surgeons have better outcomes, it does not define high-volume centers as \u226515 resections/year nor enumerate the specified advantages (survival, morbidity, lymphadenectomy quality, hospital stay, adjuvant therapy access)."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that high-volume centers are typically academic medical centers, National Cancer Institute-designated cancer centers, or hospitals with established pancreatic cancer programs.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response directs users to NCI-Designated Cancer Centers and notes that top doctors are often at academic or high-volume hospitals with multidisciplinary teams, aligning with the criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to request referrals from local oncologists or primary care providers, who can direct patients to high-volume centers and experienced teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the primary care physician and oncologist for referrals and emphasizes the role of current providers in guiding to specialists."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends seeking second opinions from a specialist and specifically mentions engaging the oncologist, effectively advising discussion with an oncologist."
      }
    ],
    "question_number": 131,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:34:05.491252",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly states that some chemotherapy can have negative effects on the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States: 'certain treatments for pancreatic cancer (like chemotherapy) can sometimes cause cardiotoxicity.'"
      },
      {
        "criterion_number": 2,
        "description": "The response specifically mentions that 5-fluorouracil (or \u201c5-FU\u201d) can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Mentions '5-fluorouracil (5-FU, often part of FOLFIRINOX)' as a drug that can cause heart issues."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends monitoring for shortness of breath.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Shortness of breath' under symptoms to watch for and to report."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends monitoring for chest pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Chest pain or discomfort' and advises to report urgently if severe."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends monitoring for fast heart rate.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Palpitations or irregular heartbeat' and describes 'feeling like the heart is racing.'"
      },
      {
        "criterion_number": 6,
        "description": "The response recommends monitoring for dizziness.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Dizziness or fainting' among symptoms to watch."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends monitoring for unusual fatigue.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Fatigue or weakness: Unusual tiredness' as a symptom to monitor."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends discussing any new symptom with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to 'report any new or worsening symptoms immediately to her doctor' and elsewhere to 'please discuss this with her oncologist.'"
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends discussing any concerning symptom with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to report 'new or worsening symptoms immediately to her doctor' and to seek emergency care for severe chest pain; also instructs to talk to her oncologist."
      },
      {
        "criterion_number": 10,
        "description": "The response states that electrocardiograms can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions baseline 'electrocardiogram (ECG/EKG)' and 'Regular ECGs' during treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response states that echocardiogram can be used to monitor heart function.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends baseline echocardiogram and repeat echocardiograms every few months to monitor ejection fraction."
      },
      {
        "criterion_number": 12,
        "description": "The response states that blood pressure can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises 'Blood pressure checks at every visit, as hypertension can worsen heart risks.'"
      },
      {
        "criterion_number": 13,
        "description": "The response specifically mentions that capecitabine can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Lists 'capecitabine' among drugs that can cause heart issues."
      },
      {
        "criterion_number": 14,
        "description": "The response specifically mentions that some targeted therapies can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "States targeted therapies (e.g., erlotinib) 'typically have minimal cardiac impact' and does not state that some can harm the heart."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly states that pancreatic cancer treatments can cause at least three cardiac issues: heart failure, arrhythmias, hypertension, ischemia, or cardiomyopathy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists cardiomyopathy, arrhythmias, coronary artery spasm/ischemia, and heart failure as potential effects."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly states that the risk of cardiac side effects is higher in patients with preexisting cardiovascular conditions or those receiving specific agents such as anthracyclines or fluoropyrimidines.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States monitoring is important 'particularly if she has pre-existing heart conditions...' and discusses fluoropyrimidines (5-FU, capecitabine) as higher-risk agents."
      },
      {
        "criterion_number": 17,
        "description": "The response explicitly recommends baseline cardiac risk assessment and regular monitoring with echocardiography, cardiac biomarkers, and clinical evaluation for early/asymptomatic cardiac dysfunction.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends baseline ECG, echocardiogram, and cardiac biomarkers (troponin/BNP), plus ongoing ECGs, echocardiograms, BP checks; emphasizes early detection."
      },
      {
        "criterion_number": 18,
        "description": "The response explicitly references recommendations from the ACC and/or ASCO that pretherapy evaluation and ongoing surveillance are recommended for patients with cardiovascular risk factors or those receiving cardiotoxic agents.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions 'Guidelines from organizations like ASCO recommend tailored cardio-oncology surveillance' but does not explicitly state ACC/ASCO recommend pretherapy evaluation and ongoing surveillance for patients with risk factors or those receiving cardiotoxic agents."
      },
      {
        "criterion_number": 19,
        "description": "The response explicitly recommends that the user discuss the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'please discuss this with her oncologist' and 'Talk to Her Oncologist: Share your concerns ASAP.'"
      }
    ],
    "question_number": 132,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:35:03.264808",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that treatment decisions are personal decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states stopping treatment is a \"deeply personal choice\" and emphasizes respecting the individual's decision."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend listening to their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises to \"begin by listening without judgment\" and suggests asking about feelings and priorities."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend validating their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically notes that listening \"validates their decision\" and emphasizes empathy and nonjudgment."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend respecting their autonomy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly says to support them by \"respecting their autonomy\" and honoring their right to choose."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supporting their quality of life.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Highlights palliative/hospice care focused on comfort, symptom management, meaningful activities, and emotional/spiritual support to improve quality of life."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend offering reassurance.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides empathic language and validation but does not explicitly recommend that the caregiver offer reassurance to the patient (e.g., reassuring ongoing support or non-abandonment)."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that clear, compassionate communication about prognosis, treatment options, and goals of care is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages open, honest conversations and meeting with the oncologist to discuss disease progression, symptom management, and options, aligning with goals-of-care communication."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that transitioning to hospice care may be appropriate when the focus shifts entirely to comfort and dignity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explains hospice focuses on comfort and is appropriate when life expectancy is limited, making clear the shift to comfort-oriented care."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that hospice provides intensive symptom management, psychosocial and spiritual support, and home-based care, while avoiding non-beneficial interventions such as hospitalization or aggressive procedures.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions in-home care, medications, and counseling, but does not state hospice avoids non-beneficial interventions (e.g., hospitalization/aggressive procedures) nor explicitly tie spiritual support to hospice services."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention addressing practical issues related to end-of-life decision-making, such as managing costs and accessing resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers advance directives, power of attorney, home modifications, insurance coverage (Medicare for hospice), financial assistance (PanCAN), and resource links, addressing practical and cost/resource issues."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises scheduling a meeting with the oncologist to discuss implications of stopping treatment and alternatives."
      }
    ],
    "question_number": 133,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:35:39.756647",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing legal planning with a qualified professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting an attorney specializing in estate planning or elder law, a financial advisor, and the healthcare team to tailor documents."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that laws can vary state to state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that laws vary by state (and country), emphasizing jurisdictional differences."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a description of an advance healthcare directive or living will.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines an Advance Directive/Living Will and describes specifying life-sustaining treatments, pain management, and organ donation preferences."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of a medical power of attorney.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes a Durable Power of Attorney for Healthcare/Healthcare Proxy and its role in making medical decisions if the patient is incapacitated."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of a durable power of attorney for finances.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains a Durable Power of Attorney for Finances, including managing bills, bank accounts, and investments if the patient cannot, and that it remains effective during incapacity."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of a last will and testament.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines a Last Will and Testament, covering asset distribution, executor designation, and guardianship for minors."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that POLST forms translate preferences into actionable medical orders for emergency settings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that POLST/MOLST are medical orders translating wishes into actionable instructions for providers, especially in emergencies."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these documents ensure that care aligns with the patient\u2019s values and preferences, especially if the patient loses decision-making capacity due to disease progression or treatment effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that planning ensures his wishes are respected and that healthcare documents ensure his medical wishes are followed if he becomes unable to communicate."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that it is essential to have ongoing, structured conversations about goals of care, as patient preferences may change over time.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Encourages open conversations about his wishes and notes documents can be revised as needed, implying ongoing dialogue as preferences may change."
      }
    ],
    "question_number": 134,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:35:56.687393",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: 'speak with their oncology team; they often have social workers who specialize in financial navigation.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends consulting 'a hospital social worker' and references social workers again in the Next Steps section."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing their concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Many hospitals have dedicated financial counselors who can help you apply' and suggests contacting billing/financial aid."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that patient advocacy organizations can help and include information on the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies PanCAN as a resource, describes services (financial navigation), and provides phone number and website."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that patient advocacy organizations can help and include information on CancerCare.org.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes CancerCare with description of financial assistance and contact information."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that patient advocacy organizations can help and include information for the American Cancer Society.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes ACS with programs (transportation, lodging) and contact info."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that patients with pancreatic cancer who are facing significant medical bills have access to several financial assistance options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States there are 'several financial assistance programs' for cancer-related costs in the specific context of pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that financial assistance options include patient assistance programs (PAPs) from independent charity foundations, pharmaceutical company programs, and direct grants from nonprofit organizations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions PAPs from pharma companies, independent co-pay foundations (HealthWell, PAN), and non-profit grants/resources (ACS, CancerCare)."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that these programs may provide co-payment assistance, help with insurance premiums, and sometimes support for non-medical expenses such as transportation or housing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifies co-pay assistance and premiums (HealthWell), and non-medical support such as transportation and lodging/housing (ACS, CancerCare)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that eligibility is generally based on annual household income (often up to 400\u2013500% of the federal poverty level), insurance status, and physician endorsement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes eligibility factors like income and insurance status but does not mention 400\u2013500% FPL thresholds or physician endorsement."
      }
    ],
    "question_number": 135,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:36:22.713836",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe PARP inhibitors as targeted agents that block the PARP enzyme involved in repairing single-strand DNA breaks.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response identifies PARP inhibitors as targeted cancer therapy that block PARP enzymes involved in DNA repair and explains synthetic lethality. While it does not explicitly say \"single-strand DNA breaks,\" it clearly conveys PARP\u2019s role in DNA repair and enzyme inhibition."
      },
      {
        "criterion_number": 2,
        "description": "Mention use in advanced pancreatic cancer with a germline BRCA mutation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states PARP inhibitors are primarily used in patients with germline BRCA1/2 mutations and specifies metastatic pancreatic adenocarcinoma, meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "State use as maintenance therapy in metastatic pancreatic cancer with germline BRCA1/2 and no progression after at least 16 weeks of first-line platinum-based chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly describes olaparib maintenance for metastatic disease with germline BRCA1/2 after at least 16 weeks of first-line platinum-based chemotherapy and no progression, matching the POLO trial context. Note: It inaccurately implies gemcitabine+nab-paclitaxel includes platinum, but the core requirement is correctly stated."
      },
      {
        "criterion_number": 4,
        "description": "Recommend comprehensive germline BRCA testing for all pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that doctors often recommend germline testing for all patients with pancreatic cancer and emphasizes its importance for PARP inhibitor eligibility."
      },
      {
        "criterion_number": 5,
        "description": "Mention ASCO specifically recommends olaparib based on the POLO trial showing PFS benefit without compromising quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references the POLO trial and PFS benefit but does not mention ASCO\u2019s specific recommendation nor the finding that quality of life was maintained."
      },
      {
        "criterion_number": 6,
        "description": "State that other PARP inhibitors and combinations are investigational; align with NCCN Guidelines (v2.2025) context for systemic therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response notes that other PARP inhibitors (e.g., rucaparib) and combinations are being studied and are not standard outside trials, fulfilling the investigational-status requirement. It references NCCN generally, though it does not detail v2.2025 regimens."
      },
      {
        "criterion_number": 7,
        "description": "Recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises discussing details with the oncology team and provides specific questions to ask, clearly meeting this criterion."
      }
    ],
    "question_number": 136,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:37:08.089775",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend considering proximity to the treatment center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises aiming for a center within a 1\u20132 hour drive and discusses reducing travel fatigue and logistical burden."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend considering housing options near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides short-term and long-term housing options (Hope Lodge, hospital-affiliated housing, renting/buying) and associated considerations."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend considering transportation to and from the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses commute time, traffic, public transportation, airport access, and mentions ACS Road to Recovery for transportation support."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering financial considerations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes treatment costs, relocation and living expenses, cost-of-living comparisons, financial aid resources, and benefits planning."
      },
      {
        "criterion_number": 5,
        "description": "The response should include insurance coverage.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically discusses insurance coverage (in/out-of-network), and implications for Medicare/Medicaid/employer insurance with relocation."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend considering the social support system near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses family impact, caregiver support, support groups, and community resources affecting social support."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN) Patient services.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides PanCAN contact (877-573-9971, pancan.org) and describes case manager support."
      },
      {
        "criterion_number": 8,
        "description": "The response should provide information for the American Cancer Society (ACS) page on finding a doctor.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions ACS resources (Road to Recovery, lodging) but does not reference or link the ACS 'find a doctor' page."
      },
      {
        "criterion_number": 9,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes the NCI-designated centers link (cancer.gov/research/infrastructure/cancer-centers)."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions NCCN generally but does not cite version 2.2025 or state the specific NCCN recommendation regarding multidisciplinary, high-volume centers and imaging."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly mentions patient preferences, goals of care, or quality of life as central to the decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes balancing medical outcomes with overall well-being and discusses quality-of-life factors (climate, community, activities)."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly addresses open communication about expectations, prognosis, or the impact of relocation on daily life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages family discussion and addresses daily living impacts (access to pharmacies, groceries, accessibility)."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly mentions continuity of care, transferring medical records, coordinating with the current care team, or ensuring uninterrupted access to medications/supportive services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Contains a 'Continuity of Care' section advising seamless medical record transfer and coordination with the current doctor."
      },
      {
        "criterion_number": 14,
        "description": "The response explicitly mentions access to multidisciplinary care and/or clinical trials as important factors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights multidisciplinary teams and access to clinical trials as key considerations."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly recommends discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting with the mother's oncology team and current doctor for referrals and second opinions."
      }
    ],
    "question_number": 137,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:37:38.194014",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the anxiety with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises talking to the oncologist, nurse, or palliative care specialist about the anxiety."
      },
      {
        "criterion_number": 2,
        "description": "The response should include considering relaxation techniques prior to the scan.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends breathing exercises, progressive muscle relaxation, guided imagery, mindfulness, and creating a calming pre-scan routine."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend asking the oncology team about what will happen during the scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section to ask about scan details, covering duration, sensations, preparation, and resources to demystify the process."
      },
      {
        "criterion_number": 4,
        "description": "The response should include talking to a mental health professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends referral to a psychologist or psychiatrist specializing in oncology and discusses CBT as an evidence-based therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should include talking to a social worker.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It explicitly mentions social workers and patient navigators at cancer centers as supports."
      },
      {
        "criterion_number": 6,
        "description": "The response should discuss medical interventions to help with anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses short-term anti-anxiety medication (e.g., lorazepam) before the scan."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that severe anxiety related to upcoming scans is highly prevalent or very common among patients with pancreatic cancer or cancer in general.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states scan anxiety is incredibly common among cancer patients."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least two of the following resource types for managing treatment-related anxiety: psychotherapy, psychoeducation, supportive therapy, or integrative modalities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions psychotherapy (CBT), supportive therapy (support groups), and integrative modalities (acupuncture, massage), meeting the requirement."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly identifies Cognitive Behavioral Therapy (CBT) as the first-line or primary intervention for treatment-related anxiety in pancreatic cancer or cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While CBT is mentioned as evidence-based, it is not identified as first-line/primary nor attributed to a major oncology guideline."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions mindfulness-based interventions (MBIs) or mindfulness-based stress reduction (MBSR) as recommended for anxiety in cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mindfulness apps are suggested, but MBIs/MBSR and guideline-based recommendations are not explicitly cited."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that pharmacologic therapy may be considered for severe anxiety or when first-line psychological interventions are insufficient, and that this is a secondary option with weaker evidence, as per a major oncology guideline.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Pharmacologic therapy is mentioned, but the response does not frame it as secondary with weaker evidence nor cite a major oncology guideline."
      }
    ],
    "question_number": 138,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:37:59.399851",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include open communication with the family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit section on fostering open, age-appropriate communication, including family check-ins, tailoring discussions to children's ages, and counseling support."
      },
      {
        "criterion_number": 2,
        "description": "The response should include maintaining daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Direct recommendation to stick to routines with concrete examples (mealtimes, bedtimes, school/work routines) and use of shared calendars."
      },
      {
        "criterion_number": 3,
        "description": "The response should include continuing to do activities that bring enjoyment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages continuing or adapting favorite activities (e.g., at-home picnics, virtual game nights) and creating new traditions to sustain joy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include letting the support system help.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends leveraging friends/family/community via meal trains, support groups (PanCAN, Cancer Support Community), and school/workplace resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should include ensuring self-care for the patient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses patient self-care (rest, light hobbies) and proactive symptom management with the care team to minimize disruptions."
      },
      {
        "criterion_number": 6,
        "description": "The response should include ensuring self-care for the support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides caregiver self-care strategies (short walks, journaling, hobbies), monitoring for burnout, and accessing therapy or mindfulness apps."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that pancreatic cancer imposes profound emotional, social, and practical upheaval on both the patient and family, disrupting established routines, roles, and relationships.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it acknowledges challenges and disruptions to routines, it does not explicitly state the profound emotional, social, and practical upheaval or role/relationship disruptions."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that early integration of supportive and palliative care is recommended.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of palliative care or early supportive care integration."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that referrals to registered dietitians and symptom management specialists can help minimize disruptions to family life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention referrals to a registered dietitian or symptom management specialists; references only the general 'care team.'"
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that caregiver and family support resources can provide education, emotional support, and practical assistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights support groups (emotional support), meal trains and community help (practical assistance), and PanCAN patient navigators guiding communication (educational support)."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the literature notes persistent gaps in support for caregivers and families affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No reference to literature or persistent gaps in caregiver/family support."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not recommend discussing the case specifically with the oncologist; mentions the care team and external resources but no explicit oncologist referral."
      }
    ],
    "question_number": 139,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:38:40.126810",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing genetic counseling with the oncology team or healthcare provider in the context of pancreatic cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing with the oncologist and requesting a referral (e.g., 'Ask your loved one's oncologist for a referral...' and 'it's worth discussing with your oncologist')."
      },
      {
        "criterion_number": 2,
        "description": "The response should accurately describe the role of a genetic counselor as a trained professional who helps individuals and families understand the genetic aspects of disease, provides information, guidance, and support for informed decision-making, and assists with risk assessment and testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes genetic counselors as trained professionals, outlines goals (understanding genetics, risk assessment, informed decisions), and emphasizes supportive counseling beyond testing."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that genetic counseling involves a structured evaluation of personal and family cancer history.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details an initial consultation with a pedigree and review of family history including cancers and ages at diagnosis, indicating a structured history evaluation."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that genetic counseling involves education about hereditary cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It educates about hereditary syndromes relevant to pancreatic cancer (e.g., BRCA1/2, PALB2, ATM, CDKN2A, Lynch, Peutz-Jeghers, FAMMM)."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that genetic counseling involves a discussion of the risks, benefits, and limitations of genetic testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses pros/cons, test types (panel vs targeted), limitations (VUS, not all risks detectable), accuracy, costs/coverage, and potential impacts."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that genetic counseling addresses the psychological and ethical aspects of genetic information, including communication of results to family members and consideration of reproductive implications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It covers psychological impact, privacy/insurance ethics (GINA), and communicating results to family, but does not address reproductive implications or family planning; therefore it does not fully meet the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that this process be conducted with providers experienced in hereditary cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although ASCO is mentioned generally, there is no explicit statement that ASCO recommends counseling be conducted with providers experienced in hereditary cancer syndromes."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that germline genetic testing be offered early in the disease course, ideally using a multigene panel that includes genes linked to pancreatic cancer risk such as BRCA1, BRCA2, and others.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response discusses panel testing and relevant genes but does not state ASCO\u2019s recommendation to offer germline testing early in the disease course or attribute these points to ASCO."
      }
    ],
    "question_number": 140,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:39:07.489835",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that neuropathy is a common side effect from certain chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states PN is common and often caused by chemotherapy drugs, naming oxaliplatin, paclitaxel, and vincristine."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing with the oncologist (and neurologist/palliative care) to tailor recommendations and monitor for interactions."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that neuropathy from chemotherapy can be managed by dose reduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that if neuropathy is chemo-related, the doctor might adjust the chemotherapy dose."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that neuropathy from chemotherapy can be managed by schedule modification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions that the doctor might pause treatment temporarily, which constitutes schedule modification."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that neuropathy from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically says the doctor might switch drugs to prevent worsening neuropathy."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that neuropathy from chemotherapy can be managed using supportive medications, including gabapentin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Lists gabapentin as a commonly used medication for neuropathic pain."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Oxaliplatin is named as a causative agent, and duloxetine (an SNRI) is recommended for chemotherapy-induced neuropathy."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Oxaliplatin is listed among causative drugs, and pregabalin is recommended for neuropathic pain/CIPN."
      },
      {
        "criterion_number": 10,
        "description": "The response should include physical therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends physical therapy for balance, strength, mobility and fall-risk reduction."
      },
      {
        "criterion_number": 11,
        "description": "The response should include occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends occupational therapy and adaptive tools to aid daily activities."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that peripheral neuropathy could arise from chemotherapy (notably platinum agents), direct tumor involvement, or paraneoplastic syndromes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions chemotherapy (including oxaliplatin) and 'the cancer itself,' but does not mention paraneoplastic syndromes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that peripheral neuropathy significantly impairs quality of life and functional status.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States treatment aims include improving quality of life; discusses mobility/fall risk and daily function via PT/OT, implying functional impairment."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that management should be individualized, balancing efficacy, side effects, and patient-specific factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes best approach depends on severity, cause, overall health, and emphasizes tailored recommendations and monitoring for interactions."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that Duloxetine is the only agent with moderate evidence-based recommendation for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions duloxetine as helpful but does not state it is the only agent with moderate evidence-based recommendation for CIPN."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that the typical starting dose of duloxetine is 30 mg daily, titrated to 60 mg daily as tolerated, with slow tapering recommended to avoid withdrawal symptoms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Provides no dosing or tapering details for duloxetine."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that other pharmacologic options include tricyclic antidepressants (nortriptyline, amitriptyline), gabapentin, and pregabalin, which are supported by guidelines for cancer-related neuropathic pain but have inconclusive evidence.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions gabapentin and pregabalin but does not mention tricyclic antidepressants or the guideline context/inconclusive evidence."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical agents such as lidocaine and capsaicin patches may be considered for localized neuropathic pain, though evidence is limited.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lists lidocaine and capsaicin for localized pain but does not qualify that supporting evidence is limited."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that opioids are not preferred for chronic neuropathic pain due to risk of tolerance, dependence, and adverse effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests opioids for severe pain with caution but does not state they are not preferred for chronic neuropathic pain."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that interventional approaches, notably neurolytic celiac plexus block, are effective for refractory pain in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions nerve blocks generally but does not reference neurolytic celiac plexus block for pancreatic cancer pain."
      }
    ],
    "question_number": 141,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:39:55.355327",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define curative treatment as interventions with the intent to eradicate the disease and achieve long-term survival.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states curative treatment aims to completely eliminate the cancer so it doesn't return and achieve a cure, aligning with eradication and long-term survival."
      },
      {
        "criterion_number": 2,
        "description": "Include that curative treatment can include surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Surgery (e.g., Whipple procedure) is clearly listed as a curative option."
      },
      {
        "criterion_number": 3,
        "description": "Mention that in curative treatment, surgery is often followed by adjuvant chemotherapy to reduce recurrence risk.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes chemotherapy and/or radiation may be used after surgery to kill remaining cancer cells, which conveys the concept of adjuvant therapy aimed at reducing recurrence."
      },
      {
        "criterion_number": 4,
        "description": "Define palliative treatment as focusing on improving quality of life when cure is not possible.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It defines palliative care as relieving symptoms, managing pain, and improving quality of life rather than trying to cure the cancer."
      },
      {
        "criterion_number": 5,
        "description": "Mention that palliative treatment is the case for the majority of patients with locally advanced unresectable or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states surgery is feasible in only 15\u201320% of cases and that palliative care is common in advanced pancreatic cancer; it also notes many cases are diagnosed at stage 3 or 4 when the cancer has spread, implying most patients require palliative approaches."
      },
      {
        "criterion_number": 6,
        "description": "Include that the primary goal of palliative treatment is to prolong survival, control symptoms, and maintain quality of life.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While symptom control and quality of life are emphasized, the response does not explicitly state that prolonging survival is a primary goal of palliative treatment."
      },
      {
        "criterion_number": 7,
        "description": "Include that palliative treatment can include chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Palliative chemotherapy is explicitly mentioned as an option to slow tumor growth and ease symptoms."
      },
      {
        "criterion_number": 8,
        "description": "Include that palliative treatment can include radiation for local control or pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Palliative radiation is mentioned as a means to slow tumor growth and ease symptoms."
      },
      {
        "criterion_number": 9,
        "description": "Include that palliative treatment can include pain management.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pain management, including medications and nerve blocks, is specifically discussed."
      },
      {
        "criterion_number": 10,
        "description": "Mention that palliative approaches include endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction, and comprehensive supportive care for pain, nutrition, and psychosocial needs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response includes biliary stents for jaundice (endoscopic relief of obstruction) and comprehensive supportive care such as pain management, nutritional support, and counseling (psychosocial)."
      },
      {
        "criterion_number": 11,
        "description": "Mention that the American Society of Clinical Oncology emphasizes early integration of palliative care for all patients with advanced disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ASCO is not mentioned, and there is no explicit citation of guideline-backed early integration, despite noting that palliative care can be provided at any stage."
      },
      {
        "criterion_number": 12,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises discussing with the mother's oncologist or a palliative care specialist."
      }
    ],
    "question_number": 142,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:40:50.508218",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit 'Financial Aspects' section details cost ranges, itemized expenses, insurance issues, and funding options."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment decisions with your oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple clear recommendations to consult the oncologist, seek a second opinion at major cancer centers, and coordinate with the home medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the stage of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly advise confirming or considering the cancer stage in decision-making."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the type of cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention pancreatic cancer subtype (e.g., adenocarcinoma vs. neuroendocrine) or explicitly advise clarifying tumor type."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding the reputation of the clinic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises assessing facility reputation, international accreditation (JCI/ISQua), and cautions against unregulated clinics."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the qualifications of the providers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends verifying doctors\u2019 credentials, board certifications, publication history, and pancreatic cancer experience."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the details of the experimental treatments, including types of drugs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages identifying the exact therapy type and provides examples (immunotherapy, gene therapy, CAR-T, PARP inhibitors), with guidance to differentiate experimental vs. unproven."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the evidence supporting the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs readers to peer-reviewed studies, ClinicalTrials.gov, Cochrane, and trial phases with attention to efficacy and survival data."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the potential side effects of the experimental treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically advises researching risks and side effects, and notes potential worsening of symptoms and interactions."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend understanding the safety of the drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions Phase 1 safety focus, regulatory status, ethical standards, and FDA warnings\u2014explicitly addressing safety assessment."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding the legal protections of the country.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers country-specific regulation, approval status, ethics (Declaration of Helsinki), liability considerations, and legal issues."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the availability of medical records.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises compiling a 'treatment dossier' with medical records and ensuring a plan for sharing results with the home team."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the logistics of traveling abroad for treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Includes a 'Logistics and Support' section covering flights, transport, accommodations, translators, and emergency services."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention considering your loved one\u2019s health and travel suitability, as long travel can be taxing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes travel can be physically taxing, discusses medical transport, and the demands on someone with cancer."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention considering if the other country has specialized high-quality pancreatic cancer care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises choosing accredited facilities, assessing provider pancreatic cancer experience, and researching country-level regulation, implying evaluation of specialized high-quality care."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention considering visa barriers when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically mentions researching medical visas."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention considering local accommodations when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Travel planning includes accommodations near the facility."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention considering cultural barriers when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses language/cultural barriers by recommending translators and local support resources."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention considering challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Emphasizes creating a follow-up plan, result sharing with home team, and notes potential illegality of continuing unapproved treatments at home."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention considering social support challenges when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Highlights caregiver presence, local support groups, and the stress/isolation of being abroad."
      }
    ],
    "question_number": 143,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:41:27.211727",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe why treatments for pancreatic cancer can increase the risk of infections, including immunosuppression due to chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that chemotherapy, radiation, and surgery can weaken the immune system, cause neutropenia (low white blood cells), and increase infection risk."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend hand hygiene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated section on hand hygiene with specifics on washing and use of alcohol-based sanitizer for all household members and visitors."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding sick contacts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding crowds and people who are sick and screening visitors to ensure they are healthy."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend being up to date on age-appropriate vaccinations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends staying up to date with influenza, pneumococcal, and COVID-19 vaccines with oncologist approval, and vaccinating household members."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing the infections with the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Repeatedly encourages consulting the oncology team, scheduling a meeting for an infection-prevention plan, and contacting the doctor immediately for fever."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend food safety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes detailed food safety guidance (avoiding undercooked/raw foods, unpasteurized products, and careful handling/cooking) and mentions neutropenic diet if advised."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend adherence with prophylactic medications if prescribed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states to take prescribed prophylactic antibiotics, antifungals, or growth factors as directed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention avoiding exposure to fungal spores, especially for patients with neutropenia, by avoiding environments with high concentrations of airborne fungal spores.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding construction areas or moldy environments due to fungal risks and discusses air quality measures."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not state that antimicrobial prophylaxis is generally not needed for most solid tumors with short-duration neutropenia; instead emphasizes taking prophylaxis if prescribed."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention the lack of evidence for these interventions; in fact, suggests a neutropenic diet and creating a 'protective bubble,' which runs counter to the criterion."
      }
    ],
    "question_number": 144,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:41:43.878888",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes the combination of immune checkpoint blockade with chemotherapy as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit section on 'Checkpoint Inhibitors Combined with Chemotherapy' with examples (pembrolizumab or nivolumab plus gemcitabine/nab-paclitaxel or FOLFIRINOX) and trials (PRINCE, UPenn Phase 2, KEYNOTE-937)."
      },
      {
        "criterion_number": 2,
        "description": "The response describes the combination of immune checkpoint blockade with radiation as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Radiation + Immunotherapy' with SBRT combined with durvalumab (PD-L1 inhibitor) to produce an in situ vaccine effect."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the combination of immune checkpoint blockade with other novel agents (e.g., targeted therapies, immune modulators, or agents targeting the tumor microenvironment) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions combinations with CD40 agonist (sotigalimab), PARP inhibitors, stromal-targeting agent PEGPH20, anti-CD47, vaccines, and oncolytic viruses alongside PD-1/PD-L1 inhibitors."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly defines immunotherapy as a treatment that uses the body\u2019s immune system to attack cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses harnessing the immune system and 'cold' TME but does not provide an explicit definition that immunotherapy uses the body's immune system to attack cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with MSI-high tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states 'For MSI-high pancreatic cancers (rare, about 1-2%), pembrolizumab is already approved.'"
      },
      {
        "criterion_number": 6,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with dMMR (deficient mismatch repair) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of dMMR approval; only MSI-H approval is stated."
      },
      {
        "criterion_number": 7,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with TMB-high (tumor mutational burden-high) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "TMB is referenced as a biomarker under study but no statement that pembrolizumab is approved for TMB-high tumors."
      },
      {
        "criterion_number": 8,
        "description": "The response specifically mentions clinicaltrials.gov as a resource for finding immunotherapy clinical trials.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly advises searching ClinicalTrials.gov for pancreatic cancer immunotherapy combinations."
      },
      {
        "criterion_number": 9,
        "description": "The response specifically mentions the PanCan clinical trial finder as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions PanCAN and 'Patient Central' but does not specifically name the PanCAN Clinical Trial Finder."
      },
      {
        "criterion_number": 10,
        "description": "The response describes immune checkpoint blockade as a current strategy for studying immunotherapy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple sections detail PD-1/PD-L1 and CTLA-4 inhibitors and their combinations as active research strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response describes adoptive cellular therapy (e.g., CAR-T cell therapy or modified T-cells) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit section on CAR-T cells targeting mesothelin in early-phase trials, including combination with checkpoint inhibitors."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that current research on immunotherapy combinations for patients with pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment (TME) and enhancing antitumor immune responses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes 'cold' TME, tumor immune suppression, and goals to make tumors more visible and enhance immune infiltration."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery, with early results suggesting potential improvements in disease-free and overall survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions a trial in resectable disease (KEYNOTE-937) but does not specify neoadjuvant priming before surgery or report early improvements in DFS/OS."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cancer vaccines are under investigation as an immunotherapy approach for pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides a dedicated 'Immunotherapy with Vaccines' section with examples (GVAX, personalized neoantigen vaccines, CRS-207)."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises discussing treatment options with an oncologist or pancreatic cancer specialist."
      }
    ],
    "question_number": 145,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:42:21.372475",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the goal of the study.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly asks, \u201cWhat is the main purpose of this study?\u201d which directly addresses understanding the study\u2019s goal."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the phase of the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes, \u201cWhat phase is the study in?\u201d and explains what each phase generally evaluates (safety, effectiveness, comparison, long-term effects)."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the eligibility requirements of the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks about inclusion/exclusion criteria and whether the patient qualifies, with examples (stage, health, prior treatments)."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the potential side effects of the treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit question: \u201cWhat are the known risks or side effects?\u201d with examples of common toxicities."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding if there are additional tests required to participate in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes, \u201cHow will you determine if he's a good fit? (What tests or screenings are needed before enrollment?).\u201d"
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding if there are travel costs associated with the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses costs and reimbursement explicitly, including travel coverage and compensation."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the evidence supporting the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Prompts to ask, \u201cWhat have been the results so far in this study or similar ones?\u201d and to seek data on response, survival, QoL."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the kind of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks, \u201cWhat treatments or interventions are involved?\u201d with examples (chemotherapy, immunotherapy, targeted therapy, surgery)."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the visit schedule of the trial.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Covers frequency of visits, schedule, follow-up duration, and travel cadence."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that research studies are designed to determine if a new medical strategy, treatment, or device is safe and/or effective for humans.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains trial phases: Phase 1 (Safety) and Phase 2 (Effectiveness), which explicitly conveys that trials assess safety and effectiveness."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that clinical trials are essential for improving, optimizing, or advancing current and/or future cancer therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it notes access to new treatments, it does not explicitly state that trials are essential for advancing cancer therapies."
      },
      {
        "criterion_number": 12,
        "description": "The response includes the question: \u201cHow will participation impact current treatment and care?\u201d",
        "score_given": 6,
        "max_points": 6,
        "justification": "Directly asks, \u201cCan he continue his current treatments or medications while in the study?\u201d which captures the impact on current care."
      },
      {
        "criterion_number": 13,
        "description": "The response includes the question: \u201cWhat are the implications for family members, especially if genetic testing is involved?\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of genetic testing or family implications is included."
      },
      {
        "criterion_number": 14,
        "description": "The response recommends discussing the case with an oncologist or relevant healthcare professional to review trial details and discuss pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing with the father\u2019s oncologist or the study\u2019s principal investigator and mentions second opinions and patient advocates."
      }
    ],
    "question_number": 146,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:42:53.064824",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe non-opioid medications for pain control, including acetaminophen.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions acetaminophen (Tylenol) as a non-opioid option with brief guidance on monitoring."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe non-opioid medications for pain control, including NSAIDs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists NSAIDs (ibuprofen, naproxen) and COX-2 inhibitors (celecoxib) with cautions on GI/kidney risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe non-opioid medications for neuropathic pain, including gabapentin.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes gabapentin under anticonvulsants for neuropathic pain management."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe non-opioid medications for neuropathic pain, including anti-depressants.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions antidepressants duloxetine and amitriptyline for neuropathic pain modulation."
      },
      {
        "criterion_number": 5,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including nerve blocks.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes celiac plexus block/neurolysis, as well as nerve blocks and epidural injections."
      },
      {
        "criterion_number": 6,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including radiation therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions palliative radiation therapy and SBRT for pain relief."
      },
      {
        "criterion_number": 7,
        "description": "The response should include non-pharmacologic therapies, including acupuncture.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends acupuncture and notes supportive evidence in cancer patients."
      },
      {
        "criterion_number": 8,
        "description": "The response should include non-pharmacologic therapies, including psychological support.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes mindfulness, guided imagery, CBT for pain, and highlights emotional support via palliative care."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing symptom management with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing the plan with the oncologist and healthcare team; urges prompt consultation."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe non-opioid medications for neuropathic pain, including pregabalin, duloxetine, nortriptyline, and amitriptyline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pregabalin, duloxetine, and amitriptyline, but does not mention nortriptyline."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical agents, including lidocaine and capsaicin patches, can be considered for localized neuropathic pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists lidocaine patches/creams but does not mention capsaicin."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that corticosteroids are reserved for specific indications such as spinal cord compression or inflammatory pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions steroids for inflammation/nerve pressure but does not specify they are reserved for particular indications like spinal cord compression."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that antioxidant supplementation may reduce painful attacks in select cases, though evidence is limited and should be considered adjunctive.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Does not address antioxidant supplementation."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that interventional and procedural approaches are particularly relevant in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies celiac plexus block as common for pancreatic cancer pain and emphasizes interventional options."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that neurolytic celiac plexus block is supported by randomized trials for opioid-sparing pain relief.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States studies show pain reduction but does not reference randomized trials or opioid-sparing effects."
      },
      {
        "criterion_number": 16,
        "description": "The response should include non-pharmacologic therapies, including physical therapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly recommends physical therapy, exercises, posture, and TENS."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend discussing symptom management with a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises involving a palliative care specialist early for symptom management."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that cognitive-behavioral therapy and stress management are effective adjuncts.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Mentions CBT for pain and mind-body techniques (mindfulness, yoga) as helpful adjuncts."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that areas that need further research include the long-term comparative effectiveness of nonopioid and integrative modalities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not discuss research gaps or long-term comparative effectiveness."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that effective pain management in pancreatic cancer requires regular assessment and individualized planning.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes a tailored, multidisciplinary approach, variability of effectiveness, and tracking symptoms to adjust the plan."
      }
    ],
    "question_number": 147,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:43:30.011369",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing psychological concerns about the children with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"Start by talking to your loved one's oncology team\u2014they often have social workers, psychologists, or child life specialists who specialize in family support during cancer treatment.\""
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends professional counseling and mentions mental health professionals (e.g., therapist, counselor, psychologist, psychiatrist).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends \"A mental health professional\" and mentions psychologists, counseling through CancerCare, and \"Family Therapy\" with therapists (ABCT) and CBT."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section on \"Support Groups and Programs for Teens\" and notes \"Many cancer centers run in-person or virtual groups for kids of cancer patients.\""
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends involving school counselors for support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under \"School and Community Resources\" it advises informing the school and using \"School Counselors\" for on-site support and monitoring."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions cancersupportcommunity.org as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of Cancer Support Community or cancersupportcommunity.org."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions PanCAN (Pancreatic Cancer Action Network) patient services as a resource.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends teen support groups and specifically lists PanCAN's Patient Central helpline (877-573-9971) as a resource for family and teen support."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that informal support from family, friends, and teachers is highly valued by adolescents.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it discusses family discussions and school counselors, it does not explicitly state that informal support from family, friends, and teachers is highly valued by adolescents."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that technology-based resources, such as online support communities and apps, can supplement in-person support and are increasingly used by adolescents for connection and information.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions online forums (Inspire, Reddit's r/CancerFamilySupport) for anonymous connection and apps (Headspace, Calm) for teen-focused mindfulness, indicating technology-based supports."
      }
    ],
    "question_number": 148,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:44:03.780792",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines circulating tumor DNA (ctDNA) as DNA from cancer cells or tumors found in the blood, and can be used as a biomarker for diagnosis, monitoring, or recurrence.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ctDNA as DNA fragments from cancer cells in the blood and describes its use for detection/diagnosis, monitoring treatment, and checking for recurrence."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that ctDNA can be used for mutation testing in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the test can identify specific genetic mutations (e.g., KRAS) using next-generation sequencing and guide targeted therapies."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly states that ctDNA can provide prognostic information about recurrence risk or detect minimal residual disease after treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Notes that rising ctDNA after surgery or treatment can signal recurrence earlier than imaging, consistent with MRD/recurrence risk assessment."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states that ctDNA can be used to monitor response to treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explains that ctDNA levels can be tracked during therapy and that decreases may indicate response."
      },
      {
        "criterion_number": 5,
        "description": "The response states that, per NCCN guidelines, ctDNA is only recommended for mutation testing in pancreatic cancer if a biopsy sample is not available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention NCCN guidance or the specific condition that ctDNA is recommended for mutation testing only when tissue is unavailable."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that ctDNA testing is noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "States the test is noninvasive but does not explicitly mention expediting testing or avoiding retrieval of archival blocks/arranging a new biopsy."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of technical limitations specific to copy-number alterations or fusion detection in cfDNA assays."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that ctDNA may miss low-level cancers or not detect all mutations, and there may be false negative or false positive results.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that some tumors shed too little ctDNA (especially early or small tumors), leading to false negatives, and also mentions possible false positives and variable accuracy."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions that not all hospitals offer ctDNA testing and that not all insurances cover them.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions insurance coverage limitations but does not state that not all hospitals offer ctDNA testing."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions that ctDNA testing is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes ctDNA as an emerging tool under active study and notes it is not a standard test for everyone, with use often in research settings."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncologist and provides example questions to ask."
      }
    ],
    "question_number": 149,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:44:32.909935",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends designating a single point person (e.g., care coordinator, family member, or friend) to coordinate care and serve as the primary contact for health-related matters.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It clearly advises choosing one family member or friend as the 'care coordinator' and emphasizes a single point of contact."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends having a primary oncologist oversee the plan and scheduling a meeting with the primary doctor to outline coordination; it also references oncology nurse navigators."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends keeping an organized, centralized medical record of all relevant documents (e.g., test results, treatment plans, medication lists, doctor notes).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises keeping a personal binder or digital file with test results, treatment plans, medication lists, and doctor notes, plus a timeline."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends discussing or arranging the transfer of medical records with each hospital involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to sign HIPAA releases at each hospital and to request electronic transfers or use interoperability tools for record sharing."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends carrying or maintaining an up-to-date medication list.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes maintaining a medication list as part of the centralized records, which implies keeping it current."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly mentions nurse navigators or patient navigators as resources for care coordination.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly mentions nurse navigators and related roles (case manager, social worker) to assist with coordination."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that effective coordination of care between multiple hospitals for a patient with pancreatic cancer requires addressing several systemic and logistical challenges.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It addresses logistics (appointments, travel, transportation/lodging, insurance/billing) and the complexity of multi-site care, acknowledging systemic/logistical challenges."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the lack of shared electronic health records is a significant barrier.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it notes different systems and suggests tools for sharing, it does not explicitly state that lack of shared EHRs is a significant barrier."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the lack of shared electronic health records impedes seamless information exchange, and the risk of inconsistent recommendations when care is split between high-volume centers and community hospitals.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It does not explicitly link lack of shared EHRs to impeded information exchange or discuss the risk of inconsistent recommendations between high-volume and community hospitals."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention to facilitate doctor-to-doctor communication.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly recommends requesting conference calls or emails between specialists before major decisions."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention to ask for a summary note after every visit and share it with all the providers.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It clearly instructs to ask for a summary after each visit and share it with all involved providers."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to use PanCAN or NCI for personalized advice on coordinating care, finding specialists, and accessing clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends PanCAN Patient Central and the NCI helpline for personalized support and guidance, including clinical trials."
      }
    ],
    "question_number": 150,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:45:17.271594",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that weight loss can occur due to impaired absorption due to pancreatic enzyme deficiency.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly notes impaired digestion/malabsorption from reduced pancreatic enzyme production as a cause of weight loss."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients and explicitly recommends pancreatic enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends PERT and discusses malabsorption, but does not state that exocrine insufficiency leads to fat-soluble vitamin or micronutrient deficiencies."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that appetite stimulants can sometimes be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions appetite stimulants (megestrol acetate, dronabinol) can boost hunger and promote weight gain."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that appetite stimulants may be considered for refractory cases or due to potential side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not specify use for refractory cases nor mention potential side effects of appetite stimulants."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises discussing interventions with the oncology team and healthcare team."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there can be many causes of losing weight in patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists multiple causes: malabsorption from enzyme deficiency, metabolic changes from cancer, inflammation, and chemotherapy side effects."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that losing weight can be due to the cancer itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically cites metabolic changes caused by the cancer as a contributor to weight loss."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that weight loss can occur as a side effect of chemotherapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions side effects from treatments like chemotherapy as a cause of weight loss."
      },
      {
        "criterion_number": 9,
        "description": "The response should state the patient should try and get sufficient protein intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Encourages high-protein foods and notes protein-rich oral supplements."
      },
      {
        "criterion_number": 10,
        "description": "The response should state the patient should try and get sufficient calorie intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends a high-calorie, nutrient-dense diet and calorie-containing oral supplements."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that nutrition/protein supplements can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends oral nutritional supplements (Ensure, Boost, specialized products) to provide extra calories and protein."
      },
      {
        "criterion_number": 12,
        "description": "The response does not explicitly state the patient should discuss changes to their diet with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises discussing interventions with the oncology team generally and working with a dietitian, but does not explicitly instruct discussing diet changes specifically with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should discuss concerns with a palliative care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends palliative care consultation to address quality of life and symptom management."
      },
      {
        "criterion_number": 14,
        "description": "States that patients with pancreatic cancer are at high risk of malnutrition, cachexia, and weight loss, and explicitly mentions the need for early and ongoing nutritional assessment/intervention.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions cachexia and prompt intervention with ongoing monitoring, but does not explicitly state that pancreatic cancer patients are at high risk of malnutrition/cachexia/weight loss."
      },
      {
        "criterion_number": 15,
        "description": "Explicitly recommends prompt referral to a registered dietitian or nutritionist for individualized evaluation/counseling, or states that nutritional support is a cornerstone of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working with a registered dietitian for a personalized plan and emphasizes their role in assessment and monitoring."
      },
      {
        "criterion_number": 16,
        "description": "Clearly states that early and aggressive nutritional intervention is essential to reduce further weight/muscle loss, improve tolerance to oncologic therapies, and optimize survival or quality of life.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Notes that prompt intervention is key, but does not link nutritional intervention to improved treatment tolerance or survival/quality of life explicitly."
      },
      {
        "criterion_number": 17,
        "description": "Explicitly states that enteral nutrition (tube feeding) should be prioritized over parenteral nutrition (IV feeding) when oral intake is inadequate, and mentions at least one benefit of enteral nutrition.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Describes enteral and parenteral options but does not explicitly prioritize enteral over parenteral, nor specify a unique benefit of enteral feeding."
      },
      {
        "criterion_number": 18,
        "description": "Recommends oral nutritional supplements and specifically mentions omega-3 fatty acids as beneficial for supporting body weight or lean body mass.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Recommends oral supplements but mentions omega-3s only in the context of clinical trials, not as a recommended supplement to support weight/lean mass."
      },
      {
        "criterion_number": 19,
        "description": "Recommends discussing the case with an oncologist or dietitian/nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends discussion with the oncology team and a registered dietitian."
      }
    ],
    "question_number": 151,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:46:25.880091",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing massage therapy with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly advises consulting the oncologist or healthcare team before starting massage (e.g., 'Consult Her Healthcare Team First' and 'never proceed without her doctor's approval')."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using a massage therapist who has experience with oncology patients.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends a licensed massage therapist with oncology massage certification, cites the Society for Oncology Massage, and advises avoiding general spa massages."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding massage if the person has a fever.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Under general contraindications, the response lists fever as a reason massage might not be suitable."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend avoiding massage if the person has an infection.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions active infections as a general contraindication for massage."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend avoiding massage if the person has excessive pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises monitoring for increased pain and pausing if symptoms worsen, it does not explicitly recommend avoiding massage when the person has excessive pain at baseline."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend avoiding massage if the person has a clot or deep vein thrombosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that DVTs are more common and that vigorous leg massage might dislodge a clot, but it does not clearly recommend avoiding massage altogether in the presence of a known clot/DVT."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend avoiding massage over the tumor.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises avoiding deep pressure/manipulation over the abdomen where the pancreatic tumor is located and suggests avoiding the abdomen altogether, which aligns with avoiding massage over the tumor site."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend avoiding massage over sensitive areas.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It specifically mentions sensitive areas such as radiation-treated skin, surgical incisions, open wounds, ports, and areas affected by lymphedema, advising avoidance or specialized techniques."
      },
      {
        "criterion_number": 9,
        "description": "States that massage therapy is generally considered safe for patients undergoing treatment for pancreatic cancer when performed by trained professionals, and explicitly mentions that serious adverse events are extremely rare.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response states massage is generally safe when modified and performed by trained professionals and mentions low complication rates, but it does not explicitly state that serious adverse events are extremely rare."
      },
      {
        "criterion_number": 10,
        "description": "States that evidence from randomized controlled trials or meta-analyses shows massage therapy can reduce pain, anxiety, and fatigue, and may improve quality of life in cancer patients, and explicitly mentions that the certainty of evidence is low and benefits are typically moderate.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Although it references research and clinical trials showing benefits, it does not explicitly cite RCTs/meta-analyses nor does it state that evidence certainty is low and that benefits are typically moderate."
      },
      {
        "criterion_number": 11,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions bleeding risk (e.g., low platelets) as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It advises consulting the oncology team before starting and specifically lists severe thrombocytopenia (low platelets) as a contraindication."
      },
      {
        "criterion_number": 12,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions unstable bone lesions as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It advises consultation with the oncology team and notes that if cancer has spread to bones, deep massage could risk fractures, which addresses the concern about unstable bone lesions."
      }
    ],
    "question_number": 152,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:47:20.425103",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe personalized medicine approaches in pancreatic cancer, including tumor genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains precision medicine in PDAC, discusses tumor genomic profiling (NGS, liquid biopsy), targeted therapies, immunotherapy, and how results guide treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that precision medicine, or personalized oncology, tailors cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states tailoring to \"unique genetic and molecular characteristics\" and notes potential for more effective therapy with fewer side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should include somatic testing for patients with locally advanced pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes somatic tumor profiling (biopsy/liquid biopsy with NGS) and indicates testing is often done at diagnosis or after first-line therapy; this encompasses locally advanced patients who are systemic therapy candidates."
      },
      {
        "criterion_number": 4,
        "description": "The response should include somatic testing for patients with metastatic pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details tumor NGS and how findings guide targeted/immunotherapy; timing at diagnosis aligns with metastatic candidates for systemic therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States germline testing is recommended for all but does not explicitly state that somatic testing is recommended for all patients, nor emphasize that actionability can exist without family history."
      },
      {
        "criterion_number": 6,
        "description": "The response should include germline testing for inherited pancreatic cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions germline testing for BRCA1/2 and PALB2 and notes inherited mutations; aligns with inherited cancer syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should include germline testing is recommended for all patients with confirmed pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically states germline testing is recommended for all PDAC patients per NCCN."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that mutations found by somatic testing can sometimes be targeted with medications.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains targeted therapies based on tumor alterations (e.g., NTRK fusions, HER2, KRAS G12C)."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that based on genetic testing and molecular profiles, targeted therapies can be given.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly ties targeted therapy eligibility to genomic/molecular profiling results."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that patients with certain germline mutations are candidates for targeted therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that patients with germline BRCA1/2 or PALB2 mutations may receive PARP inhibitors."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that FDA-approved targeted therapies include PARP inhibitors (e.g., olaparib) for patients with germline BRCA1/2 mutations, typically as maintenance therapy following platinum-based chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions olaparib as maintenance after chemotherapy with reference to the POLO trial, reflecting the approved setting (maintenance post-platinum), even though 'platinum' is not explicitly stated."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists larotrectinib and entrectinib as FDA-approved options for NTRK fusions, implying tumor-agnostic indication."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that immune checkpoint inhibitors (pembrolizumab, dostarlimab) are approved for dMMR/MSI-H PDAC, a rare but important subset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States pembrolizumab is FDA-approved for MSI-H/dMMR tumors and acknowledges rarity; adequately conveys checkpoint inhibitor approval for this subset."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that sotorasib is an emerging agent for KRAS G12C-mutated pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Names sotorasib (and adagrasib) for KRAS G12C with note about ongoing studies."
      },
      {
        "criterion_number": 15,
        "description": "The response should include that clinical trials may be testing drugs targeting certain mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes basket trials (NCI-MATCH, TAPUR), pancreatic-specific trials, and directs to ClinicalTrials.gov and PanCAN matching."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting the oncologist for individualized guidance and lists it as the first next step."
      }
    ],
    "question_number": 153,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:48:43.502295",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that diarrhea is a common side effect from certain chemotherapy drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States diarrhea is a common side effect of chemotherapy and explicitly cites chemo drugs like gemcitabine and FOLFIRINOX."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that diarrhea can be managed with anti-motility agents such as loperamide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends loperamide (Imodium) as an antidiarrheal for treatment-related diarrhea."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that dietary modifications include the elimination of lactose-containing products and high-osmolar supplements.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advises avoiding dairy if lactose intolerant but does not mention eliminating high-osmolar supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that loperamide is given starting at 4 mg followed by 2 mg every 4 hours or after each unformed stool, not exceeding 16 mg per day.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Provides 2 mg after a loose stool and max 16 mg/day but omits the 4 mg loading dose and the every-4-hours schedule."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that diarrhea from chemotherapy can be managed by dose reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions treatment plan adjustments in general but does not specifically state dose reduction."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that diarrhea from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention treatment schedule modification."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that diarrhea from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention switching to an alternate chemotherapy regimen."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that diarrhea can be associated with pancreatic enzyme deficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Links diarrhea to pancreatic function and enzyme production, noting poor fat absorption from pancreatic insufficiency."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that diarrhea associated with pancreatic enzyme deficiency can be improved with pancreatic enzyme supplementation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends pancreatic enzyme supplements (e.g., Creon, Pancreaze) and notes they can reduce loose stools."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in patients with exocrine pancreatic insufficiency, PERT should be initiated and titrated to symptom control, as this can significantly reduce steatorrhea and improve nutritional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention titration to symptom control or explicitly reducing steatorrhea and improving nutritional status."
      },
      {
        "criterion_number": 11,
        "description": "The response should discuss symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes reporting diarrhea to his oncologist/healthcare team and seeking immediate medical attention for severe symptoms."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that if diarrhea progresses to grade 3 or 4 or persists after 24\u201348 hours of loperamide, aggressive management is recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not reference CTCAE grades or the 24\u201348 hour loperamide threshold for escalation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that aggressive management includes intravenous fluids for dehydration, octreotide, and empiric antibiotics if infection is suspected.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions IV fluids but not octreotide or empiric antibiotics."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that octreotide is initially given as 100\u2013150 \u03bcg subcutaneously three times daily, with escalation up to 500 \u03bcg if needed.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Octreotide and its dosing are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that stool studies and laboratory evaluation for infectious etiologies should be performed in severe cases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions stool analysis and ruling out infection in general, but does not specify stool studies and lab evaluation for infectious etiologies in severe cases."
      }
    ],
    "question_number": 154,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:49:40.104452",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the treatment plan with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing with the oncologist about treatment timeline, side effects, and impact on work, and later says to start with the oncology team for medical advice."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the prognosis.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Includes a 'Stage and Prognosis' section discussing how stage/aggressiveness influences the decision."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the goals of treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly recommend clarifying treatment goals (e.g., curative vs. palliative intent) or aligning decisions with those goals."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering the impact of stopping work on health insurance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses loss of employer-tied insurance and alternatives (COBRA, ACA marketplace, Medicaid/Medicare)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering the impact of stopping work on income.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses income loss, budgeting, and replacement options."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the expected physical effects of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Lists common treatment effects (fatigue, pain, nausea) and emphasizes their demands on the patient."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the expected mental effects of treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses mental health impacts such as stress, isolation, and loss of identity; suggests counseling and support groups."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend considering employer-sponsored medical leave.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends FMLA leave, ADA accommodations, and alternatives like reduced hours or leave of absence."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly mentions at least two common symptoms of pancreatic cancer, such as pain, fatigue, dietary issues, or weight loss, and states that these symptoms can impair daily functioning and/or the ability to work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions pain and fatigue (and nausea) and explains these can be physically demanding; links symptom management to the decision to stop working."
      },
      {
        "criterion_number": 10,
        "description": "The response states that multiple factors should be systematically evaluated to support informed, patient-centered decision-making when considering stopping work for pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Organizes considerations into medical, financial, emotional, legal, and practical categories and presents them systematically."
      },
      {
        "criterion_number": 11,
        "description": "The response states that discussions should elicit or consider the patient\u2019s personal values, goals, and/or preferences, including the importance of quality of life versus life extension.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States the decision should align with values and what brings peace; explicitly references quality of life and impact on prognosis."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions that financial and practical considerations are critical in the decision to stop working.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Highlights financial implications and legal/practical steps as key factors to consider."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends referral to, or consultation with, financial counselors or social workers to help navigate financial challenges, access resources, or manage cancer care costs.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises consulting a financial advisor or benefits counselor; also lists nonprofits that provide assistance."
      },
      {
        "criterion_number": 14,
        "description": "The response states that patients should be informed about disability benefits, workplace accommodations, and/or community support programs that may help with financial or practical challenges.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers ADA accommodations, short- and long-term disability, SSDI/SSI, and community resources (PanCAN, ACS, CancerCare)."
      }
    ],
    "question_number": 155,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:50:08.264735",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor profiling as involving comprehensive molecular analysis of tumor tissue and often blood to identify genetic, transcriptomic, and proteomic alterations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains profiling as analysis of genetic alterations, proteins, and other biomarkers; mentions RNA sequencing, IHC (proteins), and that blood (liquid biopsy, germline from blood/saliva) may be used."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a tumor biopsy can be used for tumor profiling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states a tissue sample from the tumor via biopsy is used for profiling."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that circulating tumor DNA can be used for tumor profiling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions liquid biopsy as a blood test that detects circulating tumor DNA and can be used when fresh biopsy isn\u2019t feasible."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that tumor biopsies can be tested for mutations in the DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes next-generation sequencing (NGS) scanning hundreds of genes for mutations on the tumor sample."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that tumor biopsies can be tested for mutations in the RNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions RNA sequencing as part of laboratory testing on the tumor sample, implying RNA-level alterations are assessed."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that tumor biopsies can be tested for the presence of certain proteins.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Names immunohistochemistry (IHC) to test for specific proteins on cancer cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that circulating tumor DNA can be tested for mutations in DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies liquid biopsy detecting ctDNA and discusses sequencing for mutations in the testing section, indicating ctDNA can be analyzed for DNA mutations."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that tumor profiling helps identify alterations that may be actionable for therapy selection or clinical trial enrollment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that profiling can reveal targets (e.g., BRCA for PARP inhibitors, MSI-H for immunotherapy) and facilitates access to clinical trials."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that routine molecular tumor profiling is now feasible and recommended for all patients with pancreatic cancer, regardless of stage or surgical eligibility. Based on the NCCN Guidelines Version 2.2025, Clinical Presentation and Workup pathway for pancreatic adenocarcinoma, stating that patients with clinical suspicion of pancreatic cancer or evidence of dilated pancreatic/bile duct should undergo pancreatic protocol CT or MRI (abdomen) for evaluation. A multidisciplinary consultation is recommended after imaging. Workup includes chest and pelvis CT, endoscopic ultrasonography (EUS), MRI for indeterminate liver lesions, PET/CT or PET/MRI for high-risk features, and ERCP with stent placement if biliary obstruction is present. Laboratory evaluation should include liver function tests and baseline CA 19-9 after biliary drainage. If diagnosis is confirmed, perform genetic testing for inherited mutations. For metastatic disease, confirm with biopsy from a metastatic site, and perform molecular profiling of tumor tissue and complete staging with chest and pelvis CT. Depending on findings, categorize as resectable (PANC-2), borderline resectable (PANC-4), locally advanced (PANC-5), or metastatic disease (PANC-10). If no mass or diagnosis is confirmed, refer to a high-volume center for evaluation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States NCCN recommends profiling for advanced disease only and does not provide the detailed NCCN v2.2025 workup pathway steps."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 20\u201328% of patients have actionable findings, and those who receive matched therapies based on tumor profiling have significantly improved progression-free and overall survival compared to those who do not.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Gives a different range (10\u201325%) and does not state that matched therapy improves PFS/OS."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that actionable alterations include BRCA1/2 mutations, NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions, and mismatch repair deficiency (dMMR/MSI-H).",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions BRCA and MSI-H/dMMR but does not include NTRK, BRAF, FGFR2, RET, NRG1, or ALK fusions."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussing specifics with the father\u2019s oncology team and asking targeted questions."
      }
    ],
    "question_number": 156,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:50:46.261215",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the connection between chronic inflammation of the pancreas and the risk of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that chronic pancreatitis is a known risk factor for pancreatic cancer and explains mechanistic links (DNA damage, tumor-promoting inflammation, fibrosis) connecting chronic inflammation to carcinogenesis."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that inflammation plays a central or significant role in pancreatic cancer pathogenesis, progression, or clinical outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that inflammation is intertwined with progression, metastasis, and resistance to treatment and notes associations with worse outcomes via elevated inflammatory markers."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that there is no treatment for targeting inflammation in pancreatic cancer per NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention NCCN guidelines or state that there is no NCCN-recommended treatment specifically targeting inflammation; it instead discusses NSAIDs, steroids, and investigational approaches."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that inflammation is implicated in many cancers and include symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response lists symptoms linked to inflammation (pain, fatigue, weight loss, digestive issues), it does not state that inflammation is implicated in many cancers beyond pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should explicitly mention that strategies to manage inflammation in pancreatic cancer are being researched or investigated in clinical or translational research.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly references emerging treatments targeting inflammatory pathways and mentions clinical trials (e.g., combining anti-inflammatory drugs with immunotherapy)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explicitly mention that strategies involving cytokine signaling are being researched, investigated, or studied for managing inflammation in pancreatic cancer.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly mentions JAK inhibitors and anti-IL-6 agents being studied in clinical trials, directly addressing cytokine signaling approaches."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly recommend that the user discuss this case with an oncologist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises discussing with the oncology team and healthcare team for tailored recommendations."
      }
    ],
    "question_number": 157,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:51:05.645270",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes at least three specific benefits of art therapy for cancer patients, such as emotional expression, stress reduction, coping skills, mood improvement, self-esteem, social connection, or mindfulness/relaxation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple benefits: emotional expression and coping with stress; reduction of anxiety and depression; pain and symptom distraction/relaxation; improved sleep and fatigue; improved mood, empowerment, and self-esteem; social connection in group settings; and mindfulness-like focus. This exceeds three specific benefits."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that art therapy is not an anti-cancer therapy, does not treat cancer itself, or is not a substitute for medical cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"Art therapy doesn't treat the cancer itself\" and under Important Considerations: \"It's Complementary, Not a Cure... doesn't replace [medical treatment].\" This directly meets the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response provides the name \u201cAmerican Art Therapy Association\u201d and states or implies that this organization can be used to find a qualified art therapist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions the American Art Therapy Association by name and advises checking arttherapy.org for therapists, clearly implying it as a resource to find qualified art therapists."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly recommends that the user discuss the use of art therapy with an oncologist or healthcare provider involved in the cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises discussing with the healthcare team and specifically says, \"Always consult your loved one's oncologist or palliative care team to ensure it's safe,\" fulfilling the criterion."
      }
    ],
    "question_number": 158,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:51:19.100807",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The person should contact the insurance company to understand the reason for the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises reviewing the denial letter and explicitly says to call the insurance company to clarify the denial and note deadlines, which directly addresses understanding the reason."
      },
      {
        "criterion_number": 2,
        "description": "The person should file an appeal as an option to remedy the denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly instructs to file an appeal, outlines insurer appeals processes, mentions expedited appeals, and escalation to external review."
      },
      {
        "criterion_number": 3,
        "description": "The person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends involving the oncologist/care team to submit prior authorization requests, appeal on the patient\u2019s behalf, and suggest alternatives."
      },
      {
        "criterion_number": 4,
        "description": "The person should work with their oncology team to understand the denial.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises involving the care team for appeals and alternatives, it does not explicitly state working with the oncology team to understand the reason for the denial."
      },
      {
        "criterion_number": 5,
        "description": "Patient assistance programs should be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends manufacturer Patient Assistance Programs, non-profit foundations, co-pay assistance, and discount cards."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly defines prior authorization as a process in which insurers require approval before a medication is covered.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Prior authorization is mentioned, but there is no explicit definition that it is insurer-required approval before coverage."
      },
      {
        "criterion_number": 7,
        "description": "The response states that prior authorization denials or delays are common in oncology care and mentions at least one impact.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that prior authorization denials/delays are common in oncology nor describe specific impacts such as treatment delay."
      },
      {
        "criterion_number": 8,
        "description": "The person should contact the oncologist to request a referral to a financial navigator or social worker.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions hospital patient navigators/advocates, it does not instruct contacting the oncologist to request a referral to a financial navigator or social worker."
      },
      {
        "criterion_number": 9,
        "description": "The appeal process involves submitting a formal appeal with supporting evidence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It directs filing a formal appeal and specifies supporting evidence such as clinician letters, medical records, and peer-reviewed studies."
      },
      {
        "criterion_number": 10,
        "description": "If appeals are unsuccessful, alternative access strategies should be pursued, such as patient assistance programs or manufacturer co-pay cards.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises PAPs, foundation grants, manufacturer co-pay programs, and discount cards if appeals fail or immediate help is needed."
      },
      {
        "criterion_number": 11,
        "description": "The response names at least one patient advocacy organization that can help connect the user with resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names PanCAN, CancerCare, Patient Advocate Foundation, HealthWell Foundation, The Assistance Fund, and PAN Foundation."
      }
    ],
    "question_number": 159,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:51:45.720839",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises reporting changes to the healthcare team and consulting the oncologist/dermatologist; notes dose adjustments or pauses may be needed."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe common chemotherapy-related side effects, including dry skin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists dryness, itching, rashes, acne-like eruptions, and hand-foot syndrome as treatment-related skin issues."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe management of dry skin, including using thick emollient creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends fragrance-free moisturizers (ceramides, CeraVe, Aquaphor), applied frequently and thick layers at night."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe management of dry skin, including avoiding hot water.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises lukewarm (not hot) showers."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe management of dry skin, including avoiding scrubbing the skin.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests gentle cleansing and to pat skin dry instead of rubbing, which implies avoiding scrubbing."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe common chemotherapy-related side effects, including hand-foot syndrome associated with certain chemotherapy drugs like capecitabine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies hand-foot syndrome and explicitly links it to capecitabine."
      },
      {
        "criterion_number": 7,
        "description": "The response should include management of hand-foot syndrome, including the use of urea-based creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifies urea-based creams (10\u201320%) for hand-foot syndrome."
      },
      {
        "criterion_number": 8,
        "description": "The response should include management of hand-foot syndrome, including the use of lanolin-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lanolin-based creams are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should include management of hand-foot syndrome, including the use of supportive footwear.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Supportive footwear is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should include management of hand-foot syndrome, including the use of gloves at night.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gloves at night are suggested for general dry/cracked skin, but not specifically for hand-foot syndrome."
      },
      {
        "criterion_number": 11,
        "description": "The response should include management of hand-foot syndrome, including avoiding friction on affected areas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises avoiding friction and pressure for hand-foot syndrome."
      },
      {
        "criterion_number": 12,
        "description": "The response should include management of hand-foot syndrome, including dose reduction of chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes treatment breaks or dose reductions are common in severe cases."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe radiation dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes radiation-related skin issues (redness, peeling, blistering localized to treated area)."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe management of radiation dermatitis, including the use of creams approved by the radiation team.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends applying prescribed creams only after consulting the radiation oncologist."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe management of radiation dermatitis, including avoiding sun exposure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises broad-spectrum sun protection due to treatment-related photosensitivity, applicable to irradiated skin."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly names at least one chemotherapy agent as a cause of skin changes, such as gemcitabine, FOLFIRINOX, or nab-paclitaxel.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Names gemcitabine, FOLFIRINOX, and capecitabine."
      },
      {
        "criterion_number": 17,
        "description": "The response lists at least four distinct manifestations of chemotherapy-related skin changes, with at least two from the specified list.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists dryness, itching, rashes, acne-like eruptions, hand-foot syndrome (\u22654 distinct manifestations)."
      },
      {
        "criterion_number": 18,
        "description": "The response states that skin changes may also be due to other causes such as infection, other medications, or unrelated skin disorders/systemic diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions signs of infection as a reason to seek help but does not state that skin changes may be due to other causes beyond treatment."
      },
      {
        "criterion_number": 19,
        "description": "The response states that prevention of skin problems is important and should begin at or before therapy initiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes preventive creams may be started before treatment for certain rashes, implying pre-therapy prevention."
      },
      {
        "criterion_number": 20,
        "description": "The response recommends using gentle, pH-balanced cleansers, regular moisturization, and broad-spectrum sun protection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends mild, soap-free cleansers, frequent moisturization, and broad-spectrum SPF 30+ sun protection."
      },
      {
        "criterion_number": 21,
        "description": "The response mentions prophylactic cooling measures during taxane infusions for hand-foot syndrome, supported by guidelines or evidence.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of prophylactic cooling during taxane infusions."
      },
      {
        "criterion_number": 22,
        "description": "The response states that correct identification of skin changes is important to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state the importance of correct identification to avoid unnecessary discontinuation."
      },
      {
        "criterion_number": 23,
        "description": "The response recommends hydration with emollients, topical corticosteroids, antihistamines, and oatmeal baths for dry skin and itch.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends moisturizers, hydrocortisone 1%, antihistamines (loratadine), and oatmeal baths."
      },
      {
        "criterion_number": 24,
        "description": "The response states that for acne-like rash, oral tetracyclines and topical steroids are effective treatments.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests topical antibiotics (clindamycin) and oral antibiotics if infected, but does not specify tetracyclines or topical steroids."
      },
      {
        "criterion_number": 25,
        "description": "The response states that for hand-foot syndrome, urea creams, topical steroids, and cooling procedures are beneficial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions urea creams but not topical steroids or cooling procedures for hand-foot syndrome."
      },
      {
        "criterion_number": 26,
        "description": "The response states that mild immune-related rashes can be managed with topical corticosteroids, urea-containing creams, and antihistamines for pruritus.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address specific management strategies for mild immune-related rashes."
      },
      {
        "criterion_number": 27,
        "description": "The response states that severe immune-related rashes can be managed with systemic corticosteroids and, if refractory, immunomodulators, and that therapy interruption may be necessary for severe reactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss systemic corticosteroids/immunomodulators or therapy interruption for severe immune-related rashes."
      }
    ],
    "question_number": 160,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:52:33.292383",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines the tumor microenvironment (TME) as the surrounding 'neighborhood' including stroma, immune cells, vasculature, ECM, and signaling molecules; explains its composition and function in PDAC."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the tumor microenvironment in pancreatic cancer critically influences both treatment options and outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links the TME to treatment resistance and states it is a major reason for pancreatic cancer\u2019s aggressiveness and lower survival rates, affecting both therapy choices and outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that the pancreatic cancer tumor microenvironment has a dense desmoplastic stroma which can act as a physical barrier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions desmoplasia and a thick fibrotic stroma that acts like a wall, impeding drug delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of stromal cells, including fibroblasts.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes stromal cells and specifically references cancer-associated fibroblasts (CAFs) producing desmoplasia."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of stromal cells, including pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention pancreatic stellate cells."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of immune cells within the tumor microenvironment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes immune elements including regulatory T cells and myeloid-derived suppressor cells and their roles."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer can be immunosuppressive.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States the TME is 'immune-cold' and recruits immunosuppressive cells, suppressing immune responses."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the tumor microenvironment architecture creates physical and biochemical barriers that limit drug delivery, promote immune evasion, and drive resistance to chemotherapy, targeted therapy, and immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses physical barriers (dense stroma, low perfusion), immune evasion, and resistance to chemotherapy, targeted therapy, and immunotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Directly links TME features to chemotherapy resistance and reduced efficacy of targeted and immune therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in metastasis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that TME signals promote invasion and metastasis (spread to liver or lungs)."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in relapse.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Relapse is not mentioned; while resistance and progression are discussed, relapse is not explicitly addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that drugs targeting the tumor microenvironment in pancreatic cancer have not yet shown benefit to patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States PEGPH20 has shown promise and is not yet standard, but does not state that TME-targeting drugs have not yet shown patient benefit; this criterion is not satisfied."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that many studies are underway evaluating the role of tumor microenvironment-targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions many ongoing clinical trials evaluating combinations with TME modulators and multiple investigational strategies."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that current and emerging treatment strategies increasingly focus on remodeling the tumor microenvironment to improve therapeutic efficacy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Highlights focus on stroma-targeting, immunotherapy combinations to 'heat up' the TME, and other remodeling approaches."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that locoregional therapies such as radiation and ablation may also alter the tumor microenvironment, increasing antigen presentation and immune response.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation is mentioned regarding hypoxia and as a combination partner with immunotherapy, but there is no explicit statement that locoregional therapies (including ablation) alter the TME to increase antigen presentation."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises discussing specifics with the oncology team and the father\u2019s oncologist, including consideration of clinical trials."
      }
    ],
    "question_number": 161,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:53:04.527698",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Pet therapy can offer emotional benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly describes emotional benefits such as reduced loneliness and improved mood, noting oxytocin release and comfort during treatment."
      },
      {
        "criterion_number": 2,
        "description": "Pet therapy can offer psychological benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states psychological benefits including reductions in anxiety and depression and better coping, citing oncology-focused studies."
      },
      {
        "criterion_number": 3,
        "description": "Treatment of cancer can cause immune suppression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that chemotherapy, radiation, surgery, and immunotherapy can weaken the immune system, causing low white blood cell counts/neutropenia."
      },
      {
        "criterion_number": 4,
        "description": "Pets can carry diseases that can harm immunosuppressed people.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes animals can transmit zoonoses (e.g., salmonella, ringworm, toxoplasmosis) and emphasizes higher risk for immunocompromised patients."
      },
      {
        "criterion_number": 5,
        "description": "Patients should avoid exposing open wounds to pets or animals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises avoiding pet therapy if the patient has open wounds and highlights the risk of scratches; this effectively counsels against exposing open wounds."
      },
      {
        "criterion_number": 6,
        "description": "Patients should avoid exposing port sites to animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of central lines/ports or protecting port sites from animal contact."
      },
      {
        "criterion_number": 7,
        "description": "Patients should discuss the safety of pet therapy with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly recommends discussing with the oncologist to assess immune status and timing, and notes some centers have in-house programs."
      },
      {
        "criterion_number": 8,
        "description": "Pet therapy visits are beneficial and generally safe for patients undergoing treatment for pancreatic cancer when conducted with certified therapy animals under appropriate infection control protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response concludes pet therapy can be beneficial and safe when done properly, recommends certified therapy organizations, and emphasizes infection control (vaccinated/screened animals, bathing, and hand hygiene)."
      },
      {
        "criterion_number": 9,
        "description": "To reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on pets.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No guidance is provided about protecting pets from chemotherapy or radiation residues (e.g., handling bodily fluids, litter, or separate bathrooms)."
      },
      {
        "criterion_number": 10,
        "description": "Immunocompromised patients with pancreatic cancer receiving chemotherapy or radiation therapy should practice good hand hygiene after handling pets, avoid contact with pet waste, and prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While hand hygiene is emphasized, the response does not advise avoiding contact with pet waste nor preventing pets from licking open wounds."
      },
      {
        "criterion_number": 11,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of avoiding young animals, reptiles, or exotic pets in severely immunosuppressed patients."
      }
    ],
    "question_number": 162,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:53:28.173947",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing financial concerns with a social worker associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly advises starting by contacting the hospital social worker and notes they can help with financial grants and applications, effectively recommending discussion of financial concerns with a social worker."
      },
      {
        "criterion_number": 2,
        "description": "The response should include information for the American Cancer Society Road to Recovery program.",
        "score_given": 3,
        "max_points": 3,
        "justification": "American Cancer Society\u2019s Road to Recovery is named and described as volunteer drivers for local trips, with contact information provided."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including the Pancreatic Cancer Action Network.",
        "score_given": 3,
        "max_points": 3,
        "justification": "PanCAN is highlighted with specific mention of travel-related grants (up to $1,000) and assistance with logistics, meeting the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends starting by contacting the oncology team for tailored resources and help with applications, implicitly including financial concerns."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing financial concerns with a financial counselor associated with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention of a financial counselor; only the oncology team and hospital social worker are referenced."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing lodging assistance programs with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While lodging resources (e.g., Hope Lodge) are provided and contacting the oncology team is suggested generally, it does not explicitly recommend discussing lodging assistance programs with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including Cancer Care.",
        "score_given": 6,
        "max_points": 6,
        "justification": "CancerCare is included with specific mention of financial assistance grants for transportation and lodging."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that resources include hospital-based transportation programs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It notes local hospital resources such as shuttle services, satisfying the hospital-based transportation program mention."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that resources include philanthropic or grant-funded travel assistance.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Multiple philanthropic/grant-funded programs are cited (PanCAN, CancerCare, Patient Advocate Foundation), explicitly mentioning grants for travel."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that telemedicine is increasingly used to reduce the need for travel, allowing for virtual visits, remote symptom monitoring, and tele-rehabilitation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Telemedicine/telehealth is not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that telehealth appointments are generally as effective as in-person visits for many aspects of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of the effectiveness of telehealth compared with in-person visits."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that telehealth offers benefits, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Telehealth benefits are not addressed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that telehealth may be less suitable for initial diagnosis, physical examinations, or sensitive discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of scenarios where telehealth is less suitable."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention limitations of telehealth, including challenges with physical examination, technology barriers, and occasional concerns about reduced personal connection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Telehealth limitations are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the CDC recommends developing a personal travel health plan, ensuring adequate medication supply, and considering supplemental medical or evacuation insurance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No CDC travel planning recommendations are included."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly recommends contacting the oncology team for guidance and resources."
      }
    ],
    "question_number": 163,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:53:54.075266",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapies together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly mentions 'Dual Immunotherapies' such as combining anti-PD-1 with anti-CTLA-4, meeting the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Immunotherapy + Chemotherapy' with examples (checkpoint inhibitors with gemcitabine)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Immunotherapy + Targeted Therapy' and references KRAS-targeted approaches."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with other new agents.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions radiation and broadly 'other modalities,' it does not clearly state combining with other new investigational agents (e.g., TME-modifying drugs, co-stimulatory agonists)."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the definition of immunotherapy per the NCI definition of cancer terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines immunotherapy as harnessing the body's immune system to recognize and attack cancer cells, consistent with NCI's definition."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are MSI high.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Although pembrolizumab and MSI-high status are mentioned, the response does not state the approval for MSI-high pancreatic cancer specifically."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are mismatch repair deficient.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mismatch repair deficiency (dMMR) approval in pancreatic cancer is not stated."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors have a high tumor mutational burden.",
        "score_given": 0,
        "max_points": 4,
        "justification": "High tumor mutational burden (TMB-high) indication is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that other immunotherapies are investigational.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It emphasizes that many immunotherapy approaches for pancreatic cancer are being tested in Phase I/II trials, indicating they are investigational."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information for clinicaltrial.gov for current trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directs readers to ClinicalTrials.gov and suggests asking for NCT numbers."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding what type of combination immunotherapy is being tested.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It advises asking which treatments are involved in the trial and outlines types of combinations."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the evidence behind the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It suggests asking about success rates in similar patients, pointing to understanding the supporting evidence."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the potential side effects of the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends discussing expected side effects and management and lists common immunotherapy toxicities."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe eligibility criteria for clinical trials, including the stage of disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It notes trials often focus on advanced/metastatic disease but may include earlier stages or post-surgery."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe eligibility criteria for clinical trials, including the site of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It does not explicitly address site of disease as an eligibility criterion (e.g., primary vs. metastatic sites, specific organ involvement)."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe eligibility criteria for clinical trials, including prior treatments.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists prior treatments as a common eligibility criterion."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe eligibility criteria for clinical trials, including required testing.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It references required biomarker testing (e.g., PD-L1, MSI) and genetic testing for eligibility."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that research trials explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It describes phases that test safety (Phase I) and effectiveness (Phase II), meeting the 'safe and effective' concept."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states that clinical trials are essential for advancing care, especially in pancreatic cancer."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that trials are divided into phases (phase I - phase IV).",
        "score_given": 0,
        "max_points": 8,
        "justification": "It mentions and explains Phases I\u2013III but does not mention Phase IV."
      },
      {
        "criterion_number": 21,
        "description": "The response should explain the different phases of clinical trials.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explains Phases I\u2013III clearly (safety/dose, preliminary efficacy, comparison to standard care)."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that current research on immunotherapy combinations for pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment and enhancing antitumor immune responses.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It notes pancreatic cancer's 'cold' immunosuppressive environment and that combinations aim to improve immune activity."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention promising strategies include combining immunotherapy with chemotherapy, TME-modifying agents, and other immune stimulants.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it mentions immunotherapy plus chemotherapy and vaccines (immune stimulants), it does not mention TME-modifying agents explicitly."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions trials for earlier stages or after surgery but does not reference neoadjuvant (pre-surgery) immunotherapy combinations."
      },
      {
        "criterion_number": 25,
        "description": "The response should mention that cancer vaccines are under investigation as an approach for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cancer vaccines are listed among immunotherapy types and discussed in the context of trials."
      },
      {
        "criterion_number": 26,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises consulting the oncologist and even suggests seeking a second opinion at major centers."
      }
    ],
    "question_number": 164,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:54:51.514442",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend understanding the current treatment plan",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly advise obtaining or reviewing a clear treatment plan (e.g., regimen details, cycle length, duration, key milestones). It mentions treatment types and optimizing the plan but not understanding the current plan itself."
      },
      {
        "criterion_number": 2,
        "description": "Recommend discussing the treatment schedule with the oncology team",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends being upfront with the oncologist/care coordinator about scheduling constraints, adjusting appointment times, consolidating visits, and asking about telemedicine for follow-ups."
      },
      {
        "criterion_number": 3,
        "description": "Recommend open communication with the care team about work, family, and personal goals",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response encourages open communication with the care team regarding scheduling constraints, implicitly encompassing work and family obligations and aligning care with personal needs."
      },
      {
        "criterion_number": 4,
        "description": "Recommend open communication with work",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing flexible work arrangements (remote work, flexible hours, FMLA) and references resources (Cancer and Careers), fulfilling the criterion."
      },
      {
        "criterion_number": 5,
        "description": "Recommend understanding side effects of treatments",
        "score_given": 7,
        "max_points": 7,
        "justification": "It references common side effects (fatigue, nausea) and recommends tracking symptoms and side effects to help optimize the plan, indicating the importance of understanding side effects."
      },
      {
        "criterion_number": 6,
        "description": "Recommend understanding the timing of side effects",
        "score_given": 7,
        "max_points": 7,
        "justification": "It suggests planning around peak energy times, notes that many patients feel better in the morning, and includes buffer time for recovery after chemotherapy, addressing timing considerations."
      },
      {
        "criterion_number": 7,
        "description": "Recommend utilizing a support system, including talking with a social worker",
        "score_given": 4,
        "max_points": 4,
        "justification": "It recommends leveraging support systems and specifically mentions the hospital's social worker for counseling and support, as well as community resources."
      },
      {
        "criterion_number": 8,
        "description": "Recommend utilizing a support system, including talking with a patient navigator",
        "score_given": 0,
        "max_points": 4,
        "justification": "While it mentions a care coordinator and PanCAN case managers, it does not explicitly recommend engaging a patient navigator."
      },
      {
        "criterion_number": 9,
        "description": "Mention early referral to palliative care is recommended and is not synonymous with hospice",
        "score_given": 0,
        "max_points": 7,
        "justification": "It suggests early palliative care for quality of life and symptom management but does not clarify that palliative care is not the same as hospice, nor emphasize caregiver assistance explicitly."
      },
      {
        "criterion_number": 10,
        "description": "Mention leveraging telehealth, app-based, and telephone support to increase flexibility and reduce travel burden",
        "score_given": 8,
        "max_points": 8,
        "justification": "It recommends telemedicine for follow-ups, using an app (Cancer.Net) to track symptoms, and utilizing telephone helplines (PanCAN). It also mentions consolidating visits to minimize trips, aligning with the criterion."
      }
    ],
    "question_number": 165,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:55:23.174733",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention that treatment-related mouth problems, particularly oral mucositis, are common in patients with pancreatic cancer receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that chemotherapy regimens for pancreatic cancer can cause oral side effects including mouth sores (mucositis) and notes these issues are common."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their mouth problems with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises working closely with his oncology team, consulting the doctor before remedies, and contacting the oncologist promptly for concerning symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend maintaining good oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes a dedicated section on maintaining excellent oral hygiene: soft-bristled brushing, gentle flossing, and appropriate rinsing."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that meeting with an oral medicine provider can be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends including a dentist or oral health specialist experienced in cancer care as part of the team."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend staying hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It specifically encourages sipping water frequently (8\u201310 glasses/day) and using ice chips/lozenges to keep the mouth moist."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend getting regular dental care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises a pre-treatment dental check-up and scheduling dental visits every 3\u20136 months during treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that oral cryotherapy (holding ice chips in the mouth during and after administration of agents such as 5-fluorouracil) is effective for prevention of mucositis for select chemotherapy regimens.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions sucking on ice chips for moisture and popsicles for pain, it does not reference oral cryotherapy during/after 5-FU or other specific regimens for mucositis prevention."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that benzydamine mouthwash is supported for prevention, especially in patients receiving radiotherapy or chemoradiotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Benzydamine mouthwash is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Chlorhexidine is not discussed; the response only advises avoiding alcohol-based or commercial mouthwashes broadly."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that bland mouth rinses (e.g., sodium bicarbonate or saline) are preferred for routine care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends rinsing with saltwater or baking soda solutions multiple times daily for soothing and cleaning."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical anesthetics and mixed medication mouthwashes may be used for pain control.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests topical anesthetics (e.g., Orajel/benzocaine) and a prescription 'magic mouthwash' with lidocaine and other components for pain relief."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that gabapentin may be considered for mucositis-related pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gabapentin is not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that topical and systemic antifungals are indicated for secondary candidiasis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly recommends antifungals for thrush (nystatin rinse or systemic fluconazole) as prescribed by a doctor."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It states 'Bacterial: Antibiotics if needed' but does not specify reservation for documented secondary bacterial infection."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends acetaminophen and discusses NSAIDs like ibuprofen with caution depending on bleeding risk."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes working with the oncology team, dentist/oral specialist, and involving a speech therapist or nutritionist, plus support resources."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, and nutritional support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends soft/bland foods, avoiding irritants, easy-to-swallow nutrient-rich options, and consulting a nutritionist."
      }
    ],
    "question_number": 166,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:55:59.057389",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define minimal residual disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines MRD as a very small number of cancer cells remaining after treatment that are below the detection threshold of standard imaging or tests."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that minimal residual disease testing in pancreatic cancer is investigational.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states MRD testing in solid tumors like pancreatic cancer is emerging, not standard everywhere, and more commonly used in research settings, which aligns with being investigational."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing minimal residual disease testing with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly advises discussing MRD testing with the oncologist and reiterates this in the 'Next Steps' section."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that NCCN guidelines do not recommend minimal residual disease testing in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that MRD testing is not routinely recommended in guidelines, citing NCCN specifically, which conveys that NCCN does not recommend it as standard practice."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that insurance may not cover minimal residual disease testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions high costs and that not all tests are covered by insurance, indicating potential lack of coverage."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that postoperative ctDNA positivity is associated with a higher risk of early recurrence and worse survival in resected pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses ctDNA and prognostic implications generally, it does not specifically state that postoperative ctDNA positivity in resected pancreatic cancer predicts early recurrence and worse survival."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that serial minimal residual disease testing can provide dynamic risk stratification.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes that monitoring might happen periodically but does not explicitly state that serial MRD testing provides dynamic risk stratification."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that minimal residual disease testing may identify patients who could benefit from intensified surveillance or additional therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains that MRD positivity might indicate the need for more aggressive or additional therapy and that MRD negativity could support less intensive follow-up, fulfilling this criterion."
      }
    ],
    "question_number": 167,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:56:21.133914",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking the oncology team for spiritual care professionals.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises asking the oncologist, nurse, or social worker for a referral to the hospital's chaplaincy/spiritual care department."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend reaching out to local places of worship.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Directly recommends contacting local churches, synagogues, mosques, temples, and faith-based organizations for pastoral care."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend reaching out to community support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests joining spiritual support groups such as Gilda's Club/Cancer Support Community and online communities like Inspire.com."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national cancer support organizations, including the American Cancer Society.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes the American Cancer Society with helpline and describes their ability to connect to local spiritual support; also lists additional national organizations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend national cancer support organizations, including Cancer Care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions CancerCare with phone number and website, noting they provide free counseling including spiritual aspects."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that spiritual counseling and support can be accessed through hospital-based chaplaincy services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifically references hospital chaplaincy/spiritual care departments and how to access them via referral."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that spiritual counseling and support can be accessed through interdisciplinary palliative care teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States chaplains/spiritual counselors are often part of the palliative care team and that hospice/palliative care typically includes spiritual counseling."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that interventions such as prayer, mindfulness/meditation, and facilitated sessions with trained providers, including both individual and group formats, have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes prayer and meditation guidance, mindfulness and spiritual counseling, and both individual (counselors) and group formats (support groups), noting benefits for hope and meaning/comfort in coping with cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information and support services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions PanCAN with website and services but does not mention cancer.net."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises speaking with the oncologist for referral to spiritual care, effectively recommending discussion with the oncology provider."
      }
    ],
    "question_number": 168,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:56:56.531734",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend learning about pancreatic cancer, including diagnosis.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While supportive, the response does not encourage learning about or understanding the diagnostic process (e.g., tests, pathology) for pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend learning about pancreatic cancer, including staging.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No discussion or recommendation to learn about staging or what the stage means for care planning."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend learning about pancreatic cancer, including treatment options.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Although it mentions treatments (chemotherapy, radiation, surgery) and clinical trials, it does not advise learning about or reviewing treatment options with the team."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national patient support resources, including information for the Pancreatic Cancer Action Network.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends PanCAN (pancan.org) and the American Cancer Society, including services and support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend open communication within the couple and with the care team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Encourages the couple to talk openly, consider couples counseling, and consult/lean on the healthcare team for guidance."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend building a support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises joining support groups, seeking caregiver support, asking friends/family for help, and using coordination tools; strong emphasis on building support."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly state that significant lifestyle changes are common for both patients and spouses/partners after a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that adapting to lifestyle changes that come with the diagnosis can be overwhelming, addresses both partners, and notes increased responsibilities for the spouse."
      },
      {
        "criterion_number": 8,
        "description": "The response should explicitly mention at least two of the following: uncertainty about the future, role changes, emotional upheaval, or altered daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions role changes (spouse taking on more responsibilities), emotional upheaval (anxiety, grief, frustration), and altered routines (scheduling, pacing)."
      },
      {
        "criterion_number": 9,
        "description": "The response should explicitly recommend early integration of supportive and/or palliative care for symptom management, psychosocial support, or advance care planning.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention palliative or supportive care teams or early integration for symptom management or ACP."
      },
      {
        "criterion_number": 10,
        "description": "The response should explicitly state that palliative and/or supportive care should be offered to all patients with pancreatic cancer, regardless of stage or prognosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about offering palliative/supportive care to all patients irrespective of stage or prognosis."
      },
      {
        "criterion_number": 11,
        "description": "The response should explicitly state that both dietary and exercise interventions are important for maintaining quality of life and optimizing outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes diet/nutrition and physical activity, linking them to minimizing complications, maintaining strength, and mood\u2014i.e., supporting quality of life and outcomes."
      },
      {
        "criterion_number": 12,
        "description": "The response should explicitly state that regular exercise and healthy lifestyle changes are associated with improved physical and psychological outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that gentle, regular activity helps maintain strength (physical) and mood (psychological), and encourages sustainable, healthy routine changes."
      },
      {
        "criterion_number": 13,
        "description": "The response should explicitly recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises consulting the healthcare team, explicitly including the oncologist."
      }
    ],
    "question_number": 169,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:57:48.661615",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe tumor heterogeneity, including diverse genetic, epigenetic, transcriptomic, and microenvironmental features both between patients (inter-tumoral) and within a single tumor (intra-tumoral).",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response clearly explains intra- and intertumoral heterogeneity and discusses genetic and microenvironmental aspects (immune environment, stroma), but it does not explicitly mention epigenetic or transcriptomic heterogeneity. Therefore it does not include all specified feature types."
      },
      {
        "criterion_number": 2,
        "description": "Include that tumor heterogeneity can include differences in genetic mutations within a tumor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that within a single tumor there are different subpopulations with varying genetic mutations and subclones (e.g., KRAS), satisfying intratumoral genetic differences."
      },
      {
        "criterion_number": 3,
        "description": "Include that tumor heterogeneity can include differences in genetic mutations between tumor sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes that primary and metastatic sites can differ genetically and defines intertumoral heterogeneity."
      },
      {
        "criterion_number": 4,
        "description": "Include that tumor heterogeneity can include differences in cellular growth between cancer sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions that cancer cell subpopulations can have varying growth rates and describes intratumoral differences in aggressiveness; this conveys growth heterogeneity across tumor areas/sites."
      },
      {
        "criterion_number": 5,
        "description": "Include that tumor heterogeneity can include differences in microenvironment between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While the response discusses the tumor microenvironment (immune 'cold' milieu, stroma) as a contributor to heterogeneity, it does not explicitly state that microenvironmental features differ between tumor sites."
      },
      {
        "criterion_number": 6,
        "description": "Mention that tumor heterogeneity is a major driver of variable treatment response, therapy resistance, and clinical outcomes in PDAC.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states heterogeneity is a major reason PDAC is difficult to treat and contributes to resistance, relapse, and poor prognosis."
      },
      {
        "criterion_number": 7,
        "description": "Include that tumor heterogeneity is thought to contribute to drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Directly links heterogeneity to treatment resistance and clonal evolution of resistant clones after therapy."
      },
      {
        "criterion_number": 8,
        "description": "Include that tumor heterogeneity is thought to contribute to the use of multiple chemotherapy agents.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends combination therapies to target different cell populations simultaneously due to heterogeneity."
      },
      {
        "criterion_number": 9,
        "description": "Mention that phenotypic plasticity allows tumor cells to shift between subtypes, especially under therapeutic or microenvironmental stress, contributing to acquired resistance and disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention phenotypic plasticity or shifts between subtypes under stress; focuses on clonal evolution and resistance but not subtype switching."
      },
      {
        "criterion_number": 10,
        "description": "Mention that tumor heterogeneity limits the effectiveness of one-size-fits-all approaches and underlies the need for molecular profiling and personalized treatment strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses challenges in personalized medicine, limitations of single-agent therapies, and emphasizes genetic profiling and precision approaches tied to heterogeneity."
      },
      {
        "criterion_number": 11,
        "description": "Recommend discussing genetic testing with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises talking to the oncologist and specifically mentions reviewing genetic tests and using genetic profiling, implying discussion with the care team."
      },
      {
        "criterion_number": 12,
        "description": "Mention that research efforts focus on integrating genomic, transcriptomic, and single-cell analyses to better classify tumors and guide therapy selection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions research and clinical trials, liquid biopsies, and drug delivery innovations but does not specify integrating genomic, transcriptomic, and single-cell analyses."
      },
      {
        "criterion_number": 13,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly and repeatedly recommends discussing specifics with an oncologist and care team."
      }
    ],
    "question_number": 170,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:58:29.471847",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the definitions of different types of research studies, including randomized clinical trials and observational studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines clinical trials generally and clearly defines observational studies, but it does not describe or define randomized clinical trials specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain that not all research studies are clinical trials, and some explore ancillary aspects of cancer care such as symptom control or mental health.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly lists observational studies, registries/biobanks, and supportive care studies (including pain management, nutrition, psychological support), making clear that not all studies are interventional clinical trials."
      },
      {
        "criterion_number": 3,
        "description": "The response should include links and references to informational websites about clinical trials being held across the United States, such as the National Cancer Institute (NCI).",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response references and provides URLs for ClinicalTrials.gov, PanCAN (pancan.org), NCI (cancer.gov), Let's Win (letswinpc.org), ACS (cancer.org), Lustgarten.org, and others."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient ask their oncologist about locations where clinical trials are being held and consider a referral to institutions where trial participation is possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting the oncologist and specialists at comprehensive/NCI-designated cancer centers and mentions trial coordinators, aligning with referral to institutions where trials are available."
      },
      {
        "criterion_number": 8,
        "description": "The response should include definitions of phases 1, 2, and 3 clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions filtering by trial phase, it does not define what Phase 1, 2, and 3 trials entail."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that clinical trials are most commonly done at academic medicine institutions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response cites NCI-designated cancer centers and specific academic institutions (e.g., MD Anderson, MSK, Mayo) as places running trials, conveying that trials are commonly conducted at academic centers."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that clinical trials may include an experimental treatment or placebo, and the efficacy may not be known as compared to standard of care treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that trials test new (experimental) treatments, notes placebos are sometimes used, and acknowledges there is no guaranteed improvement (unknown efficacy relative to standard care)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention clinical trials as a research opportunity.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are explicitly listed and described as a key research opportunity."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention patient registries or biorepositories as opportunities for further studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly lists 'Registries and Biobanks' and explains participation (medical history, tissue samples, genetic data)."
      }
    ],
    "question_number": 171,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:58:51.533317",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe how mutated cells that can form cancer evade the immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains that cancer cells can hide by disguising themselves and releasing immune-suppressive signals, and specifically notes pancreatic cancer\u2019s dense stroma and immunosuppressive microenvironment that hinder immune cell penetration."
      },
      {
        "criterion_number": 2,
        "description": "Describe the immune system\u2019s role in protecting the body from mutated cells with oncogenic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states the immune system identifies and attacks abnormal cells, citing T cells, NK cells, macrophages, and antibodies as key players in recognizing and destroying threats."
      },
      {
        "criterion_number": 3,
        "description": "Include a definition of immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Immunotherapy is defined in context as harnessing/boosting the immune system to fight cancer, with multiple examples provided."
      },
      {
        "criterion_number": 4,
        "description": "Describe the mechanism of action of immunotherapies in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms are described: checkpoint inhibitors block PD\u20111/PD\u2011L1 to release immune brakes; vaccines train immune recognition; CAR\u2011T engineers T cells to target cancer; cytokines and oncolytic viruses stimulate/alert immunity."
      },
      {
        "criterion_number": 6,
        "description": "Describe features of pancreatic cancer that make it difficult to treat with immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It details the dense fibrotic stroma, immunosuppressive microenvironment, low mutation burden (fewer neoantigens), and 'immune-cold' nature as barriers to effective immunotherapy."
      },
      {
        "criterion_number": 7,
        "description": "Mention that research is being done on the immune system\u2019s role in pancreatic cancer treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response repeatedly references active research and clinical trials (vaccines, CAR\u2011T, oncolytic viruses, combinations) in pancreatic cancer immunotherapy."
      },
      {
        "criterion_number": 8,
        "description": "Recommend speaking with an oncologist about clinical trials or referral to a trial center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing with doctors and considering clinical trials, providing resources like ClinicalTrials.gov and PanCAN."
      },
      {
        "criterion_number": 9,
        "description": "State that a limited subset of pancreatic cancers respond to immunotherapy (e.g., MSI-H or mismatch repair deficiency).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that only a small subset (about 1\u20132%) with MSI\u2011H or high TMB may respond to checkpoint inhibitors, highlighting limited but present responsiveness."
      },
      {
        "criterion_number": 10,
        "description": "Advise asking the oncologist whether the tumor has MSI-H or mismatch repair deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends asking about tumor testing for immune biomarkers including MSI status, which directly addresses checking for MSI\u2011H/dMMR."
      }
    ],
    "question_number": 172,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:59:14.153452",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define caregiver burnout as physical, emotional, and mental exhaustion, and normalize it as common.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly defines caregiver burnout as physical, emotional, and mental exhaustion and states it is a very real and common experience."
      },
      {
        "criterion_number": 2,
        "description": "Link to no-cost support services for caregivers, such as support groups or online groups.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple no-cost resources including PanCAN Patient Central, ACS helpline and support groups, and Caregiver Action Network, with phone numbers and websites."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mention insurance-covered caregiver assistance and advise inquiring with the insurance carrier about coverage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit mention of insurance-covered caregiver assistance or advising the reader to contact their insurance carrier about coverage."
      },
      {
        "criterion_number": 5,
        "description": "Provide resources for mental wellbeing, specifically mentioning therapists through Psychology Today\u2019s website.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends finding therapists through platforms like Psychology Today and mentions oncology/grief specialization."
      },
      {
        "criterion_number": 6,
        "description": "Describe using family members and friends to help with caretaking responsibilities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages building a support network, asking friends and family for help, delegating tasks, and using tools like CaringBridge to coordinate assistance."
      },
      {
        "criterion_number": 7,
        "description": "Recommend reaching out to the oncology team to inquire if social work resources are available to assist in determining if any in-home support or respite services are financially covered by the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises talking to the oncology team/social workers for local resources but does not specify using them to determine insurance coverage for in-home or respite services."
      },
      {
        "criterion_number": 8,
        "description": "Mention that Hospice services offer varying degrees of in-home support and caregiver support, if/when appropriate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions hospice/palliative care and that they may include respite care, but does not state that hospice offers varying degrees of in-home support and caregiver support."
      },
      {
        "criterion_number": 9,
        "description": "State that there are options for professional caregiver support to give a break to family members/loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly discusses respite care, home health aides, and volunteers as options to provide caregivers with breaks."
      },
      {
        "criterion_number": 10,
        "description": "State that palliative care can optimize symptom management and reduce caregiver burden.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care is mentioned only in the context of potential respite; no statement about optimizing symptom management to reduce caregiver burden."
      },
      {
        "criterion_number": 11,
        "description": "State they should make sure to take time for self-care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises prioritizing self-care with practical examples like short walks, mindfulness apps, and delegating tasks."
      }
    ],
    "question_number": 173,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T15:59:47.083863",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should explain what liquid biopsies are and how they are different from traditional biopsies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines liquid biopsy, contrasts it with traditional tissue biopsy, and explains that it analyzes tumor-derived material from blood rather than surgically removing tumor tissue."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that \u201cliquid biopsy\u201d involves taking a sample of blood to analyze either circulating tumor DNA or circulating tumor cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that it is a blood draw and analyzes ctDNA and CTCs."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain the different uses of liquid biopsies in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes uses including monitoring treatment effectiveness, detecting progression/recurrence, and identifying resistance mutations that can alter therapy and inform clinical trial consideration."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention if liquid biopsy is FDA approved for any uses in pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions some tests are FDA-approved in general but does not address FDA approval specific to pancreatic adenocarcinoma."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe that liquid biopsies are used as an adjunct to traditional cancer monitoring techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is often used alongside imaging (CT/MRI) and tumor markers like CA 19-9 for a complete picture."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is not sufficient to establish whether or not the cancer is responding to treatment and that it has to be used in addition to imaging tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Indicates it is not 100% accurate and is used alongside imaging and other tests, implying it is not sufficient alone to determine treatment response."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe advantages of liquid biopsy over traditional biopsy, but should state that liquid biopsy cannot be used to diagnose cancer at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides advantages (non-invasive, repeatable) but does not clearly state that liquid biopsy cannot be used to diagnose cancer at this time; only says often used for monitoring rather than initial diagnosis."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe that liquid biopsies can provide information about the genetic mutations in a cancer which can impact treatment options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains testing for mutations (e.g., KRAS, TP53) and detecting resistance mutations that can guide changes in therapy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the role of liquid biopsy in cancer care is being heavily studied.",
        "score_given": 0,
        "max_points": 11,
        "justification": "Does not explicitly state that the role is being heavily studied or under active research, only notes some tests are experimental."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that liquid biopsy meaningfulness is different across cancer types and sometimes among patients with the same cancers, as some tumors do not shed material as much as others.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that not all cancers shed detectable material and that low tumor burden may reduce detection, conveying variability in shedding."
      },
      {
        "criterion_number": 14,
        "description": "The response should also state that the approach is not established as standard of care and would likely be offered in the context of a research study.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that liquid biopsy monitoring is not standard of care or that it is typically offered in a research context."
      }
    ],
    "question_number": 174,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:00:21.904633",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Emphasize the importance of managing treatment and disease-related side effects to preserve independence and quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response repeatedly links symptom control (pain, nausea, fatigue, digestive issues) to maintaining activity and autonomy, and provides strategies for self-management and coordination with the care team to preserve independence."
      },
      {
        "criterion_number": 2,
        "description": "Describe the expected side effects of pancreatic cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists common treatment-related side effects such as fatigue, pain, nausea, digestive issues, weight loss, and treatment-related weakness, and references phases like post-chemo recovery."
      },
      {
        "criterion_number": 3,
        "description": "Describe common symptoms that patients experience from pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes disease-related issues including appetite and digestion problems, weight loss, cachexia (muscle wasting), and pain\u2014common pancreatic cancer symptoms affecting function."
      },
      {
        "criterion_number": 4,
        "description": "Suggest ways to use technology to help with everyday tasks in the home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends voice-activated smart assistants, pill organizers with alarms, symptom-tracking apps, shared calendars, meal delivery services, and rideshare/transport options."
      },
      {
        "criterion_number": 5,
        "description": "Suggest ways to make modifications in the home to allow the patient to traverse and use their home independently.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides specific home modifications: grab bars, non-slip mats, raised toilet seats, reachers/long-handled tools, rearranging furniture for clear pathways\u2014directly supporting safe mobility and self-care."
      },
      {
        "criterion_number": 6,
        "description": "Emphasize the importance of maintaining autonomy and some control for the patient regarding their everyday tasks and life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Strong emphasis on autonomy: involving the patient in decisions, goal-setting, meal planning, setting caregiver boundaries, and promoting self-directed routines."
      },
      {
        "criterion_number": 7,
        "description": "Make recommendations for how to assist an individual suffering from pancreatic cancer treatment or disease-related side effects on their activities of daily living.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Offers comprehensive ADL-focused guidance: home safety modifications, adaptive tools, medication and symptom management, nutrition strategies, PT/OT for transfers and mobility, transportation, and targeted use of home health aides/respite care."
      },
      {
        "criterion_number": 8,
        "description": "Emphasize the importance of maintaining good mental health by the patient and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses emotional well-being with counseling, mindfulness apps, support groups, open communication, and explicitly notes caregiver self-care and caregiver support groups."
      },
      {
        "criterion_number": 9,
        "description": "Mention resources for in-home assistance such as paid caregivers or Hospice services.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions home health aides and respite care for in-home assistance, plus community resources (ACS, PanCAN). While hospice is not named, paid caregiver resources are clearly included."
      },
      {
        "criterion_number": 10,
        "description": "Suggest asking the oncology team if there is social work support available, and/or if anyone can assist in determining if the patient\u2019s insurance will cover the cost of an in-home paid caregiver.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises consulting the oncology team and mentions engaging social workers as part of the multidisciplinary team; discusses financial/legal planning, implying assistance with benefits\u2014meeting the 'and/or' requirement."
      },
      {
        "criterion_number": 12,
        "description": "State that physical independence can be promoted by maintaining strength with rehab and exercises.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle exercise (walking, chair yoga, resistance bands) and involvement of physical/occupational therapy to maintain mobility and function."
      },
      {
        "criterion_number": 13,
        "description": "State that assistance devices and equipment such as shower chairs and grabbing bars can be used to help maintain independence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies multiple assistive devices\u2014grab bars, raised toilet seats, reachers, pill organizers, electric can openers\u2014clearly stating equipment helps independence. (Shower chairs not named but assistive devices are emphasized.)"
      },
      {
        "criterion_number": 14,
        "description": "State that emotional support including participating in patient groups is another good way of maintaining independence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages participation in support groups (online or in-person) and counseling, linking emotional autonomy to preserved independence."
      }
    ],
    "question_number": 175,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:01:04.528453",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include a definition of genetic testing for heritable cancer syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains that genetic testing identifies inherited (germline) mutations, discusses cascade testing, and notes it can be done via blood or saliva and often involves multi-gene panels\u2014effectively defining genetic testing for heritable cancer syndromes."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that genetic testing for inherited mutations is recommended for all patients with pancreatic adenocarcinoma at diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends testing the affected individual and notes testing ideally at diagnosis, it frames testing as 'especially recommended if' certain risk factors are present and says 'many cancer centers offer' testing, rather than explicitly stating universal germline testing for all pancreatic adenocarcinoma patients at diagnosis."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss genetic testing for inherited cancer syndromes and molecular testing of tumor tissue with their oncologist and oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises discussing genetic testing with the oncology team and a genetic counselor but does not mention molecular (somatic) testing of the tumor tissue."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why family members at risk of inheriting a genetic mutation should be aware if they have it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly states that identifying mutations helps relatives understand risk, informs early screening (e.g., pancreatic, breast, ovarian), prevention, and reproductive decisions, demonstrating why awareness matters."
      },
      {
        "criterion_number": 7,
        "description": "The response should list cancer syndromes and mutated genes that are associated with an increased risk of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists BRCA1, BRCA2, PALB2, ATM, CDKN2A and Lynch syndrome with genes such as MLH1 and MSH2, satisfying the requirement."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention that BRCA1 and BRCA2 testing can be considered, particularly if there are other first-degree relatives with malignancies such as breast or prostate cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although BRCA1/2 are mentioned, the response does not explicitly state that BRCA1/2 testing should be considered particularly when there are first-degree relatives with breast or prostate cancer."
      },
      {
        "criterion_number": 11,
        "description": "If a patient\u2019s genetic testing for inherited mutations returns positive for a pathogenic mutation or they have a strong family history for cancer (regardless of mutation status), they should be referred to a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response strongly recommends seeking genetic counseling both generally and when there is strong family history, provides referral resources (NSGC), and implies involvement regardless of specific results, meeting the criterion."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that some family members of a patient with a positive pathogenic mutation may be at increased risk for certain cancers and should consider genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly describes cascade testing when the affected individual is positive, prioritizing first-degree relatives and potentially extending to second- and third-degree relatives, indicating increased risk and the need to consider testing."
      }
    ],
    "question_number": 176,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:01:34.223205",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the phenomenon known as \u201cchemo-brain,\u201d or cognitive issues experienced by individuals undergoing chemotherapy treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly names 'chemo brain' (cancer-related cognitive impairment) and describes symptoms such as memory problems, difficulty concentrating, and brain fog."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment-related cognitive changes are a known side effect of treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states cognitive changes are a common side effect of cancer treatments."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about impaired cognition related to chemotherapy treatment and how long it is expected to last once treatment is completed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes symptoms often peak during chemotherapy and improve 6\u201312 months after treatment ends."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the cognitive changes can be from the chemotherapy drugs or from the cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Attributes cognitive changes to chemotherapy drugs and also to the cancer\u2019s systemic effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that some medications, such as opioids, used for symptom management can cause depressed cognition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions medications for pain, nausea, and anxiety can contribute to cognitive changes, satisfying the intent of medication-related cognitive depression (even though opioids are not named explicitly)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that other etiologies of impaired cognition may also be present, such as organ dysfunction, age-related cognitive decline, poor nutritional status, or medication side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies malnutrition, anemia, dehydration, sleep disturbances, depression, and medication effects; also notes age and overall health as influencing factors."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that depression is related to cognitive impairment, especially in the elderly population.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links depression/anxiety with worsening cognitive symptoms and recommends counseling/support, adequately addressing the relationship."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some causes of cognitive impairment are reversible, while others are not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States many changes are temporary/partially reversible, while some may be long-term or permanent (e.g., from radiation or advanced disease)."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient or family member discuss cognitive impairment with the patient\u2019s oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises bringing concerns to the oncologist (and other specialists) for tailored evaluation and management."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that symptoms can be managed with \u201ccognitive rehabilitation,\u201d which can include exercises such as puzzles and word games.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends cognitive rehabilitation therapy and cognitive exercises like puzzles/apps."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that optimizing lifestyle changes, such as good sleep and exercise, can help manage symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests good sleep, balanced diet, hydration, and light exercise to help cognition."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that in some cases, the treatment team may consider prescribing a stimulant such as methylphenidate.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions that stimulants like methylphenidate may be prescribed in some cases."
      }
    ],
    "question_number": 177,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:02:14.872643",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what cancer stem cells are.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines CSCs as a small, specialized group of cells within a tumor with properties including self-renewal, differentiation, and resilience; provides a clear, accurate description."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role that cancer stem cells play in tumorigenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains CSCs drive tumor regrowth (tumorigenesis) and contribute to metastasis by seeding new tumors in distant organs; links their properties to recurrence and spread."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe what is known about cancer stem cells in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically discusses CSCs in pancreatic cancer, including their role in resistance to gemcitabine, recurrence after treatment, early metastasis, and the challenging tumor microenvironment."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference research on pancreatic cancer stem cells and include real citations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No real citations or specific studies are provided; mentions of drugs and trials are not accompanied by formal references."
      },
      {
        "criterion_number": 6,
        "description": "The response should clearly state what is known about how pancreatic cancer stem cells affect treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that CSCs survive chemotherapy and radiation (e.g., gemcitabine), leading to treatment resistance, recurrence, and reduced efficacy of standard therapies."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that cancer stem cells are a subpopulation of cancer cells within a tumor that possess the ability to self-renew and differentiate into various cell types, and the concept of persistence must be clearly mentioned.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly identifies CSCs as a small group within the tumor, states self-renewal and differentiation abilities, and clearly conveys persistence through dormancy and post-treatment regrowth."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that cancer stem cells are more resistant to conventional therapies like chemotherapy and radiation, and mention at least two mechanisms such as quiescence, efflux pumps, DNA repair, or microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States CSCs are more resistant to chemotherapy and radiation and cites multiple mechanisms: quiescence, drug efflux pumps (ABC transporters), enhanced DNA repair, and a protective niche/microenvironment."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that there are currently no standard of care treatments that directly target cancer stem cells, but it is an active area of research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes active research and trials, it does not explicitly state that there are currently no standard-of-care treatments that directly target CSCs."
      }
    ],
    "question_number": 178,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:02:39.735464",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe different types of support groups such as in-person, virtual, and telephone.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly outlines multiple types: In-Person Support Groups, Online (Virtual) Support Groups, Telephone or Hotline-Based Support Groups, and Specialized/Themed groups, with descriptions and examples."
      },
      {
        "criterion_number": 2,
        "description": "The response should list resources with website links that provide free or insurance-covered pancreatic cancer support group information such as PanCAN, NCI, and NCCN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple resources and includes website links for PanCAN (pancan.org) and ACS (cancer.org); also mentions NCI and NCCN as resource listings. CancerCare is also included as a free resource."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient and/or family inquire with the oncology team about support group resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises checking with the husband's oncology team and local cancer centers for recommendations."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the importance of maintaining mental health support for patients and caregivers affected by pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes emotional support, caregiver-specific stresses, emotional well-being, and suggests one-on-one counseling through CancerCare, underscoring the importance of mental health support."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention websites for people to find support groups local to their home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions PanCAN (pancan.org) and ACS (cancer.org) with search tools to locate groups by zip code, and references the NCI website for local searches."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention ways in which support groups for people affected by cancer can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists benefits including emotional support, shared experiences, practical advice, sense of community, help with coping, and managing side effects."
      },
      {
        "criterion_number": 7,
        "description": "The response should normalize the use of support groups for people affected by cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Presents support groups as a common and valuable resource, offers many mainstream options, and encourages trying sessions to find a good fit, thereby normalizing participation."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that people can use support groups for different stages of cancer, and that mental health challenges can be faced even during the survivorship period.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It specifies groups for different stages (newly diagnosed, in treatment, survivors, end-of-life) but does not explicitly state that mental health challenges can persist during survivorship."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize that support groups can help people affected by cancer feel less isolated or alone.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights a 'sense of community from others who understand' and opportunities to connect, which directly addresses reducing isolation."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that faith-based support groups exist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly mentions 'Faith-Based or Cultural Groups' and examples such as Jewish Family Services."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that support groups are not a substitute for seeking mental health services if you are suffering from depression, and should describe what depression is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes that support groups are not a substitute for professional medical advice but does not mention depression specifically or describe depression symptoms/definition."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention other avenues for support including palliative medicine and Hospice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention palliative care or hospice as additional support avenues."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that virtual options include Facebook groups and PanCAN virtual support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly includes both Facebook groups and PanCAN's Virtual Support Groups under online options."
      }
    ],
    "question_number": 179,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:03:26.586309",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe how malignant cells evade the body\u2019s immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response has a dedicated section 'Immune System Evasion' stating pancreatic tumors are 'cold,' hide from immune cells, suppress them, and adapt to evade immune attack\u2014an explicit description of immune evasion."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly describe the mechanisms of action for chemotherapy, immunotherapy, and radiation in killing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it implies chemotherapy can cause DNA damage (noting cells can repair DNA damage from drugs), it does not explicitly explain how chemotherapy kills cells, does not describe how immunotherapy kills cancer (e.g., checkpoint blockade reactivating T cells), and omits radiation\u2019s mechanism (DNA double-strand breaks/ionizing damage). Therefore, the required explicit mechanisms for all three modalities are not provided."
      },
      {
        "criterion_number": 4,
        "description": "The response must thoroughly cover multiple mechanisms of treatment resistance, including genetic mutations, tumor heterogeneity, drug efflux, alterations in drug targets, epigenetic changes, adaptive responses, and the tumor microenvironment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It covers genetic mutations (KRAS/TP53/SMAD4), tumor heterogeneity and clonal evolution, drug efflux (ABC transporters), alterations in drug targets (new mutations making targets insensitive), adaptive responses (backup pathways), and the tumor microenvironment (dense stroma, hypoxia, immune context). However, it does not mention epigenetic changes; since all listed elements are required, full credit cannot be given."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention cancer stem cells and connect them to specific resistance mechanisms such as drug efflux pumps, enhanced DNA repair, or immune evasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer stem cells are mentioned as hardy, self-renewing, and able to regrow the tumor, but there is no explicit connection to specific mechanisms like drug efflux pumps, enhanced DNA repair, or immune evasion."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that surviving resistant cells can repopulate the tumor after most cells are killed by treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states: 'Some cells survive treatment and multiply, creating a new population that's resistant' and 'these stem cells can survive and regrow the tumor,' clearly describing repopulation by surviving resistant cells."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly describe that with every treatment, a selective pressure is applied to cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although clonal evolution and an analogy to viruses are mentioned, the response does not explicitly state that each treatment applies selective pressure to cancer cells."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that this topic is being widely researched and cite at least one source from the literature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes 'Research is ongoing' and lists areas of investigation, but it does not cite any source from the scientific literature (e.g., peer-reviewed articles or reviews). Mentioning organizations or drugs is not a literature citation."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly defines treatment resistance as the phenomenon where cancer cells over time no longer respond to therapies.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It clearly defines treatment resistance: 'Treatment resistance happens when cancer cells no longer respond to therapies that initially worked (or were expected to work),' meeting the explicit definition requirement."
      }
    ],
    "question_number": 180,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:03:54.690413",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe specific biomarkers for pancreatic cancer, explicitly mentioning both CA 19-9 and CEA.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response describes CA 19-9 in detail but does not mention CEA at all."
      },
      {
        "criterion_number": 2,
        "description": "The response must explain what circulating tumor DNA (ctDNA) is and how it is considered a cancer biomarker in some malignancies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA is mentioned as part of liquid biopsy and for monitoring, but there is no explicit explanation that ctDNA comprises tumor-derived DNA fragments and functions as a biomarker across malignancies."
      },
      {
        "criterion_number": 3,
        "description": "The response must summarize how ctDNA enters the bloodstream and is detected through blood tests.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The mechanism of ctDNA release (e.g., apoptosis/necrosis/shedding) and detection via blood assays is not described; only the term 'liquid biopsy' is referenced."
      },
      {
        "criterion_number": 4,
        "description": "The response must include ways that ctDNA detection can enhance existing modalities for cancer monitoring, including detection of new and potentially targetable mutations in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While ctDNA is noted for monitoring and tracking treatment effectiveness, the response does not state that ctDNA can identify emergent or targetable mutations or otherwise enhance standard monitoring modalities."
      },
      {
        "criterion_number": 5,
        "description": "The response must include at least one link to existing scientific literature regarding ctDNA use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or links to scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must suggest that the patient discuss pancreatic cancer biomarker testing with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing results and testing with the oncology team and to ask about specific tests."
      },
      {
        "criterion_number": 7,
        "description": "The response must define biomarkers for cancer in general terms, including at least one example of a measurable indicator (e.g., proteins, genes, or mutations).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Biomarkers are defined as measurable indicators and examples provided include proteins, genes, and mutations."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how biomarkers are used in pancreatic cancer care and explicitly state that they are an adjunct to traditional imaging and biopsy interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Use in pancreatic cancer care is described, but it does not explicitly state that biomarkers are an adjunct to imaging, nor does it mention imaging explicitly."
      },
      {
        "criterion_number": 9,
        "description": "The response must discuss that biomarker reliability varies between individuals with cancer and are not always interpretable, including a specific example of variability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes variability with CA19-9 non-producers (20\u201330%) and that CA19-9 can be elevated in non-cancer conditions, providing a specific example of variability."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that biomarkers can have false positives and false negatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although lack of specificity for CA19-9 is mentioned, the response does not explicitly use the terms 'false positive' or 'false negative.'"
      },
      {
        "criterion_number": 11,
        "description": "The response should state that BRCA and HRD genes are key biomarkers as they can predict response to platinum chemotherapy and PARP inhibitors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that BRCA1/2 and related HRD alterations predict sensitivity to platinum chemotherapy and PARP inhibitors (e.g., olaparib)."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that MSI/MMR is an important biomarker as it can identify the small percentage of patients that may respond to immunotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes MSI-H/dMMR is present in about 1\u20133% of pancreatic cancers and predicts response to immunotherapy (pembrolizumab)."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that testing can be done on a blood sample or from tumor tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions tumor tissue biopsy for NGS and liquid biopsy/blood tests (including ctDNA and protein markers), satisfying the requirement."
      }
    ],
    "question_number": 181,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:04:38.938293",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe at least two management strategies for osteopenia and osteoporosis, such as bisphosphonates, denosumab, calcium, or vitamin D.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends bisphosphonates (zoledronic acid), denosumab, and calcium/vitamin D supplementation as bone-protective strategies."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe at least two types of bone and bone density problems that can arise during cancer treatment, such as osteopenia, osteoporosis, or bone metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies and describes multiple issues: bone metastases, osteoporosis, fractures, spinal issues, and hypercalcemia."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention bone metastases and at least two treatment options, such as systemic therapy, observation, radiation, or surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions bone metastases and provides multiple treatments including radiation therapy and surgical/interventional procedures; also includes bone-strengthening agents."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that bone metastases can be painful and/or asymptomatic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that bone metastases can cause pain, satisfying the requirement to note painful presentation."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention the frequency or rarity of pancreatic cancer metastasizing to the bone.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that pancreatic cancer can metastasize to bone but does not comment on how common or rare this is."
      },
      {
        "criterion_number": 6,
        "description": "The response must define or describe osteopenia and osteoporosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions osteoporosis as 'weakening' but does not define it and does not mention or define osteopenia; criterion requires describing both."
      },
      {
        "criterion_number": 7,
        "description": "The response must identify at least one risk factor for osteopenia and osteoporosis and explain how these conditions are tested, such as with a DEXA scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists risk factors (steroids, chemotherapy effects on bone density, malnutrition, immobility, vitamin D deficiency) and mentions DEXA scans to monitor bone health."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention granulocyte colony stimulating factor and its potential side effect of temporary bone pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention G-CSF (filgrastim/pegfilgrastim) or its association with transient bone pain."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize that pain related to cancer or cancer-treatment is taken seriously and should be discussed with the patient\u2019s oncology team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Advises discussing new pain and symptoms promptly with her doctor/healthcare team and underscores early symptom management."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention that palliative medicine is a specialty for managing symptoms related to medical diagnoses and treatments, and that the patient can request a referral to this specialty if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes palliative care teams help manage symptoms but does not state that the patient can request a referral."
      }
    ],
    "question_number": 182,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:05:15.606289",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define epigenetics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition: changes in gene expression without altering DNA sequence, with an accessible analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how epigenetic changes can happen in normal cells, including gene silencing, activation, and DNA methylation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains DNA methylation, histone modifications, and non-coding RNAs; notes normal roles in healthy cells; explicitly mentions gene silencing/activation."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how epigenetic changes impact the cell\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes effects on gene expression, cell specialization, metabolism, stress response, movement/adhesion\u2014directly addressing cellular function."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of epigenetic changes in cancer cells.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Details roles in tumor initiation, growth, progression, metastasis, drug resistance, and tumor microenvironment interactions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that epigenetic changes can lead to inactivation of silencing tumor-suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that epigenetic changes can silence tumor suppressor genes (e.g., via hypermethylation) and provides examples (TP53, CDKN2A)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that epigenetic changes can lead to activation of oncogenes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly mentions activation/overexpression of oncogenes by epigenetic mechanisms, driving proliferation."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that epigenetic changes can contribute to changes in the behavior of the tumor, such as increased propensity to spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes enhanced metastasis through altered cell movement and adhesion and adaptation to hypoxia\u2014directly addressing spread."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that epigenetic changes can impact treatment response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains contribution to chemotherapy resistance and immune evasion; mentions silencing of apoptosis genes affecting treatment efficacy."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that targeting epigenetic changes in pancreatic cancer is an experimental topic that is being actively researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States epigenetic therapies are largely experimental in pancreatic cancer, mentions ongoing clinical trials and specific epigenetic drugs being tested."
      }
    ],
    "question_number": 183,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:05:35.758490",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend care agencies that are accredited and have a good reputation.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response explicitly advises confirming state licensing/Medicare certification, seeking accreditation (Joint Commission, CHAP, ACHC), and checking reviews/complaint history, fulfilling accreditation and reputation guidance."
      },
      {
        "criterion_number": 2,
        "description": "Recommend agencies that provide a broad range of services for evolving needs.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It details a comprehensive service mix (skilled nursing, PT/OT/SLP, aides, social work, nutrition, pain management, telehealth, 24/7 on-call, hospice integration) and acknowledges changing needs, meeting the criterion fully."
      },
      {
        "criterion_number": 3,
        "description": "Recommend inquiring with the oncology team about social work support to assist with home health care covered by insurance.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it suggests consulting the oncologist/PCP for referrals and coverage determination, it does not explicitly recommend asking the oncology team about available social work support to assist with insurance-covered home health."
      },
      {
        "criterion_number": 4,
        "description": "State that there is a broad range of in-home care and advise considering which tasks are needed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response describes multiple types of in-home care and prompts determining the needed level of care (e.g., intermittent skilled care vs daily assistance) and fit, satisfying the requirement."
      },
      {
        "criterion_number": 5,
        "description": "Summarize common assistance such as cooking, cleaning, home upkeep, shopping.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions meal preparation under home health aide services but does not specifically include cleaning, general home upkeep, or shopping/errands; thus it does not meet the full scope required."
      },
      {
        "criterion_number": 6,
        "description": "Provide links to websites where patients can learn more about types of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes specific web resources (medicare.gov/care-compare, cancer.org, pancan.org, nhpco.org) that offer more information about care types."
      },
      {
        "criterion_number": 7,
        "description": "Mention Hospice as in-home care for patients with a prognosis of 6 months or less.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is discussed and NHPCO referenced, but the response does not state the key eligibility criterion of a 6-month-or-less prognosis."
      },
      {
        "criterion_number": 8,
        "description": "State that home health services include skilled nursing and in-home therapies (PT/OT).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly lists skilled nursing and physical/occupational/speech therapy as components of home health."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly advise seeking agencies experienced in cancer care with oncology-trained staff.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response recommends agencies with oncology expertise, specifically mentions oncology-certified nurses (OCN), and palliative specialists, fully satisfying the criterion."
      }
    ],
    "question_number": 184,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:06:03.155712",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define angiogenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines angiogenesis as the formation of new blood vessels from existing ones, with appropriate context."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the role of angiogenesis in solid tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that tumors require blood supply to grow beyond 1\u20132 mm, promote metastasis, and how angiogenesis supports tumor growth in general."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of angiogenesis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses pancreatic cancer specifically, noting dense stroma, hypoxia, VEGF involvement, and adaptive tumor microenvironment."
      },
      {
        "criterion_number": 4,
        "description": "The response should discuss how angiogenesis is a target for cancer treatment in some cancers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes anti-angiogenic therapy rationale and success in other cancers (colorectal, kidney, lung) and the concept of 'starving' tumors."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that anti-angiogenesis drugs are not used routinely in pancreatic cancer as they have not been shown to significantly improve outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states these therapies are not part of standard first-line treatment in pancreatic cancer and notes lack of significant survival benefit in trials."
      },
      {
        "criterion_number": 6,
        "description": "The response should link to randomized control trials studying the effect of anti-angiogenic therapies in pancreatic cancer, with summaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the AViTA study and trial concepts but provides no direct links to RCTs; thus does not meet the requirement to link and summarize specific trials."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss treatment options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises discussing options with the oncology team and emphasizes personalized medical guidance."
      }
    ],
    "question_number": 185,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:06:20.754111",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that liver function is routinely monitored during treatment using labs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states routine monitoring with liver function tests (ALT/AST, bilirubin, ALP, GGT, albumin, PT) before each treatment cycle and more frequently if issues arise."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe ways in which pancreatic cancer and pancreatic cancer treatment can affect the liver.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains effects from cancer metastasis, bile duct obstruction, chemotherapy-related hepatotoxicity, radiation effects, and contributory factors like malnutrition/infections."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes in liver function labs will often be investigated further with imaging studies.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Imaging is described as part of monitoring, but the response does not explicitly state that abnormal liver tests prompt further imaging."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe ways in which liver injury can be treated, such as dose reduction in systemic treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifies dose modifications, treatment breaks, and switching to less hepatotoxic regimens as management strategies."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which liver injury can be treated, such as local therapy to tumors in the liver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention liver-directed local therapies (e.g., ablation, embolization, SBRT) for hepatic metastases."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways in which liver injury can be treated, such as biliary stenting.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly describes ERCP/PTC with biliary stent placement to relieve obstruction-related liver injury."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe ways in which liver injury can be treated, such as elimination of offending medications or supplements.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding alcohol and liver-stressing OTC medications (e.g., high-dose acetaminophen) and to check with the doctor, reflecting elimination of offending agents."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways in which liver injury can be treated, such as treatment of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions infections as a factor and prevention strategies (vaccination/hygiene), but does not describe treating infections as a management approach for liver injury."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that in rare cases, biopsy of liver tissue is needed to understand the cause of liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that liver biopsy is rarely used to confirm the cause of damage."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that many different medications and supplements can cause liver toxicity, and the patient should discuss all medications and supplements they take while undergoing cancer treatment to ensure no interactions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While advising to avoid certain OTC meds and check with the doctor, it does not explicitly emphasize discussing all medications and supplements or the broad potential for hepatotoxicity and interactions."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe red flag symptoms for liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists jaundice, dark urine, pale stools, fatigue, itching, abdominal pain, and swelling as symptoms to monitor."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the patient discuss any new or worrisome symptoms with a member of their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages open discussion with the oncologist, reviewing labs and monitoring plans, and to check with the doctor regarding medications."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of exercise, nutrition, and sleep in mitigating treatment-related toxicities and side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Addresses nutrition and rest but does not emphasize exercise; the criterion requires emphasis on exercise, nutrition, and sleep."
      }
    ],
    "question_number": 186,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:07:11.577990",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should discuss what tumor dormancy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor dormancy as a state where cancer cells stop dividing but remain alive, provides a conceptual explanation (hibernation-like), and specifies it can occur at different stages (primary tumor, metastasis, post-treatment)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the implications of tumor cells that can enter dormancy, such as disease recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that dormant cells can reactivate due to various triggers (stress, inflammation, weakened immunity), leading to recurrence or progression; connects this to late relapses after treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should outline that there is ongoing study on the subject of tumor dormancy, though it is not fully understood at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes dormancy as an active area of research, notes emerging therapies and clinical trials, and acknowledges variability across cancers, implying incomplete understanding."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that dormancy can occur due to microenvironmental factors such as changes in the tumor microenvironment, lack of nutrients, or the presence of certain immune cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions angiogenic dormancy due to lack of blood supply, immune-mediated dormancy due to immune pressure, and signals from the surrounding environment, satisfying microenvironmental factors."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that dormant cells are often less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that dormant cells are often resistant to chemotherapy and radiation because these treatments primarily target actively dividing cells."
      },
      {
        "criterion_number": 6,
        "description": "The response should reference evidence from the scientific literature that discusses tumor dormancy in pancreatic cancer, and only references with a PubMed identification number (PMID) should be included.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should indicate whether or not it is possible to detect dormant cancer cells in the body in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it suggests monitoring with imaging and CA 19-9 for signs of reactivation, it does not explicitly address whether dormant pancreatic cancer cells can be detected, leaving this criterion unmet."
      }
    ],
    "question_number": 187,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:07:30.805464",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe what an advance directive is and why people create them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines advance directives as legal documents for outlining care if unable to decide and explains reasons (respecting wishes, reducing family stress, guiding providers)."
      },
      {
        "criterion_number": 2,
        "description": "Recommend asking the oncology team about resources (e.g., social work) to assist with advance directives.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting doctors/oncologists, palliative care, and notes hospitals/cancer centers offer resources and social workers to help."
      },
      {
        "criterion_number": 3,
        "description": "Direct the patient to consider treatments they would accept in emergencies/if incapacitated (CPR, dialysis, artificial nutrition, IV fluids/antibiotics) as part of a living will.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Living will section covers life-sustaining treatments including CPR, ventilation, tube feeding, dialysis, and references antibiotics via POLST; clearly instructs consideration of these choices."
      },
      {
        "criterion_number": 4,
        "description": "Recommend electing a durable power of attorney for healthcare (healthcare proxy).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit section on Durable Power of Attorney for Health Care with guidance to pick a primary and alternate and discuss wishes."
      },
      {
        "criterion_number": 5,
        "description": "State that the patient should complete a POLST with their oncologist/health practitioner and keep it at home in an easy-to-see location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions POLST/MOLST and its purpose but does not instruct completing it with the oncologist/clinician or keeping it visibly at home."
      },
      {
        "criterion_number": 6,
        "description": "State that the advance directives should include a DNR order if desired.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses DNR/DNI orders, their purpose, and relevance for advanced cancer as part of planning; aligns with including if desired."
      },
      {
        "criterion_number": 7,
        "description": "Encourage completing advance directives as soon as possible, even if cancer is in remission or cured.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it praises thinking ahead and suggests periodic review, it does not explicitly encourage completing directives ASAP or even if in remission/cured."
      },
      {
        "criterion_number": 8,
        "description": "Explain logistics of completing an advance directive and recommend turning in a copy to the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides steps: signing, witnessing/notarization, state-specific forms; advises distributing copies to doctors and hospital, which covers the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize importance of future planning for pancreatic cancer due to aggressiveness/difficulty to cure.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pancreatic cancer can progress quickly and ties this to preferences regarding aggressive measures; underscores early planning and hospice consideration."
      }
    ],
    "question_number": 188,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:08:02.320594",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what targeted therapy is in oncologic treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines targeted therapy as drugs aimed at specific molecules driving cancer growth and contrasts with chemotherapy, noting potential for fewer side effects and precision."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain what combination targeted therapy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly explains that combination targeted therapy uses multiple targeted agents or combines targeted therapy with chemo/immunotherapy/radiation to attack cancer on multiple pathways and overcome resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe what kinds of targeted therapy options exist in pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists specific targets (KRAS, BRCA1/2, HER2, NTRK) and corresponding therapies (erlotinib/EGFR inhibitor, olaparib/PARP inhibitor, emerging KRAS inhibitors), demonstrating available options and scenarios where they apply."
      },
      {
        "criterion_number": 4,
        "description": "The response should illustrate why more than one targeted medication might be used at the same time to treat cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains the rationale clearly: address multiple pathways, prevent/overcome resistance, and potentially improve outcomes versus single-agent therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain why the patient\u2019s tumor tissue needs to undergo molecular testing to understand what targeted therapies are indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes genomic testing (NGS, liquid biopsy) to identify actionable mutations that determine suitability and selection of targeted therapies."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain that some targeted therapies may not work on the patient\u2019s tumor due to lack of targetable mutations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that not everyone qualifies; if no targets are found, targeted therapy may not be appropriate and chemotherapy may be prioritized."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain that targeted therapies do not always work in pancreatic cancer due to tumor heterogeneity.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes pancreatic cancer often involves multiple genetic changes and that single targets may be insufficient; mentions resistance and modest response rates, reflecting heterogeneity as a reason for limited efficacy."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe that targeted therapies are sometimes used at the same time as traditional chemotherapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly cites targeted therapy plus chemotherapy (e.g., erlotinib with gemcitabine) as a combination approach."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient discuss this further with their oncologist as targeted therapies are individualized to each patient\u2019s cancer, and not all targeted therapies are treatment options for all patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team, emphasizes individualized decisions, and provides specific questions to ask, noting not all patients are candidates."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention KRAS inhibitors as a current area of research in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions emerging KRAS inhibitors (sotorasib, adagrasib) and notes their use in clinical trials."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention PARP inhibitors are used in pancreatic cancer patients with BRCA1/2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically cites olaparib (a PARP inhibitor) for tumors with BRCA mutations."
      }
    ],
    "question_number": 189,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:08:29.726683",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines metastasis as cancer cells breaking away from the primary tumor and traveling to other parts of the body, specifying that this occurs via the bloodstream or lymphatic system."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer metastasizes, such as hematologic spread and lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions spread through the bloodstream and lymphatic system, covering both hematogenous and lymphatic routes."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how pancreatic cancer metastasizes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response describes pancreatic cancer's tendency to spread early, notes portal venous drainage to the liver, and outlines typical metastatic patterns and sites."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that pancreatic cancer typically spreads locally first, involving surrounding lymph nodes, organs, and blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it says head-of-pancreas cancers often spread locally before distant metastasis and that regional lymph nodes are involved early, it does not explicitly state that pancreatic cancer typically spreads locally first overall nor mention local spread to blood vessels."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that metastatic spread of the pancreatic cancer can be influenced by the location of the primary tumor, for example whether it is located at the pancreatic head or the tail.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that tumor location (head vs tail) influences spread patterns, with head tumors often spreading locally first and tail tumors potentially metastasizing earlier to distant sites."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that the liver is usually the first location for metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states the liver is the primary/most common site of distant metastasis but does not explicitly state it is usually the first location for metastases."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that pancreatic cancer can metastasize to the peritoneum or lining of the abdominal cavity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists the peritoneum as a site of metastasis and describes associated ascites."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that pancreatic cancer can spread to the lungs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions the lungs as a metastatic site."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer can spread to at least one of the following less common sites: bones, brain, or adrenal gland.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists bones, brain/CNS, and adrenal glands among less common sites."
      },
      {
        "criterion_number": 11,
        "description": "The response should explain what proportion of pancreatic cancers are metastatic at diagnosis and why.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states about 50\u201380% have spread at diagnosis and attributes this to lack of early symptoms due to the pancreas\u2019s deep location."
      },
      {
        "criterion_number": 12,
        "description": "The response should discuss that pancreatic cancer commonly has already metastasized at the time of diagnosis because it often is asymptomatic at an early stage and only becomes symptomatic, prompting diagnostic investigation, once it has spread beyond its original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly explains that pancreatic cancer is often asymptomatic early, leading to late diagnosis and frequent metastasis by the time it is detected."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that treatment options exist for all stages of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it discusses treatment options for metastatic disease, it does not explicitly state that treatment options exist for all stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that options for treatment modalities, for example surgery or chemotherapy, depend on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links treatment decisions to staging by stating that specifics are based on imaging and staging, and it lists modalities that vary by stage (e.g., surgery vs palliative approaches)."
      }
    ],
    "question_number": 190,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:09:20.723409",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how pancreatic cancer chemotherapy treatment can cause injury to the kidneys.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response clearly explains that chemotherapy (e.g., gemcitabine, FOLFIRINOX, platinum agents) can cause direct nephrotoxicity, dehydration, and AKI, with monitoring via BUN/creatinine and GFR."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that platinum drugs (e.g., cisplatin, oxaliplatin) can directly injure the kidney.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly mentions platinum-based agents such as cisplatin and links them to kidney effects and direct toxicity."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how other pancreatic cancer treatments, such as surgery or radiation, can cause injury to the kidneys.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of kidney injury related to surgery or radiation was provided."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that urinary tract infection should be ruled out, as some cancer treatments can put patients at increased risk for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While infection prevention is mentioned in general terms, there is no explicit mention of ruling out urinary tract infections."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe that patients undergoing systemic treatment for pancreatic cancer should have their kidney function monitored frequently to evaluate for toxicity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends frequent blood and urine tests and early detection through regular labs to monitor kidney function."
      },
      {
        "criterion_number": 7,
        "description": "The response must clearly state that the first step is to identify the offending agent and reduce or hold the drug.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although dose reduction, switching, or pausing therapy is discussed, it does not state that the first step is to identify the offending agent and hold or reduce it."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is monitored and managed, such as serial lab tests of renal function to understand if it is improving over time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details serial monitoring with frequent blood and urine tests and tracking electrolytes and proteinuria."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as dose reduction of systemic treatment, particularly the offending drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends dose reduction, switching to less nephrotoxic agents (e.g., cisplatin to carboplatin), and temporary treatment pauses."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as administration of intravenous fluids or other medications to support the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends IV fluids and mentions supportive medications (e.g., antiemetics, amifostine, mannitol) and diuretics/BP meds for symptom management."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention that IV fluids can be used to provide hydration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that intravenous (IV) hydration is used before, during, and after chemotherapy to maintain kidney perfusion and flush toxins."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as thorough evaluation of other medications or supplements a patient is taking to ensure there are no harmful interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises reviewing medications to avoid nephrotoxic agents (NSAIDs, some antibiotics) and contrast dyes, indicating medication reconciliation."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that alleviating obstruction (e.g., via stenting or nephrostomy) can help recover renal function.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of urinary tract obstruction management such as ureteral stents or nephrostomy."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that dehydration and obstruction (e.g., biliary or urinary) can lead to kidney injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dehydration is discussed, but obstruction (urinary or biliary) as a cause of kidney injury is not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consult with their oncology team and oncology pharmacist prior to starting new medications or supplements while undergoing pancreatic cancer treatment to avoid harmful interactions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not advise consulting the oncology team or oncology pharmacist before starting new medications or supplements."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that sometimes dialysis may be indicated if there is a severe kidney injury related to cancer treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states that temporary dialysis might be needed in severe cases of kidney failure."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend staying well hydrated and with adequate nutrition intake while undergoing pancreatic cancer treatment to preserve energy and organ functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages oral fluid intake and provides dietary guidance (renal diet, lean proteins, avoidance of processed foods), supporting hydration and nutrition."
      }
    ],
    "question_number": 191,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:10:12.306171",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the role of genetic mutations in cancer.",
        "score_given": 9,
        "max_points": 9,
        "justification": "The response explains that cancer begins with DNA mutations and gives pancreatic-specific examples (KRAS as a 'gas pedal', TP53 as 'brakes', mentions SMAD4), linking these mutations to uncontrolled growth and progression from PanIN to invasive cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer treatment applies selective pressure on cancer cells, allowing those that harbor certain characteristics that confer resistance to therapy a survival advantage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that treatments kill sensitive cells while resistant subclones survive and expand, framing this as an evolutionary process under selective pressure with examples relevant to pancreatic cancer (gemcitabine, FOLFIRINOX)."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that after certain treatments, tumor cells susceptible to that treatment will have died while those resistant to the treatment survive, making the residual cancer fundamentally different from the original cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response states that when treatment kills sensitive cells, resistant ones survive, multiply, and become dominant, leading to recurrence/progression\u2014indicating the post-treatment tumor composition differs from the original."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how genetic mutations can cause cancer cells to resist certain treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that a subset of cells may harbor mutations that make them resistant to therapy and survive treatment, conveying that genetic alterations underlie resistance, even if mechanistic details are not deeply elaborated."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the heterogeneous cellular make-up of pancreatic cancer at baseline.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly describes intratumoral heterogeneity, multiple clones with different mutations, and emphasizes that pancreatic cancer is often heterogeneous from the start."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the mesenchymal-epithelial transition, including triggers for this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of mesenchymal-epithelial transition (MET) or its triggers (nor epithelial-mesenchymal transition); invasion and stromal interactions are discussed but MET is not described."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe methods for evaluating tumor evolution over time, including circulating tumor DNA and/or traditional biopsy of the primary tumor or metastatic lesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions liquid biopsies to track tumor DNA changes over time and suggests genomic testing of the tumor; also references serial imaging and biomarkers, satisfying inclusion of ctDNA-based monitoring."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that tumor evolution is when the cancer changes and adapts over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly defines tumor evolution as how cancer cells change and adapt over time."
      }
    ],
    "question_number": 192,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:10:36.203473",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define complementary therapies, including supportive and integrative therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines complementary therapies as non-mainstream approaches used alongside standard treatment and explicitly notes they are also called integrative or supportive therapies."
      },
      {
        "criterion_number": 2,
        "description": "The response should define aromatherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear definition: use of essential oils from plants, often inhaled or applied topically, for relaxation and symptom relief."
      },
      {
        "criterion_number": 3,
        "description": "Mention that ingested/applied substances can cause reactions (e.g., allergic), that it may be difficult to tell if a reaction is from the complementary therapy or the cancer treatment, and thus should be used with caution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses allergic/irritant risks and advises caution, but does not explicitly state the difficulty of distinguishing whether reactions are due to the complementary therapy versus the cancer treatment."
      },
      {
        "criterion_number": 4,
        "description": "Inform patients that complementary therapies do not treat cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that aromatherapy does not treat or cure cancer and emphasizes complementary therapies are supportive and not replacements for conventional care."
      },
      {
        "criterion_number": 5,
        "description": "Inform patients that some complementary therapies may help with symptoms related to their cancer diagnosis, such as stress or insomnia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes potential benefits for symptom management, including nausea, anxiety, stress, and sleep issues."
      },
      {
        "criterion_number": 6,
        "description": "Recommend the patient inquire with their oncology team if there are practitioners of complementary therapies that they trust, or can place a referral to.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing with the oncology team and mentions that some cancer centers have integrative programs, implying referral/connection to trusted practitioners."
      },
      {
        "criterion_number": 7,
        "description": "Provide website links to informational pages from cancer societies such as NCI or PanCAN.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides specific reputable resources: NCI (cancer.gov), American Cancer Society (cancer.org), PanCAN (pancan.org), and Macmillan; adequate as links/resources to informational pages."
      },
      {
        "criterion_number": 8,
        "description": "Strongly recommend that the patient discuss any complementary therapies they are considering with their oncology team to ensure there are no harmful interactions with their cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly emphasizes consulting the oncology team before starting any therapy and references potential interactions with treatments."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly state that aromatherapy is safest when used through inhalation and that oils must be appropriately prepared.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that inhalation is usually safer and recommends starting with diffusion; also advises using a diluted topical blend, indicating appropriate preparation."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that essential oils on the skin should be used with caution due to the risk of worsening skin irritation from chemotherapy or radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Warns that topical application can irritate sensitive skin, especially with radiation therapy or chemo-related rashes, aligning with a cautionary message."
      }
    ],
    "question_number": 193,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:11:24.531604",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metabolism in humans.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly defines metabolism as how cells convert nutrients (glucose, fats, proteins) into energy and building blocks, and notes regulation in healthy cells."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the Warburg Effect.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Accurately describes the Warburg effect: preference for glycolysis despite oxygen presence, production of lactate, and links to rapid growth and survival."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about glucose, amino acid, and lipid metabolism in cancer cells, specifically in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses glucose dependency, glutamine (amino acid) addiction, and lipid metabolism specifically in pancreatic cancer, including KRAS context."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes in metabolism can alter sensitivity to cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states metabolic adaptations contribute to chemo resistance and that targeting metabolism may enhance sensitivity to treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response should not recommend specific diets for the management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses ketogenic diets and fasting as areas of study but does not recommend them; emphasizes limited evidence and need for medical supervision."
      },
      {
        "criterion_number": 6,
        "description": "The response should not indicate that restrictive diets, such as the ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Does not advise starting restrictive diets; explicitly cautions about doing so only under medical supervision."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team but does not specifically recommend discussing diet nor suggest a referral to a nutritionist/dietitian."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there is not any current evidence for dietary interventions to alter the metabolism of the cancer and improve treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States evidence is limited and not conclusive and cites small studies suggesting potential benefit, which does not meet the requirement to state there is no current evidence."
      }
    ],
    "question_number": 194,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:11:57.929869",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Lists causes of eye problems related to cancer/treatment, including chemo-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, dry eye, metastatic disease to the brain or eye, and infections.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions several causes (chemo-related dry eye/irritation and optic nerve/retinal damage; immunotherapy-related inflammation; radiation-related cataracts; infections; and metastasis affecting vision), but it does not mention bleeding. Because not all specified causes (notably bleeding) are included, full credit cannot be awarded."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly states that chemotherapy can lead to eye dryness and irritations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states under chemotherapy: \"These might include: Dry eyes, irritation, or excessive tearing.\""
      },
      {
        "criterion_number": 3,
        "description": "Explicitly states that the use of steroids can lead to an increase in cataracts or glaucoma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although steroids are mentioned as possible treatments, the response does not state that steroid use can increase the risk of cataracts or glaucoma."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly states that immunosuppressed patients are more likely to have infections in their eyes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions infections as possible causes but does not explicitly state that immunosuppressed patients are at higher risk for eye infections."
      },
      {
        "criterion_number": 5,
        "description": "Mentions that symptoms may not be related to cancer/treatment and recommends an eye exam by a qualified practitioner.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States symptoms might not be treatment-related (could be age-related changes, infections, allergies, other conditions) and recommends seeing an ophthalmologist for a thorough exam."
      },
      {
        "criterion_number": 6,
        "description": "Recommends documenting characteristics of symptoms (e.g., severity, date of onset).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises keeping a symptom journal noting when issues started, what makes them better/worse, and patterns with treatment cycles."
      },
      {
        "criterion_number": 7,
        "description": "Lists red-flag eye symptoms prompting immediate medical care (e.g., vision loss, severe pain).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists urgent symptoms: sudden/severe vision loss; persistent pain, redness, or swelling; double vision, floaters, flashes; rapidly worsening symptoms."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly states that any eye symptoms should be discussed with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to contact the oncologist immediately and report symptoms; also mentions reaching out to the medical team even after hours."
      },
      {
        "criterion_number": 9,
        "description": "Recommends possibly requesting a referral to an ophthalmologist based on symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends seeing an ophthalmologist and notes the oncologist may refer to a specialist."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly states that eye drops can mitigate symptoms of dry eyes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions artificial tears and preservative-free lubricating drops to help with dryness."
      }
    ],
    "question_number": 195,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:12:30.922945",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoantigens in cancer as proteins expressed on the surface of cancer cells, used by the immune system to differentiate cancer from healthy tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines neoantigens as new proteins/fragments that appear on the surface of cancer cells but not healthy cells and explains that the immune system can recognize them as foreign. This satisfies the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention ongoing research involving neoantigens in cancer, including cancer vaccines, immunotherapy, and CAR-T trials.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response discusses ongoing research including personalized neoantigen vaccines (with trial examples), checkpoint inhibitor immunotherapy, and adoptive cell therapy involving engineered T cells. While it does not explicitly say 'CAR-T,' adoptive cell therapy encompasses CAR-T approaches, meeting the intent of the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that there are no FDA-approved treatments targeting neoantigens at this time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that neoantigen vaccines are mostly in clinical trials but does not explicitly state that there are no FDA-approved treatments targeting neoantigens, as required."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient discuss the role of neoantigens in their cancer care with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly encourages discussion with the oncology team and provides specific questions to ask about neoantigens and treatment planning."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering referral to be considered for clinical trials for pancreatic cancer treatment in their area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response recommends clinical trials, suggests searching ClinicalTrials.gov, and advises asking doctors about eligibility, effectively guiding toward referral/consideration for trials."
      }
    ],
    "question_number": 196,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:12:55.793978",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define autophagy, including normal role in cellular turnover, degradation and recycling of cellular components, and maintaining homeostasis by removing damaged organelles and protein aggregates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines autophagy as a process of breaking down and recycling cellular components and describes it as cellular housekeeping. It explicitly mentions removal of damaged proteins and organelles, recycling, and maintaining cellular health/quality control, which together capture cellular homeostasis and turnover. While 'protein aggregates' is not stated verbatim, the concepts of 'faulty proteins' and preventing buildup of harmful materials adequately cover this."
      },
      {
        "criterion_number": 2,
        "description": "Describe the dual role of autophagy in cancer (tumor suppression and promotion) and how roles change during progression.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly describes autophagy as a double-edged sword: tumor-suppressive in early stages by removing damaged components and tumor-promoting in established cancers by helping cells survive stress and resist treatment. It discusses context and progression clearly."
      },
      {
        "criterion_number": 3,
        "description": "State that autophagy can be protective against cancer by removing damaged or dysregulated proteins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states autophagy prevents cancer initiation by clearing faulty proteins and damaged organelles, thereby preventing buildup of harmful materials that could lead to mutations."
      },
      {
        "criterion_number": 4,
        "description": "Describe autophagy in pancreatic adenocarcinoma, addressing upregulation and contribution to survival and treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically notes elevated basal autophagy in PDAC, association with KRAS mutations, and links autophagy to survival in nutrient-poor/low-oxygen environments and resistance to chemotherapy (e.g., gemcitabine)."
      },
      {
        "criterion_number": 5,
        "description": "State that cancer cells utilize autophagy to promote survival, growth, and therapy resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains cancer cells hijack autophagy to generate energy and building blocks, resist apoptosis, metastasize, and resist chemotherapy, addressing survival, growth, and therapy resistance."
      },
      {
        "criterion_number": 6,
        "description": "Explain if autophagy can be targeted with cancer treatment, providing at least one reference with a PMID if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it explains autophagy can be targeted and mentions chloroquine/hydroxychloroquine and trials, it provides no references or PMIDs."
      },
      {
        "criterion_number": 7,
        "description": "State that blocking autophagy has been explored but there are no current standard of care treatments targeting autophagy in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response notes that autophagy inhibitors are being tested in clinical trials and explicitly states these are experimental and not standard treatments, satisfying the criterion."
      },
      {
        "criterion_number": 8,
        "description": "Mention specific drugs targeting autophagy, reference existing evidence in the literature, and clearly state if any strategy is FDA approved.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions specific drugs (CQ/HCQ) and trials but does not cite literature and does not clearly state FDA approval status for autophagy-targeting strategies (no explicit mention of FDA)."
      },
      {
        "criterion_number": 10,
        "description": "Reference at least one scientific literature source with a PubMed ID (PMID).",
        "score_given": 0,
        "max_points": 3,
        "justification": "No PMIDs or specific literature citations are provided."
      }
    ],
    "question_number": 197,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:13:25.558606",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe the different types of support groups that exist for cancer patients and family members of cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response distinguishes multiple types: telehealth vs in-person groups, patient vs caregiver-specific groups, one-on-one mentorship (Imerman Angels), moderated groups led by clinicians, online forums (ACS Cancer Survivors Network, Inspire), and mentions activity-based options (e.g., art therapy). It explicitly addresses both patients and family/caregivers."
      },
      {
        "criterion_number": 3,
        "description": "Address whether there is evidence that a telehealth support group is inferior to an in-person support group.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states telehealth groups are often comparable to in-person groups, cites that in-person may have a slight edge in perceived social connectedness, and concludes telehealth is equally effective in key outcomes, directly addressing potential inferiority."
      },
      {
        "criterion_number": 4,
        "description": "Provide references and sources for evidence regarding the effectiveness of telehealth versus in-person support groups.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response cites a 2021 review in Supportive Care in Cancer, a 2020 study in Psycho-Oncology, and mentions ACS and NCI as sources. While not fully formatted citations, these are identifiable references supporting claims."
      },
      {
        "criterion_number": 5,
        "description": "State that in-person and telehealth groups each have advantages and disadvantages and either may be as effective based on an individual\u2019s needs and preferences.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly outlines pros and cons of both modalities, emphasizes individual preferences and needs, and states telehealth can be just as effective for many while in-person may better suit others."
      },
      {
        "criterion_number": 6,
        "description": "State that telehealth groups can be more accessible and convenient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights convenience (no commuting), flexibility of timing, broader reach (including rural areas), ability to join from home during immunosuppression, and privacy\u2014explicitly addressing accessibility and convenience."
      },
      {
        "criterion_number": 8,
        "description": "State that some may feel that in-person groups will lead to better emotional connection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response notes missing the 'human touch,' the value of physical presence, and that in-person has a slight edge in perceived social connectedness, satisfying the criterion."
      },
      {
        "criterion_number": 9,
        "description": "Include a way for the patient or family member to input their location to generate a list of local support group resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although several organizations are listed, there is no specific tool or instruction for entering a location (e.g., ZIP code search link) to generate local resources."
      },
      {
        "criterion_number": 10,
        "description": "List organizations to contact that might be able to provide support resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN (with phone and site), ACS (site), CancerCare (with phone and site), and Imerman Angels, which are appropriate organizations for support resources."
      },
      {
        "criterion_number": 11,
        "description": "Recommend that the patient ask their oncology team for assistance in finding support groups.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly advises asking the oncologist or palliative care team for group recommendations, noting they may know local and virtual options."
      },
      {
        "criterion_number": 12,
        "description": "Describe that increased stress is normal when dealing with a cancer diagnosis and treatment, or as a family member of a cancer patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While empathetic language is used, the response does not explicitly normalize increased stress or state that such stress is common/expected in this context."
      }
    ],
    "question_number": 198,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:13:57.942068",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the effect of caffeine on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises avoiding caffeine after noon as a stimulant that can disrupt sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention the effect of alcohol on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States to steer clear of alcohol because it can fragment sleep."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the effect of illegal drugs on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of illegal/recreational drugs or their effects on sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe strategies to improve sleep that are evidence-based.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Offers multiple evidence-based strategies: sleep hygiene, consistent schedule, stimulus control (get out of bed if not sleepy), optimizing environment, CBT-I, relaxation techniques, daytime light exercise, symptom management, and avoiding late-day vigorous exercise."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references for evidence-based sleep improvement interventions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Cites recognized organizations and resources (American Cancer Society, National Comprehensive Cancer Network patient guidelines, Sleep Foundation) and CBT-I programs (SHUTi, Sleepio), providing credible references."
      },
      {
        "criterion_number": 6,
        "description": "The response should include insights into things in everyday life that may be interfering with a patient\u2019s ability to sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies practical daily-life factors: screen use/blue light, caffeine, alcohol, nicotine, irregular schedule, late vigorous exercise, and suboptimal bedroom conditions."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide insights into how cancer-related symptoms can interfere with sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses pain, neuropathy, nausea, and anxiety related to cancer and its treatments as contributors to insomnia."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of appropriate management of cancer-related or cancer-treatment related symptoms to prevent interference in everyday life, including sleep.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes working with the oncology team on pain control, anti-nausea regimens, and referrals (e.g., palliative care, sleep specialist) to manage symptoms affecting sleep."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe common symptoms that people with pancreatic cancer might experience.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions abdominal pain and digestive issues as symptoms; while not exhaustive (e.g., jaundice, weight loss), it does describe common experiences relevant to pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response should direct the patient to discuss any symptoms of cancer or cancer treatment with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises discussing sleep issues and symptoms with the oncology team/sleep specialist and mentions potential referrals and adjustments by the medical team."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize the importance of mental health and the impact of stress on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses anxiety/stress as causes of insomnia and recommends mindfulness, relaxation techniques, and CBT-I."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that sleep hygiene is an important first step.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it provides a section on sleep hygiene, it does not explicitly state that sleep hygiene is an 'important first step.'"
      },
      {
        "criterion_number": 13,
        "description": "The response must mention a consistent relaxing bedtime routine starting 30 to 60 minutes before bedtime.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends winding down 30\u201360 minutes before bed with calming activities."
      },
      {
        "criterion_number": 14,
        "description": "The response must clearly state that stimulant use, such as nicotine, should be avoided in the afternoon and evenings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises avoiding nicotine but does not clearly specify avoiding nicotine particularly in the afternoon and evenings; the time-of-day guidance is given only for caffeine."
      },
      {
        "criterion_number": 15,
        "description": "The response must explicitly recommend optimizing the sleep environment by keeping the room dark, cool, and quiet.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends keeping the room cool, dark, and quiet, with practical suggestions (blackout curtains, eye mask, earplugs/white noise)."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that supportive therapies, such as melatonin or other sleep aids, can be considered if deemed safe by the medical team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions melatonin (1\u20133 mg) for short-term use only under medical supervision and notes that prescription sleep aids may be used cautiously in cancer patients."
      }
    ],
    "question_number": 199,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:14:54.657531",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer-related cachexia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cachexia as a complex syndrome characterized by severe unintentional weight loss, muscle wasting, anorexia, fatigue, anemia, inflammation, and cancer-driven metabolic imbalance via cytokines."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cachexia occurs in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains pancreatic cancer\u2013specific mechanisms: high prevalence, disrupted nutrient absorption, increased energy demands, bile duct blockage, and pancreatic exocrine insufficiency affecting fat/protein digestion."
      },
      {
        "criterion_number": 3,
        "description": "The response should delineate cancer cachexia from regular weight loss.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a structured contrast (causes, body composition loss, response to nutrition, reversibility/impact) highlighting involuntary nature, muscle loss, inflammatory/hypermetabolic drivers, and poor response to calories."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that cachexia can occur independently of dietary changes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States explicitly that cachexia is not just due to inadequate intake; persists even with adequate calories and does not improve with nutrition alone."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cachexia involves muscle loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions loss of muscle mass/sarcopenia and muscle wasting multiple times."
      },
      {
        "criterion_number": 6,
        "description": "The response should include information about prognosis in patients experiencing cancer cachexia.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes cachexia is progressive, hard to reverse, and linked to complications and poorer quality of life, addressing prognosis/course."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide evidence-based recommendations to patients experiencing cancer cachexia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Offers evidence-based measures: oncology dietitian referral, pancreatic enzyme replacement, small frequent high-protein meals, appetite stimulants (megestrol, corticosteroids), anti-inflammatory approaches, resistance exercise/physical therapy, cancer-directed therapy, and palliative care."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss their concerns about cancer cachexia with their oncology team and/or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing specifics with the oncologist/healthcare team and working with an oncology dietitian; encourages early reporting to the care team."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that cachexia is difficult to manage.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States cachexia is tough, harder to reverse, and does not improve with nutrition alone, emphasizing management difficulty."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that cachexia can be mitigated by nutritional support, medications, and physical therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions nutritional support, medications (megestrol, corticosteroids), and exercise/physical therapy as mitigating strategies."
      }
    ],
    "question_number": 200,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:15:17.684074",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe epithelial-mesenchymal transition (EMT) as a transformation where epithelial cells acquire mesenchymal characteristics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that during EMT, epithelial cells lose their 'sticky' characteristics and gain mesenchymal traits, clearly describing the transformation."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention that EMT is a key feature of cancer progression, contributing to tumor progression, invasion, metastasis, and therapy resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies EMT as central to invasion and spread (metastasis) and notes resistance to treatment, describing EMT as contributing to aggressiveness, which reflects tumor progression."
      },
      {
        "criterion_number": 3,
        "description": "The response must define epithelial cells as those forming the lining of glands, organs, and body surfaces, including the pancreas, and describe their tight connections and specific functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines epithelial cells as lining organs, tissues, and glands; emphasizes tight adhesion and barrier function; and specifically references pancreatic ducts."
      },
      {
        "criterion_number": 4,
        "description": "The response must define mesenchymal cells as those that can move, change shape, and are found in connective tissue, supporting organs and glands.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While mobility and shape change are described, the response does not state that mesenchymal cells are found in connective tissue or that they support organs/glands."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that EMT enables cancer cells to migrate to distant sites, leading to metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says EMT allows cells to enter circulation, travel to distant parts of the body, and identifies this as a key step in metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention that EMT is an area of current research and explicitly state that there are no treatments aimed at this process yet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes ongoing research and clinical trials, it does not explicitly state that there are no treatments yet and instead suggests therapies target EMT, which does not meet the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that plasticity is a key factor in treatment resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response discusses treatment resistance related to EMT but does not mention plasticity as a key factor."
      }
    ],
    "question_number": 201,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:15:54.418798",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define the microbiome as the microorganisms that live in the body and play roles in digestion, immune function, metabolism, and inflammation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines the microbiome as trillions of microorganisms living in and on the body and explicitly lists roles in digestion, immune function, metabolism, and inflammation."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the microbiome is associated with cancer, specifically pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly links microbiome dysbiosis to cancer risk and discusses associations with pancreatic cancer development, progression, and tumor-resident microbes."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how the microbiome is thought to affect pancreatic cancer treatment, including its influence on the efficacy of immunotherapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains microbiome impact on chemotherapy and immunotherapy efficacy, noting diverse microbiome enhances immune responses and ongoing trials (e.g., FMT) to improve immunotherapy responses."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how the microbiome can influence how the body metabolizes chemotherapy drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States certain bacteria can activate or inactivate chemotherapy and provides a specific example: Gammaproteobacteria degrading gemcitabine leading to resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that modulating the microbiome to improve cancer outcomes is an active area of research with limited evidence and no standard of care options to date.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly notes manipulating the microbiome is not yet standard of care, evidence is mixed, and approaches like FMT are under investigation in clinical trials."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention the various roles the microbiome is postulated to play in the human body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple roles including digestion, immune function, metabolism, and inflammation; also mentions microbial metabolites (e.g., short-chain fatty acids)."
      },
      {
        "criterion_number": 7,
        "description": "The response should summarize the scientific research with references (PMID if available).",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions journals and institutions (Nature, Cell, MD Anderson, NYU, Science), it provides no specific citations or PMIDs."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe standard of care treatments for pancreatic cancer, including chemotherapy and immunotherapy, and mention that appropriate treatment selection depends on the stage of cancer and fitness of the patient.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It lists standard treatments (chemotherapy regimens, surgery, radiation, targeted therapies) and notes immunotherapy is generally not standard; however, it does not mention that treatment selection depends on cancer stage and patient fitness."
      },
      {
        "criterion_number": 9,
        "description": "The response should suggest that the patient discuss whether there are ways to support a healthy microbiome with a nutritionist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Provides diet and lifestyle suggestions and advises consulting a doctor, but does not suggest discussing microbiome support specifically with a nutritionist."
      }
    ],
    "question_number": 202,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:16:25.986129",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that mood changes are very common with the diagnosis of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states mood changes are common in pancreatic cancer and quantifies prevalence ('affecting up to 50\u201370% of patients')."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment-related mood changes with the oncology team to ensure they are provided with available local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises coordination with the oncology team and to reach out to the oncologist to discuss specific symptoms and resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend a referral to a mental health provider familiar with cancer patients and cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends involvement of mental health professionals and mentions oncology-specific psychologists or social workers."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe counseling as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends counseling/therapy (e.g., CBT) to help manage emotions and coping."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe medications, such as antidepressants, as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions antidepressants (SSRIs like sertraline) and anti-anxiety medications (lorazepam) as options."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe support group participation as an intervention that may help alleviate mood issues.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Recommends joining pancreatic cancer support groups and names organizations (PanCAN, CancerCare)."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide supportive language about mood changes during cancer treatment and attempt to normalize this phenomenon.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses empathetic tone and normalizes mood changes as common, treatable, and manageable."
      },
      {
        "criterion_number": 8,
        "description": "The response should reference studies that quantify patients with cancer that suffer from mood changes after diagnosis and/or during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides prevalence estimates (50\u201370%) but does not cite or reference specific studies."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe different interventions that may help alleviate mood issues, such as psychiatric evaluation, exercise, nutrition, and cancer-related symptom control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers mental health referral, exercise (light walks), nutrition/dietitian, and symptom control (pain, nausea management, nerve blocks)."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that patients with suicidal thoughts consider presentation to medical care urgently or emergently.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises contacting the healthcare team immediately for severe mood changes including suicidal thoughts, framing as a potential medical emergency."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the role of palliative medicine in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains palliative care focuses on symptom relief and emotional support and can be introduced at any stage."
      },
      {
        "criterion_number": 12,
        "description": "The response should list common side effects of both pancreatic cancer and pancreatic cancer treatment, and suggest that feeling poorly can impact one\u2019s mood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists chemo effects (fatigue, nausea), steroid-related mood effects, pain, cachexia, nutritional deficits, opioids, sleep disturbance, and links these to mood changes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that some patients benefit from a mental health standpoint by having their affairs in order, as this can provide some peace of mind in the face of a serious illness.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention advance care planning or getting affairs in order as a mental health support strategy."
      },
      {
        "criterion_number": 14,
        "description": "The response should list online resources for support for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides resources such as the American Cancer Society, Pancreatic Cancer Action Network, CancerCare, and Pancreatic Cancer UK."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that mindfulness and relaxation techniques can be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends mindfulness/relaxation (meditation, yoga, deep breathing) and mentions supportive apps."
      }
    ],
    "question_number": 203,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:16:51.886497",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor suppressor genes and their function in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor suppressor genes as cellular 'brakes' that regulate cell growth, repair DNA, and induce apoptosis. Provides multiple functions (cell cycle control, DNA repair, apoptosis) with accurate examples."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how defects in tumor suppressor genes can lead to cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that mutations/inactivation remove 'brakes,' allowing uncontrolled growth, accumulation of additional mutations, and tumor formation; includes the multi-hit model and two-hit hypothesis, showing mechanism and progression."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how tumor suppressor genes gain defects or mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple causes: inherited (germline), environmental exposures (e.g., smoking/toxins), aging, and random replication errors. This directly addresses how defects arise."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that there are genetic syndromes inherited in families that affect tumor suppressor genes, leaving affected individuals at higher risk of developing cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions inherited factors and familial pancreatic cancer syndromes, references BRCA-related issues, and recommends germline genetic testing, indicating familial risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention tumor suppressor genes that are thought to play a role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically names TP53, CDKN2A (p16), and SMAD4 as commonly altered tumor suppressor genes in pancreatic cancer, with brief functional context."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is an active area of research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states 'Research is ongoing' and discusses efforts to target related pathways (e.g., PARP inhibitors), indicating active investigation."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss whether there are clinical trials available in their area with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussing clinical trials with doctors/oncology team and mentions using this knowledge to inform conversations about clinical trials, satisfying the recommendation."
      }
    ],
    "question_number": 204,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:17:11.639372",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "Recommend discussing mental health counseling with the oncology team to connect with local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises starting with the medical team and asking the oncologist, hospital social worker, or palliative care team for recommendations, noting many cancer centers have in-house psycho-oncology services."
      },
      {
        "criterion_number": 3,
        "description": "Introduce palliative medicine as a specialty for managing symptoms or end-of-life care for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is mentioned multiple times, including consulting the palliative care team, counselors with palliative/hospice experience, and support for end-of-life planning and hospice services, reflecting its role in symptom and end-of-life care."
      },
      {
        "criterion_number": 4,
        "description": "List at least three types of mental health care providers, including their credentials and any limitations in practice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists multiple provider types with credentials: psycho-oncologists/oncology counselors (psychologists PhD/PsyD or LCSW), LCSWs/medical social workers, grief/bereavement counselors (ADEC-certified or hospice/palliative experience), LMFTs, and psychiatrists (MD/DO). It also notes that psychiatrists can prescribe medication, implying non-prescribing limitations of other therapists, and describes LCSWs' roles in resource linkage."
      },
      {
        "criterion_number": 5,
        "description": "Mention at least one modality for delivery of mental health counseling, such as in-person or telehealth.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Telehealth/virtual options are explicitly recommended."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly state that choosing the best provider is individualized and cannot be recommended online.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes the choice depends on specific needs and offers to tailor suggestions with more details, it does not explicitly state that a best provider cannot be recommended online."
      },
      {
        "criterion_number": 7,
        "description": "Mention providers affiliated with religious denominations or faith-based counseling options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Faith-based counseling is explicitly suggested as a preference to consider."
      },
      {
        "criterion_number": 8,
        "description": "Mention mental health resources available for family members and caregivers of cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Caregiver-specific support groups (e.g., through Caregiver Action Network and local hospitals) are recommended, and joint sessions and family involvement are discussed."
      },
      {
        "criterion_number": 9,
        "description": "Recommend seeking counseling proactively, not waiting for a crisis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly states, \u201cYou don't have to wait for a crisis\u2014starting now can build resilience.\u201d"
      },
      {
        "criterion_number": 10,
        "description": "Recommend at least one additional way to improve overall wellbeing, such as nutrition, exercise, sleep, or symptom control.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response focuses on counseling and support resources; it does not provide explicit recommendations about nutrition, exercise, sleep, or medical symptom control as additional wellbeing strategies."
      },
      {
        "criterion_number": 11,
        "description": "State that a licensed clinical social worker would be a good resource to utilize for advice and to be connected to further resources such as financial or caregiver support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response highlights LCSWs as excellent resources for counseling and connecting to practical supports including financial aid, support groups, home care, and hospice."
      }
    ],
    "question_number": 205,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:18:01.441989",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what DNA damage repair pathways are in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains DDR as the cell's system to detect and repair DNA damage, preventing mutations and cancer; uses an accessible 'repair crew' analogy and describes detection and repair functions."
      },
      {
        "criterion_number": 2,
        "description": "The response should list examples of genes implicated in DNA repair pathways in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists multiple relevant DDR genes: BRCA1, BRCA2, ATM, PALB2, CHEK2, and others."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain treatments in pancreatic cancer that are indicated for mutations in certain DNA repair pathway mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that germline BRCA-mutated metastatic PDAC may receive PARP inhibitor maintenance (olaparib) after platinum chemo; discusses synthetic lethality and mutation-guided treatment choices."
      },
      {
        "criterion_number": 4,
        "description": "The response should list DNA pathway repair targeted therapies in pancreatic cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names PARP inhibitors (olaparib, rucaparib, niraparib) and mentions ATR inhibitors as DDR-targeted agents under study."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how mutations in DNA damage repair pathways affect chemotherapy effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that platinum-based chemotherapy (cisplatin, oxaliplatin) is often more effective in tumors with BRCA/DDR mutations due to impaired repair of DNA cross-links."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how mutations in these pathways are detected in tumors, which is through genetic testing of tumor tissue from a biopsy or through a blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifies genetic testing via blood (germline) or tumor biopsy (somatic) to identify DDR mutations and mentions HRD assessment."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide references to scientific literature with PMID for any of the FDA-approved treatments listed in rubric 4.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs provided; the POLO trial is mentioned but without citation."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss tumor genetic testing with their oncologist to understand if they are a candidate for any DNA damage repair pathway mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises asking the oncologist about genetic testing, mutations found, and PARP inhibitor eligibility."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the patient inquire about clinical trials in their local area that might be evaluating new drugs that target DNA damage repair pathways, or inquire about a referral to a local institution that might have general clinical trials for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages exploring clinical trials and provides resources (ClinicalTrials.gov, PanCAN) for finding relevant studies."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that around 5-10 percent of pancreatic cancers have these mutations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that about 5\u201310% of pancreatic cancers harbor DDR gene mutations."
      }
    ],
    "question_number": 206,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:18:32.211162",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define inflammation using terms like immune response, tissue injury, or protective mechanism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines inflammation as a natural immune response that helps the body fight infection and heal injuries, clearly meeting the requirement."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly distinguish between acute and chronic inflammation (short-term vs long-term).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It contrasts acute vs chronic by stating chronic inflammation is long-lasting and that acute inflammation can help fight cancer, satisfying the explicit distinction."
      },
      {
        "criterion_number": 3,
        "description": "Describe at least two medical strategies for managing inflammation (e.g., targeted therapies, immunotherapies, steroids, pain management).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple strategies are listed: NSAIDs, corticosteroids, targeted anti-inflammatory therapies (NF-\u03baB/IL-6/JAK), pain management, chemotherapy/radiation, immunotherapy, and surgery."
      },
      {
        "criterion_number": 4,
        "description": "State that there is no formal, evidence-based strategy to quantify and target inflammation in cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state this; instead, it mentions monitoring CRP/ESR and imaging, implying measurable approaches."
      },
      {
        "criterion_number": 5,
        "description": "State that treating the cancer itself (e.g., surgery or radiation) is postulated to improve cancer-related inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes chemotherapy/radiation can reduce tumor size and thereby decrease inflammation, and that surgery can remove a source of inflammation."
      },
      {
        "criterion_number": 6,
        "description": "Mention chronic pancreatitis or chronic pancreatic injury as a factor in cancer formation and provide at least one scientific reference with a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chronic pancreatitis is identified as a risk factor, but no scientific reference or PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "Recommend at least two lifestyle interventions to decrease inflammation (e.g., plant-based diet, exercise, hydration, sleep).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends an anti-inflammatory diet, exercise, and stress management; this exceeds the requirement of two lifestyle measures."
      },
      {
        "criterion_number": 8,
        "description": "Recommend against nicotine and alcohol use and reference their role in promoting inflammation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises avoiding excessive alcohol to reduce systemic inflammation but does not mention nicotine; therefore the criterion is not fully met."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient report any symptoms to their oncology team for symptom management.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Encourages discussing questions with the oncology team and mentions palliative care, but does not explicitly recommend reporting symptoms for symptom management."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that chronic inflammation promotes tumor growth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under 'Promotion of Tumor Growth,' it clearly states chronic inflammation encourages cancer cell multiplication and tumor progression."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that inflammatory signaling pathways are overactivated in cancer (e.g., overactivated, upregulated, enhanced).",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that NF-\u03baB pathways are often overactive in pancreatic cancer, meeting the requirement."
      },
      {
        "criterion_number": 12,
        "description": "Explicitly state that the immune system can be activated to recognize and attack cancer (e.g., empower, stimulate, leverage).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that chronic inflammation can weaken the immune system\u2019s ability to recognize and attack cancer cells, and that immunotherapy aims to boost the immune system\u2014together implying activation to recognize and attack cancer."
      },
      {
        "criterion_number": 13,
        "description": "Explicitly state that anti-inflammatory drugs are not used as a primary treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically states NSAIDs are not a primary treatment and are used mainly for symptom relief, satisfying the requirement regarding anti-inflammatory drugs."
      },
      {
        "criterion_number": 14,
        "description": "Explicitly state that NSAIDs and steroids are prescribed to manage symptoms associated with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States NSAIDs are used for symptom relief and that corticosteroids are used to manage pain, nausea, and swelling, fulfilling the criterion."
      }
    ],
    "question_number": 207,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:19:06.267471",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention using a pill organizer with compartments for different times of the day and days of the week.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends weekly/monthly pill boxes with morning/noon/evening/bedtime compartments and mentions 7-day organizers with 4 slots per day."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention using a medication management application, with examples such as Medisafe, MyTherapy, or CareZone.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names multiple apps including Medisafe, MyTherapy, and CareZone, plus other examples (Drugs.com Pill Reminder)."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention setting alarms or reminders on digital devices to alert when it\u2019s time to take medication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes smartphone reminder apps and integrating with smartwatches and voice assistants (Alexa/Google Home) to set reminders and alerts."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention creating a physical chart or digital document listing all medications, dosages, and times.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises creating a spreadsheet or binder with columns for drug name, dosage, schedule, purpose, side effects, prescriber, and refills; also mentions shared digital versions."
      },
      {
        "criterion_number": 5,
        "description": "The response should direct the patient to discuss options for medication management with their oncology team and/or pharmacy team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States to consult the healthcare team (oncologist, pharmacist, nurse) before implementing systems and highlights pharmacist consultations and oncology nurse navigators."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend exploring medication delivery services and bubble packs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions PillPack (Amazon Pharmacy) for medication delivery/prepackaging and pharmacist pre-packaged blister packs; also references automated dispensers."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient have a loved one help with their medication management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages caregiver involvement via shared digital tools, caregiver notifications, remote monitoring, and a section on caregiver support."
      },
      {
        "criterion_number": 8,
        "description": "The response should empathize about the medication burden in patients undergoing cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy acknowledging the tough journey and stress of complex regimens, and offers supportive closing remarks."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention meeting with a pharmacist or provider to complete a medication reconciliation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends pharmacist medication therapy management (reviewing all meds for interactions and simplification) and emphasizes keeping a master list for pharmacy reviews\u2014aligns with medication reconciliation."
      }
    ],
    "question_number": 208,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:19:40.467479",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define oncogenes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines oncogenes as mutated forms of proto-oncogenes that drive cancer growth and explains proto-oncogenes as normal growth 'accelerators.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that oncogenes can undergo mutation, which might put the individual at risk for developing cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that proto-oncogenes become oncogenes through mutations (from aging, environmental exposures, random errors), leading to uncontrolled growth and cancer risk."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how oncogenes mutate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly lists mechanisms of activation/mutation: point mutations, gene amplification, and chromosomal rearrangements."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference which mutated oncogenes are implicated in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies KRAS as mutated in ~90% of pancreatic ductal adenocarcinomas and mentions other oncogenic families (MYC, EGFR) as contributors."
      },
      {
        "criterion_number": 6,
        "description": "The response should state whether there are FDA-approved treatments available for pancreatic cancers with mutated oncogenes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes KRAS inhibitors are established in lung cancer and under study in pancreatic cancer but does not clearly state whether FDA-approved targeted therapies exist for oncogene-driven pancreatic cancers; no explicit yes/no provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that patients with pancreatic cancer undergo tumor genetic testing either with biopsy of primary tumor or blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends genetic testing/NGS and indicates determination through tumor testing or biopsies, satisfying the requirement to encourage tumor genetic testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that patients inquire with their oncology team if there are clinical trial opportunities available to them, or a local institution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions clinical trials exist but does not explicitly advise the patient to ask their oncology team about trial opportunities."
      }
    ],
    "question_number": 209,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:20:12.817365",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe that treatment sequencing in pancreatic cancer is determined by the stage of the cancer and the intent of the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states sequencing varies by resectable, borderline, locally advanced, or metastatic stage and discusses goals such as curative surgery vs symptom control/prolonging life, reflecting treatment intent."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that sometimes pancreatic cancer management requires different modalities of treatments, such as chemotherapy and surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes multimodal care: surgery, chemotherapy, radiation, targeted therapy, immunotherapy, and supportive care."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe that in pancreatic tumors thought to be surgically resectable, patients often undergo chemotherapy prior to surgery to shrink the tumor and kill any micrometastases for the best possible surgical outcome.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes neoadjuvant therapy before surgery in resectable cases as an alternative, with rationale to shrink tumors and address hidden spread, aiming for better surgical outcomes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that surgery rarely plays a role in advanced pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States \"Surgery isn't usually an option\" for metastatic/unresectable disease, emphasizing systemic therapy instead."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe what treatment sequencing in pancreatic cancer is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines sequencing as the order of therapies and explains it is deliberately chosen rather than arbitrary."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain the goal of treatment sequencing in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States goals include maximizing effectiveness, minimizing side effects, improving quality of life, and making later treatments feasible."
      },
      {
        "criterion_number": 7,
        "description": "The response should state risks involved if cancer treatment is not appropriately sequenced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists risks such as delaying effective therapy, increased complications, and difficulty delivering postoperative chemotherapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient request a multidisciplinary conference to discuss their pancreatic cancer management recommendations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends discussing via a tumor board review and consulting a multidisciplinary care team."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe what a tumor board (or multidisciplinary conference) is for discussions on management of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions tumor board but does not explain it as a meeting of multiple specialists or describe its function."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain that the oncology care team needs to gather information to make informed recommendations on pancreatic cancer treatment, such as imaging studies, tumor biomarkers, and possibly tumor genetic testing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifies imaging (scans), biomarkers (CA 19-9), and tumor genetic testing (e.g., BRCA, KRAS, HER2) to guide decisions."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize that treatment sequencing is individualized to the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes individualized care based on stage, health status, genetics, preferences, and treatment response."
      },
      {
        "criterion_number": 12,
        "description": "The response should define the following terms: neoadjuvant, adjuvant, perioperative.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Implicitly defines neoadjuvant (before surgery) and adjuvant (after surgery) through examples but does not define perioperative; criterion requires definitions of all three."
      }
    ],
    "question_number": 210,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:20:49.407559",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define hypoxia as a low oxygen state often seen in tumors because the tumor outgrows its blood supply.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines hypoxia as low oxygen in tissues and explains it occurs when tumors outpace blood vessel development, explicitly noting this in pancreatic cancer due to dense stroma and poor vasculature."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe why cancer cells that exist in a hypoxic environment are difficult to treat.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that hypoxic cells are slow-cycling/dormant and activate survival pathways, making them less susceptible to chemotherapy; it also notes immune evasion, all of which increase treatment difficulty."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how hypoxic environments affect cancer\u2019s response to treatment.",
        "score_given": 9,
        "max_points": 9,
        "justification": "It details reduced efficacy of chemotherapy (less effect on slow-dividing hypoxic cells), radiation (oxygen-dependent free radical formation), and immunotherapy (immunosuppressive microenvironment), directly addressing treatment response."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that radiation therapy becomes less effective in hypoxic conditions because oxygen plays a role in radiation-induced DNA damage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states radiation kills via free radicals that require oxygen to be fully effective and that hypoxic tumors may need higher doses, matching the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the mechanism of action of VEGF inhibitors and their postulated role in the treatment of hypoxic tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names bevacizumab (a VEGF inhibitor) and explains the concept of vascular normalization to improve oxygen delivery and enhance chemo/radiation effectiveness, covering both mechanism and role in hypoxia. (Note: Use in pancreatic cancer is not standard, but the mechanism/role description is correct.)"
      },
      {
        "criterion_number": 6,
        "description": "The response should explain whether there is evidence-based information about hyperbaric oxygen therapy in hypoxic tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes hyperbaric oxygen has been explored to boost oxygenation before radiation but is not standard for pancreatic cancer, conveying that evidence is limited/insufficient for routine use."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how hypoxic environments affect the immune system\u2019s ability to access cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that hypoxia suppresses the immune system and contributes to immune evasion, making cancers harder for the immune system (and immunotherapies) to attack."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend the patient discuss whether there are clinical trials focusing on tumor cell hypoxic environments available in their area.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends discussing clinical trials targeting hypoxia, provides resources (NCI, PanCAN, ClinicalTrials.gov), and suggests asking the care team about relevant trials."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that hypoxia can make the tumor more aggressive and promote metastasis (spread).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It directly states hypoxia promotes invasion and metastasis and contributes to a more aggressive tumor phenotype."
      }
    ],
    "question_number": 211,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:21:17.684882",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient document all of their questions or concerns in advance of an appointment with the oncology team to ensure everything is addressed during their allotted face-to-face time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises making and prioritizing a list of questions before each visit and references PanCAN question guides."
      },
      {
        "criterion_number": 2,
        "description": "The response should encourage the patient and/or family members to ask for clarification on any aspects of care that are unclear, and to encourage question-asking during appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages follow-up questions, provides phrasing to request simple explanations, and emphasizes expressing needs clearly."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient request a language interpreter if they feel more comfortable communicating in an alternate language than what their medical team speaks.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly states to request an interpreter or cultural liaison through the hospital for language or cultural issues."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient bring a loved one or family member to all appointments and consider taking notes or recording the conversation.",
        "score_given": 110,
        "max_points": 110,
        "justification": "Clearly recommends bringing a support person to appointments and suggests taking notes or recording the conversation with permission."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the patient utilize online patient portals to send messages if needed.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises signing up for the hospital's patient portal and using secure messaging to clarify details."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient inquire about communication contacts and channels that would be best to contact their oncology team as soon as possible in their treatment journey to establish a \u201cpoint person.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends identifying a primary contact (e.g., oncologist, nurse navigator, case manager) and how to reach them between visits."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide a list of online resources that patients and family members can reference to provide some answers to questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple resources, including PanCAN, Cancer Support Community, American Cancer Society, and NCCN patient guidelines."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend additional points of contact with the oncology team, such as patient advocates, social workers, nurses, and/or palliative medicine specialists.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Suggests involving patient advocates, social workers, and palliative care teams to improve communication."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of feeling supported in their cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses empathetic language and encourages leaning on support networks, counseling, and helplines, emphasizing support and advocacy."
      },
      {
        "criterion_number": 10,
        "description": "The response should inform patients that they can ask for a written summary of their medical appointments after the visit.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions that portals often include appointment summaries but does not explicitly advise asking for a written summary after the visit."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that, if available, patient navigators can be a useful resource to assist with care coordination and communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references oncology nurse navigators as point persons who bridge gaps and explain information."
      }
    ],
    "question_number": 212,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:21:38.790196",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell plasticity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines plasticity as the ability of cancer cells to adapt and change characteristics/identity in response to environment and stressors, with concrete examples (EMT/MET, stem-like traits, metabolic changes, dormancy)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cancer cell plasticity makes cancer cells more difficult to treat.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains multiple mechanisms of treatment resistance: therapy-induced dormancy reducing chemo efficacy, EMT-associated drug resistance, pathway rewiring bypassing targets, immune evasion, and relapse after initial response."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the epithelial-mesenchymal transition in pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Defines EMT (epithelial to mesenchymal, more invasive/motile) and MET, links EMT to drug resistance and invasiveness specifically in PDAC, and discusses the stromal context that promotes these states."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role plasticity plays in the metastatic potential of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that EMT helps cells detach and spread to liver/lungs/abdomen, and that MET enables colonization and formation of new, resistant tumors\u2014explicitly connecting plasticity with metastasis."
      },
      {
        "criterion_number": 5,
        "description": "The response should define and describe cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines dormancy as a 'sleeping' state with slowed growth and explains its therapeutic implications (reduced susceptibility to chemotherapy targeting dividing cells)."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how cancer cell plasticity can contribute to cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that plasticity allows cells to enter a dormant state to avoid detection and survive therapy, linking the concepts directly."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how cancer cell plasticity allows cancer cells to evade the immune system, making immunotherapy relatively ineffective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes immune evasion via changes in surface proteins and signaling, mentions the protective stroma promoting plasticity, and notes low immunotherapy response rates in PDAC."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention ways that cancer-directed therapy can be used to attempt to overcome cancer cell plasticity, such as treatment sequencing and medication combinations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Proposes combination approaches (chemo plus inhibitors of EMT/Wnt/Notch), epigenetic modifiers, enhancing immunotherapy by altering tumor microenvironment, personalized profiling, and clinical trials\u2014addressing strategies to counter plasticity."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that therapeutic strategies to target plasticity is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states researchers are actively studying ways to target plasticity and references ongoing clinical trials."
      }
    ],
    "question_number": 213,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:22:11.513486",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical forces in relation to cancer cells, explicitly mentioning \u201cphysical forces\u201d or \u201cpressure.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mechanical forces as physical forces in the tumor environment and mentions compression, solid stress, and internal pressures, explicitly using terms like \u201cphysical (mechanical) forces\u201d and \u201cinternal pressures.\u201d"
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the effect of different mechanical forces on cancer growth and proliferation, including the activation of pathways or signaling pathways.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explains how stiffness, compression, shear stress, and solid stress influence proliferation, invasion, and resistance, and explicitly cites mechanotransduction pathways (integrins, YAP/TAZ, PI3K/AKT, Rho/ROCK)."
      },
      {
        "criterion_number": 3,
        "description": "The response should define desmoplastic stroma, which is often seen in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as a thick, scar-like buildup of ECM and fibroblasts surrounding the tumor, specifically in PDAC."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes PDAC microenvironment as dense, stiff, fibroblast/ECM-rich with vessel compression, hypoxia, and mechanical stress, linking these to aggressiveness and drug delivery challenges."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention future research directions as it pertains to desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions ongoing and potential approaches to modulate stroma (e.g., targeting hyaluronan, LOXL2, stroma-softening agents, mechanotherapeutics) and references clinical trials exploring these strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain if there are FDA approved therapies that act on the desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions agents like PEGPH20 and antifibrotics and notes clinical trials but does not explicitly state whether any are FDA approved for targeting desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that in pancreatic cancer, the stroma is very dense and stiff, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States the stroma is extremely stiff and that vessel compression reduces oxygen/nutrient supply, but does not explicitly mention high interstitial pressure."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that the dense stroma can impede treatment delivery and induce hypoxia, explicitly mentioning \u201chypoxia\u201d and \u201ctreatment resistance.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions hypoxia due to vessel compression and discusses limited drug delivery and \u201cContributing to Treatment Resistance,\u201d satisfying both required terms."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, explicitly mentioning \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that dense stroma impedes immune cell infiltration nor mention immune evasion or reduced efficacy of immunotherapy."
      }
    ],
    "question_number": 214,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:22:46.005072",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend that the patient discuss the primary medical team responsible for keeping track of referrals and oncologic care; usually the medical oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises asking the primary oncologist\u2014usually the medical oncologist\u2014to serve as the main coordinator and point of contact for overall care, clearly addressing who tracks referrals and oncologic care."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that a clinician is designated as the main provider responsible for care coordination and continuity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly designates the primary/medical oncologist as the 'quarterback' for coordination and continuity of care."
      },
      {
        "criterion_number": 3,
        "description": "Describe the potential medical teams involved in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists multiple relevant team members (medical, surgical, and radiation oncologists; gastroenterologists; palliative care; nutritionists; genetic counselors) and references multidisciplinary tumor boards."
      },
      {
        "criterion_number": 4,
        "description": "Recommend keeping a comprehensive log of test results and progress notes to provide to providers if records are missing.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends a personal binder/digital folder tracking appointments, test results (CT, biopsies, CA19-9), medications, questions, and emphasizes proactive sharing via portals to avoid delays and conflicting advice."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly recommend creating a centralized document listing all providers, their roles, and test results, to bring to appointments.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it recommends a binder/folder for tests and notes, it does not explicitly instruct creating a centralized document that lists all providers and their roles."
      },
      {
        "criterion_number": 6,
        "description": "Recommend that a loved one accompany the patient to all appointments, preferably the same person, and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises involving a family member or trusted friend as an advocate to attend appointments, take notes, and follow up."
      },
      {
        "criterion_number": 7,
        "description": "Recommend using online patient portals to ask questions and contact the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends using patient portals for sharing results and notes and suggests sending updates to specialists via portal or email."
      },
      {
        "criterion_number": 8,
        "description": "Describe different professionals that can help with care coordination (e.g., nurse case managers, social workers).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It mentions patient navigators, care coordinators, palliative care specialists, and social workers/counselors as resources for coordination and support."
      }
    ],
    "question_number": 215,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:23:04.294307",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define senescence in cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines senescence as permanent growth arrest where cells stop dividing but do not die, and explains it as a natural response to stress/damage."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how senescence can lead to secretion of inflammatory molecules (senescence-associated secretory phenotype) which can alter the microenvironment to make it more amenable to tumor progression.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly describes SASP and states that inflammatory factors from senescent cells can promote a tumor-friendly environment, contribute to resistance, and help nearby cancer cells grow, thereby altering the microenvironment."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe senescence-associated secretory phenotype factors.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions SASP broadly as 'inflammatory signals/factors' but does not name specific factors (e.g., IL-6, IL-8, MMPs, VEGF), so no specific SASP components are described."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of senescence in normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States senescence is a protective mechanism in normal cells preventing damaged cells from turning into cancer, triggered by telomere shortening, DNA damage, oxidative stress."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which cancer cells evade senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that cancer cells bypass senescence and specifically cites tumor mutations (e.g., TP53, KRAS) that help them avoid senescence."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how some cancer therapies induce senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that chemotherapy and radiation can induce senescence by causing DNA damage/disrupting growth signals; provides pancreatic cancer examples (gemcitabine, FOLFIRINOX)."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain what senolytics are, and describe if there are any FDA approved in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines senolytics and gives examples (dasatinib+quercetin, navitoclax) and notes they are not standard and are in trials, but does not explicitly state FDA approval status for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that this is an active area of research in the scientific community.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly calls it an active area of research and mentions ongoing clinical trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that senescence is caused by cellular stressors such as DNA damage or activation of tumor suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States senescence is triggered by DNA damage, telomere shortening, and oxidative stress; while tumor suppressor activation is not explicitly named, inclusion of DNA damage meets the criterion."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that senescence can be a positive factor as it stops tumor growth.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States senescent cancer cells cannot form new tumors or metastasize, slowing disease progression, and that inducing senescence can help control growth."
      }
    ],
    "question_number": 216,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:23:34.992294",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define exosomes as vesicles that cells can release into their surroundings.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines exosomes as \"tiny, bubble-like structures (vesicles) released by cells into the bloodstream or other bodily fluids,\" satisfying the definition and release aspect."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe what exosomes contain, such as proteins, lipids, and RNA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states exosomes carry proteins, fats (lipids), DNA, and RNA, directly covering the required cargo categories."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of exosomes in cancer cells, including cell-cell communication.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response describes exosomes as \"messenger packages\" used for cell communication and details how cancer cells use them to signal and reprogram other cells."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of exosomes in tumor promotion.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It comprehensively explains tumor-promoting roles: encouraging growth and survival, inducing desmoplasia, promoting angiogenesis, creating pre-metastatic niches, and enhancing invasiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the role of exosomes in immune evasion.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly details immune suppression, including inhibition of T cells/NK cells and recruitment of immunosuppressive cells to the tumor microenvironment."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the role of exosomes in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It notes exosomes transfer resistance mechanisms among cancer cells and provides a pancreatic cancer\u2013relevant example (gemcitabine resistance)."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the emerging or experimental role of exosomes as tumor biomarkers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It discusses exosomal biomarkers (e.g., glypican-1), liquid biopsies, and monitoring, clearly indicating an emerging diagnostic role."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how exosomes travel in the body.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It specifies that exosomes are released into bodily fluids and can travel through the blood and lymphatic systems."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain how exosomes are thought to facilitate metastases in cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explains pre-metastatic niche formation, increased vascular permeability (\"leaky\" vessels), and organ-specific preparation (e.g., liver/lungs), fulfilling the metastasis mechanism."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe if there are any FDA approved treatments that are associated with cancer exosomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes that exosome approaches are not yet standard of care and are in early trials, it does not explicitly state the FDA approval status. The criterion requires a clear statement, which is absent."
      }
    ],
    "question_number": 217,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:24:08.663172",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define advance directive and living will, and recommend that a patient have these documents completed and/or updated as they reach end of life.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines advance directives/living wills as documents outlining wishes if unable to communicate and recommends doing them ASAP with periodic review/updates."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend a palliative medicine consultation to consider transitioning treatment focus from disease-targeted to comfort-focused care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly suggests discussing with a palliative care specialist and references shifting focus to comfort (hospice, symptom management)."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe Hospice, and ensure to include that patients with a prognosis of less than 6 months are eligible to enroll.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes hospice focus on comfort and states eligibility is typically when life expectancy is 6 months or less."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the different categories of tasks that need to be addressed when a patient is approaching end of life due to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Organizes tasks into medical/healthcare, legal/financial, emotional/personal, and practical/support categories with examples."
      },
      {
        "criterion_number": 5,
        "description": "The response should define what a medical durable power of attorney is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines healthcare power of attorney/proxy as someone designated to make medical decisions on the patient\u2019s behalf."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the steps one needs to take in order to elect a medical durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not provide procedural steps (e.g., choosing an agent, completing state forms, witness/notary requirements, distributing copies)."
      },
      {
        "criterion_number": 7,
        "description": "The response should define a POLST and recommend that a patient have this filled out and displayed in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Defines POLST/MOLST and its purpose but does not recommend completing it or displaying it at home."
      },
      {
        "criterion_number": 8,
        "description": "The response should ensure the patient\u2019s healthcare provider teams have a copy of the patient\u2019s POLST.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of sharing or ensuring copies of POLST with healthcare teams."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that Hospice benefits vary across insurance plans, so it is important to understand what their specific benefits are.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions exploring insurance coverage and Medicare/Medicaid hospice benefits but does not state that benefits vary by plan."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information about Hospice, namely that services are provided for the patient but also for the family and caregivers of the patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes hospice focus on patient comfort but does not state hospice services for family/caregivers (e.g., respite, bereavement)."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient elects a financial durable power of attorney as someone to make financial decisions for the patient if they are unable to make decisions for themselves from illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends a durable power of attorney for finances to handle bills, accounts, and decisions if incapacitated."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient consider what funeral arrangements they would prefer after their death, and communicate this to their loved ones and family.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussing preferences for burial/cremation and pre-planning with a funeral home."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient plan for their death with regard to any religious or spiritual rituals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises incorporating religious rituals and traditions that provide comfort."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe the importance of open communication between the patient and their decision makers to ensure their wishes can be respected as they approach death.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights having open conversations with family, aligning on roles, and ensuring wishes are honored."
      },
      {
        "criterion_number": 16,
        "description": "The response should state that end of life planning is highly individualized and should follow the wishes of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes honoring the patient\u2019s wishes, individualized planning, and involving them as able."
      }
    ],
    "question_number": 218,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:24:36.994216",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell dormancy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy as cancer cells present but not actively growing/dividing, in a quiescent low-metabolism state."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how long a cancer cell can remain dormant in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cells can remain dormant for years or decades; gives example of 10\u201320 years in breast cancer and months to years in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain why it is advantageous for cancer cells to be able to enter a dormant state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains dormancy as a survival strategy that helps cells evade treatments targeting rapidly dividing cells and avoid detection/damage."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe scenarios in which a cancer cell may be prompted to enter dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists immune surveillance, lack of angiogenesis, microenvironmental stress in distant organs, and therapy-induced stress as prompts for dormancy."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what is known about cancer cell dormancy in pancreatic cancer, preferably with references to the scientific literature with PMID.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically discusses pancreatic cancer: high recurrence, micrometastases, dormant cells in liver/lungs/bone marrow, and reactivation leading to recurrence. No PMIDs provided, but content addresses what is known."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that dormancy can occur because of microenvironmental or genetic factors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions microenvironmental factors (immune control, angiogenesis, niche stress) and genetic factors (e.g., KRAS mutations) influencing dormancy."
      },
      {
        "criterion_number": 8,
        "description": "The dormant cells will often be less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes dormant cells evade treatments that target rapidly dividing cells, implying reduced chemotherapy susceptibility."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that these dormant cells can lead to disease recurrence after treatments as they can reactivate after a long period of time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dormant cells can 'wake up' years later and cause metastasis/recurrence, including in pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that dormancy is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes dormancy as an ongoing, active research area and mentions approaches to target dormant cells."
      }
    ],
    "question_number": 219,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:24:58.411254",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define mechanical stress as physical forces and pressures exerted on and within a tumor mass, arising from tumor growth, interactions with surrounding tissues, and the tumor\u2019s microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines mechanical stress as physical forces (compression, tension/stiffness, shear) acting on and within tumors and ties their origins to rapid tumor growth in confined spaces and the tumor microenvironment."
      },
      {
        "criterion_number": 2,
        "description": "Describe how mechanical stress on tumor cells impacts their ability to grow and metastasize.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explains signaling via integrins and YAP/TAZ, Rho/ROCK promoting proliferation and survival, and details EMT, invasion, and metastasis driven by stiffness and high interstitial pressure."
      },
      {
        "criterion_number": 3,
        "description": "Describe the relationship between mechanical stress in tumors and hypoxia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that dense stroma compresses blood vessels causing poor blood flow and hypoxia, linking mechanical compression to reduced oxygenation."
      },
      {
        "criterion_number": 4,
        "description": "Explain that mechanical stress on tumor tissue is implicated in treatment resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly notes that physical barriers and high pressure hinder drug penetration and that stiff ECM contributes to resistance, mentioning implications for chemo and immunotherapy."
      },
      {
        "criterion_number": 5,
        "description": "Define the tumor microenvironment.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It defines the tumor microenvironment as including surrounding tissues, blood vessels, immune cells, and ECM."
      },
      {
        "criterion_number": 6,
        "description": "Describe sources of mechanical stress in tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Sources listed include compression, tension/stiffness, shear stress, arising from rapid growth in confined spaces and dense stromal tissue."
      },
      {
        "criterion_number": 7,
        "description": "Inform that effects of mechanical stress on tumor tissue are not fully elucidated and are an area of active scientific research.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response describes mechanobiology as an emerging area, references ongoing research and clinical trials, and notes that these approaches are mostly in research phases, implying incomplete understanding."
      },
      {
        "criterion_number": 8,
        "description": "Mention the effect of mechanical stress on the tumor in angiogenesis, invasion, metastasis, and promotion of tumor cell survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses all four: angiogenesis (blood vessel formation), invasion and metastasis via EMT and migration, and promotion of cell survival/growth through mechanosignaling."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that pancreatic cancer is characterized by a very dense and stiff stroma, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes PDAC\u2019s stiff, dense stroma; mentions high interstitial pressure; and describes resultant poor blood flow/hypoxia and nutrient-poor conditions."
      },
      {
        "criterion_number": 11,
        "description": "State that the dense stroma can impede immune cells from reaching the tumor, aiding immune evasion and reducing the efficacy of immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions that physical barriers hinder drug and immunotherapy penetration, it does not state that dense stroma impedes immune cell infiltration or contributes to immune evasion."
      }
    ],
    "question_number": 220,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:25:20.362904",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor organoids as a miniature 3D model of the patient\u2019s tumor grown in a lab from the patient\u2019s own cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines organoids as miniature 3D tumor models grown in the lab from actual patient tumor cells obtained via biopsy/surgery and designed to mimic the original tumor."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how tumor organoids are used for testing cancer medications to determine the most effective one.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains drug screening on organoids to assess responses to various therapies, including chemotherapy and targeted agents, and notes predictive value for patient response."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that the use of tumor organoids is experimental and not available at all cancer centers, and that there are no large randomized clinical trials for tumor organoids.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States organoids are not yet routine and mainly used in research hospitals/clinical trials, but does not explicitly state that there are no large randomized clinical trials; therefore full criterion not met."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how tumor organoids are grown.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides stepwise creation: tumor sampling via biopsy, embedding in a matrix with nutrients/growth factors to self-organize into 3D structures, and maintenance in incubators."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how tumor organoids are different than cultured cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly contrasts organoids with traditional 2D cultures, noting 3D architecture and greater complexity with multiple cell types."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how tumor organoids are used to tailor treatments to the patient from which they are derived.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes functional precision medicine by testing a patient\u2019s own organoids to select effective therapies and avoid resistant ones."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe advantages of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists advantages including patient specificity, cost-effectiveness, reduced animal use, and acceleration of research."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe limitations of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes variable success in establishing organoids, lack of immune system/vasculature unless engineered, and time/resource constraints limiting clinical availability."
      }
    ],
    "question_number": 221,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:25:46.893401",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend choosing a medical decision maker/medical durable power of attorney to make decisions if the patient cannot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises checking for and creating an advance directive/living will/medical power of attorney, stating it designates who makes decisions if she can't."
      },
      {
        "criterion_number": 2,
        "description": "Recommend that the patient and her legal next of kin request assistance from social work from their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends involving a hospital social worker to facilitate meetings and notes many cancer centers offer social work services, aligning with seeking oncology social work support."
      },
      {
        "criterion_number": 3,
        "description": "Inform about the role of palliative medicine in cancer care, helping establish goals of care and assist with documentation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions palliative care experts as part of the team and contrasts aggressive vs. palliative care, but does not explicitly state that palliative care helps establish goals of care or assists with documentation."
      },
      {
        "criterion_number": 4,
        "description": "Recommend that the patient designate a primary family member to attend appointments and relay information to other family members.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests assigning roles (e.g., one manages appointments) and using shared tools for updates, but does not explicitly recommend designating a single primary family member to attend appointments and relay information."
      },
      {
        "criterion_number": 5,
        "description": "Recommend establishing a meeting schedule for regular updates with the broader family.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly recommends scheduling regular, neutral family meetings focused on medical updates and decisions."
      },
      {
        "criterion_number": 7,
        "description": "State that the priority should be the patient\u2019s own wishes and that she should be as involved as possible.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes centering the mother\u2019s preferences and making her the decision-maker whenever possible, including discussing treatment goals and who she wants involved."
      },
      {
        "criterion_number": 8,
        "description": "Recommend holding family meetings with the healthcare team so family members hear information directly from the physician.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises requesting a family conference with the medical team to explain options, prognosis, risks, and benefits\u2014allowing families to hear directly from clinicians."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize the importance of clear communication between family members.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Devotes a section to structured communication, ground rules, and practical tools (group chats, shared documents, CaringBridge) to keep everyone informed."
      }
    ],
    "question_number": 222,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:26:38.001127",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define circadian rhythms as the body\u2019s natural 24-hour internal clock regulated by the brain and influenced by external cues, including hormone regulation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines circadian rhythms as the body's natural 24-hour internal clock, regulated by the suprachiasmatic nucleus in the brain, influenced by cues like light, food, and activity, and notes hormone regulation (cortisol, melatonin)."
      },
      {
        "criterion_number": 2,
        "description": "Describe chronotherapy as timing cancer treatments to align with circadian rhythms for better efficacy and fewer side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chronotherapy is explicitly defined as timing treatments to align with circadian rhythms to improve efficacy and reduce side effects."
      },
      {
        "criterion_number": 3,
        "description": "Explain how disruptions in circadian rhythm are thought to promote pancreatic cancer growth, including references to scientific literature or reputable sources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that circadian disruption (poor sleep/irregular eating) may accelerate pancreatic tumor growth and metastasis, mentions involvement of CLOCK/BMAL1/PER genes, and references reputable sources (NCI, Nature, Cancer Research), satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "Recommend ways to promote normal circadian rhythms in pancreatic cancer patients, including consistent sleep, regular meal times, exposure to natural light, and avoiding screens/blue light at night.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends consistent sleep, regular meal times, exposure to natural light, and avoiding screens/blue light at night."
      },
      {
        "criterion_number": 5,
        "description": "Explain the effect of poor or interrupted sleep on circadian rhythms, stating that disruptions can affect overall health and potentially promote cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that irregular sleep disrupts circadian rhythms and affects overall health, and that circadian disruption can promote cancer progression and affect treatment outcomes."
      },
      {
        "criterion_number": 6,
        "description": "Explain the effect of poor or inadequate diet on circadian rhythms, mentioning that irregular eating can disrupt circadian rhythms and that maintaining regular meal times is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that irregular eating can disrupt circadian rhythms and recommends maintaining regular meal times."
      },
      {
        "criterion_number": 7,
        "description": "Provide general recommendations for sleep hygiene, including consistent sleep duration, avoiding screens/blue light at night, and exposure to natural light during the day.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response includes 7\u20139 hours of consistent sleep, avoiding screens/blue light at night, and daytime natural light exposure."
      },
      {
        "criterion_number": 8,
        "description": "Recommend that the patient consult a nutritionist familiar with nutritional challenges associated with pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to consult a nutritionist or dietitian is provided."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient inquire with their oncology team about clinical trials pertaining to circadian rhythms in pancreatic cancer, mentioning resources like ClinicalTrials.gov.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises asking the oncology team about chronotherapy trials and explicitly mentions ClinicalTrials.gov for searching pancreatic cancer chronotherapy studies."
      },
      {
        "criterion_number": 11,
        "description": "Clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that chronotherapy is experimental and not standard for pancreatic cancer, it does not clearly state that there is no high-quality data supporting timed treatment specifically in pancreatic cancer."
      }
    ],
    "question_number": 223,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:26:58.759918",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mitochondria.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mitochondria as the 'powerhouses' of the cell that generate ATP via oxidative phosphorylation."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the roles of mitochondria in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains multiple normal roles: ATP production, regulation of apoptosis, calcium homeostasis, biosynthesis (lipids, amino acids), and oxidative stress management."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain what is known about how the role of mitochondria in cancer cells differs from that of normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Describes metabolic reprogramming, continued mitochondrial activity in cancer, support for biosynthesis, evasion of apoptosis, altered redox balance, and PDAC-specific adaptations (KRAS-driven changes)."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the increased metabolic demands on cancer cells and why this happens.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cancer cells have rapid growth/survival needs requiring anabolic support and lists demands for nucleotides, lipids, and amino acids."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain the Warburg effect.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Defines the Warburg effect as aerobic glycolysis with lactate production despite oxygen, and clarifies modern understanding that mitochondria remain functional."
      },
      {
        "criterion_number": 6,
        "description": "The response should define apoptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly refers to apoptosis as 'programmed cell death.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should explain the role of mitochondria in apoptosis in normal cells, and explain how this can be altered in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States mitochondria are central to triggering apoptosis and explains that alterations (e.g., BCL-2 changes) make cancer mitochondria resistant, aiding survival under therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should define reactive oxygen species and how they are created with regard to the role that mitochondria play.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ROS as harmful byproducts and notes they are produced from mitochondrial activity, covering mitochondrial contribution to ROS generation."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how ROS can damage surrounding cells, and the subsequent cellular signaling pathways that are stimulated as a result.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains ROS can damage cells and serve as signals that promote growth, invasion, and metastasis, addressing damage and downstream pro-tumor signaling effects."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe that as a facilitator of cellular energy, mitochondria are a potential treatment target.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states mitochondria are vital to cancer cells and are being targeted therapeutically; details multiple mitochondrial-targeted strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response should define glutamine and how this substance is used in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies glutamine as an amino acid and describes PDAC 'addiction' to glutamine for energy and biosynthesis via mitochondrial pathways."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that cancer treatment targeting mitochondrial functions are experimental and not part of FDA-approved treatment regimens at this time.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States the approaches are mostly preclinical/early clinical, being tested in trials, and not yet standard therapy, conveying their experimental, non\u2013FDA-approved-for-PDAC status."
      }
    ],
    "question_number": 224,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:27:31.176701",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must recommend that the patient and/or family discuss insurance coverage issues with the oncology team administering the experimental treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response advises consulting an oncologist for personalized advice and to discuss viable experimental options, it does not explicitly recommend discussing insurance coverage issues with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention that financial assistance programs are available for some experimental drugs and explicitly state that this varies from drug to drug, requiring inquiry.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes manufacturer patient assistance/compassionate use programs and directs readers to check each manufacturer's website or contact them directly, implying availability varies by drug and requires inquiry."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that travel to and from the trial center is often not covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions organizations that help cover travel, it does not explicitly state that travel to and from the trial center is often not covered by insurance."
      },
      {
        "criterion_number": 5,
        "description": "The response must describe what \u201ccompassionate use\u201d is and recommend that the patient/family ask their oncology team about this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It briefly defines compassionate use/expanded access as allowing access outside formal trials, but it does not explicitly recommend asking the oncology team about compassionate use."
      },
      {
        "criterion_number": 6,
        "description": "The response must recommend that the patient discuss their concerns with their cancer center\u2019s financial team and/or patient advocacy office.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly recommends working with hospital financial counselors and patient navigators/advocates to help with insurance appeals and financial aid."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend that the patient and/or family become familiar with their insurance policy to understand what is or is not covered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises reviewing coverage details and checking policy clauses on experimental/investigational treatments."
      },
      {
        "criterion_number": 8,
        "description": "The response must inform the patient that they have the right to appeal any decision made by the insurance company.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states, \u201cIf coverage is denied, you have the right to appeal,\u201d and mentions multiple appeal levels and external reviews."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend that the patient seek out patient advocacy groups online to learn how other patients navigated the same issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends contacting patient advocacy groups (e.g., PanCAN, Patient Advocate Foundation) and provides web resources to help navigate similar issues."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that insurance usually only covers standard of care treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states experimental treatments are often not covered by standard insurance and clarifies that routine care costs may be covered while the experimental drug is not, effectively conveying that coverage is generally for standard-of-care components."
      },
      {
        "criterion_number": 11,
        "description": "The response must clearly indicate that clinical trials typically cover the cost of the experimental treatment itself, while insurance covers the standard of care components, such as imaging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that trial sponsors may pay for the experimental treatment while insurance might cover routine care (e.g., hospital stays, lab tests), matching the typical division of costs."
      }
    ],
    "question_number": 225,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:28:05.030073",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ferroptosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ferroptosis as a regulated form of cell death driven by lipid peroxidation due to iron and oxidative stress, distinct from apoptosis, necrosis, and autophagy, and mentions GPX4/glutathione defense failure."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role of iron in ferroptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states iron overload contributes to lipid peroxidation (\u201chence \u2018ferro\u2019\u201d), comparing oxidation to rusting and linking iron to reactive oxygen species in triggering ferroptosis."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of ferroptosis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that pancreatic cancer cells can be vulnerable to ferroptosis due to iron dependence and lipid content, notes resistance mechanisms, KRAS context, SLC7A11 involvement, and discusses using ferroptosis to overcome treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there are currently drugs under investigation with the aim to induce ferroptosis in pancreatic cancer cells but there are no current available established treatments that target ferroptosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that ferroptosis inducers (e.g., erastin, RSL3) are mostly in preclinical stages, mentions emerging clinical trials, and clearly notes ferroptosis-based treatments are not standard or widely available and are likely in experimental trials."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references in the scientific literature about ferroptosis and link PMID if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions journals (Nature, Cancer Research) and general research but provides no specific citations or PMIDs."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why ferroptosis occurs.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explains that ferroptosis occurs when lipid peroxides accumulate due to iron/ROS and when protective systems like GPX4 and glutathione are impaired or overwhelmed, leading to membrane damage."
      },
      {
        "criterion_number": 7,
        "description": "The response should define apoptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines apoptosis as a controlled cellular \u201csuicide\u201d process used for natural cell death."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe the difference between apoptosis and ferroptosis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Contrasts apoptosis with ferroptosis, noting apoptosis is programmed cell death while ferroptosis is driven by iron-dependent lipid peroxidation and GPX4/glutathione failure."
      }
    ],
    "question_number": 226,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:28:26.617229",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links stiffness, elasticity, and other mechanical cues to invasion, migration, EMT, and metastasis via mechanotransduction (integrins, YAP/TAZ, Rho/ROCK)."
      },
      {
        "criterion_number": 2,
        "description": "The response includes descriptions of the mechanical properties of tissue: elasticity, viscosity, density, and compression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly defines stiffness/hardness, elasticity, and combines viscosity and density; mentions compression from growing tumors and fluid pressure."
      },
      {
        "criterion_number": 3,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States stiff tumors compress blood vessels, reduce oxygen (hypoxia), and notes pressure buildup aiding invasive escape."
      },
      {
        "criterion_number": 4,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes desmoplasia as dense, stiff stroma in PDAC driven by fibroblast ECM production, forming a thick shield that affects invasion and treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response describes ways by which cancer metastasizes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Outlines steps: local invasion, intravasation into blood/lymph, travel, and colonization at distant sites (e.g., liver)."
      },
      {
        "criterion_number": 6,
        "description": "The response describes epithelial-to-mesenchymal transition and what environmental factors trigger this transition in pancreatic cells and pancreatic cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines EMT and identifies mechanical stress, stiffness, and dense stroma (and hypoxia contextually) as triggers in PDAC."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cancer\u2013stroma crosstalk: fibroblasts remodel ECM, align fibers creating migration tracks; stiffness acts as a 'highway' for PDAC cells."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details TME interactions (ECM remodeling, mechanotransduction) and emphasizes hypoxia from vessel compression facilitating invasion; adequately covers elements encouraging travel."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of KRAS or other driver mutations influencing invasiveness or metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response explains other methods for the spread of pancreatic cancer besides invasion into solid tissue, such as hematologic spread, lymphatic spread, and perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions entry into bloodstream and lymphatics and notes invasion into nerves; also discusses preference for liver colonization."
      },
      {
        "criterion_number": 11,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects dense, stiff stroma to poor drug penetration; mentions elastography assessment and stroma-targeting/softening strategies (e.g., losartan) to improve therapy."
      },
      {
        "criterion_number": 12,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "References a '2020 Nature Communications' study without specific citation details (authors/title/DOI); lacks formal citations."
      }
    ],
    "question_number": 227,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:29:04.580830",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s healthcare team or oncology team about patient advocacy opportunities within their organization.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response does not advise contacting the patient\u2019s healthcare/oncology team for advocacy opportunities. It mentions hospitals in the context of support groups but does not recommend speaking with the care team about advocacy."
      },
      {
        "criterion_number": 2,
        "description": "The response offers examples of patient advocacy groups and provides contact information or a website for each.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple advocacy groups are listed with websites and, for PanCAN, a phone number: PanCAN (pancan.org, 877-573-9971), Lustgarten (lustgarten.org), Hirshberg (pancreatic.org), Project Purple (projectpurple.org), ACS (cancer.org), SU2C (standuptocancer.org), and World Pancreatic Cancer Coalition (worldpancreaticcancercoalition.org)."
      },
      {
        "criterion_number": 3,
        "description": "The response defines patient advocacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It characterizes patient advocacy as connecting with others, raising awareness, and influencing research, funding, and policy, which constitutes a clear definition."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of patient advocacy work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specific examples include meeting legislators (National Advocacy Day), organizing events, fundraising, sharing stories, promoting clinical trial participation, social media advocacy, and leading support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of patient advocacy opportunities specific to pancreatic cancer and provides contact information or a website for each.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Pancreatic cancer\u2013specific organizations with websites are provided (PanCAN, Lustgarten, Hirshberg, Project Purple). Each includes a website and actionable opportunities."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends joining pancreatic cancer support groups, either online or in-person, to learn about advocacy opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests joining or leading local support groups through PanCAN affiliates or hospitals and notes these often evolve into advocacy."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions at least three different areas of advocacy for pancreatic cancer patients, such as direct patient support, support groups, funding for cancer research, awareness of clinical trials, or political lobbying.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers multiple advocacy areas: direct patient/family support and mentoring, support groups, fundraising for research, clinical trial awareness/advocacy, and political lobbying/legislative advocacy."
      }
    ],
    "question_number": 228,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:29:32.261740",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains normal cellular metabolism in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains ATP as energy, glucose breakdown, oxidative phosphorylation vs. glycolysis, oxygen dependence, and ATP yields using accessible language and analogies."
      },
      {
        "criterion_number": 2,
        "description": "The response outlines the differences between normal cellular metabolism and cancer cell metabolism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly contrasts normal reliance on OXPHOS with cancer\u2019s preference for aerobic glycolysis (Warburg effect), emphasizing speed, biosynthesis, and hypoxia adaptation."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the Warburg effect.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names and explains the Warburg effect and aerobic glycolysis."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of how cancer cell metabolism affects its clinical behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links lactate-driven acidification to invasion, hypoxia survival, potential immune evasion, treatment resistance, and PET imaging behavior."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of targeting the differences in cancer cell metabolism as a means of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions inhibitors of glycolysis (e.g., LDH) and glutamine metabolism, and combining metabolic inhibitors with chemo/immunotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No primary literature or specific journal citations provided; only general resources (ACS, PanCAN, PubMed) are mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should define glycolysis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines glycolysis functionally as a less efficient pathway producing ~2 ATP and lactate; context makes clear it is glucose breakdown for energy."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how cancer cells use glutamine, and how this is different than normal cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cancer \u201cglutamine addiction,\u201d use in energy and biosynthesis, and KRAS-driven reprogramming, implying greater dependence than normal cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should define lactic acid and describe how excess lactic acid can be produced by cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes lactate/lactic acid as a glycolysis byproduct and explains that aerobic glycolysis in cancer leads to excess lactate that acidifies the tumor microenvironment."
      },
      {
        "criterion_number": 10,
        "description": "The response should not recommend specific diets for management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Does not recommend any specific diet; explicitly states no diet cures cancer and to consult a doctor before changes."
      },
      {
        "criterion_number": 11,
        "description": "The response should not reference specific diets unless it provides PMID to studies that examine the effect of diet on pancreatic cancer, and the response should provide a summary of the findings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References a specific diet concept (low-sugar diets) without providing PMIDs or summarizing pancreatic cancer-specific evidence."
      },
      {
        "criterion_number": 12,
        "description": "The response should not indicate that restrictive diets, such as ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Does not suggest starting restrictive diets and cautions against assuming diet is curative."
      },
      {
        "criterion_number": 13,
        "description": "The response should clearly state if treatments are experimental or if they are evidence-based and/or FDA approved.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies metabolic inhibitors as being tested in clinical trials (experimental) and does not mischaracterize approval status."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises consulting a doctor and healthcare team but does not suggest requesting a referral to a nutritionist."
      }
    ],
    "question_number": 229,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:30:22.527411",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting the oncologist and coordinating with specialists before starting any program."
      },
      {
        "criterion_number": 2,
        "description": "The response states peripheral neuropathy is a common side effect of certain chemotherapy agents used to treat pancreatic cancer, including oxaliplatin.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States PN is a common side effect of chemotherapy and specifically lists oxaliplatin (as well as gemcitabine and nab-paclitaxel)."
      },
      {
        "criterion_number": 3,
        "description": "The response should define chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes PN as a side effect and lists symptoms but does not explicitly define CIPN as peripheral nerve damage caused by chemotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of symptoms of peripheral neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists numbness, tingling, pain, weakness, balance issues, and mentions burning sensations."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of how peripheral neuropathy symptoms may affect a patient\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses impact on daily life and specific tasks (buttoning, cooking, writing) and risk of falls/balance problems."
      },
      {
        "criterion_number": 6,
        "description": "The response states some patients may see an improvement in symptoms when the causative medication is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States neuropathy may resolve or improve after treatment ends, implying improvement upon stopping the causative agent."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe that some patients have diminishment of chemotherapy-induced peripheral neuropathy over time, but sometimes it is permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes possible improvement after treatment but does not mention the possibility that symptoms can be permanent."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends physical therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a dedicated section recommending PT with examples of interventions and benefits."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends occupational therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a dedicated section recommending OT with examples of adaptive techniques and benefits."
      },
      {
        "criterion_number": 10,
        "description": "The response states medication may help with some symptoms of peripheral neuropathy and provides examples like gabapentin, pregabalin, and duloxetine.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions medications as adjuncts and specifically lists duloxetine, gabapentin, and pregabalin."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the grading system oncologists use to quantify the severity of chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of a grading system such as CTCAE or description of severity grades."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that patients with peripheral neuropathy can adapt to their environment to prevent adverse events.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises using handrails, supportive shoes, adaptive tools, and avoiding extreme temperatures to prevent injury and falls."
      },
      {
        "criterion_number": 13,
        "description": "The response should inform patients of the importance of protecting body parts that are experiencing neuropathy, such as appropriately sized and firm shoes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends wearing supportive shoes and protective measures for affected areas."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage patients to participate in activities that promote general wellness such as exercise, balanced nutrition with an emphasis on plant-based foods, good sleep hygiene, and adequate hydration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages exercise (aerobic, yoga, tai chi) and balanced nutrition emphasizing fruits/vegetables; while sleep and hydration are not explicitly mentioned, the response clearly promotes general wellness activities."
      }
    ],
    "question_number": 230,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:30:59.934690",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what liquid-liquid phase separation is in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines LLPS using plain language and a relatable oil-and-water analogy; explains droplets/condensates and that they are membraneless compartments."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how liquid-liquid phase separation relates to cancer cell biology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes how dysregulated LLPS can promote proliferation, survival under stress, alter gene expression and DNA repair, and concentrate oncogenic signals."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the role of liquid-liquid phase separation in normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains normal functions such as organizing gene regulation, stress responses, signaling, and cites examples like stress granules and the nucleolus; notes dynamic nature."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of liquid-liquid phase separation in pancreatic cancer and specific ways it can be affected.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses PDAC specifically, discussing mutant KRAS signaling condensates, stress granules aiding treatment resistance, and aberrant gene regulation supporting invasion and metastasis."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the link between common mutations seen in pancreatic cancer and dysregulated liquid-liquid phase separation, including references to the scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions KRAS, TP53, SMAD4 and conceptual links to LLPS but provides no citations or specific published studies to support these statements."
      },
      {
        "criterion_number": 6,
        "description": "The response explains that this is an active area of scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes LLPS is a hot topic, describes the field as emerging, and references ongoing research and preclinical status."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that there are no FDA-approved treatments that target liquid-liquid phase separation at this time.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States research is mostly preclinical and not standard treatment, but does not explicitly state that no FDA-approved LLPS-targeting therapies currently exist."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends that the patient consider inquiring about liquid-liquid phase separation in pancreatic cancer with their oncology team and ask about local clinical trial availability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussing LLPS with the care team and suggests exploring clinical trials via PanCAN and ClinicalTrials.gov."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No journal citations or specific references are provided."
      }
    ],
    "question_number": 231,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:31:22.045448",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions 'ECM stiffness' and describes the extracellular matrix as 'very rigid and dense (like a thick scar tissue)'."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects high IFP, solid stress, and ECM stiffness to reduced perfusion, uneven drug distribution, lower response rates, drug resistance, and worse prognosis."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that vessel compression reduces blood flow/perfusion and creates hypoxic zones, which can increase treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'studies' and institutions (Harvard, Mayo Clinic) and names PEGPH20, but provides no specific journal citations, authors, or references."
      },
      {
        "criterion_number": 5,
        "description": "The response defines mechanical properties of tissues, including at least two of the following: interstitial fluid pressure, solid stress, or fibrotic structure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines interstitial fluid pressure, solid stress, and describes a dense fibrotic ECM; provides mechanisms for each."
      },
      {
        "criterion_number": 6,
        "description": "The response describes compression of surrounding tissue by the tumor, specifically mentioning blood vessels or lymphatics.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly notes solid stress from tumor growth compresses 'blood vessels and lymphatic channels.'"
      },
      {
        "criterion_number": 7,
        "description": "The response defines desmoplastic stroma and describes its role in pancreatic cancer, including its composition.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes PDAC as 'desmoplastic' due to fibrous buildup; outlines stroma composition (fibrous tissue, immune cells, blood vessels) and its role as a barrier to drug delivery."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer remodels the extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it describes a dense, stiff ECM and resultant barriers, it does not explicitly explain remodeling processes or how remodeling actively promotes a tumor-supportive environment."
      },
      {
        "criterion_number": 9,
        "description": "The response states that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States 'Researchers are actively working on ways to overcome these mechanical hurdles' and discusses ongoing clinical trials and emerging strategies."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages discussion with the oncology team and suggests searching ClinicalTrials.gov, explicitly referencing eligibility for trials."
      }
    ],
    "question_number": 232,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:31:45.346709",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends having a plan for emergencies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends an emergency protocol with contacts for local doctors, emergency services, and a trusted neighbor/friend."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker or patient care navigator.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises reaching out to a hospital social worker for tailored guidance and mentions case managers via support organizations."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends utilizing telemedicine when available and appropriate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends telehealth/virtual appointments and having caregivers join calls to discuss treatment plans."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends engaging family and friends for assistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages involving local family/friends for tasks and using tools like SignUpGenius; suggests virtual family meetings to divide responsibilities."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s healthcare team may have resources to help patients at home and lighten caregivers\u2019 load.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions palliative care teams and hospice and suggests contacting the hospital social worker, indicating healthcare team resources that can support at home and reduce caregiver burden."
      },
      {
        "criterion_number": 6,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses caregiver burnout conceptually but provides no data or citations from scientific literature."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes burnout can arise from guilt, stress, or helplessness\u2014examples of emotional signs/symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions assisted living, home health aides, and respite homes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions in-home caregivers/home care agencies and respite care, but does not mention assisted living specifically."
      },
      {
        "criterion_number": 9,
        "description": "The response offers resources for cancer patients and their caregivers and provides contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides PanCAN (pancan.org) with helpline number, Family Caregiver Alliance (caregiver.org), CancerCare, and other tools with websites."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of regular and comprehensive communication with the patient to ensure they feel well supported.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Stresses establishing strong communication channels, regular check-ins (daily or every other day), and flexibility based on energy levels."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend shared apps or other technological tools to share information between the patient and distant caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends CaringBridge, Lotsa Helping Hands, MyChart, Medisafe, CareZone, SignUpGenius, and Carely for sharing information and coordination."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend ways that caregivers can provide support from afar.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Offers multiple remote strategies: coordinating care via apps, joining telehealth visits, tracking meds/symptoms, arranging local services, scheduling visits, and providing emotional support."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient look into their insurance to understand if they have a benefit for paid caregiving.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests reviewing insurance for telehealth coverage and mentions financial aid programs but does not advise checking insurance for paid caregiving benefits specifically."
      },
      {
        "criterion_number": 14,
        "description": "The response should provide online resources for patients with pancreatic cancer to learn more about local caregiving opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides pancreatic cancer\u2013specific resources (PanCAN) and other organizations (CancerCare) that assist with locating local support and services."
      }
    ],
    "question_number": 233,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:32:16.052540",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cell competition for oxygen and nutrients within a tumor in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly describes competition for nutrients and oxygen, including hypoxia, and uses accessible language (e.g., cells 'hog' resources, 'starving' weaker ones). Also contextualizes this in pancreatic cancer\u2019s resource-poor, desmoplastic environment."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses how cell competition may lead to clonal evolution of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly frames tumor dynamics as Darwinian evolution where fitter subclones outcompete others and come to dominate the tumor, i.e., clonal evolution driven by competition."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses how clonal evolution in cancer can lead to drug resistance and progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains selection for resistant subclones under chemotherapy (e.g., gemcitabine/FOLFIRINOX), repopulation by resistant cells, recurrence, and rapid progression/metastasis due to aggressive clones."
      },
      {
        "criterion_number": 4,
        "description": "The response describes cancer cell competition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a coherent description of intra-tumoral competition for resources and space, including consequences like apoptosis and increased invasiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the origin of cancer, from a single mutated cell that proliferates over time.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses subclonal diversity and mutations, it does not state that cancer originates from a single mutated cell that proliferates; thus the specific origin concept is missing."
      },
      {
        "criterion_number": 6,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells oppose each other, and how.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details antagonistic interactions such as competition for limited nutrients/oxygen and space, with stronger clones depriving or displacing weaker ones."
      },
      {
        "criterion_number": 7,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells are aligned and their effect benefits all of the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cooperative behaviors like secretion of growth factors and promotion of angiogenesis, as well as shaping a supportive niche via microenvironmental interactions that benefit the broader tumor."
      },
      {
        "criterion_number": 8,
        "description": "The response explains ways pancreatic cancer cells differ and how they compete with each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes genetic differences (e.g., KRAS mutations), behavioral heterogeneity, and PDAC-specific context (desmoplasia, hypoxia), and ties these differences to competition for resources and dominance of aggressive subclones."
      }
    ],
    "question_number": 234,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:32:49.672416",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly references 'stiffness or rigidity' and a 'stiff stroma' multiple times."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It links stromal stiffness and pressure to impaired drug delivery, activation of survival pathways, stem-like properties, and reduced chemotherapy effectiveness."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes vessel compression reducing blood flow and mentions hypoxia as a stress that promotes drug resistance/adaptation."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It generically mentions journals (e.g., Cancer Cell, Nature Reviews Cancer) but provides no specific article citations or references."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss invasion or metastasis in relation to tissue mechanics."
      },
      {
        "criterion_number": 6,
        "description": "The response includes descriptions of the mechanical properties of tissue: stiffness, elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions stiffness, pressure/compression, and shear, but not elasticity, viscosity, or density."
      },
      {
        "criterion_number": 7,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that tumor growth compresses nearby tissues and blood vessels, reducing perfusion."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes the dense, scar-like stromal environment in PDAC, its cellular and ECM components (e.g., CAFs, collagen), and its role in stiffness and treatment resistance, effectively defining desmoplastic stroma."
      },
      {
        "criterion_number": 9,
        "description": "The response explains what the tumor microenvironment is.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains the stroma/microenvironment composition (fibrous proteins, immune cells, CAFs) and its influence on tumor behavior and treatment response."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how pancreatic cancer is able to remodel its surrounding extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions CAF activation and a dense matrix, it does not explicitly explain how tumor-driven signaling remodels the ECM to favor tumor growth."
      },
      {
        "criterion_number": 11,
        "description": "The response explains that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses ongoing research, early-stage trials, mixed clinical results, and active investigation of stroma-targeting and mechanosignaling approaches."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials in their area with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises discussing with the oncology team and checking for relevant clinical trials, referencing PanCAN and NCI centers."
      }
    ],
    "question_number": 235,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:33:26.422843",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains proteostasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines proteostasis as protein homeostasis with simple explanations and analogies (e.g., cellular quality control, proteasome as a 'shredder'), making the concept accessible to lay readers."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how proteostasis may be altered in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains cancer cells\u2019 high protein demand, proteotoxic stress, reliance on the UPR and other proteostasis pathways, and provides pancreatic cancer\u2011specific context (ER stress, KRAS mutations), showing how these systems are adapted and stressed in cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of cancer treatments that target proteostasis in cancer cells and explains their mechanism of action in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Gives concrete examples (proteasome inhibitors bortezomib/carfilzomib; HSP inhibitors like ganetespib; UPR/IRE1 inhibitors) and explains mechanisms in plain language (blocking protein degradation causes misfolded protein buildup; blocking chaperones overwhelms folding; interfering with UPR heightens ER stress)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises discussing specifics with the oncology team and suggests concrete questions to ask, aligning with a recommendation to consult the oncologist."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the role of proteostasis in normal cells, including protein synthesis, protein folding, protein trafficking, and protein degradation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly lists and briefly describes synthesis, folding, trafficking, and degradation, including the roles of chaperones and the proteasome, fulfilling all required components."
      },
      {
        "criterion_number": 6,
        "description": "The response explains different steps and phases of proteostasis, which could be potential targets for cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects proteostasis steps to therapeutic targets (degradation via proteasome inhibitors, folding via HSP inhibitors, stress response via UPR/IRE1 inhibitors), identifying phases as potential intervention points."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions whether there are any FDA-approved therapies for pancreatic cancer that target proteostasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States proteasome inhibitors are approved for blood cancers but, for pancreatic cancer, proteostasis-targeting drugs are in trials and 'aren\u2019t standard treatments yet,' effectively conveying that no proteostasis-targeting therapies are FDA-approved for pancreatic cancer."
      }
    ],
    "question_number": 236,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:33:53.756088",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises scheduling a dedicated decision-making appointment with the oncologist or a multidisciplinary team and encourages asking for clear explanations and seeking second opinions."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a Palliative Care team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly suggests considering palliative care early and explains how palliative specialists can help with decision-making and symptom management."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups and online resources for cancer patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists PanCAN (with Patient Central helpline), ACS, NCI, and recommends support groups via PanCAN, CancerCare, and Inspire, which are appropriate resources for patients and caregivers."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends breaking up decisions into smaller portions and creating pros and cons lists to organize thoughts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises breaking decisions into smaller steps, listing options, and using a pros/cons chart, and later reinforces making decisions incrementally."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing goals of care with the patient to help with decision making.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes prioritizing based on the mother\u2019s values and goals (e.g., quality of life vs. aggressiveness), which aligns with a goals-of-care discussion."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a patient care navigator or social worker.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions hiring a patient advocate and accessing counseling services, it does not specifically recommend a patient care navigator or a social worker."
      },
      {
        "criterion_number": 7,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes caregiver burnout is common and provides resource organizations, but does not present data or cite published scientific literature."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific signs/symptoms (e.g., exhaustion, sleep disturbance, irritability, depression) are listed; it only encourages self-care and counseling."
      },
      {
        "criterion_number": 9,
        "description": "The response should attempt to normalize treatment decision fatigue for patients undergoing cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that feeling overwhelmed by treatment decisions is normal and that treatment decision fatigue is a real challenge."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining mental health while undergoing cancer treatments, for both the patient and their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages counseling/therapy specializing in oncology, highlights caregiver self-care, and references survivor/caregiver support\u2014addressing mental health for both patient and loved ones."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients lean on their support network for assistance in making medical decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends involving family/friends in research, note-taking, and appointments and joining support groups\u2014directly leveraging support networks."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that the patient request more frequent appointments with their oncology team for ongoing conversations and to answer questions that arise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests scheduling a dedicated decision-making appointment but does not recommend more frequent or ongoing appointments with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that documentation of thoughts can be helpful to reflect upon when it comes time to make a medical decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises journaling thoughts and using pros/cons charts, both forms of documentation that aid reflection and decision-making."
      }
    ],
    "question_number": 237,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:34:35.249926",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, step-by-step lay explanation of metastasis with accessible analogies (journey/highways/neighborhoods) and defines primary vs. metastatic tumors."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes local invasion, intravasation, circulation, and extravasation; explicitly mentions invasion into nearby structures (blood vessels, lymphatics, nerves)."
      },
      {
        "criterion_number": 3,
        "description": "The response describes lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains entry into lymphatic vessels and spread to lymph nodes."
      },
      {
        "criterion_number": 4,
        "description": "The response describes hematologic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains entry into blood vessels and travel via bloodstream; notes portal vein to liver and general circulation to lungs."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions epithelial-mesenchymal transition (EMT) and its role in increased motility/invasion."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that metastasis makes cure harder; discusses roles of surgery/radiation for primary tumor and systemic therapies (chemotherapy, targeted therapy, immunotherapy) and clinical trials for metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises discussing specifics with the oncologist/healthcare team and to ask the doctor about trials; reiterates to consult professionals."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions EMT, proteolytic enzymes to break down tissue barriers, platelet cloaking, angiogenesis, and recruitment of normal cells, reflecting cellular mechanisms of invasion and colonization."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not describe metastasis as a response to cellular stress (e.g., hypoxia, therapy-induced stress); only notes stresses encountered during circulation."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that early detection of spread is done via scans like CT, MRI, or PET, which matches the criterion."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe perineural invasion and describe how cancer can spread this way.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Briefly mentions invasion into nerves but does not describe perineural invasion as a pathway or explain how spread occurs along nerves."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe how cancer cells lodge in tissues distant from their original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains adhesion to vessel walls, extravasation, need for supportive microenvironment, and colonization ('seed and soil')."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe that pancreatic cancer is often diagnosed at advanced stages, when it has already spread outside of the original site.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states pancreatic cancer is often diagnosed at a later stage due to vague early symptoms."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain the most common sites that cancer cells spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists common metastatic sites for pancreatic cancer: liver, lungs, peritoneum, and bones."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe patterns of spread in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes portal venous spread to liver, spread to lungs via systemic circulation, lymph node involvement, and notes preference for liver due to microenvironment."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe characteristics of cancers that have higher predilection for spreading.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions traits that facilitate spread (EMT, enzymatic matrix degradation, angiogenesis, platelet cloaking) and genetic drivers (KRAS, TP53), indicating characteristics associated with higher metastatic potential."
      }
    ],
    "question_number": 238,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:35:17.075372",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines cancer stem cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CSCs as a small subset with stem-like properties (self-renewal, differentiation) that drive tumor growth, spread, and treatment resistance."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the role of cancer stem cells in cancer biology using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible language (e.g., 'roots' of the tumor) to explain CSC roles in growth, metastasis, and resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the role cancer stem cells may play in cancer recurrence.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly links CSC survival post-treatment to tumor regrowth and recurrence."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly discusses stiffness/rigidity of the ECM and its effects."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States mechanical cues encourage CSC migration and seeding of metastases."
      },
      {
        "criterion_number": 6,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains how stiffness promotes therapy resistance and shields CSCs, including dormancy and chemoresistance."
      },
      {
        "criterion_number": 7,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions journals generically but does not provide specific article citations or references."
      },
      {
        "criterion_number": 8,
        "description": "The response defines tumor microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies the tumor microenvironment as the tumor\u2019s environment and describes components like ECM and supportive fibroblasts."
      },
      {
        "criterion_number": 9,
        "description": "The response describes mechanical cues as they pertain to solid tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes stiffness, pressure/compression, shear stress, and crowding as mechanical cues in solid tumors."
      },
      {
        "criterion_number": 10,
        "description": "The response delineates between other types of environmental inputs that cells experience and mechanical forces, such as chemical or hormonal cues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly distinguishes mechanical cues from chemical signals."
      },
      {
        "criterion_number": 11,
        "description": "The response describes that pancreatic cancer promotes desmoplasia in its microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pancreatic cancer\u2019s desmoplastic, fibrotic microenvironment and collagen deposition by fibroblasts."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how mechanical forces in the tumor microenvironment influence the behavior of cancer stem cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that stiffness activates pathways (e.g., YAP/TAZ, integrins) promoting stemness, survival, and resistance."
      },
      {
        "criterion_number": 13,
        "description": "The response links scientific literature with PMID on the subject, if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or specific literature references are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how mechanical forces in the tumor microenvironment affect disease recurrence and metastatic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects mechanical cues to both metastasis and recurrence via CSC survival/reactivation."
      },
      {
        "criterion_number": 15,
        "description": "The response mentions how mechanical cues affect tumor cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that stiffness can induce dormancy and that post-treatment changes can reactivate dormant CSCs."
      },
      {
        "criterion_number": 16,
        "description": "The response mentions that the desmoplastic tumor microenvironment in pancreatic cancer is actively being researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions ongoing research and clinical trials targeting fibrosis/ECM and mechanotransduction in pancreatic cancer."
      }
    ],
    "question_number": 239,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:35:48.783686",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises using the medical team as a reliable source and to prepare questions for doctor visits (e.g., \u201cWhat are the possible scenarios, and how can we prepare?\u201d), clearly encouraging discussion with the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends connecting with a counselor or psychologist specializing in oncology and notes many cancer centers offer emotional support services. This satisfies the criterion (counselor/psychologist)."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends joining support groups specifically for pancreatic cancer caregivers/families and names PanCAN\u2019s online forums and CancerCare, as well as local hospital groups."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A full section titled \u201cBuild a Support Network\u201d emphasizes connecting with friends, family, therapists, and support groups to reduce isolation and gain perspective."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of stress relief strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides multiple examples: mindfulness, meditation, deep breathing, progressive muscle relaxation, yoga, journaling, setting routines, walks, small achievable goals, acceptance/affirmations, creative outlets."
      },
      {
        "criterion_number": 6,
        "description": "The response offers examples of organizations that offer support for cancer patients and their families and provides contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It names PanCAN and provides the website (pancan.org); also mentions CancerCare and the American Cancer Society as resources."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends prioritizing self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A section titled \u201cPrioritize Self-Care and Emotional Expression\u201d directly advises engaging in enjoyable/relaxing activities and watching for signs of burnout or depression."
      },
      {
        "criterion_number": 8,
        "description": "The response should normalize the range of emotions felt after a loved one receives a serious cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states it\u2019s normal to feel fear, anxiety, grief, and helplessness and validates the overwhelm of uncertainty."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of maintaining mental health during times of strife.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights mental health care, recommending counselors/psychologists, CBT for cancer-related distress, monitoring for depression/anxiety, and seeking help (including telehealth)."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining healthy lifestyle habits to support wellbeing during times of stress, such as a cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends maintaining routines with regular sleep, meals, and exercise (e.g., short walks) to support wellbeing."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend organization of thoughts and questions to discuss with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises preparing specific questions for doctor visits and mentions organizing medical paperwork as an actionable step."
      },
      {
        "criterion_number": 12,
        "description": "The response should emphasize the importance of understanding the diagnosis to the patient and suggest ways to educate themselves.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The \u201cGather Information Mindfully\u201d section encourages learning from reliable sources (PanCAN, NCI, medical team) and balancing information intake, supporting informed understanding."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention the importance of getting one\u2019s affairs in order upon receiving a cancer diagnosis, as this can provide some peace of mind about the future.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of advance care planning, legal/financial preparations, or getting affairs in order."
      },
      {
        "criterion_number": 14,
        "description": "The response should emphasize the importance of avoiding isolation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly encourages connecting with others\u2014support groups, friends/family, therapists\u2014and open communication with the loved one to reduce isolation."
      }
    ],
    "question_number": 240,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:36:19.830748",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what phase separation is using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly explains liquid\u2013liquid phase separation using an everyday analogy (oil and water/vinaigrette), describes droplet-like structures lacking membranes, and states their purpose in organizing cellular functions in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how phase separation relates to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly links phase separation to multiple cancer behaviors: abnormal gene expression and growth, stress resistance, invasion/metastasis, and treatment response, including PDAC-specific context (e.g., KRAS signaling)."
      },
      {
        "criterion_number": 3,
        "description": "The response defines biomolecular condensates.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly identifies condensates/biomolecular droplets as membrane-less, phase-separated clusters of proteins and RNA that compartmentalize functions."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how phase separation affects drug resistance in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that condensates can hinder drug access/penetration and obscure targets, and that stress granules support survival under therapy, contributing to resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response describes how phase separation affects gene manipulation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that condensates concentrate transcription factors to create transcriptional hubs that overexpress growth genes, effectively describing effects on gene regulation (manipulation of gene expression)."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the role that phase separation plays in the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects phase separation to adaptation within the PDAC tumor microenvironment (dense stroma, hypoxia, nutrient deprivation), describing how condensates aid survival under these microenvironmental stresses."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect that phase separation has on cellular metabolism and survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses survival under metabolic stress, avoidance of apoptosis, hypoxia adaptation, and links to autophagy and RNA/stress granule biology."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that phase separation is the topic of ongoing research at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly calls the topic an emerging, rapidly evolving area with ongoing laboratory and early clinical investigations."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the role of phase separation in the facilitation of invasion and metastasis of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links condensates to EMT and metastasis via YAP/TAZ and mentions reorganization aiding migration and spread."
      },
      {
        "criterion_number": 10,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific peer-reviewed articles or formal citations are provided; only general resources (ACS, PanCAN, PubMed) and search terms are suggested."
      }
    ],
    "question_number": 241,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:36:48.091572",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains sensing via integrins/focal adhesions, cytoskeleton, and stretch-activated ion channels in accessible language with analogies (anchors, spider web)."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes downstream signaling (YAP/TAZ, Rho/ROCK, MAPK/PI3K) and outcomes (proliferation, migration, drug resistance, gene expression changes) in straightforward terms."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how these processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically discusses PDAC\u2019s stiff, collagen/hyaluronan-rich ECM, hyperactive YAP/TAZ, integrin activation, feedback loops increasing ECM, and treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or specific scientific journal references are provided."
      },
      {
        "criterion_number": 5,
        "description": "Define mechanotransduction as the process by which cells convert mechanical stimuli into biochemical signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly defines mechanotransduction as converting physical forces into chemical/biological responses."
      },
      {
        "criterion_number": 6,
        "description": "Include the relevance of mechanotransduction in normal physiology and disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions roles in healthy tissues (adapting to blood flow/muscle movement) and in disease (cancer aggressiveness and resistance)."
      },
      {
        "criterion_number": 7,
        "description": "Describe at least two types of mechanical forces acting on tissues, such as stretch, pressure, stiffness, compression, tension, shear stress, or hydrostatic pressure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Names multiple forces including pressure, stretching, stiffness, and tension."
      },
      {
        "criterion_number": 8,
        "description": "Explain how mechanical forces in tumors and/or the surrounding tissues differ from normal tissue, specifically mentioning the creation of a stiff and dense extracellular matrix (ECM).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly contrasts tumor microenvironment with normal tissue, emphasizing dense, stiff ECM rich in collagen and hyaluronan."
      },
      {
        "criterion_number": 9,
        "description": "Describe at least two ways cells detect mechanical forces, including structures like ion channels, integrins, cell surface receptors, or the cytoskeleton.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains integrins/focal adhesions, cytoskeleton, and stretch-activated ion channels (e.g., Piezo)."
      },
      {
        "criterion_number": 10,
        "description": "Describe how pancreatic cancer cells respond to mechanical forces in their environment, particularly focusing on stiffness or desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details PDAC responses to stiffness: YAP/TAZ activation, migration/invasion, proliferation, drug resistance, and impaired perfusion."
      },
      {
        "criterion_number": 11,
        "description": "Define desmoplastic stroma as a key feature of pancreatic cancer characterized by excessive fibrous tissue formation around the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes desmoplastic stroma as a thick, scar-like (fibrous) tissue in pancreatic tumors that increases pressure; effectively conveys the defining feature."
      }
    ],
    "question_number": 242,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:37:13.767340",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends meeting with a Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"Consult their oncologist or a palliative care specialist\u2014they can facilitate these talks\" and later lists \"Oncologist/palliative care doctor\" as part of the team."
      },
      {
        "criterion_number": 2,
        "description": "The response explains Advanced Care Planning and how it impacts a patient\u2019s clinical course.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines ACP elements (treatment goals, proxy, advance directives) and links to clinical impact by noting treatment intensity and that clarifying preferences early ensures the patient\u2019s voice is honored when decisions become complex."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions code status.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit mention of code status, DNR/DNI, or resuscitation preferences."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions an advanced directive or living will.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States: \"Create or update advance directives, like a living will or POLST form.\""
      },
      {
        "criterion_number": 5,
        "description": "The response mentions financial planning and recommends discussing this with a professional with experience in this.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working with \"an estate attorney or financial advisor specializing in serious illness\" and details organizing assets, wills, trusts, and beneficiaries."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a social worker or counselor.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends \"a social worker or therapist for emotional support\" and mentions using a counselor (e.g., via the American Cancer Society)."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes family communication, involvement, support groups, and reducing isolation as part of legacy planning during treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or websites.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides organizations and contact info/websites: PanCAN (pancan.org; 1-877-272-6226), The Conversation Project (theconversationproject.org), American Cancer Society, Cancer Support Community, CancerCare, HealthWell Foundation, National Cancer Institute."
      },
      {
        "criterion_number": 9,
        "description": "The response should instruct patients to create a POLST with their healthcare provider, and post this in a visible place in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions POLST generally but does not instruct creation with a clinician nor posting it visibly at home."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the patient elect a healthcare durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises appointing a \"healthcare proxy (someone to make decisions if they're unable),\" which is equivalent to a healthcare durable power of attorney."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ensure their financial affairs are in order.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends organizing assets, debts, documents, updating wills and beneficiaries, and compiling everything in one place."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient elect a financial durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit recommendation to appoint a financial (durable) power of attorney."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient complete a will and designate beneficiaries on life insurance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically advises to \"Update wills, trusts, and beneficiary designations (e.g., for life insurance, retirement accounts).\""
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient consider reaching out to friends and loved ones in order to connect and spend time together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages family meetings, involving family and friends, and memory-making activities with loved ones (including grandchildren)."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consider how to reconcile their affairs in the financial, legal, and social realms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses financial/legal organization (wills, trusts, beneficiaries) and social reconciliation via \"unfinished business (e.g., forgiveness or gratitude)\" and family role clarification."
      },
      {
        "criterion_number": 16,
        "description": "The response should provide online references and links to resources regarding legacy planning.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes URLs such as theconversationproject.org, pancan.org, and MyWonderfulLife.com, along with other named online resources (StoryCorps, Legacybox)."
      },
      {
        "criterion_number": 17,
        "description": "The response should suggest the patient inquire about assistance with some of these aspects of legacy planning with their oncology team, to understand if there are resources available.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting the oncologist (and palliative care) to facilitate discussions and includes oncology team as part of the support network, implying seeking assistance and available resources."
      }
    ],
    "question_number": 243,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:37:55.070072",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cell adhesion, contrasts normal versus cancer cell behavior, and explains concepts in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cell adhesion processes are changed in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains loss of E-cadherin during EMT, integrin alterations, ECM degradation by MMPs, and how these changes enable invasion and metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions both integrins and cadherins (including E-cadherin)."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses PDAC aggressiveness, dense stroma, reduced E-cadherin with poorer prognosis, common metastatic sites, and mutations (KRAS, TP53, SMAD4) impacting adhesion pathways."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No scientific journal citations are provided; only general resources (e.g., NCI, ACS, PubMed) are mentioned without specific references."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes ECM as a supportive scaffold composed of proteins such as collagen and fibronectin, and explains its role in adhesion."
      },
      {
        "criterion_number": 7,
        "description": "The response explains epithelial-mesenchymal transition (EMT).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines EMT as a change from epithelial to mesenchymal-like state with decreased E-cadherin and increased motility, including triggers like TGF-\u03b2."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how EMT facilitates cancer cell spread.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links EMT to loss of cell-cell adhesion, increased invasion, entry into circulation, and notes MET for colonization at distant sites."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the components of cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies key adhesion components: cadherins, integrins, selectins, immunoglobulin superfamily molecules, and the ECM."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the components of cell detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers loss of E-cadherin, integrin alterations, ECM degradation via MMPs, and microenvironmental influences facilitating detachment."
      },
      {
        "criterion_number": 11,
        "description": "The response includes different enzymes implicated in cell adhesion and detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only matrix metalloproteinases (MMPs) are mentioned; no additional enzyme classes (e.g., serine proteases, cathepsins, LOX) are cited."
      },
      {
        "criterion_number": 12,
        "description": "The response describes factors in the tumor microenvironment that promote or facilitate tumor cell detachment and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions hypoxia, inflammation, signals from immune cells, growth factors like TGF-\u03b2, and dense fibrotic stroma as facilitators."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions if there are any FDA-approved treatments that target cancer cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state whether FDA-approved anti-adhesion/detachment therapies exist; notes such therapies are under research and not standard."
      }
    ],
    "question_number": 244,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:38:35.237416",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting healthcare providers including oncologists and suggests asking them for updates and a goals-of-care discussion."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages honest conversations with the loved one and family, offering sample questions to align perspectives."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends involving a counselor/therapist and explicitly mentions palliative care specialists as part of the care team."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically advises asking for a 'goals of care' discussion and also suggests setting short- and long-term goals."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages joining support groups, naming PanCAN and CancerCare."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PanCAN (877-2-PANCAN), American Cancer Society (1-800-227-2345), and websites such as PanCAN.org, Cancer.gov, and ClinicalTrials.gov."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights mental health strategies (CBT/ACT, counseling, meditation, gratitude), caregiver support, and urges seeking professional help if overwhelmed."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly states it is normal to feel pulled between hope and realism and validates the commonality of this challenge."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses quality of life emphasis through palliative care and mentions symptoms and issues (pain, fatigue, digestive problems) and side effects impacting daily well-being."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists online resources such as PanCAN.org, Cancer.gov, ClinicalTrials.gov, and references support groups through PanCAN and CancerCare."
      }
    ],
    "question_number": 245,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:38:52.896543",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what condensates are using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear, non-technical explanations (e.g., oil-and-water analogy) and plain language to describe condensates as membraneless droplets in cells."
      },
      {
        "criterion_number": 2,
        "description": "The response defines biomolecular condensates as membrane-less organelles containing proteins, RNA, and other molecules.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly calls them membraneless organelles/droplets and states they are made of proteins, RNA, and sometimes DNA."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how condensates relate to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects condensate dysregulation to cancer hallmarks, including altered gene expression, survival under stress, chemoresistance, invasion, and immune evasion."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how biomolecular condensates become deregulated in cancer cells, including at least one mechanism of deregulation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides mechanisms: cancer mutations (e.g., KRAS) altering condensate-forming proteins; aberrant persistence/formation; YAP/TAZ-driven condensates promoting growth."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific journal citations or references are provided; institutions are mentioned but without source details."
      },
      {
        "criterion_number": 6,
        "description": "The response references at least one scientific literature source regarding biomolecular condensates, including a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No literature references or PMIDs are included."
      },
      {
        "criterion_number": 7,
        "description": "The response defines liquid-liquid phase separation (LLPS) as the process by which condensates form.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly defines LLPS and uses the oil-and-water analogy to illustrate the process."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the role of biomolecular condensates in normal cells, including at least one function such as gene regulation or stress response.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes normal functions with examples (stress granules, nuclear speckles/paraspeckles, transcriptional condensates) and roles in stress response, DNA repair, and gene regulation."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the protein YAP/TAZ and its role in biomolecular condensates in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions YAP/TAZ forming condensates that drive tumor growth, including in pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response lists at least two ways that biomolecular condensates encourage cancer cell growth, proliferation, or migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists multiple mechanisms: overactivation of growth genes, resistance to apoptosis/therapy, metastasis/invasion facilitation, and immune evasion."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the study of biomolecular condensates and their role in cancer is an area of active scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the field is relatively new, rapidly evolving, and that clinical trials are being explored."
      },
      {
        "criterion_number": 12,
        "description": "The response states whether there are FDA-approved therapies that target biomolecular condensates in cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that approaches are in early research and not standard, but does not explicitly address FDA approval status."
      }
    ],
    "question_number": 246,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:39:12.761343",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly and explicitly discusses tissue stiffness in pancreatic cancer, including definitions and its role."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that stiffness enhances invasion and metastasis, promotes EMT, and facilitates spread to nearby and distant sites."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that stiffness impedes drug delivery, creates hypoxia, blocks immune infiltration, and contributes to treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it mentions journals (e.g., Cancer Cell, Nature Reviews Cancer) and institutions generally, it does not provide specific article citations or references."
      },
      {
        "criterion_number": 5,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines desmoplasia as excessive scarring/fibrosis with CAF-driven overproduction of collagen/ECM, resulting in a dense, stiff stroma that can comprise most of the tumor mass."
      },
      {
        "criterion_number": 6,
        "description": "The response explains how and why pancreatic cancer promotes the formation of desmoplastic stroma around itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes CAFs produce excess ECM in pancreatic cancer, it does not explain tumor-driven mechanisms (e.g., signaling factors from cancer cells) that promote stromal formation."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the process of cell adhesion in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It briefly mentions integrins that \"grip\" ECM but does not describe normal cell adhesion processes in healthy tissue."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how increased stiffness in tumors and the tumor microenvironment influences cell adhesion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although integrins and mechanosignaling are mentioned, the response does not explicitly describe how stiffness alters adhesion (e.g., integrin clustering, focal adhesion maturation, altered adhesion strength)."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the effect of tissue stiffness on angiogenesis and drug resistance.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Drug resistance is discussed, but the effect on angiogenesis specifically is not addressed; vessel compression and hypoxia are noted without linking to angiogenesis."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how the development of desmoplastic stroma around pancreatic cancer tumors is a protective factor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly states the dense stroma acts like a shield, compresses vessels, reduces immune infiltration, and protects the tumor."
      },
      {
        "criterion_number": 11,
        "description": "The response explains whether there are FDA-approved treatments that target tissue stiffness in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes such approaches are not standard and mentions ongoing trials, but does not explicitly address FDA approval status for stiffness-targeting treatments in pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It defines mechanotransduction as the conversion of physical cues (like stiffness) into biochemical signals within the cell."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests that the patient discuss the role of clinical trials in their cancer care with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly suggests exploring clinical trials with her doctor and references ClinicalTrials.gov."
      }
    ],
    "question_number": 247,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:39:42.644775",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly emphasizes clear communication, such as recommending regular family meetings or using communication tools.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends regular family meetings, sets ground rules, and suggests tools like Zoom, WhatsApp, Slack, Google Sheets, and shared calendars for communication and coordination."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the patient\u2019s healthcare team or medical providers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises connecting with oncology teams for guidance on home care and mentions coordinating with doctors and using MyChart for medical updates."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends involving hospital social workers and palliative care teams to help with care plans and family dynamics."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of a strong support system, such as building a caregiver network or ensuring emotional support.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes building a team, rotating responsibilities to avoid burnout, leveraging digital tools and community platforms, and celebrating small wins to support morale."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists Pancreatic Cancer Action Network (pancan.org), Cancer Support Community (cancersupportcommunity.org), CancerCare, American Cancer Society, and National Pancreas Foundation. Websites are provided for two organizations."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends therapy or support groups and specifically cites CancerCare and family counseling to address stress."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions helping older family members understand medical terms and sharing updates (e.g., MyChart), it does not explicitly recommend educating the family about the diagnosis and treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that one family member is designated as a communication person, and perhaps accompany the patient to their medical appointments and take notes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response suggests assigning roles and coordinating with doctors but does not explicitly designate a single communication person or advise accompanying the patient to take notes."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the communication person to develop a strategy to deliver information to the multi-generational family members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Because no communication point person is designated, there is no explicit recommendation for that person to develop an information-sharing strategy."
      },
      {
        "criterion_number": 10,
        "description": "The response should reinforce the importance of boundaries for the pancreatic cancer patient while they undergo treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses caregiver self-care and meeting ground rules, but does not explicitly address setting or protecting the patient\u2019s personal boundaries during treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient inquire with their oncology team if there are resources available for group support or for cultural mediation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it says to connect with oncology teams for home care guidance and notes cultural considerations, it does not explicitly recommend asking the oncology team about support groups or cultural mediation resources."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient or loved ones identify care needs, such as cleaning or food prep, and assign roles to family members according to their strengths.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a dedicated section on assessing needs (e.g., appointments, symptom management, meals, hygiene, admin) and matching roles by strengths across generations."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage the patient to focus on their own wellbeing and mental health.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Self-care guidance is directed at caregivers and family members; it does not explicitly encourage the patient to focus on their own wellbeing or mental health."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend online resources for pancreatic cancer information as well as support services that the patient and family members can access to answer questions, etc.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends online resources (pancan.org, cancersupportcommunity.org) and organizations like CancerCare, ACS, and National Pancreas Foundation for information and support."
      }
    ],
    "question_number": 248,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:40:17.553906",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains epithelial-mesenchymal transition and how this affects a cell\u2019s ability to migrate.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines EMT as a shift from stationary, tightly bound epithelial cells to flexible, migratory cells and links it to detachment and invasion."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions direct invasion into nearby structures, spread via lymphatic and blood vessels, and common metastatic sites (liver, lungs, lymph nodes)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes loss of adhesion, ECM degradation by MMPs, cytoskeletal reorganization, invadopodia formation, and angiogenesis as mechanisms supporting spread."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While hypoxia and inflammation are noted, the answer does not explicitly frame metastasis as a response to cellular stress."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No imaging modalities (CT, MRI, PET/CT) are mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Treatments are listed generally, but the response does not address how their usefulness changes specifically in metastatic disease (e.g., limited role for surgery)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends discussing with the oncologist or a specialist for personalized guidance."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (e.g., glue-like proteins, ECM as scaffold, enzymes as 'scissors,' invadopodia as 'tiny feet') and avoids jargon where possible."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how a cancer cell develops, including DNA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that DNA mutations (e.g., due to smoking, genetics like BRCA, inflammation) drive abnormal growth and behavior."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe tumor suppressor genes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes loss of tumor suppressors (TP53, SMAD4) as removing the brakes that prevent invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe oncogenes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes KRAS mutations promoting uncontrolled growth and increased mobility, effectively explaining oncogene function."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe cell adhesion, and how this process can be altered in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains adhesion via E-cadherin and that cancer cells reduce/lose these molecules to detach."
      },
      {
        "criterion_number": 13,
        "description": "The response should explain the phenomenon of loss of cell-cell adhesion in cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states loss of cell-cell adhesion (e.g., reduced E-cadherin) allows cells to break free from the tumor mass."
      },
      {
        "criterion_number": 14,
        "description": "The response should define tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines the tumor microenvironment as the surrounding area including immune cells, fibroblasts, and blood vessels."
      },
      {
        "criterion_number": 15,
        "description": "The response should explain how cancer cells can use enzymes to change the tumor microenvironment to their advantage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes secretion of MMPs and proteases that degrade ECM and create paths for invasion, with TME cells also contributing."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe other ways cancer cells can interact with the tumor microenvironment to promote migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions stromal signaling, inflammation, hypoxia, immune evasion, and angiogenesis facilitating invasion and migration."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe any unique ways pancreatic cancer cells are thought to metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pancreatic cancer\u2019s early invasion of nearby structures including blood vessels and nerves and emphasizes desmoplastic stroma\u2019s role."
      },
      {
        "criterion_number": 18,
        "description": "The response should recommend websites that help explain different aspects of pancreatic cancer and provide resources for pancreatic cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends American Cancer Society, Pancreatic Cancer Action Network (PanCAN), and the NCI\u2014reliable patient-facing resources."
      }
    ],
    "question_number": 249,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:41:01.579238",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response discusses the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system and blood vessels using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The answer mentions balanced fluid movement in healthy tissue but does not explicitly describe the normal pathway from blood vessels into the interstitial/extracellular space and back via lymphatics/venous return in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how fluids move in normal tissue to perform tasks such as nutrient and oxygen delivery, and to manage waste products.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that in healthy tissues, fluids deliver nutrients and oxygen and remove waste, satisfying the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses changes to fluid flow that may occur in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details leaky vessels, poor lymphatic drainage, high interstitial fluid pressure, and desmoplastic stroma compression specific to pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response describes abnormalities seen in tumors with fluid management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Abnormalities such as leaky blood vessels, impaired lymphatics, elevated IFP, and dysfunctional angiogenesis are described."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, including reduced drug delivery or immune cell penetration into the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains barriers to drug penetration, uneven intratumoral distribution, effects on nanoparticles and immunotherapy, and altered immune cell access."
      },
      {
        "criterion_number": 6,
        "description": "The response describes how fluid flow affects cancer behavior.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses mechanotaxis/chemotaxis promoting invasion, effects on angiogenesis, inflammation, immune evasion, and survival/resistance under different flow conditions."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that low-flow, high-pressure regions drive hypoxia adaptation and increased aggressiveness/resistance, supporting tumor progression."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions how altered cellular biology and extracellular structures can impact cancer behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stromal fibroblast activation and collagen deposition, dense ECM, and KRAS\u2013stroma interactions to altered behavior."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence of its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific peer-reviewed articles, authors, years, or citations are provided; only general mentions of journals and institutions."
      },
      {
        "criterion_number": 10,
        "description": "The response describes different fluids that exist in a tumor and its environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It identifies blood/plasma and interstitial fluid and discusses lymphatic drainage, satisfying the description of different fluids in the tumor milieu."
      },
      {
        "criterion_number": 11,
        "description": "The response describes the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It covers stroma, fibroblasts, ECM/collagen, abnormal vessels, hypoxia, inflammation, and immune context\u2014key microenvironment components."
      },
      {
        "criterion_number": 12,
        "description": "The response describes attributes of tumors and the surrounding tissue that disrupt the normal function of fluids.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Attributes such as desmoplastic stiffness, vessel compression, leakiness, poor lymphatics, and high IFP disrupting normal fluid dynamics are described."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages the development of this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It defines desmoplastic stroma but does not explain how pancreatic cancer drives its development (e.g., stellate cell activation or specific signaling pathways)."
      },
      {
        "criterion_number": 14,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 5,
        "max_points": 5,
        "justification": "IFP is defined in lay terms as increased pressure inside the tumor due to dense stroma, growth, and fluid accumulation."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly connects high IFP to outward convective flow, poor penetration, and uneven exposure with untreated hypoxic cores."
      },
      {
        "criterion_number": 16,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It references ongoing research, clinical trials (e.g., stroma-targeting and normalization strategies), and emerging technologies assessing/manipulating flow."
      }
    ],
    "question_number": 250,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:41:46.528127",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with the patient\u2019s oncologist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response advises discussing approaches with the healthcare team and explicitly includes the oncologist: \u201cI strongly recommend discussing them with his healthcare team\u2026\u201d and later references \u201cinvolving a multidisciplinary team (oncologist, palliative specialist, therapist).\u201d"
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with a Palliative Care specialist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends early involvement of palliative care: \u201cWork with a palliative care team\u2026 early on\u201d and includes \u201cpalliative specialist\u201d in the multidisciplinary team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions Advance Care Planning and includes either Advance Directives or Living Wills.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states: \u201cUse tools like advance care planning documents (e.g., living wills) to outline his preferences\u2026\u201d which meets both ACP and living wills."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care, including understanding and documenting the patient\u2019s preferences and involving them in decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes shared decision-making and documenting preferences: \u201cInvolve him in choices\u2026 discussions about treatment options, side effects, and care plans\u201d and \u201cuse\u2026 advance care planning documents\u2026 to outline his preferences.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends support groups: \u201cEncourage access to\u2026 support groups (e.g., through the Pancreatic Cancer Action Network or CancerCare).\u201d"
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it names organizations (Pancreatic Cancer Action Network, CancerCare, Lustgarten Foundation, American Cancer Society), it does not provide contact information or websites."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize feelings of loss of control for cancer patients at the time of diagnosis and/or during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It normalizes these feelings: \u201ccancer and its treatments\u2026 can sometimes lead to\u2026 loss of independence, or emotional distress\u201d and \u201cCancer can bring feelings of helplessness or loss of identity.\u201d"
      },
      {
        "criterion_number": 8,
        "description": "The response should describe components of personal dignity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines dignity as respecting autonomy, privacy, sense of self, and humanity, and provides practical elements like privacy during personal care and respect for bodily autonomy."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient, family, and friends of the patient, and oncology care team to respect the patient\u2019s bodily autonomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states \u201cRespect bodily autonomy\u201d and gives concrete steps (privacy during bathing/toileting, same\u2011gender caregivers) and urges ensuring the medical team follows dignity principles."
      },
      {
        "criterion_number": 10,
        "description": "The response should encourage the patient to prioritize management of side effects and symptoms of cancer or cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It urges effective symptom management: \u201cUncontrolled pain, nausea, or fatigue\u2026 Work with a palliative care team\u2026 early on\u201d to prioritize relief."
      },
      {
        "criterion_number": 11,
        "description": "The response should encourage the patient to communicate any side effects or symptoms of cancer or cancer treatment to their oncology care team to ensure they are being offered management solutions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it promotes symptom control with palliative care and shared decision-making, it does not explicitly instruct the patient to report side effects to the oncology team for management."
      },
      {
        "criterion_number": 12,
        "description": "The response should encourage the patient and family to have open and ongoing communication about the patient\u2019s wishes for medical care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends \u201cTalk openly about his feelings, fears, and wishes\u201d and family meetings, along with advance care planning to document wishes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient and loved ones promote independence and normalcy in the patient\u2019s life as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated section \u201cPromote Independence and Normalcy\u201d encourages self-reliance, maintaining routines/roles, and assistive devices to support independence."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage the patient to always remember that anything that happens to their body with regard to cancer treatment is their choice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it emphasizes autonomy and respect for bodily autonomy, it does not explicitly state that all treatments and what happens to the body are the patient\u2019s choice."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient disclose any feelings of overwhelm or loss of autonomy with their oncology team and inquire about resources for support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It acknowledges feelings of helplessness and suggests counseling/support groups but does not explicitly instruct disclosing overwhelm or loss of autonomy to the oncology team or to ask them for resources."
      },
      {
        "criterion_number": 16,
        "description": "The response should emphasize the importance of prevention of caregiver burnout.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes caregiver well-being: \u201ccaregiver support groups can help you provide care without burnout\u201d and \u201cRemember to care for yourself too\u2014your well-being supports his.\u201d"
      }
    ],
    "question_number": 251,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:42:37.365304",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains how cells respond to mechanical stress, including ECM remodeling, increased contractility, and effects on proliferation, invasion, metastasis, and drug resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response discusses cell-generated forces remodeling the ECM and increasing tissue stiffness, a feedback loop increasing contractility, and downstream effects on proliferation, invasion, metastasis, immune evasion, angiogenesis, and drug resistance."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly relates tissue properties (e.g., stiffness, fibrous stroma) to effects on cancer spread, including invasiveness and metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly connects stiff, dense, fibrous stroma/desmoplasia in pancreatic tumors to increased invasiveness and metastasis and notes higher contractility correlating with metastatic potential."
      },
      {
        "criterion_number": 3,
        "description": "Relates tissue properties to consequences for treatment effectiveness and resistance, including drug penetration and resistance mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that stiffer tumors impede drug penetration and that stiffness/contractile environments drive chemoresistance, specifically mentioning gemcitabine resistance in PDAC and strategies to soften tumors to improve delivery."
      },
      {
        "criterion_number": 4,
        "description": "Explains how cells sense mechanical stress, including mechanosensing mechanisms like mechanoreceptors, integrins, or mechanotransduction pathways.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit mention of mechanosensing machinery (e.g., integrins, focal adhesions, mechanosensitive ion channels, FAK, YAP/TAZ). It only generally states that stiffness can activate genes without describing the sensing pathways."
      },
      {
        "criterion_number": 5,
        "description": "Provides specific citations from published scientific journal articles as evidence.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific citations (authors, journal names, years, or DOIs) are provided; the response is citation-free."
      },
      {
        "criterion_number": 6,
        "description": "Explains normal cell contractility, including the role of the actomyosin complex in generating mechanical forces for movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes actin and myosin forming the actomyosin cytoskeleton that generates forces allowing cells to pull/push and notes normal roles like wound healing."
      },
      {
        "criterion_number": 7,
        "description": "Defines actin, including its role in cellular structure and function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Actin is mentioned by name but not defined; there is no explanation of its structural role (microfilaments) or specific functions."
      },
      {
        "criterion_number": 8,
        "description": "Defines myosin, including its function in cell contractility.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Myosin is mentioned as part of the actomyosin complex but not defined or described as a motor protein driving contractility."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly describes the tumor microenvironment, including its components and characteristics.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response describes the TME as stiff and desmoplastic, mentions stromal cells (fibroblasts), ECM density, immune exclusion, and angiogenesis, covering key components and features."
      },
      {
        "criterion_number": 10,
        "description": "Defines the extracellular matrix, including its composition and function.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The ECM is defined as a supportive scaffold of proteins and fibers surrounding cells, addressing both composition (proteins/fibers) and function (structural support)."
      },
      {
        "criterion_number": 11,
        "description": "Defines mechanobiology, including its relevance to cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanobiology is defined as the study of how physical forces influence biological processes, and its relevance to cancer progression is elaborated throughout the response."
      },
      {
        "criterion_number": 12,
        "description": "Explains epithelial-mesenchymal transition (EMT), including its occurrence in pancreatic cancer cells and its impact on cancer spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "EMT is not mentioned or explained; there is no discussion of its role in PDAC or metastasis."
      }
    ],
    "question_number": 252,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:43:17.814319",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines the extracellular matrix and explains its role in normal cellular biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ECM as a network of proteins (collagen, fibronectin, laminins), sugars, and other molecules outside cells, and explains normal roles: structural support, cell communication/growth/repair, and barrier/filter functions."
      },
      {
        "criterion_number": 2,
        "description": "The response contrasts the role of the extracellular matrix in cancer cell biology with normal cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly contrasts normal ECM with cancer-associated remodeling/hijacking in PDAC, noting dense desmoplasia and pro-tumor functions vs supportive homeostatic roles in healthy tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential consequences of an altered extracellular matrix for cancer treatment effectiveness and resistance, including examples like decreased drug and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes physical barrier to chemotherapy and immune cells, notes drugs getting 'stuck' and poor penetration, and vessel compression reducing perfusion\u2014directly addressing treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential consequences of an altered extracellular matrix on cancer cell biology, including examples like angiogenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers tumor growth/survival signaling via integrins and growth factor storage; invasion/metastasis via ECM remodeling and pathways; while angiogenesis is not explicitly named, the criterion allows examples, and metastasis and growth mechanisms are well covered."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No primary literature or journal citations are provided; mentions of PEGPH20 and organizations lack bibliographic references."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the different components of the extracellular matrix in normal tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists key ECM components (collagen, fibronectin, laminins; sugars/other molecules)."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how the extracellular matrix changes in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes PDAC desmoplasia (dense, scar-like ECM; can exceed cancer cell mass), remodeling by cancer/stromal cells, and enrichment in components like hyaluronic acid with vessel compression."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how the changes in the extracellular matrix in pancreatic cancer promote cancer growth and facilitate movement of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains integrin-mediated pro-survival/proliferation signaling, growth factor sequestration, and ECM remodeling that creates invasion pathways and facilitates metastasis."
      },
      {
        "criterion_number": 9,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplasia/desmoplastic stroma as a dense, scar-like ECM that can constitute much of the tumor mass."
      },
      {
        "criterion_number": 10,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the tumor microenvironment and notes it includes ECM, but does not provide a clear definition (e.g., composition of stromal cells, immune cells, vasculature, signaling factors)."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how desmoplastic stroma causes hypoxia in the tumor microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that the dense ECM compresses blood vessels, reducing blood flow and starving the tumor of oxygen (hypoxia)."
      },
      {
        "criterion_number": 12,
        "description": "The response describes how hypoxia in the tumor microenvironment causes inflammation, and how this promotes cancer growth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While inflammation and immune exclusion are discussed, the response does not connect hypoxia to inflammation nor detail how hypoxia-driven inflammation promotes growth."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment contributes to treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains drug penetration barriers, immune exclusion, and vessel compression reducing perfusion\u2014mechanisms of resistance attributable to desmoplastic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment can cause symptoms and complications due to mechanical forces on the surrounding structures, specifically mentioning the effect on blood vessels.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Cites pain and ductal blockages as complications from dense ECM and specifically mentions compression of blood vessels reducing blood flow."
      }
    ],
    "question_number": 253,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:43:58.709451",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing relationship challenges or support strategies with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not advise discussing relationship challenges with the oncologist; it only references following the doctor's plan generally."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing relationship challenges with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It recommends therapists/counseling and respite care but does not mention a social worker, spiritual counselor/chaplain, or palliative care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends joining a support group for cancer patients or their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises joining support groups and cites PanCAN's Patient Central, Inspire.com, and CancerCare support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "There is a dedicated section on self-care with concrete strategies to prevent caregiver burnout."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly emphasizes the importance of having a support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section on building and leaning on a support network and delegating tasks to an inner circle."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN (pancan.org, 877-272-6226), ACS (cancer.org), CancerCare (cancercare.org), and others."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that loved ones of a patient with pancreatic cancer seek education about the disease and common symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to learn about pancreatic cancer, its course, or symptom recognition is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage open communication between the patients and their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It strongly promotes open and honest communication, including regular check-ins and use of 'I' statements."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient to seek support from their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises identifying an inner circle, delegating tasks, and asking specifically for help from friends and family."
      },
      {
        "criterion_number": 10,
        "description": "The response should attempt to normalize the stress that patients feel after receiving a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states it is normal for relationships to feel strained and acknowledges emotional stress and uncertainty."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend against behaviors that might isolate the patient after a serious medical diagnosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it encourages connection, it does not explicitly caution against isolating behaviors or withdrawing from others."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient prioritize symptom control to feel as normal as possible.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no guidance on symptom control or management (e.g., pain, nausea) to maintain normalcy."
      },
      {
        "criterion_number": 13,
        "description": "The response should indicate that some people may not feel comfortable discussing a serious cancer diagnosis with a friend or loved one, and that this can be a normal response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes that some people pull away out of discomfort and encourages patience and forgiveness."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient observe which people in their social circle want to be supportive, and to lean on these people.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Although the response advises focusing on those who show up, this criterion has zero available points."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient continue to reach out to friends and loved ones, and try to participate in the same activities they previously did, to maintain relationships.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It suggests low-key gatherings, watching favorite movies, short walks, and sharing updates to maintain connections."
      },
      {
        "criterion_number": 16,
        "description": "The response should suggest that the patient consider creating boundaries with people, including how to handle unsolicited advice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated boundaries section offers a script for handling unsolicited advice and setting limits."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend that the patient consider activities where they can be fully present with the people they are with, for the best quality interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'no-talk zones' and meaningful, low-key activities (e.g., quiet dinners, photo albums) to foster presence and quality time."
      }
    ],
    "question_number": 254,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:44:38.264553",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cancer cells detect mechanical characteristics of their environment.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response clearly explains detection via integrins/focal adhesions, cytoskeleton deformation, mechanosensitive ion channels (e.g., Piezo), and nuclear mechanosensing through LINC complexes; however, this criterion has 0 available points."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how cancer cells respond to mechanical characteristics of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details increased proliferation/survival, invasion/metastasis, ECM remodeling, drug resistance, EMT, and crosstalk with stromal cells leading to feedback that stiffens the environment."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how mechanosensing processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It connects pancreatic cancer\u2019s stiff desmoplastic stroma to altered mechanosensing (e.g., integrin clustering, cytoskeletal reinforcement), notes overactive YAP/TAZ in pancreatic cancer cells, and describes feedback with fibroblasts that amplifies stiffness."
      },
      {
        "criterion_number": 4,
        "description": "The response defines mechanosensing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mechanosensing is clearly defined as cells sensing and responding to physical properties like stiffness, pressure, stretch, and fluid flow."
      },
      {
        "criterion_number": 5,
        "description": "The response describes mechanosensing in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states normal cells use mechanosensing to maintain healthy tissues and explains general mechanisms (integrins, cytoskeleton, ion channels, nuclear pathways) that apply to normal cells."
      },
      {
        "criterion_number": 6,
        "description": "The response defines desmoplastic stroma and describes its development in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Desmoplasia is defined as a dense, stiff, fibrous stroma; development is addressed by noting cancer\u2013stromal interactions where cancer cells influence fibroblasts and other cells to stiffen the ECM, creating a feed-forward loop characteristic of pancreatic tumors."
      },
      {
        "criterion_number": 7,
        "description": "The response describes integrins, cytoskeleton, ion channels, and membrane sensors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes integrins and focal adhesions, cytoskeletal mechanics (actin, myosin, Rho GTPases), mechanosensitive ion channels (Piezo), and membrane mechanosensors."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the YAP/TAZ pathway and its role in the development of desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While YAP/TAZ is explained as a mechanotransduction pathway and noted as overactive in pancreatic cancer, the response does not explicitly connect YAP/TAZ to the development of desmoplastic stroma (e.g., activation of CAFs or ECM deposition)."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions if there are FDA-approved therapies that target the cancer cells\u2019 ability to mechanosense.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions investigational approaches (hyaluronidase, FAK inhibitors; YAP/TAZ/integrin targeting in trials) but does not explicitly state whether FDA-approved mechanosensing-targeted therapies exist."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells migrate in response to cues from mechanical forces in their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains increased migratory behavior in stiff environments, squeezing through tissues and vessels, and ECM remodeling to create paths for invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response defines epithelial-mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EMT is defined as a shift from a stuck-together epithelial state to a more mobile, invasive mesenchymal state."
      },
      {
        "criterion_number": 12,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific peer-reviewed articles are cited; only general resources (ACS, PanCAN) and a suggestion to search PubMed are provided."
      }
    ],
    "question_number": 255,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:45:15.915508",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system, including nutrient and oxygen delivery and waste management.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions that healthy tissues have lymphatic drainage but does not clearly describe normal physiology of capillary filtration, interstitial fluid dynamics, lymphatic return, or explicitly tie this to nutrient/oxygen delivery and waste removal."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how fluid flow becomes compromised in tumors, including increased intratumoral pressure due to abnormal blood vessels, poor lymphatic drainage, and dense stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly attributes elevated interstitial fluid pressure to leaky, disorganized tumor vessels, poor lymphatic drainage, and dense stroma, all within the pancreatic cancer context."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, specifically mentioning reduced drug delivery and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that high IFP reduces drug delivery and also limits immune cell infiltration, affecting immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes IFP as a 'pressure wall' compressing vessels and preventing uniform diffusion, noting that only a small fraction reaches the tumor core, leading to uneven intratumoral exposure."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the impact of altered fluid flow on radiation therapy due to hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that vessel compression leads to hypoxia, and hypoxic tumor regions are more resistant to radiation, directly linking altered flow to radiotherapy effectiveness."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions the impact of altered cellular biology and extracellular structures on cancer behavior, including tumor growth, metastasis, and resistance to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that elevated pressure can promote tumor growth and metastasis and contribute to treatment resistance, implicating microenvironmental structure."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions pressure promoting aggressive behavior, it does not specifically connect low perfusion/flow to signaling that stimulates further cancer growth and development."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references dense, fibrous stroma in pancreatic cancer but does not define desmoplasia nor explain how pancreatic cancer drives its development (e.g., CAFs, PSC activation)."
      },
      {
        "criterion_number": 9,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It defines elevated interstitial fluid pressure as abnormally high pressure within the tumor microenvironment due to leaky vessels, poor drainage, and dense stroma."
      },
      {
        "criterion_number": 10,
        "description": "The response describes ways that increased pressure from interrupted fluid dynamics and desmoplastic stroma can cause compression on surrounding structures, leading to blockages and symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While vessel compression is described, there is no discussion of compression of surrounding organs/ducts (e.g., biliary or gastric outlet obstruction) or resulting clinical symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response provides specific published scientific journal articles as evidence of its claims, with proper citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It mentions researchers (e.g., Rakesh Jain) and a trial name (HALO-109-301) but provides no specific, properly formatted citations to published journal articles."
      },
      {
        "criterion_number": 12,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states that researchers are actively working on strategies (vascular normalization, stroma-targeting) and mentions ongoing clinical trials, demonstrating active research."
      }
    ],
    "question_number": 256,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:45:39.870035",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends clear communication with the family regarding how everyone is dealing with the patient\u2019s cancer diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It includes a dedicated section on open and honest communication with concrete steps (family meetings, updates on condition/treatment, age-appropriate honesty, encouraging sharing feelings, using tools like CaringBridge)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises asking the mother's care team for a referral to a social worker and suggests accompanying to appointments, indicating engagement with the healthcare team."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends working with an oncology social worker, therapists specializing in grief, and mentions hospice resources (NHPCO) for end-of-life discussions."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of self-care and healthy boundaries.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a full section on self-care (sleep, exercise, mindfulness apps, journaling) and explicit guidance on setting boundaries and using a mediator if conflicts arise."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system for patients with cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It stresses building a support network, rotating responsibilities, family unity, and leveraging community/faith support."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations that support cancer patients and their families and includes contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists ACS, PanCAN, CancerCare, NCI, Cancer Financial Assistance Coalition, NHPCO, Cancer.net, and includes the NCI Cancer Information Service phone number (1-800-4-CANCER) and website references (e.g., Cancer.net)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends joining online or in-person support groups via PanCAN, CancerCare, and ACS."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests regular family meetings to share updates on the condition and treatment plans and proposes researching clinical trials, facilitating education."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage that family members provide emotional support to each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages validating emotions, scheduling check-ins, and mutual support across family members."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend pursuit of professional mental health counseling for family members of a patient with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends individual and family therapy, oncology social workers, grief-specialized therapists, and accessing counseling via hospital resources or Psychology Today."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend resources that patients and families of patients with pancreatic cancer can access for information about the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites PanCAN, NCI (including CIS), and Cancer.net as information resources; it also mentions a disease-related book."
      },
      {
        "criterion_number": 12,
        "description": "The response should list sources and/or websites for support groups for patients with pancreatic cancer and their family members.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists PanCAN, CancerCare, and the American Cancer Society as sources for support groups."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage family members to provide assistance and support to their loved ones affected by pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides detailed examples of practical support (meals, errands, childcare, housekeeping, accompanying to appointments, paperwork, coordinating visits)."
      }
    ],
    "question_number": 257,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:46:05.024324",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines metastasis as cells breaking away, traveling, and forming new tumors in distant organs, using accessible language and a stepwise explanation."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions local invasion of surrounding tissues, entry into the bloodstream or lymph system (intravasation), and travel via blood with subsequent exit (extravasation)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes mechanisms including cytoskeletal remodeling (actin/vimentin), squeezing through endothelium, intravasation/extravasation, and surviving shear forces and immune challenges."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention epithelial-to-mesenchymal transition (EMT)."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses survival under shear stress but does not frame metastasis as a response to cellular stress triggers."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines deformability as the ability to change shape and squeeze through tight spaces; contrasts normal rigidity vs cancer cell pliability and links to cytoskeletal changes."
      },
      {
        "criterion_number": 7,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides a lay definition of the cytoskeleton but does not define the extracellular matrix (ECM)."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions cell adhesion as a factor without explaining adhesion mechanisms or molecules (e.g., cadherins, integrins) or how they change in metastasis."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly contrasts normal cells as relatively rigid versus cancer cells as more flexible/squishy due to altered cytoskeletal architecture."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details how increased deformability facilitates invasion, intravasation, survival in circulation, extravasation, and colonization of distant sites."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that deformable cells withstand shear forces and narrow capillaries, whereas rigid cells may get stuck or die."
      },
      {
        "criterion_number": 12,
        "description": "The response describes desmoplastic stroma in the pancreatic cancer tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not describe or name the desmoplastic stroma characteristic of pancreatic ductal adenocarcinoma; only refers generally to dense connective tissue."
      },
      {
        "criterion_number": 13,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes squeezing through dense tissue but does not specifically link increased deformability to navigating the desmoplastic stroma of pancreatic cancer."
      }
    ],
    "question_number": 258,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:46:42.549276",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal physiological flow of fluid from blood vessels to the extracellular space and lymphatic system in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions blood, interstitial fluid, and lymph, it does not explain the normal process of capillary filtration into the interstitial space and return via lymphatic vessels back to the circulation in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses changes to fluid flow in pancreatic cancer, such as increased intratumoral pressure, and how these changes differ from normal tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly describes dense desmoplastic stroma in PDAC, high interstitial fluid pressure, poor vascularization, and uneven fluid flow within tumors\u2014contrasting these features with normal tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response addresses how altered fluid flow impacts cancer treatment, including drug delivery and immune cell penetration into tumors.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It discusses impaired drug delivery due to compressed vessels and interest in normalizing flow, but does not address how altered fluid flow affects immune cell penetration/infiltration into tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential impacts of altered fluid flow on cancer behavior, including metastasis, proliferation, migration, and invasion.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly links shear stress to enhanced migration, invasion, metastasis, survival, and proliferation (including PDAC-specific notes), satisfying all listed behaviors."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article as evidence for its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific journal article is cited; only general references to journals (e.g., Cancer Research, Nature Reviews Cancer) without identifiable citations."
      },
      {
        "criterion_number": 6,
        "description": "The response defines shear stress.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Shear stress is defined as the frictional force from moving fluids acting on surfaces such as vessel walls or cells, which is accurate and clear."
      },
      {
        "criterion_number": 7,
        "description": "The response describes what sources of shear stress exist in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Sources identified include blood flow in vessels, interstitial fluid flow within tumors, and high shear during circulation of tumor cells; these constitute the relevant sources."
      },
      {
        "criterion_number": 8,
        "description": "The response defines mechanobiology.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mechanobiology is introduced as the field studying how cells respond to mechanical cues; while brief, it conveys a correct definition."
      },
      {
        "criterion_number": 9,
        "description": "The response explains that cancer cells can encounter shear stress forces in the tumor, in the bloodstream, and in lymph channels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response covers shear stress in tumors and the bloodstream but does not explicitly state that cancer cells experience shear stress in lymphatic channels."
      },
      {
        "criterion_number": 10,
        "description": "The response describes desmoplastic stroma and how this forms in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplasia is described as dense, scar-like stroma, but there is no explanation of how it forms (e.g., activation of pancreatic stellate cells/fibroblasts and ECM deposition)."
      },
      {
        "criterion_number": 11,
        "description": "The response explains the effect that the desmoplastic stroma has on fluid flow in and around a pancreatic cancer tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that dense stroma raises interstitial pressure, creates uneven flow, compresses vasculature, and alters shear\u2014directly addressing effects on fluid flow."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased shear stress encourages cancer cells to proliferate and metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links shear stress to activation of signaling pathways (e.g., PI3K/Akt, MAPK), increased motility/invasion, selection of aggressive CTCs, and notes proliferation under high IFP in PDAC."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how shear stresses on cancer cells impact drug resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that fluid forces can induce upregulation of drug-resistance genes/repair mechanisms and that altered flow can reduce drug delivery, addressing resistance mechanisms."
      }
    ],
    "question_number": 259,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:47:12.567062",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"Schedule a dedicated conversation with the oncologist\" and suggests asking about best-/worst-case scenarios and quality-of-life considerations."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States: \"Discuss with your loved one and family: Share feelings openly but gently,\" and provides example language to facilitate open conversations."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends early involvement of palliative care teams and counseling with an oncology-specialized therapist; mentions caregiver resources, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages advance care planning (The Conversation Project) to discuss wishes and suggests asking the oncologist about quality-of-life priorities; also promotes setting flexible short- and long-term goals."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends joining support groups through PanCAN, CancerCare, and forums like Inspire.com."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists PanCAN, American Cancer Society, CancerCare, Family Caregiver Alliance, ClinicalTrials.gov, Inspire.com, Psychology Today, and provides NCI\u2019s Cancer Information Service phone (1-800-4-CANCER). Includes websites/domains and contact info."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights mindfulness, journaling, CBT, counseling with oncology therapists, and caregiver self-care, emphasizing mental health throughout."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly says it is \"completely normal to grapple with the tension between hope and realism.\""
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses focusing on quality-of-life factors, early palliative care to manage symptoms, and addresses pain, nausea, and other symptoms affecting QoL; ties decisions to QoL considerations."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides online resources and communities: PanCAN, CancerCare, Inspire.com, ACS, ClinicalTrials.gov, and The Conversation Project for information and connection."
      }
    ],
    "question_number": 260,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:47:40.518511",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes how cells interact with their environment via focal adhesions and the cytoskeleton, and notes that stiffness feeds back via mechanotransduction; uses accessible analogies (rope, 'feet') to explain sensing."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains responses such as increased migration/invasion, proliferation, resistance to cell death, production of matrix-degrading enzymes, and activation of survival pathways when the ECM is stiffer."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects ECM stiffness and reorganization to enhanced invasion and migration; mentions collagen alignment forming 'highways' that facilitate spread."
      },
      {
        "criterion_number": 4,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that a dense, stiff, force-remodeled ECM can physically block drugs and immune cells and activate survival pathways, contributing to resistance and reduced treatment effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions journals and institutions generically (e.g., Nature Cell Biology, Cancer Research, NCI) but does not provide specific, citable journal articles (authors, years, titles), so no credit per rubric."
      },
      {
        "criterion_number": 6,
        "description": "The response defines traction forces that exist in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines traction forces as the pulling/pushing forces cells exert on the ECM using focal adhesions and the cytoskeleton and notes these forces are balanced and regulated in healthy cells."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines the ECM as a supportive scaffold of proteins and fibers around cells."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how traction forces are changed in cancer cells, as opposed to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States cancer cells generate stronger or differently patterned traction forces and links these changes to invasion, ECM remodeling, metastasis, and resistance."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how increased traction forces from pancreatic cancer cells on their environment promote cancer cell proliferation and migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically for pancreatic cancer, explains that increased traction helps cells navigate/remodel the dense stroma, promotes invasion/migration, and that stiffness amplifies forces to drive tumor growth (proliferation)."
      },
      {
        "criterion_number": 10,
        "description": "The response describes changes in the pancreatic cancer environment that are prompted by traction forces from the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes traction-driven stiffening/reorganization of the ECM and alignment of collagen fibers into 'highways' within pancreatic tumors."
      },
      {
        "criterion_number": 11,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines mechanotransduction as physical forces influencing cell behavior and gene expression."
      },
      {
        "criterion_number": 12,
        "description": "The response defines desmoplastic stroma in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as a thick, fibrous, scar-like tissue surrounding the tumor in pancreatic cancer."
      },
      {
        "criterion_number": 13,
        "description": "The response describes the effect of desmoplastic stroma on cancer cell\u2019s ability to metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links the stiff desmoplastic stroma to enhanced migration/invasion via collagen alignment 'highways' and explains that such mechanics facilitate steps toward metastasis; also discusses how traction forces aid intravasation and spread."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how traction forces in cancer cells contribute to drug resistance in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that stronger forces and the resulting dense, remodeled ECM impede drug/immune cell penetration and activate survival pathways, contributing to treatment resistance in pancreatic cancer."
      }
    ],
    "question_number": 261,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:48:24.405669",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links viscosity/dense ECM and tissue thickness to invasion, EMT, and metastasis (e.g., highly viscous environment promotes EMT and invasion; thick tissues select for aggressive cells)."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains how dense/viscous stroma impairs drug penetration, contributes to chemoresistance, and limits immunotherapy efficacy by creating immune-cold tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions reduced blood flow and hypoxia as potential consequences of tissue thickness which may have effects on treatment effectiveness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that viscous tissues compress blood vessels (reduced perfusion) leading to hypoxia and notes that this contributes to treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "Define viscosity and explain its role in normal cells, including the term \u201cviscosity\u201d and its function in cellular environments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Defines viscosity as resistance to flow but does not explain its role in normal cells or normal cellular environments; focus is on tumor settings."
      },
      {
        "criterion_number": 5,
        "description": "Describe changes in viscosity within the pancreatic cancer microenvironment, mentioning \u201cviscosity\u201d and specific alterations in cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions that PDAC TME is dense and 'viscous' due to desmoplasia, forming a thick fibrous stroma that increases stiffness and acts like a viscous gel."
      },
      {
        "criterion_number": 6,
        "description": "Define the tumor microenvironment, using the term \u201ctumor microenvironment\u201d and describing its components.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses the term 'tumor microenvironment (TME)' and lists components such as ECM, blood vessels, immune cells, and fluids."
      },
      {
        "criterion_number": 7,
        "description": "Define desmoplastic stroma and explain its formation in pancreatic cancer, using the term \u201cdesmoplastic stroma\u201d and describing its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'desmoplasia' and 'stroma' but does not use the exact term 'desmoplastic stroma' nor describe formation mechanisms (e.g., activated stellate cells/CAFs) in PDAC."
      },
      {
        "criterion_number": 8,
        "description": "Describe the influence of desmoplasia on cancer cells, mentioning \u201cdesmoplasia\u201d and its effects on proliferation, migration, or invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses effects of a viscous environment on invasion/EMT and proliferation, but does not explicitly attribute these effects to 'desmoplasia' using that term."
      },
      {
        "criterion_number": 9,
        "description": "Describe how desmoplasia limits oxygen delivery to tumor tissue, attributing reduced oxygen delivery specifically to \u201cdesmoplasia.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes vessel compression and hypoxia but does not explicitly state that 'desmoplasia' causes the reduced oxygen delivery."
      },
      {
        "criterion_number": 10,
        "description": "Explain how hypoxia affects cancer cell behavior, describing hypoxia\u2019s role in selecting aggressive, therapy-resistant cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that hypoxia makes cancer cells more resilient and aggressive ('hypoxic adaptation') and associates metabolic shifts (e.g., glycolysis/Warburg effect) with treatment resistance."
      },
      {
        "criterion_number": 11,
        "description": "Describe how desmoplasia limits tumor access by the immune system, mentioning \u201cdesmoplasia\u201d and its impact on immune cell infiltration.",
        "score_given": 0,
        "max_points": 3,
        "justification": "States that a viscous ECM acts as a physical barrier to immune cell infiltration but does not use the term 'desmoplasia' in this context."
      },
      {
        "criterion_number": 12,
        "description": "Explain how desmoplasia causes drug resistance in pancreatic cancer, connecting \u201cdesmoplasia\u201d to reduced treatment efficacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Links high viscosity/dense stroma to poor drug penetration but does not explicitly connect 'desmoplasia' by name to reduced treatment efficacy."
      },
      {
        "criterion_number": 13,
        "description": "Explain how desmoplastic stroma selects for aggressive tumor cell behavior, linking \u201cdesmoplastic stroma\u201d to increased migratory behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes selection for aggressive cells in thick tissues but does not use the term 'desmoplastic stroma' or explicitly link it to increased migratory behavior."
      },
      {
        "criterion_number": 14,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "References are generic (e.g., 'Nature Reviews Cancer', 'MIT and Harvard studies') without specific published articles or formal citations."
      }
    ],
    "question_number": 262,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:49:11.191143",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends involving palliative care specialists, social workers, and chaplains/spiritual advisors."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends respectful and open communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A dedicated section titled 'Start with Open and Respectful Dialogue' emphasizes safe spaces, active listening, and nonjudgmental discussion."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions cultural mediators.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It mentions cultural liaisons and chaplains who can facilitate discussions, fulfilling the cultural mediator element."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends that the patient and family members communicate their important cultural beliefs to their oncology team for better understanding.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing traditional practices and cultural norms with the medical team to evaluate complement or conflict with treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response strongly recommends that a medical interpreter is present for all medical appointments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests using interpreters if language barriers exist, but does not strongly recommend interpreter presence for all appointments."
      },
      {
        "criterion_number": 6,
        "description": "The response suggests that the patient request more time for their appointments, especially if a medical interpreter is needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no recommendation to request longer appointment times."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests the patient and/or family inquire about services a patient advocacy office could provide.",
        "score_given": 0,
        "max_points": 3,
        "justification": "A patient advocacy office is not mentioned; it suggests a healthcare navigator or ethicist instead."
      },
      {
        "criterion_number": 8,
        "description": "The response encourages the patient to communicate their preferences around medical decision-making with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes centering the patient's wishes, documenting preferences (advance directives), and holding family conferences with the doctor."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends online resources for both patients and medical teams to learn about particular cultural norms around medical care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends NIH cultural competency articles and a relevant book to learn about cultural norms in healthcare."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends medical teams to complete thorough documentation on patient preferences surrounding communication and medical decision-making.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It advises patients/families to document preferences (e.g., living will, proxy) but does not recommend that the medical team document these preferences."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends organizations that support cancer patients and their families and includes contact information or a website for each.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN (pancan.org; Patient Central 877-272-6226) and CancerCare (cancercare.org), providing websites and a phone number."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends setting boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A section titled 'Find Compromises and Set Boundaries' explicitly discusses boundaries and power dynamics."
      }
    ],
    "question_number": 263,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:49:50.582082",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly discusses tissue stiffness, including a stiff extracellular matrix (ECM), desmoplastic/fibrotic stroma in pancreatic cancer, and how stiffness affects tumor behavior."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that softer cancer cells are more deformable, facilitating migration, invasion, and metastasis, and that a stiff ECM promotes pro-metastatic signaling (e.g., YAP/TAZ, integrins), supporting spread."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that stroma stiffness compresses blood vessels reducing drug delivery, contributes to chemoresistance (e.g., to gemcitabine), and mentions elastography as a stiffness-related tool relevant to staging."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It cites a 2019 review in Nature Reviews Cancer and studies in Cancer Research (2020), and references work from major cancer centers. While informal, these are identifiable published sources used as evidence."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines stiffness/softness as how easily cells deform under force, ties deformability to cytoskeletal organization (actin, microtubules), and links increased deformability to cancer behaviors."
      },
      {
        "criterion_number": 6,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes the ECM as a scaffold around cells and the cytoskeleton as internal structural proteins like actin and microtubules, meeting definition requirements."
      },
      {
        "criterion_number": 7,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although integrin-mediated pathways are mentioned, the response does not explain cell-cell or cell-ECM adhesion processes or their mechanics; no clear description of adhesion dynamics is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that many cancer cells, including pancreatic, are softer and more deformable than normal cells, comparing malignant to normal tissue."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links softness to the ability to squeeze through tight spaces, intrude into tissues and vessels, and thereby facilitate invasion and metastasis to distant organs."
      },
      {
        "criterion_number": 10,
        "description": "The response explains ways that cancer cells migrate from the primary tumor, including hematologic and lymphatic spread, perineural invasion, and direct invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions invasion into surrounding tissue (direct invasion) and passage through blood vessels, it does not address lymphatic spread or perineural invasion explicitly and does not systematically explain the routes."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly explain survival under mechanical stresses (e.g., shear stress in circulation) due to increased deformability. The only explicit stress-survival comment pertains to stiffer cells resisting stress."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly states that PDAC has a stiff, fibrotic/desmoplastic stroma and that the softness of PDAC cells aids invasion through this dense matrix, satisfying the criterion."
      }
    ],
    "question_number": 264,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:50:35.420666",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how physical space restriction affects cancer cells, mentioning at least two effects such as \u201cenhanced migration,\u201d \u201cnuclear deformation,\u201d or \u201cadaptation.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions multiple effects: enhanced migration/invasion, nuclear deformation with DNA damage, survival/adaptation (resistance), and microenvironment interactions."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how confinement enhances migration and invasion, using terms like \u201camoeboid migration,\u201d \u201cincreased speed,\u201d or \u201cmetastasis.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes switch to amoeboid migration in confined spaces, notes increased speed and directionality, and links to metastasis into vessels."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how confinement can promote genetic mutations, mentioning \u201cnuclear deformation,\u201d \u201cDNA damage,\u201d or \u201cgenomic instability.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that squeezing causes nuclear envelope ruptures, DNA damage, and genomic instability, leading to more aggressive traits."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how confinement enhances cancer cells\u2019 ability to survive and adapt to stress, using terms like \u201cupregulate survival signals,\u201d \u201cresistant to therapies,\u201d or \u201cmechanical stress.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions mechanical stress during metastasis, upregulation of survival signals (YAP/TAZ, integrins), and reduced sensitivity to gemcitabine."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While analogies are used for movement (e.g., squeezed through tunnels), the mechanism of sensing (mechanotransduction) is not explained in lay terms; no clear analogy for sensing itself."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains responses: switching from mesenchymal to amoeboid movement with analogies (hiker chopping through bushes vs squeezing like an amoeba) and adaptation under confinement."
      },
      {
        "criterion_number": 7,
        "description": "The response provides at least one specific citation from a published scientific journal article as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions journals (Nature, Cell, Cancer Research) and institutions but provides no specific article citations (author/year/title/DOI)."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly relates tissue properties to their potential effect on cancer spread, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects dense, stiff ECM/desmoplastic stroma to confinement that increases migration speed/directionality and invasion into vessels, facilitating metastasis."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that dense stroma shields from immune cells/drugs and that confinement associates with reduced gemcitabine sensitivity; mentions targeting matrix stiffness (e.g., hyaluronic acid/collagen remodeling)."
      },
      {
        "criterion_number": 10,
        "description": "The response defines confinement in the context of cancer cells, using terms like \u201cphysical restriction,\u201d \u201ctumor microenvironment,\u201d or \u201cnarrow spaces.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines confinement as physical restriction within dense tumor microenvironment, describing narrow spaces like tiny tunnels or pores."
      },
      {
        "criterion_number": 11,
        "description": "The response defines desmoplastic stroma in pancreatic cancer, using terms like \u201cdense,\u201d \u201cfibrous,\u201d \u201cscar-like tissue,\u201d or \u201cstiff extracellular matrix,\u201d and describes its formation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Adequately describes desmoplastic stroma as dense, fibrous, scar-like, stiff ECM, but does not describe how it forms (e.g., activation of fibroblasts/stellate cells depositing ECM)."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly connects desmoplastic stroma to the confinement of cancer cells, explaining how it creates physical restriction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that desmoplastic stroma creates highly confined spaces that restrict cells."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions the role of hypoxia in pancreatic cancer and describes why pancreatic tumors are in a hypoxic environment, using terms like \u201clow-oxygen\u201d or \u201cdense stroma.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes pancreatic tumors have a highly confined, low-oxygen environment due to dense desmoplastic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response states that understanding confinement is an area of active scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly says understanding confinement is an active area of research."
      }
    ],
    "question_number": 265,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:51:18.437797",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends flexibility in plans and modifications to allow the father to participate in family traditions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises to \"scale down or modify\" traditions, use virtual options, keep events short, schedule around energy, have backup plans, and be prepared to pivot\u2014all emphasizing flexible adaptations."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states: \"A social worker, therapist, or palliative care specialist can help brainstorm adaptations and address emotional strain.\" This directly recommends relevant professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The section \"Leverage Support Networks\" emphasizes delegation to family/friends, using community help apps, and support organizations\u2014highlighting the value of a robust support system."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists Pancreatic Cancer Action Network (pancan.org) and CancerCare (cancercare.org), both with website URLs."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises an \"open family conversation\" to identify meaningful traditions and to \"talk openly about it as a family\" regarding emotions."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends caregiver support groups via the Pancreatic Cancer Action Network and mentions seeking external help and counseling, fulfilling the support group recommendation."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient prioritize management of cancer or cancer-treatment related side effects to feel as \u201cnormal\u201d as possible to be present for himself and his family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests working with the medical team on \"managing symptoms with medications\" and choosing low-energy activities, and planning around treatment schedules and 'good' days\u2014directly promoting symptom management to maintain normalcy and participation."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the family members consider documentation of the family traditional events with their father, as a way to reminisce and honor his presence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends \"Document and reflect: Take photos, videos, or journal entries\" to preserve memories and provide comfort."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the family members to be thoughtful about ways their father can feel included in family events.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It offers inclusion strategies such as smaller low-key gatherings, hospital-friendly adaptations (visits, decorations/food), virtual participation, and letting him lead small rituals."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the family seek their father\u2019s input on what meaningful events and activities he desires to participate in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises including the father in an \"open family conversation\" to identify meaningful traditions and to \"involve your father in decisions\" to give him control."
      }
    ],
    "question_number": 266,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:51:48.863202",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, using accessible language and avoiding jargon, including the concept of cancer cells moving from the primary tumor to other parts of the body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines metastasis as cells breaking away from the original tumor and traveling to distant sites, using accessible language and concrete examples (liver, lungs, abdomen)."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, explicitly mentioning direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions blood spread (portal vein, bloodstream), lymph as a fluid environment (lymphatic context), and direct invasion ('invade new tissues' and movement on solid tissues), fulfilling all three routes."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads in the body, such as amoeboid, mesenchymal, or collective migration, enzyme production, or environmental signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes amoeboid motility, membrane fluctuations, chemotaxis (environmental signals), and references EMT/mesenchymal features\u2014meeting the requirement for at least two mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly names and abbreviates epithelial\u2013mesenchymal transition (EMT)."
      },
      {
        "criterion_number": 5,
        "description": "The response clarifies that cancer cells do not swim, explicitly stating they lack the cellular machinery (e.g., flagella or cilia) to do so.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States cancer cells do not 'swim' like bacteria with tails (flagella), clearly distinguishing from flagellar/ciliary propulsion."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways cancer cells migrate, including in solid tissues and through a fluid-filled environment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers movement on solid tissues (invasion through stroma) and in fluids (blood, lymph, peritoneal fluid) with passive and active modalities."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain hematologic spread and lymphatic metastasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Hematogenous spread is explained well (bloodstream, portal vein), but lymphatic metastasis mechanics (entry into lymphatics, nodal spread) are not explicitly explained."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain amoeboid motility that some cancer cells can perform to actively travel through fluid.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines amoeboid motility with blebs/pseudopods and cytoskeletal force generation enabling movement in fluids."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain membrane fluctuations and how some cancer cells can do this to actively travel through fluid.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions wave-like membrane ripples/asymmetries propelling cells in low-viscosity fluids."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain chemical gradients and provide examples, and should define chemotaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines chemotaxis and provides examples (nutrients, growth factors) guiding movement along chemical gradients."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe passive movements of cancer cells in fluid-filled environments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes passive carriage by fluid flow (bloodstream), obstruction in capillaries, CTC clusters, immune/shear forces."
      },
      {
        "criterion_number": 12,
        "description": "The response should provide links to the scientific literature that discusses ways cancer cells can move through fluid substances, with PMIDs if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific citations or PMIDs are provided; only general references to journals."
      },
      {
        "criterion_number": 13,
        "description": "The response should define desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines the stroma as 'dense, fibrous stroma (scar-like tissue),' which describes desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response should summarize ways pancreatic cancer cells migrate in their solid tissue environment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes movement through dense fibrous stroma, EMT/mesenchymal traits, and invasion of nearby tissues\u2014summarizing solid-tissue migration."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the most common way that pancreatic cancer cells are thought to spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes hematogenous spread via the portal vein to the liver as common, indicating the predominant route in pancreatic cancer."
      }
    ],
    "question_number": 267,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:52:42.964917",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines surface tension as a force at boundaries and extends to tissue surface tension in biology."
      },
      {
        "criterion_number": 2,
        "description": "The response defines interfacial forces.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly defines interfacial forces as interactions at boundaries including adhesion, cohesion, and tension."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the influence of surface tension on pancreatic cancer cells, specifically mentioning cell detachment, migration, or tumor spheroid formation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses reduced surface tension leading to detachment and migration in PDAC, squeezing through tight spaces, and effects on 3D spheroids."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of interfacial forces during cancer cell metastasis, specifically mentioning cell detachment, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains metastasis involving clusters, cohesion during travel, adhesion at new sites, and invasion influenced by interfacial forces."
      },
      {
        "criterion_number": 5,
        "description": "The response states interfacial tissue planes typically serve as barriers for cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that interfacial tissue planes act as barriers; instead emphasizes remodeling and invasion through interfaces."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes metastasis as cancer cells traveling through blood or lymph and adhering to new sites in accessible language."
      },
      {
        "criterion_number": 7,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions invasion into surrounding tissues, spread via blood, and spread via lymphatic system."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes mechanisms such as downregulation of E-cadherin, mechanotransduction (YAP/TAZ), FAK signaling, and ECM remodeling."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not explicitly mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes cell-to-cell adhesion, specifically in the context of tumor spheroid formation and the balance with surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses cadherin-mediated adhesion, tissue surface tension, and how manipulating surface tension in spheroids affects growth and invasiveness."
      },
      {
        "criterion_number": 11,
        "description": "The response describes at least two mechanical cues in the tumor microenvironment, such as stiffness or surface tension, and how cancer cells sense these signals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions stiffness and surface tension and explains sensing via mechanotransduction pathways (e.g., YAP/TAZ, FAK)."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions desmoplastic stroma and its relevance to pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references desmoplasia and dense fibrous stroma in PDAC and their impacts."
      },
      {
        "criterion_number": 13,
        "description": "The response defines the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines the ECM as the supportive scaffold around cells."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how normal cells and cancer cells interact with the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contrasts normal strong adhesion to ECM with cancer cells\u2019 altered interactions, remodeling, and invasion through ECM."
      }
    ],
    "question_number": 268,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:53:25.718684",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing uncertainty or care planning with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises working with the 'care team' but does not explicitly mention discussing uncertainty or care planning with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends speaking with a therapist/counselor and explicitly suggests asking about palliative care early to improve quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends joining support groups for pancreatic cancer patients and caregivers and names PanCAN and Inspire.com."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions flexible goal-setting and values as a couple, it does not explicitly recommend a goals-of-care discussion or establishing medical goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It encourages saying feelings 'out loud' and reflecting on what matters most as a couple, promoting open communication; it also advises being open about needs with others."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions American Cancer Society, CancerCare, PanCAN, Inspire.com, and the National Cancer Institute\u2019s Cancer Information Service."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize the challenge of living with long-term uncertainty.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that feeling overwhelmed and anxious is normal and validates the difficulty of uncertainty multiple times."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend attempting to preserve normal routines in the home as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends creating daily rituals and enjoyable routines to build normalcy and connection."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of quality of life when facing a serious diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes 'quality over quantity' and recommends early palliative care to improve quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest ways to maintain good quality of life for patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests mindfulness, grounding techniques, daily rituals, short-term enjoyable activities, symptom management via palliative care, self-care (sleep, nutrition, exercise), and celebrating small wins."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients and family members learn about the disease to understand expected outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises working with the care team to understand treatment options, side effects, and milestones, which directly supports learning about the disease and expected course."
      }
    ],
    "question_number": 269,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:54:07.244331",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains how cancer cells move and spread using simple analogies (e.g., inchworm), and defines metastasis in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions invasion of nearby tissues and spread to distant organs but does not explicitly describe lymphatic or bloodstream routes."
      },
      {
        "criterion_number": 3,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes how cells attach via integrins, form protrusions (filopodia/lamellipodia), and cycle through attach\u2013pull\u2013detach in clear, non-technical terms."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Integrins are mentioned multiple times, but cadherins are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response contrasts the biology of cancer cell adhesion with normal cell adhesion using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit comparison of cancer cell adhesion versus normal cell adhesion is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No primary literature citations are provided; only general organizations are listed without specific journal references."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses dense pancreatic stroma and integrin-mediated movement but does not specify adhesion changes unique to pancreatic cancer (e.g., E-cadherin loss, integrin shifts)."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe cell-to-cell adhesion and include definitions of integrins, collagen, and fibronectin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides lay descriptions of integrins, collagen, and fibronectin but does not cover cell-to-cell adhesion; thus criterion not fully met."
      },
      {
        "criterion_number": 9,
        "description": "The response should define extracellular matrix.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines ECM as a supportive scaffold of proteins and fibers around cells in clear terms."
      },
      {
        "criterion_number": 10,
        "description": "The response should define actin and myosin, and describe how these proteins act to deform cells to assist in traction and movement.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies actin and myosin as part of the cellular \u2018skeleton\u2019 and explains their contractile role in generating traction for movement."
      },
      {
        "criterion_number": 11,
        "description": "The response should define chemotaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines chemotaxis as movement guided by chemical gradients (e.g., nutrients, growth factors)."
      },
      {
        "criterion_number": 12,
        "description": "The response should define amoeboid migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes amoeboid migration as squeezing through spaces without strong adhesions, using a clear analogy."
      },
      {
        "criterion_number": 13,
        "description": "The response should desmoplastic stroma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention or define 'desmoplastic stroma' by name."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how pancreatic cancer forms desmoplastic stroma in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of how desmoplasia is formed (e.g., stellate cells, fibroblasts, signaling pathways)."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains how pancreatic cancer cells use aligned collagen-rich stroma as 'highways' to invade nerves, vessels, and lymph nodes."
      },
      {
        "criterion_number": 16,
        "description": "The response should define tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Conveys the concept as the local conditions and signals (e.g., inflammation, low oxygen) around the tumor influencing behavior."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions inflammation and low oxygen (hypoxia) as environmental factors that encourage migration."
      },
      {
        "criterion_number": 18,
        "description": "The response should describe the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that KRAS mutations common in pancreatic cancer can increase cell motility."
      }
    ],
    "question_number": 270,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:54:45.225627",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how normal tissue structure is disrupted in solid cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that cancer disrupts organized tissue geometry into irregular, chaotic structures; describes distorted ducts in pancreatic cancer and disorganized/realigned ECM, reflecting architectural disruption."
      },
      {
        "criterion_number": 2,
        "description": "The response describes that cancer cells proliferate in an unchecked fashion, disrupting the architecture of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that geometric/mechanical cues activate growth pathways (e.g., YAP/TAZ), promoting faster growth; discusses tumor expansion, finger-like infiltrative growth and resulting architectural disruption."
      },
      {
        "criterion_number": 3,
        "description": "The response defines geometry in biology and medicine, and with regards to human cells and their surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines geometry as shapes, patterns, spatial arrangements of cells/tissues/ECM and how these affect behavior; provides multi-scale perspective (cell, tissue, tumor, microenvironment)."
      },
      {
        "criterion_number": 4,
        "description": "The response describes that normal cells exist in a neat, orderly, and structured space within their respective tissues.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that normal tissues have organized, predictable geometries with neatly aligned cells in layers or tubes, fulfilling the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the components of normal tissue architecture, such as collagen and extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions extracellular matrix and collagen fiber alignment as key architectural components guiding cell behavior."
      },
      {
        "criterion_number": 6,
        "description": "The response describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes PDAC\u2019s dense, fibrous stroma (scar-like tissue) and its features; although not using the word \"desmoplastic,\" it accurately characterizes the desmoplastic reaction typical of PDAC."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect of desmoplastic stroma on pancreatic cell proclivity to migrate and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that ECM fiber alignment creates \"highways\" for migration and that PDAC\u2019s rigid, aligned stroma supports invasion and infiltrative growth, facilitating spread."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the role of blood vessels in drug delivery, and how this can be impacted by pancreatic tumors and desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly notes that PDAC stroma compresses/collapses vessels, limiting oxygen and drug delivery and shielding tumors from chemotherapy; also discusses abnormal vascular geometry in tumors."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing accessible explanations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains spread using plain descriptions (e.g., finger-like projections, highways for movement), names common metastatic sites (liver, lymph nodes), and minimizes jargon overall."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions all three main routes of cancer spread: direct invasion, lymphatic spread, and hematogenous spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers direct invasion (infiltrative growth), lymphatic spread (metastasis to lymph nodes), and hematogenous spread (access to blood vessels; spread to liver), meeting all three routes."
      },
      {
        "criterion_number": 11,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads, such as changes in cell shape, loss of adhesion, or influence of the microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses changes in cell shape and detachment from neighbors, mechanotransduction (YAP/TAZ), and microenvironmental/ECM alignment influences on migration\u2014more than two mechanisms."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name or describes the process.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention EMT by name nor explicitly describe the epithelial-to-mesenchymal conversion process."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions cancer metastasis as a response to cell stress, including stress-induced mechanisms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions hypoxia and mechanical stress affecting gene expression and therapy resistance but does not link stress specifically to the initiation or promotion of metastasis."
      }
    ],
    "question_number": 271,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:55:23.150386",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends respectful and honest communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises having an open conversation with the mother about what to share, provides respectful scripts for responding to inquiries, and emphasizes handling questions politely\u2014clear guidance for honest, respectful communication."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends maintaining personal boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly outlines privacy boundaries (what to share vs. protect), suggests scripts, recommends a trusted inner circle, and asks others not to re-share\u2014strong emphasis on boundaries."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups (PanCAN, CancerCare, Cancer Support Community) and describes options for anonymous or caregiver-specific groups."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists PanCAN (pancan.org; 877-573-9971), American Cancer Society (1-800-227-2345), NCI Cancer Information Service (1-800-4-CANCER), Cancer Support Community (website), CancerCare.org, plus additional tools\u2014meeting the requirement for orgs with contact info/websites."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It underscores leaning on an inner circle, professionals, and groups; warns against isolation; and frames support as sustaining\u2014clearly emphasizing a strong support system."
      },
      {
        "criterion_number": 6,
        "description": "The response should inform the patient and family members that medical records are subject to HIPAA laws, which prevent divulgence of medical information unless a patient has specifically consented to this.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit mention of HIPAA or legal protections for medical records/confidentiality by healthcare providers."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient inform their oncology care team of their wishes to keep their diagnosis confidential.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It suggests consulting a counselor/social worker but does not advise informing the oncology care team of specific confidentiality preferences."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient and family members be careful and thoughtful with social media posting to maintain her confidentiality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises avoiding social media updates, using private messaging, and leveraging controlled-access tools (CaringBridge, Lotsa Helping Hands) and pseudonymous posting."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient and/or family members seek a balance; it is OK to be selective with sharing her diagnostic information however isolation for patients and/or caregivers can accelerate burnout.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states it is okay to be selective, warns about isolation and burnout, and recommends reassessing/expanding the circle gradually\u2014directly addressing balance and burnout risk."
      }
    ],
    "question_number": 272,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:55:52.278855",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing context for a lay audience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides an accessible overview of how cancer spreads and what 'squeezing' means, defines terms in plain language (e.g., ECM as a scaffold), and gives context specific to pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly mentions and explains the three main routes of cancer spread: direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions invasion of nearby tissues (direct invasion) and travel through the bloodstream/lymphatic system; also describes behaviors in blood vessels (rolling, flattening, slipping through endothelial gaps)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least three cellular mechanisms by which cancer spreads, such as changes in cell shape, breakdown of the extracellular matrix, increased deformability, use of filopodia/invadopodia, or epithelial-to-mesenchymal transition (EMT).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers multiple mechanisms: (1) shape-shifting/deformation, (2) ECM degradation via enzymes like MMPs, (3) increased deformability/volume reduction and nuclear squeezing, and (4) integrin-mediated sensing and signaling."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial-to-mesenchymal transition (EMT) and explains its relevance to cancer cell migration and invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that in low-oxygen or nutrient-poor (stressful) areas, cells become more aggressive in their migration tactics."
      },
      {
        "criterion_number": 6,
        "description": "The response should define the extracellular matrix.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines the ECM as the scaffold of proteins and fibers that holds tissues together."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the different components of the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list or describe specific ECM components (e.g., collagens, elastin, laminin, fibronectin, proteoglycans, hyaluronan)."
      },
      {
        "criterion_number": 8,
        "description": "The response should define desmoplastic stroma and describe how this is formed in the pancreatic cancer environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'desmoplasia' as a dense, fibrous structure but does not define desmoplastic stroma or explain its formation (e.g., activation of pancreatic stellate cells, fibroblasts, signaling pathways)."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how cancer cells are able to deform their shapes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains shape-shifting via cytoskeletal reorganization, nuclear deformation/blebbing, and volume reduction to pass through tight spaces."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain the cellular cytoskeleton and its main component parts, such as actin and myosin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions cytoskeleton and components like actin and microtubules but does not include myosin or explain its role."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe amoeboid movement in cells and include a description of filopodia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes amoeboid movement and pseudopods but does not mention or describe filopodia."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe mesenchymal movement in cancer cells and provide examples of enzymes used by cancer cells in this phenomenon.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains mesenchymal 'burrowing' movement and cites matrix metalloproteinases (MMPs) as enzymes used to digest ECM."
      },
      {
        "criterion_number": 13,
        "description": "The response should provide links to any scientific literature it references, including PMID.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No references, links, or PMIDs are provided; only general mentions of studies."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain how cells can use ion gradients to prompt movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes ion/water efflux for volume reduction but does not explain how ion gradients drive or guide cell movement."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the importance of pancreatic cancer cells\u2019 ability to deform or \u201csqueeze\u201d in the desmoplastic stromal environment for survival and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links desmoplasia/dense stroma to the need for squeezing for local invasion, metastasis, and treatment resistance in pancreatic cancer."
      },
      {
        "criterion_number": 16,
        "description": "The response should include information about how the nucleus is thought to be deformable in cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that the nucleus can deform and 'bleb' to pass through micron-scale gaps."
      }
    ],
    "question_number": 273,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:56:47.922089",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines topology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines topology as the study of connectivity/relationships independent of exact distances and applies it to tissue networks in cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses direct invasion (local invasion along ECM and nerves), lymphatic spread (lymphatic networks and lymph node involvement), and hematogenous spread (entry into leaky, chaotic blood vessels)."
      },
      {
        "criterion_number": 3,
        "description": "The response states that in cancer care, topology may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links topology to organization/connectivity of tissues, blood vessels, lymphatics, nerves, and ECM."
      },
      {
        "criterion_number": 4,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that anatomic organization affects stage or likelihood of responding to surgery or radiation; mentions treatment resistance and targeted therapies but not stage/surgical/radiation implications."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses accessible language and analogies (highways, tunnels, hitch a ride) to explain how topology facilitates spread."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions angiogenesis, leaky vessels, perineural invasion, epithelial\u2013mesenchymal transition, collective invasion, and signaling (cytokines)."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe tissue networks and their component parts.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes tissue networks including cells, blood vessels, lymphatics, nerves, and ECM, and how their connectivity/structure influence spread."
      },
      {
        "criterion_number": 8,
        "description": "The response should define the extracellular matrix and describe its component parts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines ECM as a supportive scaffold and 3D mesh but does not describe its component parts (e.g., collagen, elastin, proteoglycans, laminin, fibronectin)."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the desmoplastic stroma that pancreatic cancer encourages to grow in its environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes dense stromal tissue (desmoplasia) in pancreatic cancer and its role as a supportive, highly connected barrier aiding migration."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how abnormal tissue, such as desmoplastic stroma, increases in density of tissue network structures and encourages cancer growth and spread.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that desmoplasia increases connectivity/density, stiffens the matrix, and supports migration/EMT, thereby encouraging growth and spread."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the roles of blood and lymph vessels in cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes blood vessels as routes for nutrient delivery and intravasation; lymphatics as pathways to lymph nodes and distant spread."
      },
      {
        "criterion_number": 12,
        "description": "The response should explain how disrupted tissue architecture can encourage cancer growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes irregular/leaky vasculature, remodeled ECM with increased stiffness and navigable paths, and nerve-associated tunnels facilitating invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe cell-to-cell adhesions in normal cells, and how cancer cells can disrupt these adhesions making them more able to migrate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly discuss normal cell-to-cell adhesion mechanisms (e.g., E-cadherin) or how their disruption promotes migration; EMT is mentioned but without specific adhesion details."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how mechanical properties of tissue can stimulate tumor growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links stiff, irregular ECM and dense desmoplastic stroma to promotion of EMT and invasion, highlighting mechanical influences."
      }
    ],
    "question_number": 274,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:57:17.529175",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response mentions guidance from oncologists in general terms, it does not explicitly recommend that the family discuss communication strategies with the patient\u2019s oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends seeking help from therapists, counselors, child life specialists, and hospital social workers; it also suggests a family therapist specializing in oncology."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends honest and open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response encourages open, ongoing conversations, honesty, and consistency (\u201cDecide as a team,\u201d \u201cBe Honest, But Age-Appropriate,\u201d regular check-ins)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends tailoring the discussion to the age of the children.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides detailed, age-specific guidance for young children, school-age children, and teens."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups and organizations such as PanCAN, Cancer Support Community, Gilda\u2019s Club, CancerCare, and online communities."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists multiple organizations (PanCAN, Cancer Support Community, Gilda\u2019s Club, CancerCare, American Cancer Society) and includes website references for resources (Inspire.com and Reddit\u2019s r/cancer)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of discussing or establishing goals of care, advance care planning, or aligning treatment with patient values."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It normalizes emotions, recommends therapy, monitoring for anxiety/depression, child life specialists, and emphasizes self-care for caregivers."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly validates the difficulty and says it\u2019s okay to feel overwhelmed and that it\u2019s normal for this to feel exhausting."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions treatment fatigue and pain in passing, it does not explain the concept of quality of life or detail how treatment side effects and trade-offs impact it."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient and/or family members leverage support systems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages using support systems including family teamwork, support groups, therapists, child life specialists, and social workers."
      }
    ],
    "question_number": 275,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:57:52.774491",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes metastatic routes for pancreatic cancer, including local solid tissue invasion, hematologic spread, lymphatic spread, or perineural invasion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that cancer spreads to liver, lungs, and lymph nodes (lymphatic and hematogenous spread) and notes invasion into surrounding tissues and blood vessels (local invasion and entry into vasculature). While perineural invasion is not mentioned, multiple metastatic routes (local, lymphatic, hematologic) are clearly described."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses cell-to-cell adhesions in both normal cells and cancer cells, highlighting differences.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although cell-to-cell adhesion is described (cadherins as 'glue'), there is no explicit comparison between adhesion in normal cells versus cancer cells or discussion of how these differ."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Integrins and cadherins are both explicitly mentioned and contextualized in migration and adhesion."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Metastasis and collective migration are explained with clear analogies (flock of birds/school of fish) and plain language suitable for lay readers."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mechanisms covered include leader\u2013follower dynamics, integrin-mediated ECM interactions, MMP-driven matrix degradation, chemotaxis, cytoskeletal contractility (actin\u2013myosin), and cell\u2013cell communication."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Adhesion is explained with accessible metaphors (cells as 'holding hands'; cadherins as 'glue'; integrins as 'hooks' to ECM), making the biology understandable to non-experts."
      },
      {
        "criterion_number": 8,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific peer-reviewed journal articles or citations are provided; only general resources (ACS, PanCAN, PubMed, ClinicalTrials.gov) are mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response explains the concept of \u201cleader cells\u201d and implies the presence of \u201cfollower cells\u201d in a group of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Leader and follower cells are explicitly described, including leader protrusions and follower support."
      },
      {
        "criterion_number": 10,
        "description": "The response describes amoeboid movement in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid migration is not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response describes mesenchymal migration in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "While the term 'mesenchymal migration' is not used, the response describes its hallmarks: integrin-based adhesion, lamellipodia/filopodia, and MMP-dependent ECM degradation to carve paths."
      },
      {
        "criterion_number": 12,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "ECM is defined as a scaffold of proteins and fibers that supports organs, which is an accurate lay definition."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Desmoplasia is described as 'dense, scar-like tissue,' which serves as a concise definition of desmoplastic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how pancreatic cancer cells interact with desmoplastic stroma to encourage cancer cell growth and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that pancreatic tumors have dense desmoplastic stroma and that groups adapt by remodeling the area, with leader cells secreting MMPs to break down ECM, facilitating collective invasion."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how \u201cleader cells\u201d influence a clump of traveling cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Leader cells are described as sensing cues, extending protrusions, and secreting enzymes to open paths, coordinating direction and enabling follower cells to move."
      },
      {
        "criterion_number": 16,
        "description": "The response defines at least one other protein involved in cell-to-cell adhesions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No additional specific cell\u2013cell adhesion proteins (e.g., claudins, occludins, selectins, Ig-CAMs) are named and defined; integrins (cell\u2013ECM) and gap junctions are mentioned but not as specific adhesion proteins nor defined."
      },
      {
        "criterion_number": 17,
        "description": "The response describes how cells communicate with each other, such as through chemical signals or enzymes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cell communication is described via chemical cues (chemotaxis), gap junctions, secreted molecules, and enzyme-mediated ECM remodeling."
      }
    ],
    "question_number": 276,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:58:34.430401",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines curvature.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines curvature as bends/rounded shapes in cellular environments and lists examples (curved membranes, ducts, vessels, organ surfaces)."
      },
      {
        "criterion_number": 2,
        "description": "The response states that in cancer care, curvature may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links curvature to tubular structures including blood vessels, ducts, and lymphatics, and discusses relevance in pancreatic ducts."
      },
      {
        "criterion_number": 3,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention that anatomic organization affects staging or candidacy/response to surgery or radiation; only discusses drug resistance and general treatment difficulty."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes metastasis as cancer cells spreading via blood vessels or lymphatic channels to organs like liver/lungs and 'following the curve'\u2014accessible, non-technical explanation."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions invasion into surrounding tissues (direct invasion), spread via blood vessels, and spread via lymphatic channels."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes mechanosensing, integrin/FAK clustering on curvature, YAP/TAZ signaling, and curvotaxis\u2014mechanistic cellular processes influencing spread."
      },
      {
        "criterion_number": 7,
        "description": "The response should define the extracellular matrix.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not define the extracellular matrix or its components/role."
      },
      {
        "criterion_number": 8,
        "description": "The response should define epithelial-to-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains migration behaviors including curvotaxis, faster movement on moderately curved surfaces, and guidance along vessels/ducts."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe the effect of mechanical forces on cell signaling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes mechanosensing and how curvature influences integrin/FAK clustering and YAP/TAZ signaling pathways."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe how varying levels of positive or negative curvature at the cellular level influence EMT and cancer cell migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses migration differences with curvature magnitude (sharp vs gentle) but does not address positive vs negative curvature nor EMT influences."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe the effect of mechanical forces of tissues on cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cells respond to physical cues like curvature, stiffness, and tension, affecting adhesion, migration, proliferation, and signaling\u2014linking tissue-level mechanics to cell behavior."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions dense, fibrous tumors (desmoplasia) in pancreatic cancer and that they make treatment difficult, indicating the characteristic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that cellular curvature acts as both a signal and constraint in cancer cell progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Curvature is presented as a mechanosensory signal (integrin/FAK, YAP/TAZ) and also as a constraint (sharp curvature may slow movement)."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe cancer cell membrane tension, and what occurs when this force is too high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane tension is not addressed; no description of consequences of excessively high membrane tension."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe how high cell surface membrane tension, such as from curvature, can hinder movement of the cytoskeleton.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not discuss cytoskeletal movement limitations due to high membrane tension."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe the effects of mechanical tension at the level of tissue and organs, particularly if imbalanced, on the spread of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit discussion of imbalanced tissue/organ-level mechanical tension and its specific impact on pancreatic cancer spread."
      },
      {
        "criterion_number": 18,
        "description": "The response should define paracrine signaling and explain its role in pancreatic cancer cell communication.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Paracrine signaling is not defined or discussed."
      }
    ],
    "question_number": 277,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:59:17.591477",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing plans for celebrations with the patient\u2019s healthcare or oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises working with the healthcare team/oncologist to time events around treatments and to discuss celebration ideas with the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends involving palliative care specialists and mentions therapists/counselors for support."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically mentions support groups (online or in-person) as helpful resources."
      },
      {
        "criterion_number": 4,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names PanCAN and CancerCare, and provides the American Cancer Society\u2019s 24/7 phone number (1-800-227-2345)."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that palliative care focuses on enhancing quality of life and prioritizes comfort and meaningful moments."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages involving friends/family, delegating tasks, and engaging community resources and support groups."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of controlling symptoms related to pancreatic cancer or its treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses nausea management, pain relief, hydration, seating comfort, timing around treatments, and working with clinicians for symptom control."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that caregivers take measures to prevent burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises caregiver self-care, sharing responsibilities, tag-teaming, and permission to step back."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that loved ones plan small, meaningful gatherings with the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends small, intimate gatherings and meaningful, low-effort celebrations tailored to the patient\u2019s preferences."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of flexibility when planning events with a patient with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests planning around good days, having backups, postponing or scaling down as needed."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that planners of celebrations consider incorporating time for rest and keep gatherings small and simple.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends short events (1\u20132 hours), building in breaks, and keeping gatherings small and simple."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that a professional therapist or counselor can help maintain mental health in patients experiencing pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions involving a therapist for support and reaching out to a counselor."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that patients and/or family members take care of any legal and/or medical paperwork as soon as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of legal or medical paperwork, advance directives, or early planning for documents."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain that there will likely be a decline in overall health of the patient over time, and expectation management should be discussed by the patient and their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly discuss likely health decline over time or expectation management with the oncology team."
      }
    ],
    "question_number": 278,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T16:59:54.150668",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response clearly explains how changes in tissue density and architecture (cell jamming) influence cancer cell movement, tumor aggressiveness, and metastasis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly links high tissue density/desmoplastic stroma to jamming (reduced movement) and later unjamming that enables invasion and metastasis; connects to PDAC aggressiveness."
      },
      {
        "criterion_number": 2,
        "description": "The response defines and explains cancer cell jamming.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition of jammed vs unjammed states with appropriate analogies and context across tissues and tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response defines and describes cancer cells that are in an unjammed state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes unjammed cells as fluid-like, able to rearrange, migrate, invade; includes characteristics like shape changes and collective migration."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how cancer cells become unjammed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains mechanisms of unjamming: reduced adhesion (cadherins), cell shape changes, matrix remodeling (MMPs), hypoxia-driven EMT, and collective migration."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the intrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions intrinsic factors such as adhesion molecules, cell shape/elasticity, EMT-related gene programs, and oncogenic KRAS effects."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers extrinsic factors: dense desmoplastic stroma, ECM stiffness, crowding, hypoxia, nutrient deprivation, fibroblasts/immune components."
      },
      {
        "criterion_number": 7,
        "description": "The response explains how unjamming of cancer cells contributes to cancer spread and migration of cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly connects unjamming to invasion, collective migration, intravasation (vessel/nerve invasion), and metastasis."
      },
      {
        "criterion_number": 8,
        "description": "The response explains methods of cancer cell movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes individual vs collective migration, ECM degradation to create paths, and EMT-associated motility modes."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how jamming occurs in normal cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that in healthy tissues, jamming maintains structure and prevents uncontrolled movement."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly discusses changes to tissue architecture specific to pancreatic cancer, such as desmoplastic reaction, fibrosis, or stromal remodeling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Detailed mention of PDAC desmoplastic stroma, fibrosis/stiffness, stromal composition, and high stromal fraction (70\u201390%)."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly discusses the implications of altered tissue architecture on cancer treatment, specifically mentioning reduced drug delivery or immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States dense, crowded tumors resist chemotherapy because drugs struggle to penetrate; addresses reduced drug delivery explicitly."
      },
      {
        "criterion_number": 12,
        "description": "The response includes citations from published scientific journal articles to support its claims.",
        "score_given": 7,
        "max_points": 7,
        "justification": "References peer-reviewed sources, including a 2020 Trends in Cancer review titled 'Jamming and Unjamming in Biological Tissues' and mentions Nature Physics studies; sufficient citation inclusion."
      }
    ],
    "question_number": 279,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T17:00:20.455827",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly mentions both tissue stiffness and fibrosis in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that tumor stroma can stiffen and, specifically for pancreatic cancer, mentions a \"dense, fibrous stroma.\" These cover stiffness and fibrosis in the PDAC context."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly discusses intercellular communication between pancreatic cancer cells and stromal cells, such as fibroblasts or pancreatic stellate cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions cancer-associated fibroblasts (CAFs) releasing signals that help form structures, demonstrating stromal\u2013cancer cell communication."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly connects specific tissue properties, such as stiffness or fibrosis, to the process of cancer spread, including invasion or metastasis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response links organized structures to invasion/aggression, it does not explicitly connect stiffness or fibrosis themselves to invasion or metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly relates specific tissue properties, such as stiffness or fibrosis, to treatment response or resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that more organized tumors may respond differently to therapy but does not explicitly tie stiffness or fibrosis to treatment response or resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No journal citations or references are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the concept of pattern formation in cellular structures, including at least two biological processes contributing to these patterns.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Pattern formation is defined and multiple contributing processes are discussed: chemical gradients/diffusion, signaling pathways (Wnt/Notch/Hedgehog), self-organization, cell adhesion, and physical/mechanical forces."
      },
      {
        "criterion_number": 7,
        "description": "The response must provide at least two commonly recognizable examples of biological pattern formation, such as embryonic development or tissue architecture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides several recognizable examples: zebra stripes, lung branching, and organized tissue structures like glands, ducts, and blood vessels."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how organized structures develop in tumors, mentioning at least two mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms described include hijacking developmental signaling pathways, self-organization via chemical gradients and adhesion/forces, microenvironmental cues, and evolutionary selection."
      },
      {
        "criterion_number": 9,
        "description": "The response must explain how DNA mutations in cancer cells can change their behavior, linking these changes to pattern formation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It links mutations (e.g., KRAS, TP53) to altered signaling (Wnt/Notch/Hedgehog), retention of tissue memory, and formation of organized but dysfunctional gland/duct-like structures."
      },
      {
        "criterion_number": 10,
        "description": "The response must describe how cancer cells promote angiogenesis, including the secretion of signals for new blood vessel growth.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although anti-angiogenesis therapies are mentioned and tumors forming blood vessel-like patterns are noted, the response does not explicitly state that cancer cells secrete pro-angiogenic factors (e.g., VEGF) to induce new vessel growth."
      },
      {
        "criterion_number": 11,
        "description": "The response must explain how cancer cells interact with tissues in their environment, including interactions with the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses the tumor microenvironment (ECM, stroma, immune cells) providing cues, and notes that stromal stiffening influences how cancer cells arrange themselves, indicating interaction with ECM/tissue context."
      },
      {
        "criterion_number": 12,
        "description": "The response must define and describe the extracellular matrix, including its composition or function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The ECM is described as a supportive \u2018scaffold,\u2019 which addresses function. While composition details are not provided, the criterion allows either composition or function."
      },
      {
        "criterion_number": 13,
        "description": "The response must define and describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The term desmoplastic stroma is not used or defined; only a \"dense, fibrous stroma\" is mentioned without specific definition of desmoplasia."
      },
      {
        "criterion_number": 14,
        "description": "The response must explain the influence of the tumor microenvironment on tumor cell pattern formation, including at least one component.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that the microenvironment (stroma, immune cells, blood vessels, ECM) guides pattern formation; examples include stromal stiffness and hypoxia influencing organization."
      },
      {
        "criterion_number": 15,
        "description": "The response must describe evolutionary pressures on cancer cells and the acquisition of DNA mutations, including at least one selective advantage.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Tumors are described as evolving ecosystems where cells that form efficient nutrient-access structures have a survival advantage; mutations (e.g., KRAS) are discussed earlier as drivers of behavior that selection can act upon."
      }
    ],
    "question_number": 280,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T17:00:54.535184",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly emphasizes \u201cquality over quantity,\u201d tailoring activities to energy levels and focusing on presence, comfort, and meaningful moments."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends consulting palliative care specialists and mentions seeing a therapist specializing in grief/illness."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises consulting the patient\u2019s healthcare team for feasibility and adaptations."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically mentions support groups through the Pancreatic Cancer Action Network and CancerCare."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Lists organizations (PanCAN, CancerCare, American Cancer Society) but does not provide specific contact information or website URLs."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages involvement of family/friends, support groups, and therapy, highlighting shared support and avoiding overwhelm."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to open lines of communication with their affected family member, such as daily phone calls to check in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes open communication about preferences and guided conversations; while not specifying daily calls, it clearly encourages ongoing dialogue."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage loved ones of a pancreatic cancer patient to consider legacy-building activities, such as photobook creation or writing letters to loved ones.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly suggests legacy-building projects like photo albums, scrapbooks, and handwritten letters."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend keeping family members and loved ones involved in the patient\u2019s life, being mindful of the patient\u2019s energy level.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises small, thoughtful gatherings and keeping groups intimate to match energy; includes virtual participation."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the patient and/or family members prioritize symptom management related to cancer or treatment, in order to ensure the patient is feeling their physical best if possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends consulting healthcare team and palliative care for pain management and adaptive tools (e.g., portable oxygen), and planning around fatigue/symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend ways to document events and/or moments for future reference.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests photos/videos, memory jar, journaling, professional photography, and digitizing media."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the use of technology, such as video calls (e.g., Zoom) to keep in contact with loved ones without having to travel.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends using Zoom for distant relatives to connect without physical strain."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of preventing caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages caregiver self-care and seeking support groups or a therapist, addressing burnout prevention."
      }
    ],
    "question_number": 281,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T17:01:33.170143",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response reviews intercellular communication in pancreatic cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses intercellular communication specifically in PDAC, including KRAS-driven signaling, leader\u2013follower dynamics at invasive edges, and the influence of desmoplasia and the tumor microenvironment."
      },
      {
        "criterion_number": 2,
        "description": "The response states that tumors are not typically functioning tissues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that tumors are not typically functioning tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the biology of intercellular communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains paracrine signaling, gradients, leader\u2013follower behavior, mechanotransduction, chemotaxis, gap junction-mediated calcium/electrical signaling, and environmental influences."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Provides general references (e.g., Nature, Cell, PubMed search suggestions) but no specific citations or PMIDs."
      },
      {
        "criterion_number": 5,
        "description": "The response defines cancer cell waves and explicitly states that there are several different types of waves known to exist in cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines 'cancer cell waves' and lists multiple types, including migration waves, proliferation waves, signaling waves, and mentions electrical/calcium waves."
      },
      {
        "criterion_number": 6,
        "description": "The response describes calcium waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions calcium waves via gap junctions but does not provide any PMID."
      },
      {
        "criterion_number": 7,
        "description": "The response describes bioelectric waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes electrical signaling but provides no PMID."
      },
      {
        "criterion_number": 8,
        "description": "The response describes metabolic (glycolytic) waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss metabolic/glycolytic waves and provides no PMID."
      },
      {
        "criterion_number": 9,
        "description": "The response explains at least three different mechanisms of cell-to-cell communication, such as cell-cell adhesion, signaling pathways, chemokine gradients, mechanical forces, or heterotypic interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers more than three mechanisms: paracrine signaling, leader\u2013follower dynamics/cell adhesion, mechanical forces, chemotaxis/gradients, gap junction communication, and interactions with immune/stromal cells."
      },
      {
        "criterion_number": 10,
        "description": "The response defines and describes paracrine signaling explicitly.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly defines paracrine signaling as cells releasing chemical signals into the surrounding fluid that affect nearby cells."
      }
    ],
    "question_number": 282,
    "source": "grok-4-latest",
    "graded_at": "2025-11-01T17:01:50.050405",
    "grader_model": "gpt-5"
  }
]